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Deamination or the hydrolytic removal of one hydroxyl group from a base in DNA 
or RNA can lead to changes in the transcript and protein produced. Examples of this 
are the deamination of cytosine residues in DNA by activation induced deaminase 
(AID) during antibody diversification, or deamination of adenosine at the Q/R site in 
the GluR-B transcript by adenosine deaminase acting on RNA 2 (ADAR2), which 
regulates calcium permeability in neurons.  The initial focus of my thesis was to 
characterise a putative novel deaminase APOBEC4.  APOBEC4 was identified in a 
bioinformatic search for proteins containing the core catalytic residues common to 
the whole family of Cytidine Deaminase enzymes.  The aim of the project was to 
express and purify recombinant APOBEC4 for in vitro characterization, however 
despite using different expression systems and purification conditions the majority of 
the recombinant protein was inherently insoluble and I could not isolate sufficient 
amounts of protein for further studies.  Recombinant protein with a GST-tag was 
used to generate polyclonal antibodies which recognised recombinant protein but 
were unable to detect endogenous APOBEC4.  
 
The focus of my thesis then changed to the process of adenosine to inosine editing in 
RNA, which is a post-transcriptional mechanism for generating protein diversity.  
The enzyme family responsible for catalysing this reaction is known as ADAR, and 
Drosophila melanogaster has only one Adar gene.  Flies lacking the Adar gene show 
locomotion defects and age-dependent neurodegeneration, however little is known 
about the molecular mechanism underlying these defects.  To investigate this 
phenotype I performed microarray analysis on RNA isolated from heads of 5 day old 
flies lacking the Adar gene to characterize gene expression changes in the fly heads 
before neurodegeneration caused secondary effects.  Analysis was also performed on 
Adar-null flies expressing either an active Adar gene or a catalytically-inactive Adar 
gene in cholinergic neurons to determine which transcripts could be directly 
regulated by Adar.  I confirmed the microarray results by real-time PCR, and 
demonstrated that the changes in transcript level could be reversed by expression of 
either active or catalytically-inactive Adar.  Expression of edited transcripts did not 
 
 ii
change dramatically.  Filter-binding analysis and electrophoretic mobility shift assay 
revealed that recombinant ADAR could bind to all RNA transcripts analysed with 
similar affinity; both known substrates and potential new substrates for Adar, as well 
as transcripts that were chosen as negative controls due to their expression not 
altering in  the expression microarray.  Recombinant ADAR bound to dsRNA with a 
very high affinity; other transcripts investigated bound with considerably lower 
affinity, yet all transcripts investigated were bound by ADAR. 
 
Further analysis of transcript changes in Adar-null flies was investigated by 
performing microarray analysis with a custom-made splicing-sensitive microarray.  
Analysis revealed that a subset of transcripts were differentially spliced in Adar-null 
flies; however this group of transcripts was distinct from the group identified as 
being altered on the expression microarray, indicating that the splicing changes are 
independent of changes in expression.  Analysis of exon-specific probes on the 
splicing array confirmed the transcript changes identified in the expression array.  
Real-time PCR confirmed the changes in splicing, and these transcripts were further 
examined by sequence analysis.  This revealed several transcripts identified as 
altered by the AS array showed use of alternative polyadenylation sites indicating 
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Chapter 1: Introduction 




The term “RNA Editing” was originally coined to describe the insertion of uridine 
residues in trypanosome mitochondrial cytochrome oxidase subunit II (CoxII) 
mRNA (Benne et al., 1986).  Since then the term has been used to describe insertion 
or deletion of nucleotides, as well as conversion of one nucleotide to another.  
Uridine to cytidine (U-to-C) RNA editing, or amination, has been observed in the 
RNA for the Wilms’ Tumour susceptibility gene (WT1) in mammals (Sharma et al., 
1994).  However this thesis will focus on the process of base conversion editing.  
Hydrolytic deamination or removal of an amine group to release ammonia can occur 
on several bases within DNA or RNA: adenosine to inosine (A-to-I) in RNA; 
cytosine to uracil (C-to-U) in DNA or RNA; and 5-methylcytosine to thymine 
(5MeC-to-T) in DNA, see Figure 1.1.  These deamination events are mediated by 
cytidine deaminase (CDA) enzymes which include the adenosine deaminases that act 
on RNA (ADAR) family, and the apolipoprotein B mRNA-editing enzyme catalytic 
polypeptide (APOBEC) family.   
 
The consequences of base conversion can be dramatic.  When occurring in DNA 
base conversion can induce chromosomal rearrangements or loss of the epigenetic 5-
methylcytosine mark.  In messenger RNA (mRNA) nucleotide conversion can 
change the coding capacity of the transcript, alter splice donor, acceptor or regulatory 
sequences, or create alternative start or stop codons.  Hence the need for a greater 
understanding of the enzymes that perform these reactions and their substrates.  In 
this thesis I attempted to characterise a novel member of the cytidine deaminase 
family APOBEC4 however this proved to be technically challenging. I then went on 
to investigate the role of Drosophila mealogaster ADAR as an RNA-binding protein, 
which is independent of its role as an adenosine deaminase.    
 





1.2 Structure and evolution of the cytidine deaminase 
domain 
The crystal structure of the CDA domain from two key enzymes has been solved.  
The structures of murine adenosine deaminase (ADA) (Wilson et al., 1991) and 
E.coli cytidine deaminase (CDA) (Betts et al., 1994) revealed a zinc atom within the 
active site and four conserved residues that coordinate the zinc atom.  These residues 
are highly conserved throughout the CDA family and are essential for catalytic 
activity.  ADA and CDA enzymes both deaminate free nucleosides through 
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hydrophilic attack, although ADA targets carbon 6 of a purine ring and CDA targets 
carbon 4 of a pyrimidine ring. 
 
Sequence alignment revealed that there was an expanded family of deaminases that 
contain the conserved CDA domain (Gerber and Keller, 2001).  The conserved 
residues within the CDA domain are: a cysteine (C) or histidine (H) residue followed 
by a glutamic acid (E) residue which acts as a proton donor during the nucleophilic 
deamination reaction; a proline (P) followed by two conserved cysteine residues 
which coordinate the zinc atom in the active site; and a conserved secondary 
structure of alternating α helices and β sheets.  These conserved residues are 
organised into three motifs: motif I (H/CxE), motif II (PC) and motif III (C), where x 
indicates any amino acid (see Figure 1.2 for alignment of the CDA domain). 
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The CDA domain is shared throughout several diverse families which deaminate 
adenosines or cytidines within an RNA or DNA substrate (Gerber and Keller, 2001).  
The conserved domain indicates these processes are linked despite their obvious 
differences, most notably the different substrates. ADAR family members deaminate 
adenosine residues within a double-stranded RNA substrate whereas members of the 
AID/APOBEC family deaminate cytosine residues from single stranded RNA or 
DNA substrates.   
 
APOBEC2 (A2) was the first member of the AID/APOBEC family to have its crystal 
structure solved (Prochnow et al., 2007).  The structure was solved as a tetramer, 
although in this formation the active site is not accessible indicating this structure is 
either unique to A2 or the protein may be active as a dimer (Bransteitter et al., 2009).  
Furthermore the E.coli CDA functions as a dimer (Betts et al., 1994) and APOBEC1 
(A1) is believed to form a dimer through the leucine-rich, carboxy-terminal domain 
(Lau et al., 1994).  APOBEC3G (A3G) can form multimers and is believed to 
function as a tetramer, however it was recently shown by mutational analysis that 
A3G monomers are catalytically active (Opi et al., 2006).  But this could indicate 
that the model used to infer crucial residues involved in multimerisation for 
mutational inactivation is incorrect.  Some members of the APOBEC3 (A3) sub-
family contain two deaminase domains; therefore dimers of these proteins may have 
the structure and appearance of tetramers of single deaminase domain proteins which 
complicates the analysis. 
 
ADARs function as dimers (Cho et al., 2003; Gallo et al., 2003; Jaikaran et al., 2002; 
Macbeth et al., 2004; Poulsen et al., 2006; Valente and Nishikura, 2007), however 
the occurrence of heterodimers between different family members remains 
controversial (Chilibeck et al., 2006; Cho et al., 2003).  The CDA superfamily 
deaminates residues within double-stranded oligomers.  These can be formed 
intermolecularly or intramolecularly where the complementary region is termed the 
editing complementary sequence (ECS) (Higuchi et al., 1993). 
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1.3 The ADATs 
It has long been known that inosine base occurs at the “wobble” position of several 
tRNA anticodons, however little was known about the process of generating inosine 
residues in tRNA until discovery of a tRNA-specific adenosine deaminase 
(Tad1p/ADAT1) in Saccharomyces cerevisiae (Gerber et al., 1998).  ADAT1 was 
identified through homology to ADARs, although it lacks the characteristic double-
strand RNA binding domains (dsRBDs) of other family members.  ADAT1 was 
shown to deaminate A-to-I at position 37 of tRNAAla, however the Tad1p gene is not 
essential and ADAT1 is not able to edit the “wobble” position. 
 
Editing of an adenosine residue at the “wobble” position of the anticodon (position 
34) allows the third base of the anticodon to recognise adenine, cytosine or uracil in 
the messenger RNA (mRNA) thus reducing the number of tRNA molecules required 
for translation.  Further investigation showed that this editing event is performed by a 
heterodimeric enzyme complex comprised of an ADAT2 and an ADAT3 monomer, 
with the catalytic activity provided by ADAT2 (Gerber and Keller, 1999).  Both 
genes encoding these subunits are essential indicating the importance of inosine at 
the “wobble” position.  ADAT2 contains a conserved CDA domain and is 
catalytically active, whereas ADAT3 lacks crucial residues from the CDA domain 
and is not catalytically active.  Interestingly, a recent paper describes a tRNA-editing 
enzyme purified from Trypanosoma brucei (TbADAT2) that can deaminate both A-
to-I in tRNA and C-to-U in DNA, providing direct evidence these enzymatic 
activities are related (Rubio et al., 2007).  However the TbADAT2 enzyme showed 
some specificity as it was not able to deaminate cytosine in RNA or adenosine in 
DNA.  Some members of the AID/APOBEC family can deaminate cytidine residues 
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1.4 The AID/APOBEC family 
The AID/APOBEC family of cytidine deaminases in mouse includes APOBEC1 
(A1), APOBEC2 (A2), APOBEC3 (A3), Activation Induced Deaminase (AID) and 
the newest putative member APOBEC4 (A4; see Figure 1.3).  Expansion of the 
AID/APOBEC family occurred around the same time as vertebrate divergence and 
adaptive immunity evolved.  Phylogenetic analysis revealed that AID and A2 are the 
ancestral members of the AID/APOBEC family; only one copy of AID is present but 
two copies of A2 exist in the Zebrafish genome likely due to genome duplication 
events.  AID and A2 are located in syntenic chromosomal regions across human, 
mouse and chicken genomes (Conticello et al., 2005).  In contrast, A1 is a mammal-
specific gene that is likely to have arisen from a duplication of AID, with a distinct 
C-terminal region that displays the most divergence from AID.  It is now proposed 
that the ability of A1 to edit mRNA may have evolved after it diverged from the 
ancestral AID/A2.   
 
It is likely that the A3 locus also originated from a duplication of the AID gene, and 
the region shows synteny between mouse and human despite a massive expansion 
from one copy in mouse to seven copies in primates (Jarmuz et al., 2002).  The seven 
copies of human A3 (A, B, C, DE, F, G, and H) present at one locus on chromosome 
22 have undergone extensive rearrangements and are interspersed with repetitive 
element sequences.  This indicates that retrotransposition of the repetitive elements 
which included the neighbouring genes may be responsible for the amplification of 
the A3 genes in the primate lineage (Conticello et al., 2005; Jarmuz et al., 2002).  
There is also another A3-like gene in humans on 12q24.11, however this gene 
contains no introns and no expressed sequence tags (ESTs) have been annotated to 
this gene, indicating it is probably a pseudogene.  Mouse A3 contains two deaminase 
domains indicating a duplication event followed by a fusion of two copies of the 
gene occurred in the A3 lineage.  During the primate-specific expansion four A3 
genes evolved containing two deaminase domains (A3B, A3DE, A3F, and A3G) 
whilst three genes retain only one deaminase domain (A3A, A3C, and A3H).  A3 
proteins containing two deaminase domains are much larger than those with one 
deaminase domain which has implications for their subcellular localisation.  It has 
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been demonstrated that the A3 genes are under strong positive selection, which is 
commonly seen in genes involved in host-pathogen interactions.  Surprisingly the 
positive selection of A3G pre-dates evidence of lentiviral infection of the genomes 
studied, indicating the A3 genes are evolving in response to other pathogens (Sawyer 




APOBEC enzymes were first discovered during the study of Apolipoprotein (Apo) 
B, a large glycoprotein which has important roles in lipid metabolism and the 
regulation of lipoprotein levels in plasma (Powell et al., 1987).  Two active isoforms 
of the ApoB protein occur in mammals: one corresponds to the full length transcript 
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(ApoB100); the other is encoded by the 2,152 amino terminal residues (ApoB48).  
ApoB48 is generated via a single C-to-U editing event in the ApoB mRNA at 
cytosine nucleotide number 6666, which converts a glutamine codon (CAA) to a 
premature stop codon (UAA).  This editing reaction is catalysed by APOBEC1 (A1), 
a 27kDa protein which is a member of the AID/APOBEC group of the CDA family 
(Navaratnam et al., 1993; Teng et al., 1993).  ApoB editing is functionally important 
due to its role in atherosclerosis.  Lipoprotein particles containing ApoB100 are 
required for the production of very low density lipoprotein (VLDL) particles, which 
are then metabolized to intermediate density lipoprotein (IDL) and low density 
lipoprotein (LDL).  Whereas, lipoprotein particles containing ApoB48 are 
metabolised faster and are not processed into LDL particles.  LDL particles transport 
plasma cholesterol around the body, and LDL levels have been shown to be one of 
the major risk factors for coronary heart disease.  The role of ApoB in atherogenesis 
and the process of RNA editing are reviewed in (Davidson and Shelness, 2000). 
 
A1 is expressed in the small intestine in mammals where editing of ApoB mRNA 
occurs to 70-95%, however in rodents editing of ApoB also occurs in the liver to 
approximately 60%.  Two different transcripts are produced from the rat Apobec1 
locus due to alternative splicing and different promoter use; one isoform of 1kb 
expressed in the small intestine and one of  1.24kb expressed in the liver (Teng et al., 
1993).  
 
Apobec-1 knockout mice lack editing of the ApoB transcript and no ApoB48 protein 
is detected in plasma, but the mice are viable and fertile (Hirano et al., 1996).  A 
more detailed examination of Apobec1-null mice revealed that the absence of 
ApoB48 was accompanied by an increase in the amount of ApoB100 protein, which 
produced an imbalance in the proportion of high density lipoprotein (HDL) to LDL 
(Morrison et al., 1996; Nakamuta et al., 1996).  This mild phenotype was 
unexpected, and indicates the primary function of A1 is in modulating lipid 
metabolism through editing of the ApoB mRNA, and this function cannot be 
performed by another enzyme in the absence of A1.  
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To determine whether editing of the ApoB transcript is developmentally regulated 
mice were engineered to endogenously express either ApoB48 or ApoB100 
(uneditable).  However, these mice developed normally and were healthy and viable, 
although differences in plasma LDL levels remained (Farese et al., 1996), indicating 
the editing of ApoB mRNA is dispensable during mouse development.  Current 
thinking supports the hypothesis that editing of the ApoB mRNA is regulated in 
response to changing hormone levels via an increase in Apobec1 expression.  Indeed, 
Apobec1 expression is increased, as is editing of ApoB mRNA, in rat primary 
hepatocytes in response to insulin treatment (Sowden et al., 2002). 
 
Yamanaka et al, noticed a correlation between animals that edit ApoB transcripts in 
the liver and lower levels of plasma LDL and reasoned that expression of A1 in the 
liver may be sufficient to reduce LDL levels (Yamanaka et al., 1995).  Animals 
engineered to express Apobec-1 in the liver developed liver dysplasia and tumours 
similar in profile to hepatic carcinomas.  Non-specific editing of mRNAs not known 
to be substrates for A1 was demonstrated and hypothesised to be the cause of the 
tumour development (Yamanaka et al., 1995).  As yet no other in vivo substrates 
have been found for A1, but this study reveals that it is capable of editing 
endogenous liver mRNAs.   
 
Editing of ApoB mRNA occurs in the nucleus immediately after transcription, and is 
probably coupled with the processes of splicing and polyadenylation (Lau et al., 
1991).  Editing of the ApoB mRNA by A1 requires the correct secondary structure of 
the RNA sequence surrounding the edited position.  Mutation analysis revealed a 
critical “mooring sequence” of 11 nucleotides which occur 3’ of the edited cytosine 
and form a stem-loop structure (Backus and Smith, 1991).  An upstream enhancer 
region was also identified and the spacing between these cis elements was found to 
be important for efficient editing (Backus and Smith, 1992). 
 
Editing of ApoB mRNA requires both the catalytic A1 deaminase and at least one 
co-factor called APOBEC1 complementation factor (ACF) (Mehta et al., 2000).  The 
ACF transcript is alternatively spliced to produce two isoforms of 64 and 65kDa in 
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mice, which differ in the inclusion of one exon encoding 8 amino acids.  
Interestingly ACF expression is widespread, including many tissues that lack ApoB 
and Apobec1 expression suggesting it has other biological functions (Mehta et al., 
2000).  ACF is present in both the cytoplasm and associated with heterochromatin in 
the nucleus.  ACF is a member of the hnRNP family and contains three RNA 
recognition motifs (RRMs), through which it interacts with AU-rich sequences in the 
ApoB mRNA and also with A1.  ACF contains a NLS and can shuttle in and out of 
the nucleus via interaction with transportin 2, indeed ACF is required for the 
localisation of A1 to the nucleus for editing of ApoB mRNA (Blanc et al., 2001).  
However, in vitro studies have shown that A1 is capable of editing ApoB mRNA 
without its cofactor ACF (Chester et al., 2004), indicating the role of ACF in vivo 
may be to localise A1 to the nucleus.  
 
ACF null mice are embryonic lethal, with embryos unable to survive past the 
blastocyst stage (E3.5) indicating that ACF has crucial functions distinct from its role 
in the editing of ApoB mRNA (Blanc et al., 2005).  Heterozygous mice are viable, 
fertile and healthy despite lower levels of ACF protein, and surprisingly they 
displayed a higher level of ApoB RNA editing in the liver and kidney though levels 
in the small intestine were unchanged.  Cell culture experiments indicated loss of 
ACF resulted in an increase in apoptotic cell death, and this effect was independent 
of Apobec-1 expression (Blanc et al., 2005).  Taken together these results indicate 
ACF has a crucial role early in development which is independent of ApoB editing. 
 
To further investigate the DNA deaminase activity of A1 and other members of the 
AID/APOBEC family, an E.coli DNA mutator assay was developed (Harris et al., 
2002; Petersen-Mahrt et al., 2002).  The assay relies on mutation of a gene (in this 
instance rpoB) giving rise to a positive selectable marker (rifampicin resistance, the 
assay is described in detail in (Coker et al., 2006)).  The assay was used successfully 
to demonstrate that A1, as well as AID, A3C and A3G can deaminate cytosine 
residues in DNA, whilst in this assay A2 could not deaminate DNA (Harris et al., 
2002).  Mutation rates were significantly increased in uracil DNA glycosylase-
deficient E.coli (Ung-1); indicating the resistance was due to deamination of cytidine 
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to uracil.   Indeed, sequence analysis showed the enzymes displayed distinct 
preferences for the sequence context of the cytidine to be deaminated.  Recent work 
on A1 has shown it is capable of deaminating ssDNA in vitro, indicating it may have 
a more varied biological role than previously described (Petersen-Mahrt and 
Neuberger, 2003).  Interestingly A1 and AID can also deaminate 5-methylcytosine to 
thmidine in a modified E.coli DNA mutator assay, where a CpG-directed 
methyltransferase is co-expressed in a methylation restrictive defective E.coli strain 
(Morgan et al., 2004). 
 
APOBEC2 
A2 is an ancestral member of the AID/APOBEC family, thought to have originated 
from a duplication of the AID gene in bony fish (Conticello et al., 2005).  Expression 
of A2 is restricted to heart and skeletal muscle, however it was unable to substitute 
for A1 in an ApoB mRNA editing assay and little is known about its function or 
substrates in vivo (Liao et al., 1999).  Biochemical investigation showed that 
recombinant A2 has little or no affinity for either non-specific AU rich RNA or Apo-
B RNA in vitro, indicating it does not function as an RNA deaminase.  Deletion of 
the gene in mice produced apparently healthy, fertile mice with no immediately 
obvious phenotype (Mikl et al., 2005).  Further investigation of the A2-null mice 
revealed a muscle-specific phenotype that increased in severity with age resulting in 
a mild myopathy (Sato et al., 2009).  This was accompanied by a 15-20% decrease in 
total body mass, evident from birth.  The role of A2 remains unclear however a clear 
myopathic phenotype albeit mild, in the A2 knockout mice indicates a function in 
skeletal muscle.  This may be mediated through nucleic acid binding rather than 
cytidine deaminase activity, and substrates remain to be identified. 
 
APOBEC3 
The A3 subfamily consists of seven proteins in primates (APOBEC3- A, B, C, DE, 
F, G, and H), which are potent inhibitors of retroviruses.  Several A3 genes have 
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been shown to be expressed in human tumour cell lines when expression is not 
normally detected in the tissues they are derived from (Jarmuz et al., 2002). 
 
Anti-retroviral activity was initially observed when HIV-1 mutants were isolated that 
lacked the virion infectivity factor (Vif).  These mutants failed to replicate in certain 
CEM (T-cell) cell lines (termed “non-permissive”) but replicated normally in other 
CEM cell lines (termed “permissive”).  Sheehy et al (2002) used a cDNA library 
subtraction screen to identify a host factor APOBEC3G/CEM15 (A3G) as the protein 
that conferred the non-permissive phenotype when expressed in permissive cells 
(Sheehy et al., 2002).  Initial investigations demonstrated that the inhibition occurs 
via A3G interacting with the viral gag protein which is a component of the viral 
nucleocapsid.  A3G is subsequently incorporated into the new virus particle along 
with the viral RNA (Alce and Popik, 2004; Zennou et al., 2004).  Following 
infection of a new cell viral RNA is reverse transcribed into DNA and A3G 
deaminates cytidine residues in the single-stranded minus strand of the nascent 
proviral DNA (Yu et al., 2004).  The resulting uracil residues are excised by virion-
specific uracil DNA glycosylase-2 (UNG2) and the proviral DNA is degraded by 
apyrimidic endonuclease (APE) (Yang et al., 2007).  Therefore A3G is a potent 
inhibitor of HIV-1 in the absence of Vif, and as such A3G provides a powerful 
potential therapeutic in the fight against HIV-1 and AIDS. 
 
However, HIV-1 counteracts the anti-retroviral activity of A3G through the virally 
encoded protein Vif.  Further studies to characterise this interaction revealed the 
HIV-1 Vif protein can counteract the antiviral effects of A3G in several ways: Vif 
binds and sequesters A3G preventing it from being packaged into virions (Mariani et 
al., 2003); Vif promotes A3G ubiquitination which targets it for proteasome-
mediated degradation (Kobayashi et al., 2005); and Vif directly inhibits translation of 
A3G mRNA (Kao et al., 2003).  In combination these measures effectively ensure 
that no A3G is incorporated into budding virions.  The Vif-A3G interaction is highly 
species specific, as it has been shown that HIV-1 Vif protein could not inhibit mouse 
A3 (Mariani et al., 2003).  Further investigation revealed that HIV-1 Vif could not 
inhibit A3G from species that are evolutionarily much closer to humans such as 
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African green monkeys and macaques (Mariani et al., 2003).  Conversely, human 
A3G is not susceptible to inhibition by simian immunodeficiency virus (SIV) Vif 
protein.  Several groups managed to refine the species-specific inhibition by HIV-1 
Vif to one critical residue, aspartic acid 128, which corresponds to a lysine residue in 
African green monkey A3G (Bogerd et al., 2004; Mangeat et al., 2004; 
Schrofelbauer et al., 2004; Xu et al., 2004).  Mutating human A3G amino acid 128 
from aspartic acid to lysine can render it susceptible to SIV Vif but resistant to HIV-
1 Vif.  This level of specificity indicates that A3G has undergone recent evolution, 
possibly in response to rapid evolution of retroviruses.  A3G also displays antiviral 
activity against Hepatitis B virus (HBV), which undergoes a reverse transcription 
step during replication (Turelli et al., 2004).  However, in this case A3G interferes 
with packaging of the viral pre-genome, and there is no evidence of hypermutation. 
 
The antiviral activity of A3 is not specific to the primate lineage.  A mouse locus 
outside of the major histocompatibility complex involved in recovery following 
infection with Friend Virus (FV) termed Recovery from Friend Virus 3 (Rvf3) was 
recently found to encode mouse A3 (Santiago et al., 2008).  The Rvf3 viral resistance 
factor locus was identified as an autosomal dominant trait in 1979, which resulted in 
reduced viral load and increased neutralising antibodies following infection with FV 
(Chesebro and Wehrly, 1979).  Susceptible mouse strain BALB/c was found to 
produce an alternatively spliced A3 transcript lacking exon 2, which displayed 
reduced antiviral activity in in vitro studies.  Therefore mouse A3 contributes to 
reduced viral load in vivo, but also appears to stimulate neutralising antibodies 
indicating a wider role for A3 in the immune system.  The authors concluded that the 
absence of the ability to stimulate an antibody reaction following HIV-1 infection 
may be due to the presence of Vif.  Mouse A3 is predominantly expressed in 
lymphoid tissues and knockout mice display no obvious phenotype (Mikl et al., 
2005).  However further investigation revealed that mouse A3 inhibits the murine 
Mammary Tumour virus (MMTV) replication in vivo, such that A3-null mice were 
more susceptible to MMTV infection (Okeoma et al., 2007).   
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APOBEC3 and transposable elements 
Only a small fraction of cellular A3G is incorporated into the budding HIV-1 virions 
and this prompted investigation into alternative cytoplasmic roles for A3G.  Chiu and 
colleagues observed that activation of CD4+ T cells was accompanied by a shift in 
A3G from a low molecular mass complex to a high molecular mass complex, and 
this shift coincided with a loss of antiretroviral activity (Chiu et al., 2005).  The shift 
could be reversed by treatment with RNase A, which caused the high molecular 
weight complex to dissociate.  Analysis of the high molecular weight complexes 
revealed that they were Staufen-containing RNA transport granules, Ro 
ribonucleoprotein (RNP) complexes and pre-spliceosomes.  Analysis of the RNA 
species present in the RNP complexes revealed that they contained Alu and small Y 
nonautonomous retroelement RNAs, as well as mRNAs encoding both A3G and A3F 
amongst others.  Further experiments showed that activation of T cells induces 
expression of retroelements.  The retroelement RNA intermediates are bound by 
A3G and sequestered into high molecular mass RNP complexes.  This process is 
independent of cytidine deaminase activity, and results in a loss of antiretroviral 
activity against the HIV-1 virus as the total cellular A3G is now associated with the 
high molecular mass RNP complexes (Chiu et al., 2006). These findings demonstrate 
A3G is able to inhibit endogenous retrotransposons through binding and sequestering 
their RNA intermediates.  Therefore A3G has a role as an RNA-binding protein 
although deamination of RNA was not observed.  Further, these results indicate a 
potential mechanism of regulating A3G activity through its association with high 
molecular mass RNP complexes.  Localization studies indicated these high molecular 
weight RNP complexes are cytoplasmic RNA processing (P) bodies, where 
translationally silenced mRNAs can be stored or degraded (Wichroski et al., 2006).  
A3G could be relocated to stress granules following heat shock, along with specific 
mRNAs and components of the RNA-induced silencing complex (RISC) (Gallois-
Montbrun et al., 2007; Kozak et al., 2006).  These results indicate A3G may have 
additional biological roles through its interaction with cellular mRNAs in P bodies. 
 
The discovery that A3 proteins are capable of restricting retroviruses and inhibiting 
Alu elements retrotransposition led to investigation of the role of APOBEC proteins 
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in the inhibition of other endogenous retrotransposons.  Retrotransposon-derived 
sequences account for approximately 45% of the human genome and the three major 
classes that are still active replicate through an RNA intermediate (Lander et al., 
2001).  Long terminal repeat (LTR) retrotransposons contain viral gag and pol genes 
that are flanked by repeat sequences which control transcriptional regulation and are 
capable of autonomous retrotransposition.  Retroviruses, like HIV-1, are thought to 
have originated from LTR-retrotransposons by the acquisition of the env gene which 
encodes the envelope proteins, and they replicate in a similar manner to retroviruses 
utilising a reverse transcriptase to create an RNA intermediate.  Long interspersed 
elements (LINEs) can also replicate autonomously and contain an RNA polymerase 
II promoter upstream of two open reading frames (ORFs).  Following translation the 
LINE proteins bind to its RNA and the LINE RNA is reverse transcribed in a process 
termed “target-site primed reverse transcription”, which often fails to complete 
resulting in many 5’ truncated inactive repeat elements.  LINEs comprise 
approximately 21% of the human genome, the most common being the LINE-1 (L1) 
element (Lander et al., 2001).  Short interspersed elements (SINEs) are similar to 
LINEs but cannot replicate autonomously, however LINE encoded proteins can 
function in trans to replicate SINE elements.  SINEs account for approximately 13% 
of the human genome, yet only one family remains active which is also the most 
abundant; the Alu element (Lander et al., 2001).  
 
Retrotransposition events can have serious consequences for the host genome, not 
least through the accumulation of genetic material.  Several potential consequences 
are described here, for a comprehensive review see (Cordaux and Batzer, 2009).  
Consequences of retrotransposition include insertional mutagenesis, whereby a 
retrotransposon can insert into the coding sequence or regulatory elements of a gene, 
or insertion-mediated deletion where genetic information is lost from regions 
adjacent to the insertion site. Retrotransposons can also induce genomic 
rearrangements whereby recombination events take place between homologous 
retrotransposon sequences on different chromosomes.  During replication 
retrotransposons can copy flanking genes, or parts thereof, and integrate them locally 
or elsewhere in the genome (this occurred during the primate specific expansion of 
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A3 genes which is described earlier).  Whilst sometimes these rearrangements can be 
beneficial, the potential for deleterious mutation is great, therefore host genomes 
have evolved mechanisms to limit retrotransposition.   
 
There are numerous studies on the effect of APOBEC proteins on retrotransposition, 
some of which are described below, others are summarised in Table 1.1.  A3G and 
A3F were shown to inhibit retrotransposition if the LTR-retrotransposon Ty1 in 
Saccharomyces cerevisiae, through deamination of the reverse transcribed DNA 
intermediate (Schumacher et al., 2005). Investigation of mouse LTR-
retrotransposons Intracisternal A-particles (IAPs) revealed mouse A3 and human 
A3G were able to significantly inhibit retrotransposition via hypermutation of the 
DNA intermediate, however mouse A1 and A2 had no effect (Esnault et al., 2005).  
Another study into inhibition of IAPs showed that A3G and A3B reduced 
retrotransposition by 4-fold and 20-fold respectively (Bogerd et al., 2006a).  This 
inhibition was mediated by association of A3G or A3B with the IAP Gag protein 
which resulted in the inclusion of the A3 protein into the virus-like particle where it 
hypermutated the nascent cDNA. However, A3A was shown to reduce 
retrotransposition of the murine IAP by 100-fold yet failed to associate with the IAP 
Gag protein in vivo, and IAP transcripts analysed did not show hypermutation 
indicating that A3A inhibits retrotransposons by a novel cytidine deamination-
independent mechanism (Bogerd et al., 2006a).   
 
These studies show that A3s are effective against LTR-containing retrotransposons, 
however initial investigations into inhibition of L1 and Alu retrotransposition 
indicated that only A3A and A3B were capable of inhibiting these elements through 
a deamination-independent mechanism (Bogerd et al., 2006b).  Further studies 
including all human A3s (A-H) showed that they are all capable of inhibiting L1 
retrotransposition, although some are more effective than others (Kinomoto et al., 
2007).  Thus the same mechanism of deaminating the nascent cDNA strand resulting 
in hypermutation and degradation of proviral DNA is observed in the inhibition of 
both retroviruses and retrotransposons.  However, additional cytidine deamination-
independent mechanisms are also involved in the inhibition of retrotransposons. 
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Investigation into the mechanism of A3B and A3F inhibition of L1 retrotransposition 
revealed key catalytic site residues were dispensable and no evidence of cytidine 
deamination was found (Stenglein and Harris, 2006). Inhibition of L1 
retrotransposition by A3B and A3F resulted in fewer copies of integrated L1 DNA 
indicating inhibition occurred before integration; however the precise mechanism of 
inhibition is as yet undetermined.  This data and other similar results have led to an 
increase in investigations into the function of A3 proteins and how they are able to 
inhibit different viruses and retroviruses.  Thus, the expanded A3 family present in 
the primate lineage has an important role in the immune system protecting the 
genome from endogenous retrotransposons and exogenous retroviruses. 
 
Recent data indicates that A3 proteins may function at several different stages of the 
innate immune response to infection.  The discovery that A3A has limited antiviral 
activity against HIV-1, but is capable of restricting retrotransposition of Alu elements 
prompted further research into its biological function.  A3A is expressed in 
macrophages and can be induced by both interferon and foreign DNA leading 
Stenglein et al to hypothesise that it is involved in the immune system response to 
foreign DNA (Stenglein et al., 2010).  They showed that A3A can extensively 
deaminate foreign dsDNA with up to 97% of cytidines being converted to uracil, 
resulting in degradation of the foreign DNA through UDG-mediated cleavage.  This 
was demonstrated with a striking experiment showing the transfection of a plasmid 
encoding A3A leads to progressive loss of expression of A3A as it targets its own 
plasmid for degradation.  This makes further studies difficult and past ones open to 
re-interpretation.  Furthermore, despite the very high level of editing detected there 
was no evidence of endogenous DNA deamination, only foreign DNA was targeted 
for deamination by A3A indicating a stringent mechanism for recognition of foreign 
DNA.  This study highlights the diverse roles APOBEC proteins play in the immune 
system, and suggest further investigations are necessary to elucidate the specific 
biological substrates of each family member. 
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  HIV-1 MLV HBV IAP Alu L-1 dsDNA ssDNA 5MeC RNA 
Subcell. 
Localn 
APO1           nuc/cyto 
APO2             
APO3A           nuc/cyto 
APO3B           nuclear 
APO3C weak     weak weak    nuc/cyto 
APO3DE weak     weak     cyto 
APO3F            cyto 
APO3G           cyto 
APO3H      weak     nuc/cyto 












































et al., 1993; 




et al., 2007) 
 
Table 1.1: Summary of activity of APOBEC proteins 
Activity of APOBEC proteins tested is listed where  indicates positive,  indicates negative and blank indicates not tested.  References are listed, 
some references describe later studies including comparisons of several family members are written as “summarised in”. 
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Methylation of transposable elements 
The consequences of retrotransposition events are rarely beneficial to the host 
organism and germline insertions play a role in heritable diseases including 
haemophilias and Duchenne Muscular Dystrophy (Chen et al., 2005).  Therefore host 
organisms have evolved complex mechanisms for preventing retrotransposition 
events which include silencing transcription through modification of DNA 
sequences, reviewed in (Maksakova et al., 2008).  These modifications consist of 
methylation of CpG dinucleotides within the promoter region of the retrotransposons 
and remodelling of the core histones to make the DNA less accessible to 
transcription factors.  Methyl groups are attached to cytosine residues by DNA 
methyltransferase enzymes (Dnmts) and this causes transcriptional repression 
through binding of proteins containing methyl binding domains (MBDs).  MBD 
proteins can recruit chromatin modifying enzymes such as histone methyltransferases 
and histone deacetylases, which modify the N-terminal tails of core histone proteins 
leading to a more compact chromatin structure.  These modifications act in concert to 
silence transcription through establishing and maintaining an inactive chromatin 
state.  Indeed, artificial targeting of Methyl CpG-binding Protein 2 (MeCP2) to the 
L1 promoter region effectively represses L1 expression and retrotransposition (Yu et 
al., 2001). 
 
Activation Induced Deaminase 
Activation Induced Deaminase (AID) has been shown to have a crucial role in the 
adaptive immune response where it is required for several distinct steps in the 
affinity maturation of antibodies during an immune response (summarised in Figure 
1.4).  The first step of antibody maturation occurs without AID, and involves 
homologous recombination to select one segment from each of three genes (variable 
V, diversity D, and joining J genes).  V(D)J recombination occurs between 
recombination signal sequences located either side of the gene segments and results 
in a wide repertoire of low affinity antibodies that are all of class IgM, the process is 
reviewed in (Maizels, 2005).   
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AID functions in the next step of antibody affinity maturation, which is class switch 
recombination (CSR, Figure 1.3 middle panel).  This results in an intrachromosomal 
deletion of the IgM constant region and its replacement by a downstream constant 
region gene producing antibodies with different constant regions.  CSR is dependent 
on AID, which is demonstrated in patients deficient in AID that display hyper-IgM-2 
syndrome, who only produce IgM antibodies as they are unable to undergo CSR 
(Revy et al., 2000).  AID is believed to initiate double strand breaks (DSBs) in DNA 
required for CSR via deaminating cytosine residues in the immunoglobulin S region 
to uracil residues.  The uracil is recognised by a uracil DNA glycosylase enzyme (for 
example UNG) and subsequently removed, either by UNG or by mismatch repair 
(MMR) enzyme MSH2, leaving an abasic site exposed (Rada et al., 2004).  Repair of 
staggered DSBs occurs through non-homologous end-joining (NHEJ) and produces 
functional antibodies of different classes from one locus. 
 
AID is also involved in the process of somatic hypermutation (SHM) which allows 
the immune system to produce a wide repertoire of antibodies with different effector 
function following activation of naïve B cells by antigen.  This process of affinity 
maturation is achieved through inducing random point mutations within a 1.5-2kb 
region spanning the recombined V(D)J section, which encodes the antigen-binding 
region of the antibody (Lebecque and Gearhart, 1990).  The mechanism whereby 
AID is targeted to the immunoglobulin locus remains elusive, although histone 
modifications are thought to create an accessible chromatin environment (Nambu et 
al., 2003) and cis acting sequence elements likely play a role (Zarrin et al., 2005).  
The mutation rate in this region is in the order of 104/base pair/generation, which is 
considerably higher than any other loci (Berek and Milstein, 1988).  The mechanism 
is similar to that of CSR, however DSBs are not formed.  AID deaminates cytidines 
in the DNA to uracil, which can lead to several different outcomes.  If replication 
occurs before the uracil is detected a transition mutation (dC-dT) occurs.  If the uracil 
is detected by UNG it can be excised leaving an abasic site and replication at this 
stage across the abasic site results in any base being incorporated in this position.  
Finally, the mismatched uracil can be repaired through either the base excision repair 
(BER) pathway or the mismatch repair (MMR) pathway, which can utilise error-
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prone polymerases capable of inducing multiple mutations in the surrounding bases.  
The process of SHM generates a large pool of diverse antibodies, which are then 
subjected to selective pressure to generate antibodies with higher affinity.  
 
The processes of CSR and SHM described above depend on AID deaminating 
cytosine residues in DNA within the immunoglobulin locus.  This hypothesis is 
supported by in vitro experiments showing that purified AID can deaminate cytosine 
in single-stranded DNA (Bransteitter et al., 2003).  The spectrum of mutations 
produced in vitro demonstrated that AID preferentially deaminates cytidine residues 
in the motif “WRC” (where W is adenosine or thymine, R is a purine, and C is 
cytidine), which concurs with the SHM mutation “hotspots” observed in vivo (Pham 
et al., 2003).  AID is also capable of mutating DNA when it is expressed in E.coli 
(Petersen-Mahrt et al., 2002) and yeast (Poltoratsky et al., 2004).  Yet this is not 
conclusive evidence as over expression of A1 in E.coli results in deamination of 
DNA when its in vivo target is RNA (Harris et al., 2002).  Furthermore, SHM 
requires active transcription from the immunoglobulin locus and AID is localised to 
the immunoglobulin switch loci during CSR and can be co-immunoprecipitated with 
RNA Polymerase II (Nambu et al., 2003). 
 
However, there are two potential mechanisms of AID action: AID may act directly 
on DNA as described above, known as the “DNA-editing hypothesis”; or potentially 
AID may edit one or more transcripts which encode endonucleases or recombinases 
that act on the DNA, known as the “RNA-editing hypothesis”.  To date it has not 
been conclusively shown which nucleic acid is the substrate of AID. 
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Evidence in support of an RNA intermediate comes from experiments showing that 
de novo protein synthesis is required to form double strand breaks in DNA during 
CSR, following activation of AID (Begum et al., 2004).  However, this does not 
exclude the possibility that AID requires co-factors that must be newly synthesised; 
therefore current thinking favours the model whereby AID acts directly on DNA at 
the immunoglobulin locus.  Other evidence in support of the RNA-editing hypothesis 
comes from data which shows AID can be immunoprecipitated in a complex with 
polyadenylated mRNA in vivo, although a direct interaction between AID and RNA 
was not shown (Nonaka et al., 2009).  The authors hypothesise that AID could have 
an RNA-binding co-factor analogous to A1 and its co-factor ACF; however the 
interaction of AID with RNA polymerase II (Nambu et al., 2003) could be 
responsible for the indirect association observed between AID and mRNA.  In 
conclusion, AID is required for efficient antibody affinity maturation likely through 
deamination of DNA at the immunoglobulin locus, although the mechanism of 
targeting AID to this locus and the co-factors involved are yet to be determined. 
 
Given AID’s role in generating mutation through deamination it was hardly 
surprising when it was found to be involved in the development and progression of 
cancer.  Reciprocal translocations involving the immunoglobulin locus and a 
selection of different proto-oncogenes are commonly found in B cell malignancies, 
such as the c-Myc-Igh translocation in Burkitt’s lymphoma, reviewed in (Ramiro et 
al., 2006).  The DSBs at the Igh locus are characteristic of AID deamination, and 
AID may also be involved in generating DSBs within the c-myc locus (Robbiani et 
al., 2009).  This results in massive upregulation of the proto-oncogene when the 
naïve B-cell is stimulated to generate antibodies, and can lead to cancer when 
tumour-suppressor genes such as p53 are lost. 
 
Similar to recent findings which demonstrated that A3s are capable of inhibiting 
retrotransposition, AID was shown to inhibit both mouse retrotransposons L1 and 
MusD, but not the yeast retroelement Ty1 (MacDuff et al., 2009).  Intriguingly, the 
catalytic site glutamic acid residue, and several of the zinc-coordinating cysteine 
residues were not required for this inhibition.  Indeed no evidence of deamination 
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was detected confirming that the inhibition of LINEs by AID occurs via a 
deamination-independent mechanism.  The authors detected expression, albeit weak, 
of Aid in the ovary indicating inhibition of retroelements in the germline may be 
another function of AID. 
 
Regulation of AID expression 
The genomic region surrounding miR-155 has long been of interest since it was 
identified as the integration site for proviral DNA from the Avian Leukosis Virus 
(ALV) in chickens.  Expression of a noncoding transcript from this region denoted as 
Bic (B cell integration cluster) was stimulated by the ALV promoter and resulted in 
oncogenesis (Tam et al., 1997).  Bic is the primary miRNA precursor from which 
miR-155 is processed, and subsequently many B cell lymphomas have been found to 
overexpress either miR-155 or Bic (Eis et al., 2005). Indeed transgenic 
overexpression of miR-155 from an immunoglobulin promoter results in malignant 
lymphomas (Costinean et al., 2006), whereas mice lacking miR-155 have immune 
response defects and are unable to produce a full repertoire of antibodies (Thai et al., 
2007).  Expression of miR-155 is induced following stimulation of B cells to 
undergo CSR, indicating it plays a role in this process, yet miR-155 is widely 
expressed in the lymphatic system and is predicted to have over 60 targets in vivo.  
One target of miR-155 is the Aid transcript and mice engineered to lack the AID 
3’UTR target site for miR-155 produce higher levels of AID, which results in a 
higher frequency of CSR (Teng et al., 2008).  Mice lacking the miR-155 target site in 
the Aid 3’UTR showed expression of Aid in a subset of mature circulating B cells 
where it would normally not be found following stimulation of an immune response.  
However, this was not a general mis-regulation of Aid as peripheral T lymphocytes 
had correctly switched off Aid expression.  This indicates AID expression is tightly 
regulated in both a temporal and a cell-specific manner, and that additional 
mechanisms exist for regulating Aid expression.  Despite higher levels of Aid these 
mice did not have increased SHM of immunoglobulin genes but elevated AID in the 
germinal centre resulted in off-target deaminase activity which induced 
hypermutation at the oncogene Bcl6 locus (Teng et al., 2008). 
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A parallel study revealed the incidence of Burkitt’s lymphoma-associated Myc-Igh 
translocations was 3-6 fold higher in mice lacking the miR-155 target sequence 
(Dorsett et al., 2008).  Curiously these mice did not show elevated levels of B cell 
lymphoma despite harbouring higher levels of the causative translocation, indicating 
further mutations are required for lymphoma development.  Mice ubiquitously 
expressing AID develop T cell tumours however they do not develop lymphomas 
which led the authors to postulate that AID activity is also regulated post-
transcriptionally in B cells (Muto et al., 2006).   
 
AID as a demethylase 
Recent work has shown that AID and A1 can deaminate methylated cytosine 
residues in an artificial E.coli assay resulting in thymine incorporation and a loss of 
methylation (Morgan et al., 2004).  The authors demonstrated that AID and A1 are 
located within a cluster of pluripotency genes including Nanog and Stella on 
chromosome 6, and showed that all four genes were expressed in oocytes, ovaries, 
embryonic germ (EG) cells and embryonic stem (ES) cells, implying a role for 
deamination in early development.  Further analysis revealed low levels of AID 
expression, but no detectable A1, in primordial germ cells (PGC), indicating that 
AID may play a role in removing methylation marks early in spermatogenesis.  AID 
is also expressed later during spermatogenesis (Schreck et al., 2006).   
 
Scientists have long searched for an enzyme capable of actively removing the 
epigenetic 5-methylcytosine mark from DNA, so it was intriguing when AID was 
shown to be capable of performing this through deamination.  AID deamination 
would result in a dG-dT mismatch, which would require further repair by a 
glycosylase enzyme such as thymidine DNA glycosylase (TDG) or methyl-binding 
domain protein 4 (MBD4).  Rai et al presented exciting data suggesting that 
overexpression of AID, A2A and A2B (Zebrafish homologues of A2) in Zebrafish 
embryo’s can promote demethylation of an injected methylated DNA fragment when 
MBD4 is co-expressed (Rai et al., 2008).  However, this data raises several questions 
as they propose that AID is acting on dsDNA yet AID has not been shown to 
deaminate dsDNA despite extensive investigation.  Further MBD4 knockout mice do 
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not show demethylation defects indicating there is redundancy or a different pathway 
occurring in mammals.  Nevertheless this does present an interesting concept which 
warrants further exploration. 
 
Continuing the investigation of AID as a demethylating enzyme Bhutani et al 
employed a novel system to study candidate demethylases and analysed AID in this 
context (Bhutani et al., 2009).  They fused mouse embryonic stem (ES) cells and 
primary human fibroblasts to create heterokaryons, and then analysed the 
methylation and transcriptional state of human genes with human-specific primers.  
Using this method they detected extensive demethylation and transcriptional 
activation of human pluripotency genes (Oct4 and Nanog) within one day of fusion 
and in the absence of replication.  Knockdown of AID severely reduced the levels of 
demethylation observed indicating AID plays an active role in the demethylation of 
pluripotency genes.   
 
Taken together these studies indicate a novel function of AID cytidine deaminase in 
the removal of the 5-methylcytosine mark from DNA.  The discovery that AID is 
expressed early in development indicates it may function during the first wave of 
demethylation that follows fertilization.  Although a potential new role for A1 in 5-
methylcytosine deamination later in development should not be ignored (Morgan et 
al., 2004).  Further work is required to determine the co-factors required for this 
process, and whether there is redundancy within the AID/APOBEC family as AID-
null mice are viable (Muramatsu et al., 2000) and do not display gross abnormalities 
or develop tumours indicative of de-regulation of methylation.  Overexpression of 
Dnmt1 methyltransferase causes embryonic lethality in mice (Biniszkiewicz et al., 
2002) as does loss of the de novo methyltransferases Dnmt3a and Dnmt3b (Okano et 
al., 1999) indicating regulated methylation is essential for viability.  However it is 
unclear whether more than one mechanism of demethylation occurs and therefore 
what the phenotype associated with loss of a candidate demethylase would be.  
Consequently a more detailed analysis of methylation status in AID knockout mice is 
required.  To accomplish this Popp and colleagues employed a genome wide 
bisulphite next generation sequencing approach to analyse DNA methylation levels 
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throughout the genome in wild type and AID deficient primordial germ cells (Popp et 
al., 2010).  This revealed that AID deficient mice retained higher levels of DNA 
methylation in primordial germ cells, specifically within introns and intergenic 
regions as opposed to promoters, but also on LTR-transposable element sequences.  
Interestingly, this was restricted to PGCs and the effect was more pronounced in 
female PGCs indicating an analogous system may be operational in the male 
germline.   
 
APOBEC4 
Given the diverse endogenous and important antiviral activities attributed to the 
AID/APOBEC family the discovery of a putative novel member of this family is 
intriguing.  Bioinformatic searches of nucleotide genome sequences (NCBI and 
Ensembl databases) using the human AID protein sequence as a query revealed an 
uncharacterized vertebrate protein family termed APOBEC4 (A4) (Rogozin et al., 
2005), which was conserved from humans to Xenopus tropicalis.  Importantly, 
reciprocal searches using A4 as the query returned other AID/APOBEC family 
members suggesting these proteins are homologs.   
 
Alignments revealed conservation of the characteristic zinc-coordinating deaminase 
domain motif (H/C)xE….PCxxC (where x indicates any residue), although A4 
contained a four amino acid insertion between the conserved cysteine residues, 
creating the motif PCxxxxxxC.  However, longer inserts between the conserved 
cysteine residues have been observed in functional deaminases within the CDA 
superfamily, see Figure 1.2. These include members of the ADAR and ADAT 
enzymes (Dance et al., 2001), although the substrate for both of these enzymes is 
structured RNA indicating the extra amino acids may enable the accommodation of 
larger substrates in the active site.  Secondary structure prediction indicated A4 has 
the characteristic conformation of alternating α-helices and β-sheets which is shared 
by members of the CDA superfamily, and also contains an extra α-helix that is 
specific to the AID/APOBEC family (Huthoff and Malim, 2005).  A4 has an 
Chapter 1: Introduction 
 
 29
extended carboxy-terminal region that contains a coiled-coil domain not present in 
any other family members.  
 
Phylogenetic analysis revealed that A4 is closely related to A1, with emergence of 
these genes from a common AID/A2 ancestor estimated to have occurred before the 
amphibian-reptile divergence (Rogozin et al., 2005).  Importantly, sequence analysis 
indicated that A4 is evolving at a similar rate to A1, which is faster than AID but 
slower than A3 family members.  The fast rate of evolution of A3 genes is attributed 
to their antiviral role in the innate immune system.  The in silico expression profile 
of the A4 protein revealed that expression is restricted to the testis, indicating a 
potential function in spermatogenesis.   
 
Mouse spermatogenesis   
Mouse spermatogenesis is a continuous process which begins in the early embryo, by 
7.5 days post coitum (dpc) there is a specified population of approximately 45 
primordial germ cells (PGCs).  PGCs are diploid pluripotent precursors of the 
primary spermatogonia, derived from proximal epiblast tissue (Lawson and 
Pedersen, 1992).  Following proliferation and migration to the genital ridges male 
PGCs enter mitotic arrest at 13.5 dpc.  In PGCs the inherited methylation pattern 
present at single copy genes and imprinted loci at 10.5 dpc is rapidly erased by 12.5 
dpc when PGCs enter the gonad (Hajkova et al., 2002).  A de novo wave of 
monoallelic sex-specific methylation occurs throughout spermatogenesis which is 
performed by the de novo DNA methyltransferases Dnmt3a and Dnmt3b (Kato et al., 
2007).  PGCs remain in mitotic arrest until shortly after birth when mitosis continues 
to produce type A spermatogonia stem cells, and the process of spermatogenesis 
begins.   
 
The first wave of spermatogenesis occurs synchronously and is completed by 30 
days post partum (dpp).  This can be divided into three distinct processes: mitosis, 
meiosis, and spermiogenesis, which occur in the seminiferous tubule, reviewed in (de 
Rooij, 1998).  Primary spermatogonia (undifferentiated diploid germ cells) are 
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located at the basal lamina, surrounded by supporting somatic sertoli cells.  Germ 
cells undergo multiple rounds of asymmetric mitotic cell divisions to preserve a 
population of primary spermatogonial germ cells and produce differentiated primary 
spermatocytes that enter the first round of meiosis at approximately 9 dpp.  Primary 
spermatocytes are characterized by highly condensed chromatin, and migrate from 
the basal lamina to the central lumen of the seminiferous tubule.  After meiosis I 
secondary spermatocytes undergo one more meiotic division to produce haploid 
round spermatids, which progress towards the lumen as they mature.  Finally, round 
spermatids undergo spermiogenesis (beginning around 20 dpp and complete by day 
30), a metamorphosis into mature elongated spermatozoa.  Spermiogenesis involves 
condensation of the genome into a nucleus approximately 5% the size of a somatic 
cell, shedding of excess cytoplasm and formation of the sperm tail. During 
spermatogenesis the whole genome undergoes extensive chromatin remodelling as 
histones are exchanged for protamines, coupled with establishing the pattern of 
paternal epigenetic modifications, which produces a highly condensed nucleus 
(reviewed in (Rousseaux et al., 2005)).  The mature sperm nucleus is believed to be 
transcriptionally silent due to chromatin compaction. 
 
Methylation during early development  
In mammals addition of a methyl group to a cytosine residue in the dinucleotide 
motif CpG is associated with heritable transcriptional silencing.  Allele specific 
methylation can confer parental imprinting patterns and regulates the process of X-
inactivation, whereas promoter regions of retrotransposons are heavily methylated on 
both strands to prevention of mobilization of retrotransposons.  Approximately 70% 
of CpG dinucleotides are methylated in the vertebrate genome and these levels 
remain fairly constant in differentiated somatic tissues, however methylation levels 
show dynamic changes in the germline and in the preimplantation embryo (reviewed 
in (Morgan et al., 2005)).   De novo and maintenance DNA methyltransferases are 
responsible for transferring a methyl group from an s-adenosylmethionine (SAM) 
donor onto cytosine residues, this group of proteins is described in (Klose and Bird, 
2006).  However, to date there are no known enzymes capable of removing the 
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methylation mark.  Several hypotheses have been suggested but they remain to be 
conclusively proven.  Interestingly, a recent paper demonstrated that siRNA 
knockdown of components of the RNA polymerase II Elongator complex (Elp1, 2, 
and 3) impaired paternal genome demethylation after fertilization (Okada et al., 
2010).  No catalytic demethylation activity was described but the focus of the study 
was on the Elp3 subunit which contains a radical SAM domain indicating it can bind 
to methyl groups.  A homologous Archaea Elp3 protein is able to cleave SAM in 
vitro to generate methionine and 5’deoxyadenosine, raising the possibility that this 
could be occurring in vivo during demethylation (Paraskevopoulou et al., 2006).  
Another potential mechanism for genome demethylation is cytidine deamination of 
5-methylcytosine to thymine, with an intriguing paper highlighting the role of AID in 
this process in PGCs [discussed earlier see the section on AID as a demethylase and 
(Popp et al., 2010)].   
 
At fertilization the paternal genome is haploid and the DNA is densely packaged 
around protamines.  The female pronucleus however, is diploid, packaged with 
histones and arrested in metaphase II.  Following fertilization, the male and female 
genomes remain condensed in distinct pronuclei, which only fuse at the first mitosis 
division.  During this time the male pronucleus undergoes a rapid exchange of 
protamines for histones, followed by a wave of active demethylation before DNA 
replication has occurred.  Demethylation of the male pronucleus occurs within 4 
hours of fertilization in the mouse embryo and can be visualised using a 5-
methylcytosine antibody (Santos et al., 2002).  Not all sequences are demethylated 
though, paternally imprinted genes and IAP retrotransposons remain methylated 
whilst L1 retrotransposons are demethylated (Lane et al., 2003). 
 
Sheep and rabbits do not have genome-wide demethylation of the paternal genome 
following fertilization, indicating that development can occur in some species 
without this step.  This can be used to dissect the contribution of paternal and 
maternal factors and to determine the mechanism of demethylation.  Beaujean et al, 
used intracytoplasmic sperm sperm injection (ICSI) to deliver mouse sperm into a 
sheep oocyte and showed that the male pronucleus underwent a limited loss of 
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methylation, indicating there is a paternal factor present in the mouse sperm which is 
capable of demethylating DNA (Beaujean et al., 2004).  The reciprocal experiment 
introducing sheep sperm into mouse oocytes showed a gradual loss of methylation 
that appeared to coincide with the decondensation of the paternal genome which 
occurs during the protamine to histone exchange, implying there is also a maternal 
factor present in the mouse oocyte that contributes to DNA demethylation. 
 
1.5 The Adenosine Deaminase that act on RNA 
(ADAR) Family 
ADARs were originally described as an activity that could unwind dsRNA and 
modify it such that it migrates differently when electrophoresed on a native gel and 
could not reform a duplex.  This activity was first observed in Xenopus laevis 
embryo extracts, where up to 50% of the adenosine residues in the dsRNA tested 
were deaminated to inosines (Bass and Weintraub, 1987, 1988). 
 
The ADAR family are thought to have evolved from Tad1/ADAT1 by the 
acquisition of several dsRBDs. Drosophila melanogaster contains an ADAT1 
homolog, with a deaminase domain showing 38% identity and 47% similarity to the 
deaminase domain from human ADAR2 (Keegan et al., 2000).  This shows the 
ADAT1 protein, which also edits an adenosine residue in tRNA, is more closely 
related to the ADAR family than to the yeast Tad1 family. Interestingly, recombinant 
dADAT1 is unable to edit adenosine residues in dsRNA as ADAR family members 
do, as it lacks dsRBDs.  
 
There are four members of the ADAR family in mammals, depicted in Figure 1.5.  
ADAR1 contains two translation start sites giving rise to two distinct isoforms that 
differ in their subcellular localisation and have different substrates (Kawakubo and 
Samuel, 2000).  The longer ADAR1 isoform is interferon inducible indicating a role 
in the immune response, whereas the shorter isoform is constitutively expressed.  
Drosophila melanogaster has only one Adar gene, which shows the highest 
homology to mammalian ADAR2 (Palladino et al., 2000a).  Expression of ADARs 
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1, 2, and 3 is highest in the CNS, where most of the known specific substrates have 
been identified.  Another member of the family known as testis-expressed nuclear 
RNA-binding protein (TENR) is expressed in the testis; however it lacks crucial 
conserved residues involved in catalysis and is likely to be catalytically inactive 





The ADAR1 locus contains multiple promoters.  Direct constitutive expression of 
transcripts from one promoter utilise an internal start site at methionine 296 to 
generate the p110 isoform (Kawakubo and Samuel, 2000).  ADAR1 p110 protein 
was originally purified from calf thymus (O'Connell and Keller, 1994).  
Subsequently the cDNA was cloned (O'Connell et al., 1995), and ADAR1 was 
Chapter 1: Introduction 
 
 34
shown to edit the GluR-B transcript at the R/G site in vitro (Maas et al., 1996).  
Mammalian ADAR1 p110 is a nuclear protein which is widely expressed, although 
higher levels are detected in the brain and CNS.   
 
In the lymphatic system ADAR1 expression is regulated by an interferon-inducible 
promoter, which results in use of the first methionine to generate the longer p150 
isoform (Patterson and Samuel, 1995).  The p150 isoform is mainly cytoplasmic due 
to an NES signal within the first Z-DNA binding domain, leading to the hypothesis 
that this isoform may have additional cytoplasmic substrates from those of the 
constitutively expressed p110 nuclear isoform (Poulsen et al., 2001).  The Z-DNA 
binding domains allow interaction with nucleic acids in the Z-form such as DNA and 
structured RNA, and editing efficiency is lower when key residues in the Z-DNA 
binding domains are mutated (Herbert and Rich, 2001).  ADAR1 p110 has been 
shown to localize to the nucleolus.  Photobleaching experiments indicate this 
localisation is dynamic, and the protein leaves the nucleolus to interact with 
substrates (Desterro et al., 2003). 
 
A study into the genetics of Dyschromatosis Symmetrica Hereditaria (DSH) 
identified several mutations across the ADAR1 gene (Miyamura et al., 2003).  DSH 
is an autosomal dominant skin pigmentation disorder, which predominantly affects 
the hands and feet, although the disorder is relatively benign with no other symptoms 
described.  The discovery of 30 different point mutations in the ADAR1 gene 
associated with this disorder indicates that ADAR1 has an as yet undefined role in 
melanocyte development or pigmentation.  One reported case with the mutation 
G1007R also presented with chronic dystonic posturing and calcification in the brain.  
The mutated residue is highly conserved and lies within the deaminase domain.  
Functional assays show the G1007R mutant protein is not capable of RNA editing 
although it retains RNA-binding activity indicating it may behave as a dominant 
negative mutant (Heale et al., 2009).  This mutation has subsequently been reported 
in another individual with DSH, dystonia and calcinosis of the brain; however the 
mother who carried the mutation did not have neurological symptoms indicating this 
mutation may have reduced penetrance (Kondo et al., 2008). 
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Altered RNA editing of the serotonin (5-HT2C) receptor transcript has been linked to 
schizophrenia and suicide (Niswender et al., 2001; Sodhi et al., 2001).  However it is 
unclear from these studies on RNA editing levels in post-mortem brain whether the 
changes are causative of disease or a consequence of medication. 
 
ADAR1-null mice 
Unlike ADAR2 there is no transcript that requires to be edited by ADAR1.  
However, there are five known editing sites in exon 5 of the serotonin 5-
hydroxytryptamine subtype 2C (5-HT2C) receptor (Burns et al., 1997) and ADAR1 
has been shown to edit three of these sites in vitro (Liu et al., 1999).  It was therefore 
surprising when ADAR1-null mice displayed a severe embryonic phenotype of 
massive liver disintegration and died at embryonic day (E) 12.5 (Hartner et al., 2004; 
Wang et al., 2004).  No role for ADARs during development has been described, and 
no edited transcripts in the liver have been found.  Characterisation of the liver 
phenotype revealed a defect in proliferation of haematopoietic cells, with those 
present showing fragmented DNA indicative of apoptotic cell death.   
 
Analysis of mouse embryonic fibroblast cells derived from ADAR1-null mice 
showed elevated apoptosis in response to serum starvation indicating a widespread 
predisposition to apoptotic cell death (Wang et al., 2004).  The onset of the ADAR1-
null apoptotic phenotype correlated with an induction of the interferon-inducible 
p150 isoform following serum starvation implying a role for ADAR1 in mediating 
the induction of apoptosis in response to stress.  Interestingly, analysis of the 
serotonin 5-HT2C receptor transcript isolated from E12 ADAR1-null embryo’s 
showed that exon 5, which contains all five editing sites, was aberrantly spliced out.  
This implies splicing and editing, or the lack of, are linked.  Mice deficient in 
ADAR1 and ADAR2 show a similar phenotype to the single ADAR1 knockouts 
indicating ADAR2 does not have a similar role in early development (Hartner et al., 
2004). 
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Further characterisation of the liver phenotype in ADAR1-null mice revealed that 
ADAR1 is crucial for the maintenance of haematopoietic stem cells (Hartner et al., 
2009).  During liver development ADAR1 acts to suppress interferon signalling and 
in the absence of ADAR1 elevated apoptosis occurs with aberrant activation of 
interferon-inducible genes.  This is intriguing as ADAR1 is a dsRNA-binding protein 
and dsRNA is known to activate the interferon response (Geiss et al., 2001).  
Therefore the hypothesis was proposed that an as yet unknown substrate of ADAR1 
in the embryonic liver elicits an immune response in the absence of ADAR1 (Hartner 
et al., 2009).  The ADAR1-null phenotype could be rescued by expression of 
ADAR1 and rescue was largely, but not entirely, dependent on RNA-editing 
(XuFeng et al., 2009). 
 
ADAR2  
The presence of inosine at the Q/R site in the GluR-B transcript, coupled with the 
observation that ADAR1 does not edit this site in vitro, led to the search for another 
deaminase and ADAR2 was identified (Melcher et al., 1996b).   
 
ADAR2 is a nuclear protein and like ADAR1 p110 it has been shown to localise to 
the nucleolus in a dynamic manner (Desterro et al., 2003; Sansam et al., 2003).  
Further investigation revealed that a region encompassing the first dsRBD is required 
for nucleolar localisation, and the ADAR2 protein re-localises to the nucleoplasm 
upon expression of a substrate.  However, it is unclear whether the region harbours a 
nucleolar localisation signal or whether RNA-binding is required for the nucleolar 
localisation.  Experiments with an ADAR2 mutant containing point mutations within 
both dsRBDs displayed exclusion from the nucleolus indicating RNA-binding was 
required for nucleolar localisation (Sansam et al., 2003).  These results suggest that 
ADAR2 activity is regulated through subcellular localisation. 
 
The crystal structure of ADAR2 revealed an inositol hexakisphosphate molecule is 
buried in the core of the enzyme (Macbeth et al., 2005).  The residues which 
coordinate the inositol hexakisphosphate are conserved throughout the ADAR and 
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ADAT1 families, but absent from the ADAT2/3 family. The inositol 
hexakisphosphate molecule stabilises the ADAR2 protein structure and is essential 
for catalytic activity. 
 
ADAR2 substrates 
Glutamate receptors are grouped according to the synthetic agonists that they bind to, 
into α-amino-3-hydroxy-5-methylisoxasole-4-propionate (AMPA), N-methyl-D-
aspartic acid (NMDA), and kainite receptors.  Pre-mRNAs encoding AMPA and 
kainite receptor subunits are edited leading to variation at key residues within the 
receptor subunits.  To date no mRNAs encoding NMDA receptor subunits have been 
found to be edited.  NMDA receptors are highly permeable to calcium and mediate 
the slow component of the excitatory post-synaptic transmission.  In contrast the 
AMPA receptors usually have low calcium permeability, although this is controlled 
by the presence of the GluR-B subunit which is edited, and mediate fast excitatory 
synaptic transmission.   
 
Editing of the glutamate receptor B subunit transcript (GluR-B, also called GluR-2) 
changes a CAG codon to a CIG which is interpreted by the translation machinery as 
a CGG codon.  This changes the genomically encoded glutamine at position 607 to 
an arginine residue, termed the Q/R site (Higuchi et al., 1993).  Editing of the Q/R 
site occurs to >99% in the mouse and human CNS.  This editing event is performed 
by ADAR2, although ADAR1 can edit this site to approximately 10% as 
demonstrated in ADAR2-null mice (Higuchi et al., 2000).  Editing at this position 
regulates the permeability the AMPA receptor to calcium as inclusion of GluR-B 
subunits with the genomically encoded glutamine renders the channel permeable to 
calcium, whereas the arginine residue included as a result of RNA editing renders 
channels impermeable to calcium (Burnashev et al., 1992).  Thus, one site-specific 
RNA editing event has great functional importance for neuronal calcium 
homeostasis.  However, AMPA receptors are tetrameric and can be formed by homo- 
or hetero-oligomeric assembly of any two or more subunits from a pool of four 
(GluR-A/B/C/D).  Therefore receptors can lack a GluR-B subunit altogether making 
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them permeable to calcium, which occurs in aspiny neurons throughout the CNS.  
Calcium concentration is regulated in cells that do not express the GluR-B subunit 
through local calcium extrusion pumps and calcium-binding proteins.  However, 
AMPA subunit composition is also dynamically remodelled in response to neuronal 
activity, the role of AMPA receptor subunits in synaptic plasticity is reviewed in (Liu 
and Zukin, 2007).  Interestingly, despite sharing considerable sequence and structural 
homology the other three GluR subunit transcripts A, C, and D, do not undergo 
editing at the Q/R site and retain a glutamine at the corresponding amino acid.   
 
Editing and alternative splicing of the GluR-B transcript has also been shown to 
affect receptor biogenesis in the endoplasmic reticulum (ER).  Editing at the Q/R site 
results in retention of the GluR-B subunit with the ER, whilst the unedited GluR-B 
(Q) subunit is efficiently assembled into receptors and transported to the cell surface 
(Greger et al., 2002).  ER retention is thought to promote inclusion of the GluR-B 
(R) subunit into heterotetramers whereas GluR-B (Q) subunits more readily form 
homotetramers (Greger et al., 2003).  Interestingly it has recently been shown that 
RNA editing at the R/G site modulates AMPA receptor assembly in an analogous 
fashion by slowing the trafficking of AMPA receptors within the ER  (Greger et al., 
2006).  Therefore RNA processing events determine the kinetics and assembly of 
AMPA receptors at the synapse. 
 
The calcium permeability of kainate receptors is also regulated by editing at one 
position which corresponds to the Q/R site in the GluR-B transcript.  Editing of the 
transcripts encoding the kainate receptor subunits GluR-5 and GluR-6 is both 
spatially and developmentally regulated, and editing of each subunit transcript is 
independent of the other (Bernard et al., 1999).   
 
The transcripts encoding GluR subunits A-D are alternatively spliced which 
increases the variety of AMPA receptors.  Two mutually exclusive exons termed 
FLIP and FLOP present in the ligand-binding domain of all four GluR subunits are 
thought to regulate the desensitisation kinetics of the channel (Koike et al., 2000; 
Sommer et al., 1990).  Editing of another site in the GluR-B transcript which lies 
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close to the FLIP/FLOP exons results in a change from the genomically encoded 
arginine to a glycine residue (R/G site).  The R/G site is also edited in GluR-C and 
GluR-D transcripts, however it is absent from GluR-A due to loss of a functional 
ECS region (Lomeli et al., 1994).  Editing at the R/G site is performed by both 
ADAR1 and ADAR2, and occurs at low levels during development increasing to 
approximately 75% in adult mouse brain.  The resulting glycine substitution 
increases the rate of recovery of the channel from desensitisation (Lomeli et al., 
1994).  Therefore the range of receptor subunits available is considerably increased 
through alternative splicing and editing.   
 
ADAR2 transcriptional regulation 
Rat ADAR2 is alternatively spliced which generates several different isoforms 
(Rueter et al., 1999).  One alternatively spliced exon located near the 5’ end of the 
gene is 47bp long and inclusion of this exon alters the predicted reading frame of the 
protein.  Use of the canonical translation start site in the presence of the 47bp exon 
would generate a truncated protein lacking the dsRBDs and the catalytic domain.  
However, use of an internal translation initiation site (Met25) generates a functional 
deaminase lacking the first 24 amino acids, although this protein is only detected at 
low levels in rat brain suggesting inefficient translation from the internal methionine.  
Further investigation revealed that the inclusion of this 47bp sequence was dependent 
upon editing of an adenosine residue at the -1 position of the 3’ splice site, which 
would create an AI dinucleotide that mimics the canonical AG acceptor site.  Editing 
at this site occurred to 47% in ADAR2 pre-mRNA isolated from rat brain.  Therefore 
rat ADAR2 has evolved a complex autoregulatory feedback, such that alternative 
splicing of its own transcript is dependent on the presence of a functional ADAR2 
protein (Rueter et al., 1999).  Mice lacking an ECS for the -1 editing position had 
elevated levels of ADAR2 protein and increased editing of ADAR2 substrates 
indicating the ADAR2 autoediting event functions in vivo to regulate ADAR2 
activity  (Feng et al., 2006). 
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ADAR2 autoediting also occurs in human cell lines, where the level of auto-editing 
and inclusion of the alternatively spliced exon have been shown to correlate, such 
that higher expression of ADAR2 results in increased inclusion of the 47bp exon 
(Maas et al., 2001).  This is independent of ADAR1 expression.  The stem-loop 
structure surrounding the edited splice site is created by interactions between intron 4 
and the downstream exon and contains a loop of 1354 nucleotides, yet the paired 
regions are highly conserved.  Interestingly, the adenosine residue at position -2 
(neighbouring the -1 site) was shown to be edited by ADAR1 in cell culture 
experiments and editing occurred in 23% of ADAR2 transcripts isolated from rat 
brain indicating editing of this site occurs in vivo (Dawson et al., 2004).  
Deamination of this residue would abrogate the cryptic splice site created by ADAR2 
mediated editing of the -1 position, providing another potential mechanism to 
regulate ADAR2 activity via ADAR1.   
 
Human ADAR2 cloned from a brain cDNA library showed two main isoforms, 
which differ through alternative splicing of an Alu cassette within the deaminase 
domain (Gerber et al., 1997).  Characterisation of the two ADAR2 isoforms revealed 
that they both showed the same substrate specificity, but inclusion of the Alu-
containing exon led to a two-fold reduction in ADAR2 activity on a GluR-B R/G site 
substrate in vitro. 
 
ADAR2 transgenic mice 
In contrast to the embryonic lethal phenotype resulting from deletion of the ADAR1 
gene, mice lacking ADAR2 survive to birth but died by post natal day 20 with an 
increasing predisposition to epileptic seizures (Higuchi et al., 2000).  Interestingly, a 
similar phenotype was seen in mice engineered to express an uneditable GluR-B 
allele which lacks a functional ECS region (Brusa et al., 1995), whereas mice that 
only express the edited version of GluR-B (R) are phenotypically normal (Kask et 
al., 1998).  The ADAR2-null mice show reduced editing at the GluR-B Q/R site: 
10% of pre-mRNA transcripts were edited but this represents 40% of mature 
messages in these mice due to preferential splicing of the edited GluR-B transcript.  
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The authors attribute the low level of residual GluR-B editing to ADAR1 whose 
expression was unaffected by alterations in ADAR2.  Further processing defects 
were observed for the GluR-B transcript.  Inefficient editing led to accumulation of 
unspliced pre-mRNA in the nucleus that retained intron 11 where the ECS is located 
(Higuchi et al., 2000).  These processing problems resulted in a five-fold decrease in 
the amount of mature GluR-B mRNA.  A similar problem with GluR-B processing 
was observed in mice expressing an uneditable GluR-B transcript lacking the ECS 
(Brusa et al., 1995).  The RNA processing defects resulted in five-fold less GluR-B 
protein being produced, which led to an alteration in glutamate receptor physiology 
such that the CA1 pyramidal neurons displayed a 30-fold higher permeability to 
calcium compared to wild type.  This defect in calcium homeostasis ultimately 
resulted in death of the affected neurons.  The ADAR2-null phenotype could be 
completely rescued by expression of an edited GluR-B (R) transgene indicating the 
primary function of ADAR2 is to edit the GluR-B transcript (Higuchi et al., 2000).  
The rescue also confirms that there is no obvious role for the unedited GluR-B (Q) 
allele as the rescued mice were phenotypically wild type.   
 
Interestingly, expression of a GluR-B transgene in mice with an asparagine residue at 
the Q/R site led to selective death of motoneurones that increased with age (Kuner et 
al., 2005).  The asparagine residue conferred a 2-fold increase in calcium 
permeability but did not significantly alter the AMPA channel conductance.  The 
motoneuron phenotype was similar to that observed in a mouse model of familial 
amyotrophic lateral sclerosis (fALS) in which a mutation in the superoxide dismutase 
1 (SOD1) gene results in selective motoneuron pathology (Gurney et al., 1994).  
Indeed, crossing the GluR-B (N) mice with SOD1 mutants enhanced the motoneuron 
degeneration, implicating a role of GluR-B mediated calcium homeostasis in human 
motoneuron diseases such as ALS (Kuner et al., 2005).  This is explored later in the 
section on ADAR2 as a “neuronal gatekeeper” and reviewed in (Buckingham et al., 
2008). 
 
Transgenic mice overexpressing ADAR2 under the control of a CMV promoter 
developed adult-onset obesity, similar in phenotype to transgenic mice null for the 
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serotonin 5-HT2C receptor (Singh et al., 2007).  Interestingly, the same adult-onset 
obesity phenotype was observed with transgenic mice overexpressing a catalytic site 
mutant ADAR2 E396A, indicating the phenotype was not due to aberrant adenosine 
deamination.  Editing at several known sites including the serotonin 5-HT2C receptor 
was shown to occur at similar levels to wild type littermates.  However the transgenic 
mice also expressed endogenous ADAR2 and levels of transgenic ADAR2 protein in 
the brain were only 1.2-fold higher than endogenous levels, leading to the hypothesis 
that the phenotype was due to transgene expression in tissues that do not normally 
express ADAR2.   
 
ADAR3 
A third ADAR protein was initially identified in rat (Melcher et al., 1996a).  The 
human homologue of this protein, ADAR3, is only expressed in specific regions of 
the brain including the amygdala and thymus (Chen et al., 2000).  In vitro studies of 
recombinant ADAR3 showed it was capable of binding to dsRNA like the other 
ADAR proteins, but also to ssRNA through an N-terminal Arginine and lysine rich 
region (R domain) that is not found in other members of the family.  However, in 
vitro deaminase assays on known targets of other ADAR proteins (the GluR-B 
subunit transcript and the serotonin 5-HT2C receptor subunit transcript) revealed that 
ADAR3 was not capable of deaminating these transcripts.  A chimera generated from 
the ADAR3 dsRBDs and the ADAR2 deaminase (DA) domain was able to direct 
deamination of known substrates, but the reciprocal chimera containing the ADAR3 
DA domain had no deaminase activity (Melcher et al., 1996a).  In vitro analysis 
showed that ADAR3 could act as an effective competitor by binding to the same 
transcripts as ADARs 1 & 2 and preventing deamination (Chen et al., 2000).   
 
To date no known function has been described for ADAR3, however the 
conservation of the deaminase domain as shown by amino acid alignment (Keegan et 
al., 2004) indicates there may be selective pressure to keep it unchanged.   
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Testis Expressed Nuclear RNA-binding protein (TENR) 
Testis-expressed nuclear RNA-binding protein (TENR), a novel member of the 
ADAR family, was found to be expressed in the round spermatids in the testis.  
TENR was identified in a screen to find RNA-binding proteins that interact with the 
3’UTR of the protamine 1 (Prm1) RNA (Schumacher et al., 1995).  TENR-null male 
mice are sterile (Connolly et al., 2005).  This is due to low sperm counts and a high 
incidence of sperm morphological defects indicating TENR plays a role in sperm 
morphogenesis.  However TENR lacks the conserved residues within the deaminase 
domain that are essential for catalytic activity indicating it is not a functional 
deaminase (Connolly et al., 2005).  No substrates have been identified and the 
biological function of TENR remains unclear. 
Drosophila ADAR 
Drosophila melanogaster contains only one Adar gene and the dADAR protein 
shows the greatest homology to mammalian ADAR2, with the deaminase domain 
showing 67% identity to human ADAR2 (Palladino et al., 2000a).  To date several 
different Drosophila Adar mutant alleles have been described (Ma et al., 2001; 
Palladino et al., 2000b).  Several deletion strains at the Adar locus were generated by 
P-element mobilisation, the largest of which encompasses the whole Adar gene and 
promoter region and is termed Adar5G1.  The ends of the Adar5G1 deletion have been 
defined and the deletion also removes two neighbouring genes (CG32806 and 
CG14809).  These flies show a complete loss of both site-specific and non-specific 
RNA editing.  Adar5G1 flies also have severe behavioural and locomotive defects 
with no attempts at courtship and extremely uncoordinated movement with frequent 
falls.   They display temperature-sensitive paralysis and tremors which progress in 
severity with age and flying is rarely observed and only occurs in response to 
repeated stimulation (Palladino et al., 2000b). Adar1F1 mutants, in which only the 
promoter region of Adar is deleted, have reduced viability but under optimal 
environmental conditions they survive to 60 days, however in a mixed population the 
Adar1F1 mutants fail to thrive indicating they are at a selective disadvantage.  The 
ADAR-null flies developed a progressive age-dependent neurodegenerative 
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phenotype characterised by accumulation of vacuoles in the brain that was not 
observed in age-matched controls (Palladino et al., 2000b).   
 
Similar behavioural defects to those observed in ADAR-null flies are observed in fly 
strains with mutations in ion channel genes which are known substrates of ADAR.  
For example flies with a temperature-sensitive mutation in the cacophony calcium 
channel display convulsions and with uncoordinated locomotion similar to Adar 
mutants.  Defects in the courtship song were also observed for cacophony, paralytic 
and slowpoke temperature-sensitive mutants, and the transcripts from these genes are 
edited by ADAR (Peixoto and Hall, 1998).  This indicates there is an overlap in the 
phenotype associated with Adar deletion and the defects arising from mutations in 
the genes which encode substrates of ADAR.  However none of these mutants show 
a neurodegenerative phenotype indicating perhaps the neurological defects in Adar-
null flies do not arise from defects in site-specific editing. 
 
Two alleles of Drosophila Adar termed hypnos-2P and hypnos-2L were discovered in 
a genetic screen for loss-of-function mutations that show increase sensitivity to 
hypoxia (Ma et al., 2001).  Ma et al showed that the Adar mutant hypnos-2 had a 
delayed recovery following oxygen deprivation, and went on to characterise the 
hypnos-2 mutant as having decreased locomotor activity and age-dependent 
neurodegeneration.  The hypnos-2P allele is a 434bp deletion of the genomic DNA 
encoding exons 5 and 6 of the Drosophila Adar gene.  This is an in-frame deletion 
and removes the second dsRBD and part of the deaminase domain, yet the critical 
motif (HAE) containing the histidine residue that coordinates with the zinc atom and 
the glutamic acid residue that acts as a proton donor in the hydrolytic deamination 
reaction is not affected by this deletion.  It is not clear whether protein is generated in 
these flies; however sequence analysis of known substrates of ADAR in the hypnos-
2P mutants revealed no evidence of site-specific editing.  The hypnos-2P flies have 
reduced locomotor function and reduced lifespan when compared to Canton S flies 
and develop progressive neuronal degeneration in the medulla and lobula complex.  
Furthermore the mutant phenotype could be rescued by expression of a wild type 
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Drosophila Adar transgene under control of the 32B promoter which expresses 
highly in the eye (Ma et al., 2001). 
 
Drosophila ADAR expression 
Drosophila Adar is expressed from 2 different promoters termed -4a and -4b which 
generate transcripts with different 5’ exons.  Whereas transcripts from the -4a 
promoter could be detected throughout development transcripts from the -4b 
promoter were only present in pupae and adult flies indicating this isoform is 
developmentally regulated (Palladino et al., 2000a). Transcripts from both promoters 
are subject to alternative splicing of exon -1, whereas only transcripts from the -4a 
promoter showed inclusion of the alternatively spliced exon 3a, giving rise to a total 
of 6 isoforms that are regulated both spatially and temporally (Marcucci et al., 2009).  
Interestingly the alternatively spliced exon 3a occurs between the two dsRBDs.  
Altering the distance between dsRBDs could alter the substrate specificity of the 
deaminase as inclusion of exon 3a gives a protein that shows the same distance 
between dsRBDs as human ADAR2, and exclusion of exon 3a is comparable to 
human ADAR1 dsRBD spacing.  Expression of Drosophila Adar is highest in the 
central nervous system throughout development, although expression is also detected 
in testis and ovary (Marcucci et al., 2009; Palladino et al., 2000a). 
 
Sequence analysis revealed that the dAdar transcript undergoes auto-editing within 
exon 7 which produces an amino acid change of a serine to a glycine residue within 
the deaminase domain (Keegan et al., 2005).  Analysis of the dAdar transcript 
throughout development indicated that the auto-editing in exon 7 was highly 
regulated; editing was low in embryonic and pupal stages but increased after eclosion 
to reach approximately 40% in adult flies.  However, further analysis revealed that 
transcripts containing the alternatively spliced exon 3a were never found to be edited, 
indicating that dAdar auto-editing is both transcript-dependent and temporally 
regulated (Palladino et al., 2000a).  In vitro analysis revealed that the exon 7 editing 
site was edited to approximately 70% by a recombinant ADAR 3/4 S/G (lacking 
exon 3a, a mix of both edited and unedited isoforms) protein purified from Pichia 
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pastoris (Keegan et al., 2005).  Analysis of the edited isoform containing a serine 
residue versus the unedited isoform containing a glycine residue, revealed that 
editing reduces catalytic activity by approximately 8-fold in vitro.  Therefore 
dADAR editing of its own transcript provides an auto-regulatory feedback to lower 
catalytic activity.  Indeed constitutive expression of an uneditable dAdar 3/4 S 
transgene under control of a ubiquitous actin promoter is lethal, whereas the glycine 
isoform is not (Keegan et al., 2005).   
 
Characterisation of the role of ADAR within the developing nervous system revealed 
that activity increases throughout development with highest editing levels observed 
in the adult which correlates with increased auto-editing of Adar exon 7 (Keegan et 
al., 2005). Analysis of editing at 10 positions in the cacophony transcript 
demonstrated that editing frequency is low in embryos and highest in the adult with 
larval editing at an intermediate level.  In Drosophila melanogaster many ADAR 
substrates have been identified indicating a more widespread role for dADAR in 
protein diversity.  Sites in several substrates are edited to 100% however no 
transcripts have been identified that can rescue the ADAR-null phenotype as occurs 
with the GluR-B (Q) transcript in ADAR2-null mice (Higuchi et al., 2000).  In 
Drosophila the compact genome restricts the number of proteins generated, therefore 
processes such as alternative splicing, alternative promoter usage and RNA editing 
are employed to increase the diversity of the protein repertoire.   
 
RNA binding by ADARs 
ADAR belongs to a diverse group of proteins that share one or more copies of a 
common dsRBD of approximately 70 amino acids (reviewed in (Fierro-Monti and 
Mathews, 2000)).  Few residues are conserved throughout the family but all dsRBDs 
analysed share the same secondary structure of alpha helices and beta sheets, 
organised as α1-β1- β2- β3- α2, where the alpha helices make contact with the same 
face of the RNA.  Other family members include Staufen a protein involved in 
mRNA transport; PKR, an interferon-inducible, RNA-dependent protein kinase; and 
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many proteins involved in the RNA interference pathway including Ribonuclease III, 
an RNA nuclease. 
 
Importantly, these dsRBD-containing proteins do not exhibit sequence specificity, it 
is the secondary structure of the A-form RNA that they recognise.  The substrate 
preference of RNA over DNA arises from the protein-RNA interactions that occur 
with the 2-hydroxyl group of the ribose sugar.  Experiments to determine the binding 
and activity of ADAR2 were performed on a short RNA encompassing the GluR-B 
Q/R site and surrounding sequence to ensure secondary structure is formed (Stephens 
et al., 2004).  This demonstrated that ADAR2 dsRBDs exhibit selective RNA-
binding on the GluR-B Q/R site and the regions contacted are distinct from the 
binding site of a dsRBD from PKR.  The dsRBD occupies approximately 16bp of 
dsRNA but many can accommodate or prefer binding to bulges or loops within the 
dsRNA.  However, individual dsRBDs display preferences for different duplex RNA 
structures, for example the ADAR2 dsRBDs exhibit different binding specificities 
when analysed separately which could enhance substrate specificity (Poulsen et al., 
2006; Stefl et al., 2006).  dsRBD1 preferentially binds to perfect duplex dsRNA 
located in the stem-loop region, whereas dsRBD2 shows preference for dsRNA 
containing an A-C mismatch which is usually located near to the editing site.  Both 
dsRBDs are required for efficient editing by ADAR2 (Stefl et al., 2006). 
 
In mammals ADAR1 contains three dsRBDs whereas ADAR2 and ADAR3 contain 
two dsRBDs.  Drosophila ADAR shows most homology to ADAR2 with two 
dsRBDs (Palladino et al., 2000a), which show the greatest homology to ADAR1 
dsRBDs 1 and 3.  ADAR1 dsRBDs 1 and 3 are required for catalytic activity, but 
dsRBD2 is dispensable, indicating the conserved dsRBDs 1 and 3 are involved in 
interactions with the RNA substrate (Lai et al., 1995).  Intriguingly, mutants 
analysed by Lai et al, that lack one of the conserved dsRBDs (ΔdsRBD1 or 3) do not 
show impaired binding to dsRNA but lose deaminase activity indicating binding and 
editing are separate events, and that binding of both dsRBDs is required for 
deamination (Lai et al., 1995).  Analogous experiments with ADAR2 revealed that 
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deletion of dsRBD1 reduced editing efficiency whereas loss of dsRBD2 abolished 
editing altogether (Poulsen et al., 2006). 
 
To investigate the specificity of the deaminase (DA) domain from ADAR1 and 
ADAR2 chimeric proteins with the dsRBDs from one ADAR and the DA domain 
from another were created (Wong et al., 2001).  This revealed that the editing 
specificity in the chimeric proteins was provided by the DA domain.  In contrast, 
exchanging the dsRBDs between ADAR1 and PKR resulted in a loss of substrate 
recognition, indicating specificity is also provided by the dsRBDs although this 
chimeric protein retained the ability to deaminate some substrates (Liu et al., 2000).  
ADAR3 is the only member of the ADAR family known to bind to ssRNA, and 
experiments have shown this interaction is mediated through the arginine and lysine-
rich R domain in the amino terminus of the protein which is not found in other 
ADAR proteins (Chen et al., 2000).  ADAR3 is also capable of binding dsRNA 
through its canonical dsRBDs but it is unable to edit either known substrates or 
dsRNA.   
 
The formation of homodimers is required for adenosine deamination by ADAR 
enzymes (Cho et al., 2003; Gallo et al., 2003; Jaikaran et al., 2002; Poulsen et al., 
2006).  A ternary complex can be observed when increasing amounts of ADAR are 
added to substrate RNA, such that one monomer binds and then another indicating 
dimerisation is RNA-dependent (Jaikaran et al., 2002).  Analysis of RNA editing in 
vitro using one wild type monomer and one catalytically inactive monomer showed 
that both monomers contribute to hyper-editing of dsRNA and site specific editing of 
substrates (Cho et al., 2003).  Fluorescence energy resonance transfer (FRET) 
experiments indicate that ADAR1 and 2 form homodimers in an RNA-independent 
manner, and are capable of forming heterodimers in vivo (Chilibeck et al., 2006).   
 
However, conflicting reports have been published on whether RNA-binding is 
required for dimerisation (Chilibeck et al., 2006; Gallo et al., 2003; Jaikaran et al., 
2002; Poulsen et al., 2006; Valente and Nishikura, 2007).  The conflict likely arises 
from the use of single or multiple point mutants which are predicted to abolish RNA-
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binding but may have secondary effects on regulatory or structural residues which 
could account for differences in experimental results.  Further, studies indicate that 
both dimerisation and RNA-binding are mediated through the dsRBDs, which 
complicates mutational analysis.  
 
The minimal dimerisation domain for Drosophila ADAR comprises the N-terminal 
region including the first dsRBD, and mutations to abolish RNA binding within 
dsRBD1 also abolish dimer formation (Gallo et al., 2003).  Yet a deletion which 
inhibits dimer formation does not affect RNA binding indicating monomers can bind 
dsRNA consistent with step-wise formation of dimers on dsRNA as observed for 
mammalian ADAR2 (Jaikaran et al., 2002).  In vitro experiments mixing wild type 
dADAR with a mutant dADAR protein which lacks RNA-binding activity revealed 
editing efficiency was not affected indicating dADAR monomers do not interact 
without RNA-binding (Gallo et al., 2003).  Similar experiments with a catalytic 
mutant dADAR demonstrated a 50% decrease in editing efficiency indicating both 
catalytic sites perform the deamination reaction.  However for mammalian ADAR2, 
which shows the highest homology to Drosophila ADAR (Palladino et al., 2000a), 
the N-terminal region of the protein is dispensable for both dimerisation and editing 
(Macbeth et al., 2004; Poulsen et al., 2006).  Addition of the N-terminal region of 
ADAR2 in trans reduced editing efficiency leading to the hypothesis that the N-
terminal region of ADAR2 has an auto-inhibitory effect on catalytic activity.  
Binding of both dsRBDs to a dsRNA substrate is required to relieve the auto-
inhibition for efficient editing (Macbeth et al., 2004). 
 
To assess the role of RNA-binding in dimerisation Valente and Nishikura (2007) 
made mutations in three conserved lysine residues (KKxxK>EAxxA) within each of 
the dsRBDs of ADAR1 and ADAR2.  The mutations introduced were based on data 
from alanine-scanning mutagenesis of the Drosophila RNA-binding protein Staufen, 
which demonstrated that mutation of exposed lysine residues within the conserved 
dsRBD eliminated RNA-binding without disrupting structure (Ramos et al., 2000).  
Sequential purification of protein complexes containing both wild type and mutant 
ADAR proteins demonstrated that homodimerisation of ADAR proteins occurs 
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independently of RNA-binding (Valente and Nishikura, 2007).  However dimeric 
ADAR proteins containing one mutant and one wild type monomer behaved in a 
dominant negative manner in both an RNA-binding assay and an in vitro editing 
assay indicating that RNA-binding of both monomers is required for deamination to 
occur.  These results contradicts earlier studies utilising Drosophila ADAR protein 
which demonstrated that ADAR monomers do not interact without RNA-binding 
(Gallo et al., 2003).  The differences likely arise from use of different mutations to 
abolish RNA-binding which may affect phosphorylation sites or dimerisation 
domains, alternatively the purification procedures may impact on the results as RNA 
may be present in the protein preparations.  Interestingly Valente & Nishikura also 
observed that a dimer formed between a catalytic site mutant monomer and a wild 
type monomer exhibits normal RNA-binding and a 50% reduction in deamination in 
vitro (Valente and Nishikura, 2007), which confirms earlier results using dADAR 
(Gallo et al., 2003).   
 
In yeast, ADAT2 and ADAT3 have been shown to function as a heterodimer where 
ADAT2 provides the catalytic function and ADAT3 provides substrate specificity 
(Gerber and Keller, 1999).  This raised the possibility that ADARs may function as 
heterodimers.  Heterodimerisation between ADAR proteins may reveal a role for 
ADAR3 where ADAR1 or 2 provides the catalytic activity and ADAR3 provides 
substrate specificity; however no heterodimer formation was found between 
members of the ADAR family in an in vitro analysis (Cho et al., 2003).  This may be 
due to different subcellular localisation as the isoforms analysed were ADAR1 p150 
which is cytoplasmic and ADAR2 which is nuclear.  FRET analysis indicates 
heterodimers between ADAR1 and ADAR2 monomers form in vivo (Chilibeck et al., 
2006) and heterodimers between ADAR1 and ADAR2 were co-immunoprecipitated 
from astrocytoma cell lines where it was demonstrated that increased levels of 
ADAR1 can inhibit editing of substrates by ADAR2 (Cenci et al., 2008).  It remains 
to be seen whether overexpression of ADAR3 can have the same effect.  Dimers 
formed between the two isoforms of ADAR1 (p110 and p150) are readily detectable 
indicating that the Z-DNA binding domains absent in the p110 isoform are not 
required for dimerisation (Cho et al., 2003). 
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Secondary structure of RNA substrates 
Initial investigation into editing of the GluR-B transcript at the Q/R site revealed an 
editing complementary sequence (ECS) located in the downstream intron was 
required for editing to occur (Higuchi et al., 1993).  The ECS sequence forms an 
imperfect stem-loop structure which is bound by the dsRBDs of ADAR2.  Point 
mutations which destabilised the stem-loop decreased the editing frequency, but this 
could be restored by making the complementary mutation in the opposite base, 
indicating it is the structure not the sequence that is important.  Comparative SELEX 
using dsRBDs from Xenopus laevis ADAR1 and Xlrbpa revealed no sequence 
specificity but showed both dsRBDs had a similar structural preference for two stem-
loop structures which incorporate bulges and mismatches, although perfect duplex 
RNA also showed strong binding affinity (Hallegger et al., 2006).   
 
Mammalian ADARs 1 and 2 show some overlapping substrates yet others are clearly 
specific for one or other protein, raising questions about substrate recognition.  
Whilst there is no consensus sequence surrounding edited adenosine residues ADAR 
enzymes exhibit local sequence preferences.  For example: the 5’ nearest neighbour 
preference for ADAR1 is U=A>C>G, similarly for ADAR2 it is U=A>C=G 
(Lehmann and Bass, 2000).  However, editing does not occur at adenosine residues 
located near to the end of a dsRNA helix (Lehmann and Bass, 2000).   
 
The carboxyl terminal region of ADAR enzymes contains motifs shared with DNA 
methyltransferase enzymes, which suggests that deamination of an adenosine residue 
may occur via a base-flipping mechanism similar to the addition of a methyl group 
by DNA methyltransferases (Hough and Bass, 1997).  The addition of a methyl 
group by a DNA methyltransferase occurs outside the DNA helix, with the target 
residue rotated or flipped 180 degrees allowing modification of the internal face of 
the base and minimising structural disruption (Roberts and Cheng, 1998).   
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Substrates of mammalian ADARs 
RNA editing plays a crucial role in the life cycle of the hepatitis delta virus (HDV) 
(Polson et al., 1996).  The viral genome contains an amber stop codon (UAG) which 
is altered by A-I editing to produce a UIG codon which is translated as tryptophan 
(UGG) by the translation machinery.  The two proteins produced: short (p24) and 
long (p27), differ by 19 amino acids and have specific roles in the viral life cycle.  
p24 is required for replication of the viral RNA genome whereas p27 represses 
replication and is required for packaging  of the virus.  Editing at the HDV amber/W 
site was shown to occur in vitro with recombinant Xenopus laevis ADAR (Polson et 
al., 1996), and this in vitro editing event was used to analyse Drosophila 
melanogaster cell extract to show that an ADAR activity was present and conserved 
(Casey and Gerin, 1995).  Editing at this site is inhibited by the HDV p24 protein via 
RNA-binding which provides an internal feedback loop that regulates the HDV life 
cycle through regulation of RNA editing (Polson et al., 1998). 
 
Inosine occurs at frequency of approximately one base in every 17,000 nucleotides in 
mouse brain poly (A)+ RNA (Paul and Bass, 1998).  This frequency of inosine 
nucleotides cannot be accounted for with known site-specific editing events and 
prompted the search for new ADAR substrates.  Many attempts have been made to 
conclusively describe the list of ADAR substrates in different model organisms 
through detection of A-G transition changes when comparing cDNA and genomic 
DNA sequences.  However this approach is difficult due to the high frequency of 
single nucleotide polymorphisms (SNPs) and sequencing errors.   
 
Levanon et al, used a bioinformatic approach to search for expressed sequence tags 
(ESTs) containing A-G mismatches (Levanon et al., 2004).  As the substrate for 
ADAR is dsRNA they limited their search to double-stranded regions in ESTs.  This 
approach identified 12,723 putative editing sites in 1,637 genes, 26 of which were 
validated by sequencing genomic DNA and cDNA from the same individual.  
Interestingly 92% of editing sites identified using this approach were located within 
Alu elements, and 1.3% were in LINE elements.   
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Using a similar approach Athanasiadis et al, searched databases for clusters of 
multiple A-G changes within short sequences, reasoning that these were unlikely to 
be SNPs or sequencing artefacts (Athanasiadis et al., 2004).  They also found that A-
G changes clustered at the site of Alu repeat element insertions.  This approach 
identified 1,445 mRNAs that were edited at 14,500 sites, which is equivalent to the 
majority of the inosine observed in brain mRNA.  Alu insertion favours actively 
transcribed regions, often occurring in UTR regions and within intronic regions, 
therefore these regions are present in the pre-mRNA ADAR substrate.  The edited 
Alu repeat elements were found to occur in tandem in inverted repeat orientation 
such that when transcribed a dsRNA stem-loop structure would form between the 
two inverted repeats and be edited by ADAR.  Due to the extensive similarity 
between Alu elements the stem-loop structures formed are inherently stable, although 
bulges and mismatches were edited more frequently than near-perfect duplexes 
reflecting the in vivo substrate preference of ADARs.  Some editing events were 
found to alter splice sites resulting in exonisation of a partial or whole Alu element, 
although the novel alternative splice sites were usually used at a low frequency and 
rarely constitutively (Athanasiadis et al., 2004).  Surprisingly editing of other known 
repeat elements was considerably lower than that of Alu elements, which is likely to 
be due to the high level of conservation between Alu element sub-groups and the 
frequency of inverted insertions which create the required secondary structure. 
 
The prevalence for editing within Alu elements was further confirmed using similar 
large scale bioinformatic approaches (Blow et al., 2004; Kim et al., 2004).  These 
studies all conclude that the majority of pre-mRNA editing occurs within non-coding 
regions and may act to inhibit retrotransposition of repetitive elements.  A further 
attempt to find novel editing sites in mammalian transcripts which generate re-coding 
events in the amino acid sequence used a screen based on known re-coding editing 
events (Clutterbuck et al., 2005).  This led to the identification of a novel ADAR 
substrate BC10, which contains three re-coding editing events. 
 
Recently a deep sequencing project was performed to analyse potential editing sites 
in non-repetitive sequences using unique linked primers that form a “padlock” across 
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potential editing sites and following amplification and ligation these small regions 
were analysed by high throughput sequencing (Li et al., 2009).  This approach 
identified ten known substrates, along with 207 putative new substrates, although this 
list was considerable longer when the stringent selection criteria were relaxed as 
many transcripts showed low levels of editing (<5%).  Of the sites identified 55 
occurred in coding regions, and 38 led to amino acid changes, indicating re-coding 
editing events in humans are more common than originally thought.  Editing also 
varied with brain region analysed, indicating there may be substrates of ADAR that 
are only edited in specific brain regions.  Next generation sequencing technology has 
made the identification and verification of novel editing sites easier, however the 
functional consequences of these newly identified editing events remains to be 
determined.   
 
 Drosophila Adar substrates 
RNA editing in Drosophila was initially described in the rnp-4f transcript isolated 
from fly head.  However this editing was distinct from the site-specific editing 
observed in mice, as it appeared that numerous adenosine residues were edited 
throughout the transcript (263 A-G mutations in a 4kb mRNA) (Petschek et al., 
1996).  This editing pattern is reminiscent of hyper-editing observed with perfect 
duplex dsRNA; however it was unclear how the dsRNA structure required for editing 
could form as the editing events occurred throughout coding and non-coding regions.  
Further investigation of the locus revealed that the neighbouring gene sas-10, which 
is transcribed from the opposite DNA strand, is transcribed from dual promoters.  
One promoter directs read-through of the termination signal to produce a long 
transcript which is perfectly complementary to the rnp-4f transcript.  Interestingly the 
expression of these transcripts is inversely proportional such that rnp-4f is expressed 
early during development and declines into adulthood, and sas-10 is induced at late 
stages of embryo development and peaks during the second instar larval stage.  
Sequence analysis revealed these RNAs are expressed in the same cells and both 
transcripts showed evidence of editing.  However despite many attempts only one 
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cDNA was cloned which showed extensive non-specific hyper-editing indicating this 
is not a common occurrence (Peters et al., 2003). 
 
RNA editing has been described at four positions in the paralytic sodium channel 
subunit transcript (Hanrahan et al., 2000).  This provided the first comprehensive 
study of editing that resulted in re-coding in Drosophila and showed that editing of 
all positions was low in the embryo through to the third instar larvae stage and 
dramatically increased at pupation to high levels (maximum 70%) which were 
maintained into adult.  Pairwise analysis of two sites revealed editing at each position 
was independent, and analysis of different isoforms generated by alternative splicing 
of one exon indicated that there was no preferential editing of specific isoforms.  
Comparison of D.melanogaster and D.virilis genomic sequence revealed highly 
conserved intronic regions likely to contain a putative ECS sequence, and one of 
these was confirmed by expression of a minimal cassette containing the edited site 
and the ECS region in vivo (Hanrahan et al., 2000).  Interestingly, secondary 
structure prediction indicated that despite differences in the surrounding regions the 
edited site and the ECS from D.melanogaster and D.virilis formed almost identical 
stem-loop structures.   
 
Maleless (mle) is a dsRNA helicase involved in sex-specific dosage compensation; 
however a mle mutant allele has been characterised that shows temperature-sensitive 
paralysis and was therefore called no action potential (napts).  The mlenapts mutant 
phenotype is due to a decreased level of correctly processed para transcript.  para 
transcripts are aberrantly spliced in the region surrounding the editing events in the 
mlenapts mutant leading to the hypothesis that the dsRNA helicase is required to solve 
local secondary structures and allow correct splicing to occur (Reenan et al., 2000).  
The mlenapts mutant probably acts as a dominant negative mutation by binding to the 
region but failing to unwind the RNA.  After editing has occurred the duplex 
structure is usually resolved by an RNA helicase, however in the mlenapts flies this 
does not occur and a splicing catastrophe ensues.  In support of this hypothesis the 
mlenapts mutant phenotype can be rescued by expression of an extra copy of para. 
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Further editing events were characterised in the DmcalA transcript which encodes a 
calcium channel subunit associated with the cacophony mutant (Keegan et al., 2005; 
Smith et al., 1996), and the GluClα transcript encoding a chloride channel subunit 
(Semenov and Pak, 1999). Following publication of the Drosophila genome 
sequence further genes encoding nicotinic acetylcholine receptor subunits were 
identified and one of these (nAcRα-30D) was found to be edited at several sites in a 
developmentally regulated manner (Grauso et al., 2002).  The nAcRα-30D (also 
known as Dα6) transcript also undergoes alternative splicing which, together with 
editing of seven adenosine residues, can potentially generate >30,000 transcript 
variants.  Since these discoveries several attempts have been made to characterise the 
complete range of ADAR substrates in Drosophila.  As there is only one Adar gene 
in Drosophila, all identified editing events can be attributed to one enzyme. 
 
The discovery that the sequence surrounding an editing site is protected from 
mutation allowed the use of comparative genomics to identify novel editing sites 
(Hoopengardner et al., 2003).  The secondary structure formed with the ECS is 
required for site-specific editing and mutations that disrupt the base pairing are not 
tolerated.  Therefore comparing the genomic sequence of candidate genes from 
Drosophila melanogaster and Drosophila pseudoobscura to find highly conserved 
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Category Identifier Gene Name Function Sites
CG34405 NaCP60E Voltage-gated sodium channel 1
CG15899 Ca-α 1T Voltage-gated calcium channel 1
CG4894 Ca-α 1D Voltage-gated calcium channel 5
CG12295 straightjacket Voltage-gated calcium channel accessory subunit 3
CG12348 Shaker Voltage-gated potassium channel 6
CG10952 ether-a-go -go Voltage-gated potassium channel 6
CG10693 slowpoke Voltage-gated potassium channel 2
CG3139 synaptotagmin 1 Calcium sensing at synapse 4
CG2999 unc13 SNARE binding 1
CG12473 stoned B Synaptic transmission 1
CG32490 complexin SNARE protein 3
CG2520 lap/like-AP180 Synaptic transmission 1
CG4498 nAcRα-34E Nicotinic acetylcholine receptor channel subunit 7
CG11348 nAcRβ-64B Nicotinic acetylcholine receptor channel subunit 4
CG6798 nAcRβ-96A Nicotinic acetylcholine receptor channel subunit 2










Table 1.2: ADAR substrates identified by Hoopengardner et al, 2003.   
A total of 16 edited transcripts were identified using a comparative genomics approach to 
find conserved regions in candidate genes (Hoopengardner et al., 2003) 
 
However, despite showing high levels of conservation across Drosophiladae species, 
ECS regions can be located up to 2 kilobases (kb) away from the site of editing.  
They can also form extremely complex secondary structures making identification if 
ECS’s difficult. A well characterised example occurs in the Drosophila melanogaster 
Synaptotagmin I transcript which undergoes editing at four sites within the same 
exon.  There are two separate ECS regions for these editing sites; both located over 
one kb downstream within an intron, which form a complex pseudoknot structure 
that spans several kb (Reenan, 2005).   
 
Several approaches have been used to identify novel substrates for ADAR in 
different systems.  Xia and colleagues (2005) developed an antibody against inosine 
which they used to enrich inosine-containing mRNA from Drosophila heads; this 
was then applied to a cDNA microarray (Xia et al., 2005b).  Using this approach a 
shortlist of 62 potential new substrates for ADAR were discovered, and further 
investigation of 12 transcripts revealed that 7 contained A-G mutations, these are 
listed in Table 1.3.  Two of these transcripts have been previously identified as 
ADAR substrates; however known edited transcripts such as para and cacophony 
were not identified in this screen despite containing multiple editing sites and 
therefore multiple inosine residues per transcript.  The authors attributed this to low 
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expression levels of these transcripts, and showed that the new substrates they 
identified were more abundant (Xia et al., 2005b).  However the authors were also 
able to detect inosine-containing RNA in Adar-null flies used as a negative control.  
This could indicate that there is another mechanism for generation of inosine 
operating in Adar-null flies, possibly through spontaneous deamination, or it may 
indicate that the antibody used was not specifically recognising inosine.  The fly 
strain used has a partial deletion of the Adar locus encompassing the second dsRBD 
and the beginning of the deaminase domain, and retains all of the conserved motifs 
within the deaminase domain indicating this strain may produce ADAR protein that 
retains some catalytically active Adar protein.  This may explain how inosine was 
detected in these flies. 
  
Identifier Gene Name Function Sites
CG18314$ DopEcR G-protein couples amine receptor 5
CG11348$ nAcRβ-64B Nicotinic acetylcholine receptor channel subunit 2*
CG13167 - Hydrogen-transporting two-sector ATPase 1*
CG9619 - Protein phosphatase type 1 regulator 1
CG8428 spinster
Synaptic vesicle endocytosis, programmed cell 
death 1
CG12076 YT521-B Unknown 2
CG14936 Tetraspanin 33B Unknown 2  
Table 1.3: ADAR substrates identified by Xia et al, 2005. 
Two previously identified transcripts were confirmed and five new substrates were identified 
using an antibody to purify inosine-containing transcripts from fly head RNA (Xia et al., 
2005b).  Where $ indicates transcripts previously identified * indicates transcripts that 
contained guanosine at the editing site in Adar-null flies. 
 
More recently a list of 27 new ADAR substrates was published by Stapleton et al, 
(2006), listed in Table 1.4.  They employed a different approach by analysing 
sequence data from the Drosophila Gene Collection database which includes cDNAs 
from over 10,000 genes (Stapleton et al., 2006).  Analysing sequence discrepancies 
in cDNAs from different tissues showed a clear predominance of A>G substitutions 
in head cDNA, indicative of RNA editing by ADAR.  Eleven previously identified 
substrates were confirmed with this screening approach.  This screen did not focus 
on candidate genes as previous screens have (Hoopengardner et al., 2003) which 
removes sampling bias, yet this screen also identified numerous transcripts involved 
in neurotransmission reflecting the high expression of Adar in the CNS. 
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Category Identifier Gene Name Function Sites
CG34410 Rab26 GTPase activity 1
CG11622 Ral interacting protein Ral GTPase activator 10
CG5627 Rab3-GEF Rab guanyl nucleotide exchange factor 3
CG14296 endophillin A Promotes synaptic vesicle budding 2
CG4260 α-adaptin Component of endocytosis, subunit of AP-2 1
CG8110 sundaydriver Kinesin-dependent axonal transport 1
CG4795 Calphotin Calcium sequestration 1
CG18660 Nckx30C Potassium-dependent sodium/calcium antiporter 1
CG1090 - Potassium-dependent sodium/calcium antiporter 3
CG5670 Atpα Sodium/potassium exchanging ATPase 1
CG32699 - Calcium-binding, acyltranferse activity 1
CG34123 - kinase activity, transmembrane ion transport 5
CG11711 mob2 Activator of Trc kinase 1
CG8285 bride of sevenless G-protein-coupled receptor 2
CG10706 SK
Small conductance calcium-activated potassium 
channel 2
CG31116 - Chloride channel 4
CG10076 spire Actin-nucleation factor 1
CG5166 ataxin2 Regulation of actin-filament formation 2
CG42540 - Structural constituent of cytoskeleton 6
CG32809 - ATP-binding 1
CG9528 real-time phosphatidylinositol transporter 1
CG14616 lethal (1) G0196 acid phosphatase 3
CG3556 - Cobalamin (vitamin B12) binding 1
CG1552 - - 1
CG31531 - - 1
CG9801 - - 1













Table 1.4: ADAR substrates identified by Stapleton et al, 2006. 
27 novel ADAR substrates were identified by screening of the Drosophila Gene Collection 
database and experimentally verified (Stapleton et al., 2006). 
 
The total number of transcripts identified as ADAR substrates in Drosophila has now 
reached 55 and new questions have arisen about the biological function of these site-
specific editing events.  Recent advances in sequencing technology have enabled 
ideantification of hundreds of transcripts which undergo RNA editing in humans (Li 
et al, 2009), however it remains to be seen whether these new techniques will 
identify more substrates of Drosophila ADAR.  To date most of the known ADAR 
substrates are involved in neurotransmission, whether at the level of recycling the 
neurotransmitter or of regulating the channel conductance.  This indicates RNA 
editing plays a crucial role in modulating neural signalling, whether this is 
constitutive mechanism of generating protein diversity or regulated in response to 
different stimuli remains to be determined.   
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Consequences of Inosine-containing RNA 
Deamination of adenosine bases in RNA results in transcripts that contain one or 
many inosine bases, which can have consequences for the cell.  In coding sequences 
the inosine base is read as guanosine by the translation machinery which can lead to 
recoding of proteins with different properties as is the case with the GluR-B subunit, 
as described earlier.  Deamination of adenosine residues that occur close to splicing 
junctions can affect the inclusion/exclusion of either introns or exons which can alter 
the RNA transcript.  For example, the ADAR2 auto-editing site which changes a 
splice site and generates a non-functional protein (Rueter et al., 1999).  In one 
example editing of the PTPN6 transcript within an intron was shown to alter the 
conserved adenosine residue found at the branch point causing retention of the intron 
(Beghini et al., 2000).  The retained intron contains an in frame stop codon which is 
predicted to generate a truncated protein lacking catalytic activity.  Editing can also 
remove a stop codon altering the protein produced as occurs with the HDV viral 
proteins p24 and p27 also described earlier (Polson et al., 1996).  Additionally, 
editing can result in the exonisation of Alu elements via generation of splice site 
consensus sequences (Athanasiadis et al., 2004).  
 
Editing of non-coding regions is widespread (Li et al., 2009), however little is known 
about the effects of these editing events.  Editing within 3’UTR regions can alter 
miRNA binding sites (Borchert et al., 2009) or polyadenylation signal sequences (Gu 
et al., 2009) however this has yet to be described in vivo.  Editing can also alter the 
processing of miRNAs or alter their target specificity.  These processes are discussed 
later in the section on Editing and RNA interference. 
 
The formation of one or many I-U base pairs in dsRNA can have structural 
implications as an I-U base pair is less stable than an A-U pairing, and has a 
considerably lower melting temperature (Serra et al., 2004).  I-U base pairs are also 
likely to alter the stacking of the dsRNA helix.  In hyper-edited substrates these 
changes are likely to have a more substantial effect. 
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Hyper-editing of dsRNA transcripts where up to 50% of the adenosine residues in a 
single transcript are deaminated to inosines has been described for a voltage-
dependent potassium channel (sqKv2) RNA from squid, where up to 17 adenosines 
are modified in a 360 base region (Patton et al., 1997).   
 
Highly edited RNAs were found to be cleaved by a cytoplasmic factor.  Subsequent 
investigation revealed the Tudor staphylococcal nuclease (Tudor-SN) protein, a 
component of the RNA-induced silencing complex (RISC), specifically binds to 
inosine-containing RNA and promotes cleavage (Scadden, 2005).  The cleavage site 
(5’-IIUI-3’) was shown to be generated in dsRNA in vitro through editing by 
ADAR1, ADAR2 and Drosophila ADAR indicating that this is a highly preferred 
editing site (Scadden and O'Connell, 2005). 
 
Inosine-containing RNA regulates gene expression in trans 
Immobilised inosine-containing dsRNA was used to isolate proteins that specifically 
interact with inosine-containing dsRNA (Scadden, 2005).  This led to the 
identification of numerous factors which are associated with stress granules (SG), 
including poly(A) binding protein (PABP), and components of the eukaryotic 
initiation complex (eIF-4A, 4G, and 4E) (Scadden, 2007).  Cytoplasmic SG are 
formed when cells undergo environmental stress and proteins required for survival 
must be synthesised rapidly whilst synthesis of other non-essential proteins is halted, 
(reviewed in (Anderson and Kedersha, 2009)).  As such SGs comprise a host of RNA 
processing proteins and cellular mRNAs that are maintained in a translationally silent 
state until the stress is relieved.  The observation that SG-associated proteins also 
interact with inosine-containing dsRNA led to the hypothesis that inosine-containing 
dsRNA could affect mRNA expression levels through the induction of SGs.  This 
hypothesis proved to be true for several different dsRNAs containing I-U base pairs 
and to a lesser extent dsRNAs with G-U base pairs, including an endogenously 
edited miRNA-142.  Inosine-containing dsRNA transcribed within the cell resulted 
in a decrease in mRNA levels of both endogenous mRNAs and reporter mRNAs.  
This was accompanied by a decrease in translation which was due to inhibition of 
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translation initiation.  A model was proposed whereby editing of dsRNAs by ADAR 
produces inosine-containing dsRNAs which are sequestered into SGs with cellular 
mRNAs and translation initiation factors leading to a decrease in translation within 
the cell (Scadden, 2007).  The decrease in available translation factors results in 
increased traffic of cellular mRNAs to SGs, which are then either degraded in 
processing (P) bodies or held in a translationally silent state.  The translation block is 
relieved when inosine-containing dsRNAs are degraded by Tudor-SN (Scadden, 
2005) a component of the RISC complex, providing a mechanism for temporary 
silencing of endogenous mRNAs in response to dsRNA.  However further work is 
required to test this model. 
 
Nuclear retention of inosine-containing RNAs 
Mouse CTN-RNA is a nuclear poly(A)+ transcript which is expressed highly in 
mouse liver, brain, and lung.  It is expressed from the same locus as the mCAT2 
transcript through use of an alternative promoter, which results in an almost identical 
transcript apart from a different 3’UTR (Prasanth et al., 2005).  The unique CTN-
RNA 3’UTR is approximately 4.5kb, therefore the total transcript is approximately 
8kb, compared to the cytoplasmic mCAT2 mRNA which is approximately 4.2kb.  
Within this long 3’UTR are four repeat sequences of approximately 100bp, predicted 
to have originated from SINE elements.  The repeats are orientated such that one is 
forward and three are in reverse, giving the possibility of creating a large dsRNA 
hairpin structure which provides a substrate for ADAR.  Analysis of transcripts from 
mouse liver revealed that the CTN-RNA 3’UTR was indeed edited at several 
positions within the repeat regions.  Further investigation revealed that the edited 
CTN-RNA is retained within the nucleus, until cells are stressed whereupon the 
3’UTR is cleaved and the CTN-RNA is released into the cytoplasm and translated to 
produce mCAT2 protein (Prasanth et al., 2005).  Therefore, in this situation the 
unique CTN-RNA 3’UTR has a specific secondary structure, which is the target of 
editing by ADAR, and the transcript is retained in the nucleus until it is needed in 
times of stress.  However this may be coincidental as no experiments were performed 
in the absence of ADAR therefore it is not clear what role, if any, ADAR plays in 
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altering the subcellular localisation of CTN-RNA.  Further studies into human and 
C.elegans transcripts containing a dsRNA structure have failed to replicate these 
findings, in fact here the edited transcripts could be amplified from polysomes 
following sucrose gradient sedimentation indicating nuclear export and translation of 
edited transcripts occurs (Hundley et al., 2008).   
 
Editing and RNA interference (RNAi) 
RNA interference (RNAi) is the process by which a double-stranded short interfering 
RNA (siRNA) or micro RNA (miRNA) of approximately 21-23 nucleotides (nt) can 
target the degradation of an mRNA with complementarity to it.  The process of RNA 
silencing via siRNA and miRNA and their biogenesis is reviewed in (Carthew and 
Sontheimer, 2009).  Briefly, siRNAs are cleaved from longer dsRNAs by DICER in 
the cytoplasm and show complete complementarity to their target mRNAs.  Whereas 
miRNAs are processed from transcripts, often encoded in intronic regions of 
mRNAs, which form stem-loop dsRNA structures. These stem-loop primary 
miRNAs (pri-miRNAs) are cleaved from surrounding sequence in the nucleus by the 
microprocessor complex to generate a pre-miRNA. The pre-miRNA of 
approximately 75nt is then exported form the nucleus and processed further by 
DICER to remove the loop region and produce a mature miRNA (Kim, 2005).  In 
contrast to siRNAs, miRNAs can contain mismatches although a critical “seed” 
region of 4-7nt must be complementary to their target mRNA.  One strand of the 
mature miRNA or siRNA associates with the RISC complex (Gregory et al., 2005) to 
direct silencing of target mRNAs, which can be mediated through cleavage and 
degradation of the target or translational inhibition.  siRNAs and miRNAs activity 
depends on the formation of dsRNA during biogenesis and for functional RNA 
silencing, and given that ADARs bind dsRNA it has long been hypothesised that 
they could modulate the RNAi pathway.   
 
An initial survey to analyse the extent of miRNA editing revealed that 13% pri-
miRNAs were edited and that levels of editing varied across tissues analysed (Blow 
et al., 2006).  However this corresponded to 6% of mature miRNAs which were 
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edited and target site prediction software indicated that editing of mature miRNA 
could change their target specificity.  A more comprehensive sequence analysis of 
primary miRNA (pri-mRNA) transcripts revealed numerous editing sites and led to 
the prediction that up to 16% pri-miRNAs could be edited in human brain (Kawahara 
et al., 2008).  This indicates that editing of miRNA occurs more frequently than 
initially thought.   
 
The reported consequences of miRNA editing are varied, however only one example 
of re-direction of target specificity has been reported.  In the case of the human 
miRNA-376 cluster editing occurred to nearly 100% at several sites (Kawahara et 
al., 2007b).  One editing site was located within the seed region of the mature 
miRNA and editing at this site was shown to alter the target specificity of the 
miRNAs produced.  Furthermore the functional consequence of redirection of one 
mi-RNA was confirmed as altered levels of target protein expression and function 
were detected in ADAR2-null mice.   
 
However, most reported cases of miRNA editing appear to inhibit biogenesis of the 
miRNA by DROSHA or DICER (Heale et al., 2009; Kawahara et al., 2007a; Yang et 
al., 2006).  Although one report indicates this inhibition is mediated through binding 
of ADARs to miRNAs (Heale et al., 2009), and another through the presence of 
inosine in the pri-miRNA which inhibited cleavage by DICER (Kawahara et al., 
2007a).  Yang and colleagues found that processing of pri-miR-142 by DROSHA 
was inhibited by editing of adenosine residues located close to the DROSHA 
cleavage site (Yang et al., 2006).  Consequently, downstream DICER processing was 
also inhibited; however edited pri-miR-142 did not accumulate to high levels due to 
specific degradation of inosine-containing pri-miR-142 by Tudor-SN. Therefore 
editing of pri-miR-142 serves to reduce the level of mature miR-142 by targeting the 
edited miRNA for degradation.  Higher levels of endogenous miR-142 were found in 
ADAR-null mice confirming that this mechanism is used in vivo to regulate miR-142 
levels (Yang et al., 2006).  Therefore it is likely that ADARs can have numerous 
effects through either binding to or editing miRNAs during processing.  However, 
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only a subset of edited pri-miRNAs have been identified indicating ADARs target 
pri-miRNAs with specific dsRNA structure (Yang et al., 2006). 
 
Redirection of miRNAs can also occur via editing within the 3’UTR of the target 
mRNA.  Editing frequently occurs within non-coding regions (Li et al., 2009).  
Borchert et al recently published a bioinformatic screen analysing the impact of RNA 
editing within UTRs on miRNA:mRNA interactions (Borchert et al., 2009).  They 
found that a quarter of the editing sites analysed (over 3000 sites from 12,723 
analysed) generated new miRNA target sites and a considerable number of target 
sites were also destroyed indicating editing may have a wide impact on miRNA 
binding sites.  Cell culture experiments indicate redirection can occur through this 
mechanism (Borchert et al., 2009; Heale et al., 2009).  However the difficulty in 
functionally verifying alterations in a miRNA target sequence has hampered 
investigation of this phenomenon in vivo. 
 
Caenorrhabditis elegans contains two adar genes and strains lacking both adr-1 and 
adr-2 were used to investigate antagonism of RNAi (Knight and Bass, 2002).  This 
revealed that adr-1/adr-2 mutant worms showed strong somatic transgene induced 
RNAi which was absent from wild type worms.  This is due to editing of the dsRNA 
in wild type worms which prevents the dsRNA from cleavage by Dicer and entry 
into the RNAi pathway.  However C.elegans adar genes are not well conserved and 
editing events which lead to re-coding have yet to be identified in C.elegans 
indicating adar may have a different role in nematodes.  Therefore C.elegans may 
provide an ideal system to investigate the editing-independent function of ADARs. 
 
ADAR and disease 
Several groups have reported a link between decreased levels of ADAR activity and 
tumour progression (Cenci et al., 2008; Maas et al., 2001; Paz et al., 2007).  
Decreased editing of the GluR-B and serotonin receptor transcripts was first 
described in malignant gliomas and a correlation was shown between tumour stage 
and editing level indicating a progressive loss of editing (Maas et al., 2001).  
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However levels of ADAR remained unchanged indicating the change in activity was 
post-translational.  Investigation on non-specific editing of Alu repeat sequences 
indicated significant global hypoediting in tumours from brain, prostate, lung, kidney 
and testis tumours (Paz et al., 2007).  Further analysis showed that RNA levels of 
ADAR-1, -2, and -3 were also reduced, and overexpression of ADAR-1 or -2 in a 
glioblastoma cell line resulted in decreased proliferation, leading the authors to 
conclude that the loss of editing enzymes was involved in the pathogenesis of cancer.   
 
ADAR activity was also shown to be reduced in pediatric astrocytomas (Cenci et al., 
2008).  In this study the level editing was also shown to correlate with the grade of 
malignancy such that high grade tumours showed the lowest levels of editing.  In 
astrocytoma cell lines the low levels of editing were restored by expression of 
ADAR2, and this inhibited proliferation of the tumour-derived cell lines.  However, 
no difference in ADAR2 expression was detected between tumour and control 
samples.  Investigation of the expression levels of other ADARs revealed both 
ADAR1 and ADAR3 were significantly overexpresses in the astrocytomas.  In vitro 
experiments confirmed that increased expression of ADAR1 led to decreased editing 
of ADAR2 substrates.  The ADAR1 and ADAR2 proteins were shown to co-
immunoprecipitate indicating heterodimers were formed and this decreased editing 
of ADAR2 substrates (Cenci et al., 2008).   
 
ADAR2 protects against neuronal degeneration following 
ischemic insult 
ADAR2 has recently been implicated in recovery from forebrain ischemia.  
Following transient disruption of the blood flow to the brain, which can be caused by 
several factors including cardiac arrest, there is a selective degeneration of specific 
neuronal subsets.  This has been observed for a long time, however it was unclear 
what determined the specific vulnerability of some neuronal subsets and not others.  
In the hippocampus one of the affected neuronal populations is the CA1 pyramidal 
neurons, which were shown to have an 18-fold increased permeability to calcium 
following ischemic insult (Liu et al., 2004).  Further investigation revealed the 
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increased permeability to calcium resulted from a decrease in edited GluR-B (R) 
which correlated with a decreased level of ADAR2 mRNA.  This led to the “GluR-B 
hypothesis” that ADAR2-mediated editing of GluR-B Q/R was disrupted in CA1 
pyramidal neurons following ischemic insult, and this led to an influx of calcium 
which led to neuronal degeneration.  In support of “GluR-B hypothesis” Peng et al, 
(2006) showed siRNA knockdown of Adar2 in the dentate gyrus increased the 
sensitivity of neurons to ischemic insult (Peng et al., 2006).  The loss of ADAR2 led 
to decreased editing at the GluR-B Q/R site, which increased AMPA receptor 
calcium permeability and led to neuronal death.  Interestingly, the neuronal death 
associated with knockdown of Adar2 could be rescued by expression of the edited 
GluR-B (R) transcript, in a similar manner to the rescue of the ADAR2-null mouse 
(Higuchi et al., 2000).  Further ectopic expression of ADAR2 was shown to have a 
protective effect, and reinstate editing at the GluR-B Q/R site to >95%.  Finally the 
authors showed that expression of ADAR2 is regulated by cyclic AMP response 
element binding protein (CREB) (Peng et al., 2006) which has been shown to be 
decreased in CA1 pyramidal neurons following ischemic insult (Walton et al., 1996).  
Taken together these results implicate ADAR2 as an important effector of cell death, 
such that when stress pathways are activated ADAR2 levels fall, calcium 
permeability increases and neuronal degeneration occurs.  However similar studies 
have failed to replicate the observation that editing levels are lower following 
ischemic insult, which could reflect analysis of different regions of the brain or large 
tissue samples which contain multiple cell types. 
 
ADAR2 as a “neuronal gatekeeper” 
A recent study showed that editing of the GluR-B subunit transcript at the Q/R site 
was downregulated in single motor neurons isolated from patients with sporadic 
amyotrophic lateral sclerosis (sALS)  (Kawahara et al., 2004).  ALS is a progressive, 
degenerative disease characterised by a selective loss of motor neurons which leads 
to paralysis and death.  There is currently no effective treatment.  This led to the 
hypothesis that GluR-B acts as a “neuronal gatekeeper” in the same manner as the 
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model of ischemic stroke, such that decreased editing of the GluR-B Q/R site renders 
the neuron permeable to calcium which leads to cell death (Buckingham et al., 2008). 
 
Editing of the GluR-B transcript was investigated as motor neurones are vulnerable 
to AMPA-receptor mediated neurotoxicity similar to CA1 pyramidal neurones as 
described above (reviewed in (Kwak and Weiss, 2006)).  Editing at the Q/R position 
of the GluR-B transcript was analysed in single motor neurones isolated by laser-
capture microdissection from the spinal chord of patients with ALS and controls.  
Editing efficiency was 100% in control motor neurones; however motor neurones 
form ALS patients showed a range of 0-100% editing, with an average of 
approximately 60% (Kawahara et al., 2004).  The decrease in editing was specific to 
the motor neurones as editing in Purkinje cells from these patients was 100%, and it 
was also specific to sALS patients as patients with another neurodegenerative disease 
retained 100% editing.  The decrease in GluR-B Q/R editing correlated with a 
decrease in Adar2 RNA levels (Kwak and Kawahara, 2005).  The observation that 
GluR-B-deficient mice do not develop seizures despite showing increased calcium 
permeability indicates that having unedited GluR-B present is more toxic to neurons 
than absence of the GluR-B subunit (Jia et al., 1996).  However, loss of GluR-B Q/R 
site editing is not observed in motor neurons from patients with familial ALS (fALS) 
or mouse models of fALS that contain mutations in the SOD1 gene, indicating 
despite similar phenotypes there are multiple mechanisms of pathogenesis of ALS. 
 
 
Drosophila models of human neurodegenerative disorders 
Drosophila melanogaster is an ideal model organism for studying processes that are 
involved in human neurodegenerative disorders.  The short lifespan, ease of genetic 
manipulation, and wealth of anatomical information about the CNS along with the 
high conservation of cell biological pathways makes Drosophila a valuable tool for 
investigating neurological disease processes.  Drosophila display complex motor 
coordination and courtship rituals, indicating that they are capable of complex 
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processing and memory functions.  Coordinated locomotion provides an easily 
quantified measure of complex brain function. 
 
Drosophila mutants for modelling human neurodegenerative diseases fall into two 
general classes (reviewed in (Muqit and Feany, 2002)). Firstly, transgenic 
Drosophila mutants that are null for a homolog of a disease-causing gene or express 
a human gene associated with neurodegenerative disease, or a mutant thereof.  These 
models require prior knowledge of disease-associated genes but can be used 
effectively to recreate aberrant expression patterns associated with human disease.  
Examples of these models include flies overexpressing polyglutamine expansions, 
which can be used to model human disorders including Huntington’s disease (HD).  
Fly models of Huntington’s have been used to demonstrate that expression of an 
expanded polyglutamine peptide alone cause neurodegeneration (Marsh et al., 2000).  
This observation highlighted the toxicity of the gain-of-function polyglutamine 
expansion whilst revealing the contribution of the protein containing the 
polyglutamine expansion to the disease process.  Although the pathology is similar 
across polyglutamine expansion disorders, specific neuronal subsets are affected in 
different disorders, which is thought to be due to the protein containing the 
expansion. 
 
The second type of Drosophila model has mutations in endogenous genes which 
produce a neurodegenerative phenotype.  This approach requires no prior knowledge 
of the gene involved and can be used to identify genes involved in neurodegeneration 
that may otherwise remain unknown.  Examples of this include the Drosophila 
mutants swiss cheese (Kretzschmar et al., 1997) and bubblegum (Min and Benzer, 
1999).  swiss cheese (sws) mutants develop age-dependent neurodegeneration with 
extensive apoptosis and an abnormal glial phenotype (Kretzschmar et al., 1997).  
Further work has shown that the sws homolog in mouse also produces a 
neurodegenerative phenotype when mutated, and the SWS protein is thought to 
function in the metabolism of organophosphates, indicating it could be functionally 
important in organophosphorus-induced delayed neuropathy (Muhlig-Versen et al., 
2005).  The bubblegum mutant was isolated in a screen to identify P-element 
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mutations that produce a neurodegenerative phenotype (Min and Benzer, 1999).  
bubblegum mutants were shown to have elevated levels of very long chain fatty acids 
(VLCA), and the causative mutation was identified in a VLCA acyl coenzyme A 
synthetase-like gene. This phenotype was similar to a human disease 
adrenoleukodystrophy (ALD), in which causative mutations have been mapped to the 
ABCD1 peroxisomal transporter.  VLCA levels are altered in ALD and bubblegum 
could now become a model for screening therapeutics for ALD. 
 
Suppression of neurodegeneration by expression of Adar in 
the cholinergic neurons 
A previous student in the lab Leeanne McGurk characterised the neurodegenerative 
phenotype in Adar5G1 flies as a progressive vacuolisation of the neuropil in the 
mushroom bodies with associated retinal degeneration (McGurk. L., 2008).  This 
phenotype can be suppressed by expression of an Adar transgene in the cholinergic 
neurons utilising the binary expression system developed by Brand & Perrimon 
(Brand and Perrimon, 1993).  Adar5G1 flies with GAL4 expression in certain cell 
subsets, here cholinergic neurons using the Cha-GAL4 driver, were crossed with flies 
that contain a randomly integrated transgene which comprises the GAL4 upstream 
activating sequence (UAS) directing expression of a gene of interest.  Using this 
system to express Adar in the cholinergic neurons restored locomotion defects 
observed in Adar5G1 flies indicating the phenotype is due to loss of ADAR function.  
Expression of a catalytically inactive Adar also showed suppression of the 
neurodegenerative phenotype but interestingly this did not restore the observed 
locomotion defects.   
 
Further investigation demonstrated that human ADAR1 p110, ADAR2 and ADAR3 
could suppress the neurodegenerative phenotype however ADAR1 p150 could not, 
indicating expression of ADAR in the nucleus is critical for suppression of the 
Adar5G1 phenotype (Leeanne McGurk, Thesis).  Although suppressed by expression 
of these Adar transgenes evidence of the neurodegenerative phenotype was still 
present, seen as holes in the brain, but fewer in number and smaller than those 
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observed in the Adar5G1 flies.  This indicates the progressive nature of the 
neurodegenerative phenotype, and suggests that the suppression may act to delay the 
onset of degeneration indicating it is not a complete “rescue”. 
 
Comparison of GAL4 driver lines revealed that constitutive expression of Adar using 
an Actin promoter was lethal, indicating high levels of Adar are not tolerated.  Other 
driver lines were tested for their ability to rescue the Adar5G1 locomotion defects.  
The D42-GAL4 strong neuronal driver (Parkes et al., 1998) was able to suppress the 
locomotion defects, as was a muscle tissue driver Mef2-GAL4 although this also 
directed expression to the mushroom bodies (Ranganayakulu et al., 1996).  Neither 
of these lines was able to restore locomotion to wild type levels and Cha-GAL4 gave 
the best rescue results (Keegan et al., 2005). 
 
1.6 Alternative splicing  
Splicing of pre-mRNA is the process of removal of intronic sequences and splicing 
together exonic sequences to form a mature mRNA and was initially described in the 
late 1970’s (Berget et al., 1977; Chow et al., 1977).  Splicing occurs in the nucleus 
when short, degenerate sequences which demarcate the intron-exon boundaries are 
recognised by splicing factors; see Figure 1.6 for a summary.  Splicing is performed 
by a large multiprotein complex termed the spliceosome which assembles at the 
splice site and catalyzes the two-step splicing reaction (for a review see (Black, 
2003)).  Briefly, small nuclear ribonucleoproteins (snRNP) components of the 
spliceosome complex recognise the consensus sequences at the 5’ and 3’ splice sites, 
the branch point is bound by the SF1 branch point binding protein and the U2 
auxilliary factor 65kDa subunit (U2AF65) bind to the polypyrimidine tract.  In the 
first reaction the 5’ splice site of an exon performs a nucleophilic attack on the 
conserved adenosine residue located within the branch point (BP) consensus 
sequence (YNYURAY).  This results in cleavage of the exon from the intron at the 
5’ splice site and ligation of the 5’ end of the intron with the branch point adenosine 
creating a lariat structure.  In the second reaction additional snRNPs are recruited and 
the free hydroxyl group at the 5’ exonic splice site performs a nucleophilic attack on 
the 3’ splice site and the resulting transesterification reaction fuses the 5’ and 3’ 
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splice sites of the exons together and releases the intronic lariat sequence (Moore and 
Sharp, 1993). 
 
The consensus sequence which demarcates the 5’ splice site is A/CAG|GURAGU 
and that which denotes the 3’ splice site is YAG|R, where | indicates the exon-intron 
boundary, R indicates any purine, Y indicates any pyrimidine, and the underlined 
nucleotides are invariate.  Both these sequences contain adenosine and guanosine 
residues, of particular note is the invariate guanosine residues at both 5’ and 3’ splice 
sites.  As inosine is read as guanosine editing of an adenosine residue which follows 
another adenosine would create an AI dinucleotide which mimics a 3’ splice site.  
Similarly editing of the adenosine of an AG dinucleotide present at a 3’ splice site 
would generate an IG dinucleotide which abolishes the splice site.  Therefore there is 
a great potential impact of editing on altering splice site consensus sequences. 
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Many mRNAs have different splicing patterns and alternative splicing (AS) can 
generate multiple mature mRNAs from one pre-mRNA.  Different patterns of AS, 
summarised in Figure 1.7, can be utilised at one locus to generate many different 
mRNAs with distinct functions (reviewed in (Black, 2003)).  Regulation of AS can 
occur at the stage of spliceosome assembly, however there are numerous non-
spliceosomal RNA-binding proteins such as the SR and hnRNP protein families 
which regulate AS through binding to regulatory sequences.  Binding of accessory 
proteins can enhance or repress splicing of neighbouring exons and the abundance 
enhancer and repressor proteins likely plays a role in determining the splicing 
pattern.  Control of AS can be sex-specific, developmentally regulated, tissue-
specific or even controlled through signalling cascades such as the insulin response 
pathway (Hartmann et al., 2009).  A well documented AS cascade involves the 
somatic sex determination pathway in Drosophila where the female specific RNA-
binding protein Sex Lethal (sxl) represses splicing patterns which lead to male 
development.  This example of sex-specific splicing regulation is described in detail 
in (Black, 2003).  However unlike the regulation of sex determination through AS 
which generates either a female or a male splicing pattern, many AS genes generate 
numerous transcripts from one locus and the balance between the isoforms generated 
can be crucial.  AS can alter the reading frame of a transcript or cause the inclusion 
of a premature termination codon (PTC) which targets the transcript for nonsense 
mediated decay (NMD) (Lejeune and Maquat, 2005). 
 
Levels of AS correlate with complexity of tissue and AS occurs at high levels in the 
human CNS creating splicing patterns which are distinct from other tissues (Yeo et 
al., 2004).  One example of the variation that AS can generate from one locus is the 
Drosophila melanogaster Down syndrome cell adhesion molecule (Dscam) gene.  
The Dscam pre-mRNA contains 115 exons which are organised into twenty 
constitutively spliced exons and four clusters of exons which are spliced in a 
mutually exclusive manner.  The exon 4 cluster contains 12 alternative exons, the 
exon 6 cluster has 48 alternative exons, the exon 9 cluster has 33 alternative exons, 
and the exon 17 cluster contains 2 alternative exons.  Assuming all combinations are 
possible the repertoire of isoforms generated from the Dscam locus is 38,016 
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different transcripts (Schmucker et al., 2000).  The alternative exons 4, 6, and 9 
encode immunoglobulin domains whilst alternative exon 17 encodes a 
transmembrane domain.   
 
Investigation into the mechanism of AS at the Dscam locus revealed that the 
mutually exclusive splicing of one exon from the exon 6 cluster is regulated through 
extensive secondary structure formation (Graveley, 2005).  Interaction between 
highly conserved regions within the Dscam gene generates a stem-loop structure.  A 
“docking site” located downstream of the constitutively spliced exon 5 base pairs 
with a “selector site” which is immediately upstream of each of the exon 6 
alternatives, and ensures that only one of the mutually exclusive exons can associate 
with the 5’ splice site.  Heterogeneous nuclear ribonucleoprotein hrp36 ensures only 
one of the exon 6 alternatives is included in the mature Dscam mRNA through 
binding to all the exon 6 alternatives and repressing activity of SR proteins (Olson et 
al., 2007).  
 
DSCAM is involved in neuronal wiring and axon guidance, and multiple isoforms 
are required for axon self-avoidance through homophilic binding (reviewed in 
(Schmucker, 2007).  The Dscam gene demonstrates the complex AS events which 
must be carefully regulated to ensure correct development of the Drosophila brain.  
Further investigation of the mechanism of Dscam-mediated self avoidance revealed 
that over 1000 isoforms are required for correct neuronal connections (Hattori et al., 
2009).  Genetic manipulation to remove the multiple alternative exons from specific 
clusters showed that flies expressing 4,752 isoforms were indistinguishable from 
wild type and that the neurological defects associated with limited Dscam diversity 
get progressively more severe as the number of potential Dscam transcripts are 
limited. 
   
Trans-splicing has also been demonstrated in Drosophila melanogaster.  This occurs 
in a similar manner to pre-mRNA splicing but results in the fusion of two separate 
mRNAs to create a new transcript.  Trans-splicing occurs at the mod(mdg4) locus, 
where the common constitutively cis-spliced N-terminal four exons are fused to one 
Chapter 1: Introduction 
 
 75
of 26 different downstream regions, reviewed in (Dorn and Krauss, 2003).  An 
unusual feature of this locus is that some of the downstream regions are transcribed 
from the same DNA strand as the common exons whilst others are transcribed from 
the antiparallel DNA strand, although all 26 isoforms are generated through trans-
splicing of two separate transcripts. 
 
 
Chapter 1: Introduction 
 
 76
Alternative splicing and neurodegeneration 
Single base pair substitution mutations that affect AS account for approximately 10% 
of known human disease-causing mutations, and the majority of these mutations 
occur within 20bp of a splice site (Krawczak et al., 2007).  Mutation of a conserved 
splice site sequence can result in exon-skipping or use of a cryptic splice site, 
whereas mutations which affect regulatory sequences can have more subtle effects.  
The affects of alternative splicing on disease are reviewed in (Caceres and 
Kornblihtt, 2002).  One example of this is mutations within the tau gene which are 
associated with frontotemporal dementia with Parkinsonism linked to chromosome 
17 (FTDP-17).  Missense, silent or intronic mutations within the tau gene are 
pathogenic due to alterations in the splicing of tau exon 10 (D'Souza et al., 1999).  In 
the tau gene exon 10 encodes a microtubule-binding domain, therefore aberrant 
inclusion or exclusion of this exon can have a profound affect on the function of the 
tau protein.  Pathological mutations within the tau gene have also been shown to alter 
exonic splicing enhancer and silencer sequences, and also an intronic splicing 
silencer. 
 
ADAR and alternative splicing 
As described earlier ADAR2 autoedits its own transcript within an intron creating an 
alternative splice acceptor site which leads to a truncated protein lacking both 
dsRBDs and the deaminase domain (Rueter et al., 1999).  This provides a negative 
feedback loop to regulate the amount of active ADAR2, and alternative splicing 
directly correlates to the activity of the ADAR2 enzyme (Maas et al., 2001).  
 
The ADAR2 knockout mice showed an elevated level of incorrectly processed GluR-
B pre-mRNA which retained intron 11 (Higuchi et al., 2000).  Intriguingly intron 11 
contains the ECS region which facilitates editing at the GluR-B Q/R site, leading to 
the hypothesis that the processes of editing and splicing are linked.  The GluR-B R/G 
editing site occurs within 2bp of the 5’ splice donor site of the mutually exclusive 
FLIP/FLOP exons, providing an excellent system for studying the effect of editing 
on alternative splicing.  In addition to the coding region editing events there are two 
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“hotspot” regions within the GluR-B pre-mRNA which are edited within intron 11 at 
the +60 site (hotspot 1) and the +262/263/264 sites (hotspot 2) (Higuchi et al., 1993).  
Analysis of editing and splicing of these regions of the GluR-B transcript in a cell 
culture assay revealed that editing at both the Q/R site and intronic hotspot 2 is 
required for efficient splicing of intron 11 (Schoft et al., 2007).  This could account 
for the observed editing of mature GluR-B transcript which is close to 100% in vivo, 
as unedited transcript would not be processed correctly.  The intronic hotspot 2 
editing event may alter a splice-repressor signal as mutations which disrupt the 
structure of this region did not increase splicing efficiency (Schoft et al., 2007).  
Furthermore a cryptic splice site within exon 11 was discovered which spliced out 
the Q/R site altogether, and this cryptic splice site was utilised in vivo revealing more 
complex splicing patterns are associated with this region. 
 
In contrast, editing at the R/G site reduced the efficiency of splicing downstream of 
the editing event, however the decreased splicing efficiency correlated with an 
increase in splicing fidelity (Schoft et al., 2007).  Inhibition of splicing by ADAR2 
was also observed with in vitro splicing reactions on a GluR-B fragment containing 
the R/G site, although the inhibition was partially alleviated by addition of RNA 
helicase A indicating there was a structural requirement for the inhibition (Bratt and 
Ohman, 2003).  Conversely, an “uneditable” construct with a mutated ECS showed 
skipping of both of the downstream FLIP/FLOP exons, which produced a transcript 
containing a premature stop codon (Schoft et al., 2007).  These results indicate that 
editing at the R/G site facilitates correct splicing of the downstream FLIP/FLOP 
exons. A construct containing an inosine residue at the R/G site mimicking 
constitutive editing also showed inhibition of downstream splicing indicating the 
effect is due to the presence of inosine rather that ADAR2 binding (Schoft et al., 
2007).  Therefore editing at the GluR-B R/G site inhibits downstream splicing, and 
this is probably due to the presence of inosine at the edited site.  When analysing the 
flanking regions the edited R/G site shows greater similarity than the unedited to the 
consensus binding site for hnRNP A1, indicating this may be the cause for the 
observed changes in splicing however further work is required to determine whether 
hnRNP A1 binds in this region.  No correlation between editing and choice of the 
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mutually exclusive FLIP/FLOP exons was observed in adult mouse brain (Schoft et 
al., 2007). 
 
There are 5 known editing sites in the coding region of the human serotonin (5-HT2C) 
receptor transcript which all occur within a dsRNA stem-loop formed between exon 
5 and an ECS in intron 5 (Burns et al., 1997).  This region also undergoes alternative 
splicing with one canonical and two alternative exon 5 5’splice sites.  Examination of 
editing and splicing in this region of the serotonin receptor transcript revealed a link 
between increased numbers of sites edited and use of the canonical 5’ splice site 
(Flomen et al., 2004).  As the alternative 5’ splice sites produce truncated inactive 
protein, this indicates a link between editing and production of functional serotonin 
receptor protein.  This effect is likely due to disruption of the stem-loop structure 
which allows access of splicing factors to the canonical 5’ splice site, however the 
effect of editing on changes in splicing regulatory signals cannot be excluded. A 
study into editing in malignant gliomas which demonstrate hypoediting revealed an 
increased abundance of transcripts which utilise the alternative 5’ splice site in the 
serotonin 5HT2C receptor, and therefore produce truncated inactive protein (Maas et 
al., 2001). 
 
Characterisation of the human protein tyrosine phosphatase PTPN6 gene and its role 
in acute myeloid leukaemia revealed increased expression of an isoform that retained 
a 251bp intron (Beghini et al., 2000). Sequence analysis of this isoform demonstrated 
multiple A-to-G mutations were present in the retained intron, one of these occurred 
27bp upstream of the 3’ splice site and altered the branch point adenosine residue to 
an inosine residue.  Loss of the branch point adenosine led to retention of the intron, 
which was confirmed with an in vitro splicing reaction.  Furthermore the retained 
intron contains an in frame stop codon which would produce a truncated protein 
lacking the phosphatase domain.  Interestingly, levels of the abnormally spliced 
isoform were significantly higher in patients at the time of diagnosis than when they 
had entered remission indicating a correlation between PTPN6 splicing and disease 
state. 
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In Drosophila editing events were linked with downstream alternative splicing 
decisions but upstream splicing events were unaffected (Agrawal and Stormo, 2005).  
This correlation was only demonstrated with one transcript and requires further 
investigation; however this is the first study into the effects of editing on splicing 
decisions which occur some distance away from the editing event. 
 
Further work on the edited transcript resistance to dieldrin (rdl) initially identified in 
the Hoopengardner screen (Hoopengardner et al., 2003) has revealed the extent to 
which RNA editing and alternative splicing impact on the function of this transcript.  
Rdl encodes a γ-aminobutyric acid (GABA) receptor subunit, which contains 
naturally occurring point mutations at amino acid alanine 302 that confer resistance 
to cyclodiene insecticides (ffrench-Constant et al., 1993).  Rdl is alternatively spliced 
at two mutually exclusive exons to produce four different isoforms (ffrench-Constant 
and Rocheleau, 1993).  In addition it can be edited at four different positions which 
all result in amino acid changes, resulting in 96 potential variant from one genomic 
locus.  However the isoform expression in adult CNS is not random with a 300-fold 
difference between the least abundant splice-form and the most abundant splice-form 
(Jones et al., 2009).  Analysis of editing isoforms showed that one site (I283V) was 
edited to ~95% in all isoforms whilst the other three sites showed lower levels.  RDL 
subunits form homo-oligomeric receptors providing an excellent system for 
evaluating the effect of alternative splicing and RNA editing on the function of the 
receptor.  Injection of transcripts encoding 32 different isoforms into Xenopus laevis 
oocytes revealed that the potency of the GABA receptor varied widely (Jones et al., 
2009).  The combined editing of three sites had a profound effect on the GABA 
potency in one splice-form but hardly altered the potency of another splice-form.  
This indicates that both editing and alternative splicing can modulate the potency of 
the GABA receptor formed, however these processes could also impact on receptor 
trafficking and assembly as shown for mammalian GluR-B transcripts (Greger et al., 
2003). 
 
There are 10 genes encoding subunits of the nicotinic acetylcholine receptor in 
Drosophila melanogaster and four of these are known to be edited.  Together with 
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alternative splicing editing serves to diversify the receptor composition and alter the 
physiological properties of the receptor.  Editing and alternative splicing changes 
affect transmembrane regions, ligand-binding domains and at a conserved N-linked 
glycosylation site, which act in concert to produce a wide range of receptor subunits 
(Sattelle et al., 2005).  Five subunits combine to create each nicotinic acetylcholine 
receptor resulting in a range of receptors with different properties which are 
generated from a low number of genes through post transcriptional modification, 
however not all RNA editing events have been functionally tested therefore the full 
extent of the effects are unknown.  
 
Comparative genomic analysis of the nicotinic acetylcholine receptor subunit 30D 
(nAcRα-30D) transcript across five different insect orders which span ~300 million 
years of evolution revealed that editing was present in four of the five insect orders 
analysed however the sites and frequency varied (Jin et al., 2007).  Sites which were 
edited in some species contained a genomically encoded guanine at the 
corresponding residue in other species, indicating RNA editing may be an 
evolutionary intermediate state.  Interestingly, several editing sites were discovered 
in the silkworm Bombyx mori which were not present in the other species analysed.  
Editing at these sites correlated with inclusion of two exons (3a and 3b) which were 
normally spliced in a mutually exclusive manner in the other species examined.  This 
correlation suggests that editing at sites within exon 4 of the nAcRα-30D transcript in 
Bombyx mori leads to inclusion of two exons which are normally spliced in a 
mutually exclusive manner.  However transcripts containing both exons 3a and 3b 
have been isolated from Drosophila melanogaster yet no evidence of editing of the 
neighbouring exon 4 has been found (Grauso et al., 2002). 
 
These studies indicate that where editing and splicing occur in the same region of a 
transcript the processes can be linked either through alterations in RNA structure (5-
HT2C receptor) or through alteration of splicing regulatory sequences (GluR-B R/G 
site).  However the observed interactions between editing and splicing appear to be 
transcript specific and cannot be extrapolated to other pre-RNAs.  Only one study 
addresses the issue of long-range effects of editing on alternative splicing (Agrawal 
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and Stormo, 2005) yet this focuses on one transcript, therefore more work is required 
to address the effects of editing on alternative splicing. 
 
Coordination of editing and alternative splicing 
mRNAs are transcribed in vivo by RNA polymerase II (RNAP II), and the processes 
of splicing, 3’ end formation and 5’ capping are linked to transcription through 
association of the factors involved in these processes with the C-terminal domain 
(CTD) of RNAP II (McCracken et al., 1997a; McCracken et al., 1997b).  Therefore 
investigations into the coordination of splicing and editing have focussed on the C-
terminal domain (CTD) of RNAP II.  Studies utilising a truncated RNA pol II 
lacking the CTD region revealed that the CTD is required for efficient editing of the 
rat Adar2 transcript at the autoediting site (Laurencikiene et al., 2006). This 
autoediting event creates a cryptic splice site and is therefore linked to alternative 
splicing; however absence of the RNA pol II CTD did not affect the efficiency of the 
splicing reaction.  Further investigation of the GluR-B transcript revealed that the 
RNA pol II CTD was only required for efficient editing at the R/G site when splicing 
occurred concomitantly indicating a role for RNA pol II CTD in coordinating editing 
and splicing (Ryman et al., 2007).  At the Q/R site which is located 24 nucleotides 
upstream of a spice donor site the effect was similar in that editing enhanced efficient 
splicing.  These results indicate the CTD of RNA pol II is required to coordinate 
editing and splicing, possibly through delaying the splicing event until editing has 
occurred thereby allowing these processes to occur sequentially.   
 
Furthermore, ADARs 1 and 2 have been shown to co-localise with large nuclear 
ribonucleoprotein (lnRNP) particles which contain numerous splicing factors 
indicating these RNA processing events may be coordinated (Raitskin et al., 2001). 
 
 
1.7 Project outline & Aims 
The diverse roles attributed to the APOBEC family members that have been 
characterised to date indicate these enzymes perform crucial roles in the innate 
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immune system and in the maintenance of genome integrity.  Therefore the discovery 
of a putative novel member of the family whose expression is restricted to the 
germline warrants further investigation.  However, several members of the human 
A3 sub-family show antiretroviral activity that is independent of deaminase function.  
Crucial to understanding the function of this novel deaminase is determining its 
substrate specificity and investigating its expression and subcellular localisation 
during spermatogenesis.  This is the first step to identifying the specific substrates of 
this putative novel deaminase. 
 
The original aims of this thesis were to express and purify recombinant A4 for in 
vitro biochemical analysis to determine the substrate specificity.  At the same time an 
antibody was generated and affinity purified to analyse the expression of endogenous 
A4 in mouse testis and sperm.  This would also aid in the identification of specific 
substrates through the expression pattern and the subcellular localisation of the 
protein.  Finally a characterised E.coli DNA mutators assay was used to determine 
whether A4 could deaminate cytosine in DNA as other AID/APOBEC family 
members can.  However due to the inherent insolubility of the recombinant A4 
protein and its lack of catalytic activity in the E.coli DNA mutators assay, along with 
several external factors, this project was not continued.  
 
Therefore a new project was initiated with the aim of characterising gene expression 
changes in Drosophila melanogaster that lack the Adar gene.  These flies show 
locomotion defects and develop age-dependent neurodegeneration; however the 
neurodegeneration can be suppressed by expression of a catalytically inactive 
transgene in the cholinergic neurons.  This indicates that ADAR has a deaminase-
independent role in the CNS.  To characterise this role microarray analysis was 
performed on 5 day old flies and gene expression changes were verified by real time 
PCR.  In vitro binding and editing experiments were performed to determine whether 
ADAR interacts directly with these transcripts. 
 
To determine if ADAR binding or activity influence alternative splicing and this was 
responsible for the altered expression levels observed in Adar-null flies a custom AS 
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array was performed.  This identified many genes which show altered splicing in the 
absence of ADAR.  Characterisation of two of these genes demonstrated that 
aberrant polyadenylation occurs in the absence of ADAR suggesting a novel role for 
ADAR in 3’ end processing of transcripts.  
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Table 2.1. Preparation of Materials 
 
4x Lower Tris  
36.34g Tris base 
8ml 10% SDS 
H20 to 200ml 
pH to 8.8 with HCl 
4x Upper Tris 
6.06g Tris base 
4ml 10% SDS 
H20 to 100ml 
pH to 6.8 with HCl 
   PBS  
   137 mM NaCl
   2.7 mM KCl 
   10  mM Na2HPO4  






Blocking Buffer for Immunoblotting 
5% Milk Powder in PBS-T 
 
Blocking Buffer for Immunostaining 
1% BSA, 5% serum in PBS-T 
 
Carnoy’s Fixative 
6 volumes ethanol 
3 volume chloroform 
1 volume acetic acid 




10mM Tris-HCl pH6.7-7.0 
0.1% Bromophenol blue 
LB Agar 
10 g NaCl 
10 g Bacto-tryptone 
 5 g Yeast extract 
15 g Difco Agar 
Adjust volume to 1 L with dH2O 
 
Luria Broth (LB)  
10 g NaCl 
10 g Bacto-tryptone 
5 g Yeast extract 
Adjust volume to 1 L with dH2O 
 
 
NuPAGE Running Buffer 
104.6 g MOPS 
60.6 g Tris Base 
10 g SDS 
3 g EDTA 
Adjust volume to 500 ml with dH2O 
 
Paraformaldehyde (4%)  
4 g paraformaldehyde in 66ml PBS 
Heat to 60ºC with stirring (in fumehood) 
Add 0.5 M NaOH until solution clears 
Adjust volume to 100 ml with PBS, pH7 
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TBE (10X)  
108 g Tris base
55 g Boric acid
9.3 g EDTA 
Adjust volume to 1L with dH2O 
TBS 
20 mM Tris-HCl pH 7.5 
137 mM NaCl 
 
 
Transfer buffer  
4.04 g TrisBase
14.4 g Glycine
200 ml Methanol  
Adjust volume to 1L with dH2O 
Tris-Glycine Running buffer (10x) 
30g Tris base 
144g Glycine 




2.2 Molecular Biology Methods 
RNA isolation 
RNA was extracted TRIZOL reagent (Invitrogen) according to the manufacturer’s 
protocol.  For Drosophila, RNA was extracted from 50 mutant or 100 wild type fly 
heads which had been collected and stored in 500µl TRIZOL at -70 oC.  Briefly, fly 
heads were homogenised in 500µl TRIZOL and then an additional 500µl TRIZOL 
was added and samples were left at room temperature for 5 mins.  200µl chloroform 
was added to the samples and they were shaken vigorously for 15 secs then 
centrifuged at 12,000 x g for 15 mins at 4oC to separate the phases.  The upper 
aqueous phase containing the RNA was transferred to a fresh tube and the RNA was 
precipitated by addition of 500µl isopropanol.  Samples were mixed and incubated at 
room temperature for 10 mins before centrifuging at 12,000 x g for 10 mins at 4oC.  
RNA pellets were washed with 1ml 75% ethanol and air dried.  RNA was 
resuspended in RNase-free water at room temperature for 10 mins and stored at -
70oC.  RNA was treated with Turbo DNA-free kit (Ambion) prior to first strand 
synthesis according to the manufacturer’s instructions.  Briefly, 1µl Turbo DNase I 
was added per 10µg RNA, Turbo DNase I 10x buffer was added to a final 
concentration of 1x, and 1µl RNAse IN+ RNase Inhibitor (Promega) was added.  
Samples were incubated at 37oC for 30 mins.  Turbo DNase I was removed by 
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addition of 0.1 volume of DNase Inactivation reagent supplied with the kit, samples 
were mixed and incubated at room temperature for 5 mins.  DNase Inactivation 
reagent was removed by centrifuging samples at 10,000 x g for 1.5 mins and RNA 
was transferred to a fresh tube.  RNA was quantified with a Nano Drop ND-1000 
Spectrophotometer or when performing microarray analysis samples were analysed 
with the Agilent Bioanalyser (Agilent).  RNA integrity was analysed by gel 
electrophoresis on a 2% agarose gel in 1x TBE buffer and RNA was visualised with 
SYBR Green I nucleic acid stain (Invitrogen) diluted 1:10,000 in 1x TBE buffer.  
Prior to loading onto the gel RNA samples were resuspended in deionised formamide 
with 1x gel loading buffer (supplied with DNA ladder from Promega).  Samples 
were heated to 65oC for 5 mins to denature the RNA, chilled on ice for 5 mins, and 
then loaded on the gel. 
 
cDNA synthesis 
First strand cDNA synthesis was performed with M-MLV Reverse Transcriptase, 
RNase H minus, point mutant (Promega) using the manufacturer’s protocol.  cDNA 
was synthesised with oligo dT primers (Promega).  Briefly 1µg RNA was denatured 
in the presence of 50ng oligo dT primers at 70oC for 5 mins and chilled on ice.  
MMLV RT reaction buffer was added to a final concentration of 1x along with 1mM 
dNTPs and 1µl MMLV RT enzyme.  Nuclease-free water was added to a final 
volume of 25µl.  The reaction was incubated at 40oC for 10 mins then at 50oC for 90 
mins. 
 
Polymerase Chain Reaction (PCR) 
PCR was performed with 1µl DNA or cDNA template (~40ng).  Fast start taq 
(Roche) was used for standard PCR reactions and Phusion polymerase (NEB) was 
used when high fidelity amplification was required for cloning or analysis of RNA 
editing frequency.  Both enzymes were used as per the manufacturer’s instructions.  
A typical PCR reaction followed these cycling conditions: 95oC for 5 mins 
denaturation followed by 30 cycles of (95oC- 1 min, 55oC- 30 secs, 72oC- 1 min) and 
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a final elongation step of 5 mins at 72oC.  Time and temperature were varied 
depending on the primers used and the length of the product.  Sequences of the 
primers used in this thesis are given in Appendix II, Table AII.4. 
 
Real time PCR 
Real time PCR was performed with gene-specific primers designed to amplify 
products of 100-150bp with SYBR Green PCR master mix (Applied Biosystems) on 




PCR products were separated by electrophoresis on a 1.5% agarose gel in 0.5X TBE 
buffer supplemented with ethidium bromide at a final concentration of 0.5µg/ml.  
Sizes of DNA fragments were estimated with the assistance of either 1 kb DNA 
ladder (Promega) or 100 bp DNA ladder (Promega).  Samples were loaded in an 
appropriate volume of 6X gel loading buffer supplied with DNA ladder (Promega). 
 
PCR purification by gel extraction 
PCR products were electrophoresed on a 1.5% agarose gel and extracted with a 
Qiagen gel extraction kit and protocol (Qiagen). The manufacturer’s instructions 
were followed and PCR products were eluted in water which had been heated to 
50oC to aid elution. 
 
Phenol/chloroform extraction and ethanol precipitation 
The sample was adjusted to 100µl volume and an equal volume of 
phenol/chloroform (Ambion) was added to the sample, followed by centrifugation at 
12,000 x g for 15 mins. Organic and aqueous components divided into phases and 
the aqueous, DNA containing, top phase was removed. DNA was precipitated from 
the aqueous phase by the addition of 3M sodium acetate at 1/10th of the sample 
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volume, and 2.5 volumes of 100% ethanol. The DNA was centrifuged for 15 mins at 
12,000 x g at 4ºC. The pellet was washed with 70% ethanol to remove residual salt 
and left to dry at room temperature. The DNA was re-suspended in an appropriate 
volume of RNase free water. 
 
Sequencing 
Big Dye v3.1 (Applied Biosystems) sequencing kit was used. The manufacturer’s 
instructions were followed and the sequences were run on an ABI Prism 3730 
Genetic Analyser (MRC HGU Core Facility). Sequences were analysed using either 
Sequencher Version 4.0.5 software or Lasergene Seqman software.  
 
pGEM-T easy cloning 
Taq polymerases such as Fast start (Roche) frequently add 3' deoxyadenosine to the 
ends of PCR products in a non-template directed fashion, however high fidelity 
enzymes such as Phusion polymerase do not.  Therefore to A-tail Phusion PCR 
products the gel purified PCR product was incubated with 1µl 2mM dATP, 1µl Fast 
Start taq (Roche), and 0.1 volumes of the 10x PCR buffer supplied with the enzyme. 
Reactions were incubated at 95ºC for 5 mins and then 70ºC for 30 mins.  Fast start 
PCR products were gel purified prior to ligation into the PGEM T-easy vector.  PCR 
products were added to the Promega ligation mixture, according to the 
manufacturer’s instructions and incubated at 16ºC overnight. 5µl of the ligation 
mixture was transformed into chemically competent E.coli XL1 Blue cells. 
 
2.3 Bacterial Methods 
Bacterial transformations 
5µl of the ligation mixture was incubated on ice for 20 mins with 50µl of chemically 
competent E.coli XL1 Blue cells.  The mixture was then heat shocked at 42ºC for 30 
secs, before being left on ice for a further 2 mins. 900µl of antibiotic-free LB was 
added and the mixture incubated at 37ºC with shaking for 1 h. The transformed cells 
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were spread onto agar plates containing the appropriate antibiotic and incubated 
overnight at 37ºC. If blue/white selection was employed then X-gal (50ng/ml) and 
IPTG (500ng/ml) were added to the plates before plating the transformed cells.  
 
Bacterial Cell culture 
400ml LB were inoculated with E.coli and the appropriate antibiotic (ampicillin at 
20mg/ml or kanamycin at 20mg/ml) was added.  Cultures were grown in an Innova 
4200 incubator shaker (New Brunswick Scientific) set to 220 rpm for >16 h at 37ºC. 
 
Isolation of plasmid DNA 
Plasmids were isolated from the positive transformants with QIAGEN mini-prep kit 
and QIAGEN maxi-prep kit according to the manufacturer’s instructions. 
 
 
2.4 Cell Culture Methods 
p53-/- mouse embryonic fibroblast cell culture  
p53-null mouse embryonic fibroblasts (MEFs) kindly donated by Jamie Hackett 
(Richard Meehan’s lab) were maintained in DMEM media (Invitrogen) 
supplemented with 10% fetal calf serum (FCS), 1% penicillin/streptomycin, and 
0.5ml β-mercaptoethanol, and grown at 37ºC in the presence of 5% CO2. 
 
Drosophila S2 cell culture  
Drosophila melanogaster S2 cells were kindly donated by Betrand Vernay (Andrew 
Jackson’s lab).  Drosophila S2 cells were maintained in Schneider’s media 
(Invitrogen) supplemented with 10% FCS and 1% penicillin/streptomycin in a 26oC 
incubator. 




p53-/- MEFs were grown to approximately 75% confluence and transfected with a 
construct encoding GFP-tagged wild type or catalytic site mutant A4 using 
Lipofectamine-2000 (Invitrogen) according to the manufacturer’s protocol.   
 
Drosophila S2 cells were counted and 1x107 cells were transfected with 20µg of 
plasmid DNA encoding Drosophila ADAR-FLIS6 using 100µl Insect GeneJuice 
reagent (Novagen) in media lacking antibiotics and serum.  Cells were incubated 
with transfection complexes for 4-5 h before it was replaced with fresh media with 
serum and antibiotics.  24 h after transfection Drosophila S2 cells were treated with 
0.6mM copper sulphate to induce expression from the metallothionein inducible 




For analysis of immunofluorescence transfected cells p53 -/- MEFs were plated on 
sterile coverslips coated in 1.5% gelatine.  GFP-tagged A4 was visualised by fixing 
cells in a 4% paraformaldehyde solution (4% pFa in PBS with 0.2% Tween-20 (PBS-
T)) at room temperature for 15 mins then washing in PBS-T.  For visualisation of 
GFP-tagged A4 coverslips were mounted directly in Vectashield (Vector Labs) with 
DAPI (1ng/ml).  For immunofluorescence with anti-A4 antibodies coverslips were 
incubated for 1 h with primary antibodies SKC001, SKC002, or SKC003 at either 
1:100 or 1:1000 dilution in PBS with 1% BSA and 5% serum.  Coverslips were 
washed three times and then incubated for 1 h with the secondary antibody Texas 
Red-conjugated anti guinea pig IgG at either 1:1000 or 1:10,000 dilution.  Coverslips 
were washed three times and mounted in Vectashield (Vector labs) with DAPI 
(1ng/ml). 
 
For immunofluorescence analysis of Drosophila S2 cells, transiently transfected 
Drosophila S2 cells in suspension were dropped onto sterile coverslips coated in 
concanavalin A (0.5mg/ml).  Cells were allowed to settle and adhere for 1 h before 
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fixing in 4% paraformaldehyde at room temperature for 10 mins.  FLAG-tagged 
ADAR protein was visualised with a mouse anti-FLAG antibody (Sigma) at a 
1:10,000 dilution.  The cells were washed three times in PBS-T and incubated at 
room temperature with FITC-conjugated anti mouse IgG secondary antibody (Sigma) 
for 1 h.  Coverslips were washed three times in PBS-T and mounted in Vectashield 
(Vector Labs) with DAPI (1ng/ml). 
 
Immunofluorescence was visualised with an imaging system comprised of a 
Coolsnap HQ CCD camera (Photometrics Ltd, Tucson, AZ) Zeiss Axioplan II 
fluorescence microscope with Plan-neofluar objectives, a 100W Hg source (Carl 
Zeiss, Welwyn Garden City, UK) and Chroma #83000 triple band pass filter set 
(Chroma Technology Corp., Rockingham, VT) with the excitation filters installed in 
a motorised filter wheel (Ludl Electronic Products, Hawthorne, NY). Image capture 
and analysis were performed using in-house scripts written for IPLab Spectrum 
(Scanalytics Corp, Fairfax, VA). 
 
 
2.5 Experimental procedures 
Plasmid constructs 
The A4-FLIS6 coding region was subcloned into the MCS of the pET21b vector via 
PCR amplification of the yeast expression vector pPICZA-A4-FLIS6 construct 
(M.Hogg, Master’s rotation project) with primers containing either Nde I or Eco RI 
restriction sites.  The resulting plasmid was sequenced to confirm an intact coding 
region and termed pET21b-A4-FLIS6.  The pET21b-A4-46-to-the-end-FLIS6 vector 
was created using Spe I sites which flank the FLAG-A4-6xHIS insert in the pPICZA-
A4-FLIS6 plasmid.  A forward primer was designed to amplify the region from 
nucleotide 136 forward (which corresponds to amino acid 46, numbering from the 
start methionine) that contained the FLAG epitope coding sequence and a Spe I site 
at its 5’ end.  The pET21b-A4-FLIS6 vector was digested with Spe I to release the 
insert and the amplified A4-46-to-the-end-FLIS6 insert was ligated into the vector.  
Chapter 2: Materials & Methods 
 
 93
The resulting pET21b-A4-46-to-the-end-FLIS6 vector was sequenced to confirm the 
insert was intact and in the correct orientation. 
 
RNA Immuno-Precipitation (RIP) 
Drosophila S2 cells transfected with pRm-ADAR-FLIS6 were harvested by scraping 
the tissue culture plate and centrifuging at 1000rpm for 4 mins to pellet, and then 
they were washed once in ice-cold PBS.  Cells were lysed in NET buffer (50mM Tris 
pH7.5, 100mM NaCl, 0.5% Igepal, 1mM DTT) supplemented with 1x complete 
protease inhibitor (Roche), 0.1U/µl RNase Inhibitor plus (Promega), and 0.1µg/µl 
yeast tRNA.  Extracts were sonicated for 5 mins and centrifuged at 20,000 x g for 15 
mins at 4oC.  Protein concentration was determined by Bradford Assay and 10% 
input was reserved as an input sample and added to 1ml TRIZOL reagent for RNA 
extraction.  50µl FLAG M2 agarose beads (Sigma) were pre-incubated with 100µg 
BSA, 100µg yeast tRNA, and 100µg herring sperm DNA in 1ml NET buffer for 1 h 
at 4oC with rotation.  Beads were washed three times with 1ml NET buffer with 
centrifugation steps performed at 1000 rpm for 1 min at 4oC.  Protein extracts were 
added to beads and incubated at 4oC with rotation for 2 h.  Beads were collected by 
centrifugation at 1000 rpm for 1 min at 4oC in a table top microfuge.  Beads were 
washed twice for 5 mins in 1ml NET buffer then transferred to a new eppendorf tube 
and washed for 15 mins at 4oC, then once more for 5 mins.  RNA was eluted from 
beads by addition of 1ml TRIZOL reagent with gentle vortexing.  Precipitated RNA 
was treated with DNase I (Promega) at 37oC for 30 mins before addition of STOP 
reagent (Promega) and incubation at 65oC for 10 mins.  The DNase I treated RNA 
was then used in RT reactions to generate cDNA.  Real time PCR analysis was 
performed with a standard curve generated from the 10% input sample.  
 
In vitro editing assay 
In vitro transcribed and purified pre-mRNAs at a concentration of 50ng per reaction 
were incubated with 50nM purified recombinant ADAR-FLIS6 protein in binding 
buffer (50mM Tris-HCl pH7.9, 150mM KCl, 5mM EDTA, 20% glycerol, 1mM 
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DTT, 1x protease inhibitor tablet/50ml, 0.15mg/ml yeast tRNA, and 0.2mg/ml BSA) 
and RNase IN+ RNase Inhibitor (Promega).  Reactions were stopped by the addition 
of 500µl TRIZOL reagent and RNA was precipitated.  cDNA reactions were 
performed with a mixture of random hexamer and gene-specific primers with control 
reactions lacking reverse transcriptase to ensure no DNA contamination was present.  
PCR reactions were performed with high fidelity Phusion polymerase (NEB) with 
gene-specific primers and products were gel purified and cloned into pGEM T-easy 
vector.  Editing frequency was determined by sequencing of individual clones. 
 
Oxidised RNA immunoprecipitation 
1.5µg total RNA purified from fly heads with TRIZOL reagent as described earlier 
was incubated with 2.5µg anti-8OHG antibody (Abcam) for 30 mins at 4oC.  20µl 
protein G sepharose beads which had been washed three times in cold PBS were 
added to each reaction and incubated overnight at 4oC.  Beads were pelleted by 
centrifugation at 1000 rpm for 1 min at 4oC in a table top microfuge.  Non-oxidised 
RNA was precipitated from the supernatant with acid phenol/chloroform and 
precipitated with 100% ethanol and 1/10th volume 3M NaAc in the presence of 1µl 
glycogen carrier.  Beads were washed three times for 5 mins in 1ml cold PBS with 
0.04% Igepal.  Oxidised RNA was eluted by addition of 300µl PBS/0.04% Igepal, 
30µl 10% SDS, and 300µl acid phenol/chloroform and this was incubated at 37oC for 
15 mins with vortexing every 5 mins. RNA was extracted with acid 
phenol/chloroform and precipitated with 100% ethanol and 1/10th volume 3M NaAc 
and 1µl glycogen.  Following resuspension all the RNA was used in first strand 
synthesis reactions with a control of 250ng input RNA which was amplified with or 
without reverse transcriptase enzyme. 
 
In vitro transcription 
Template DNA encompassing the coding region with introns and UTRs of candidate 
transcripts were cloned into the PGEM T-easy vector.  The vectors were linearised 
by digestion with Nco I for transcripts transcribed with Sp6 polymerase or Spe I for 
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transcripts transcribed with T7 polymerase.  1µg linearized DNA was incubated with 
T7 or Sp6 polymerase (Ambion) in a 20µl reaction containing 5x buffer, 1µl 
RNaseIN+ (Promega), 1µl 10mM riboNTPs, 5µg BSA, 1µl synthetic RNA cap.  
Samples were incubated at 37oC for greater than 2 h with the addition of extra 
polymerase after 1 h.  DNA was digested by addition of 1.5µl turbo DNase I 
(Ambion), with 40U RNaseIN+ RNAse inhibitor (Promega) and samples were 
incubated at 37oC for 45 mins.  RNA was precipitated with phenol/chloroform 
isoamyl alcohol (Ambion) in the presence of 1µl glycogen.  RNA was purified by gel 
electrophoresis on a denaturing polyacrylamide gel (4% for longer transcripts 8% for 
short), and bands were visualised by UV shadowing.  Bands were excised with clean 
scalpel blades and RNA was extracted by incubating the gel slice in RNA extraction 
buffer (50mM Tris pH7.5, 100nM NaCl, 10mM EDTA and 0.1% SDS) overnight at 
4oC on a rotator.  RNA integrity was analysed by agarose gel electrophoresis in a 
loading buffer containing deionised formamide, and RNAs were stored at -70oC in 
the presence of RNase IN+ RNase inhibitor (Promega). 
 
Radiolabelled substrates were transcribed as above but the riboNTP mixture was 
adjusted such that rATP, rCTP, and rUTP were included at 10mM and 3µl 
radioactive rGTP (α32P-rGTP) was included per reaction supplemented with 1µl cold 
2mM rGTP.  Transcripts were purified by gel electrophoresis on a denaturing 
polyacrylamide gel and bands were detected by exposing the gel to a film.  Bands 
were excised and RNA was purified as above. 
 
Electrophoretic Mobility Shift Assay  
Electrophoretic shift mobility assays were performed by incubating purified ADAR-
FLIS6 protein purified from Pichia pastoris (Ring et al., 2004) with in vitro 
transcribed radiolabelled Adar160 RNA.  Adar160 RNA is a fragment of the 
Drosophila Adar transcript which encompasses the self editing site within exon 7 
and the ECS.  It is edited to approximately 70% in vitro (Keegan et al., 2005).  The 
same binding buffer (50mM Tris-HCl pH7.9, 150mM KCl, 5mM EDTA, 20% 
glycerol, 1mM DTT, 1x protease inhibitor tablet/50ml, 0.15mg/ml yeast tRNA, and 
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0.2mg/ml BSA) was used for both filter binding reactions and EMSA reactions.  
Binding reactions were stopped by loading onto a 5% native polyacrylamide gel 
made with 40% acrylamide: bisacrylamide (29:1), 0.5x TBE, and 1% glycerol to 
stabilise protein-RNA complexes.  Gels were electrophoresed at 4oC for 7-8 h then 
dried at 80oC for approximately 90 mins. Dried gels were exposed to 
phosphorimager screens overnight and images were visualised on a FLA2000 laser 
scanner (IDE).  Images were quantified with ImageQuant software (GE Healthcare). 
 
Filter binding analysis of ADAR RNA-binding 
Filter binding experiments were performed with in vitro transcribed radiolabelled 
pre-mRNA transcripts and purified ADAR-FLIS6 protein (Ring et al., 2004).  
Different concentrations of purified ADAR-FLIS6 protein were incubated with α32P-
ATP labelled pre-mRNAs in binding buffer (50mM Tris-HCl pH7.9, 150mM KCl, 
5mM EDTA, 20% glycerol, 1mM DTT, 1x protease inhibitor tablet/50ml, 0.15mg/ml 
yeast tRNA, and 0.2mg/ml BSA) for 10 mins before being applied to a 0.45µm 
nitrocellulose filter (Schleicher & Schuell).  A vacuum was applied to the filter and 
filters were then washed twice with 1ml binding buffer to remove unbound RNAs 
and air dried.  Filters were immersed in 2ml scintillation fluid and counted in a 
scintillation counter.  Bound RNA was calculated using the radioactive count. 
 
RACE 
5’ and 3’ RACE were performed with the Firstchoice RLM RACE kit (Ambion) kit 
and protocol.  1.5µg total Drosophila head RNA was used for each cDNA reaction.  
RACE products were analysed by gel electrophoresis on a 2% agarose gel in 0.5x 
TBE.  Bands were gel extracted and purified, cloned into PGEM T-easy vector and 
analysed by sequencing. 
 
Chapter 2: Materials & Methods 
 
 97
SDS-PAGE gel electrophoresis 
Protein concentrations were determined by Bradford Assay with BSA standards.  
Protein samples were mixed with an appropriate amount of 4x laemelli buffer (see 
Materials section) and boiled at 100oC for 5 mins before cooling to room temperature 
before loading onto gels.  Gels used were either 4-12% Nu-Page Bis-tris pre-cast gels 
(Invitrogen) which were electrophoresed in Nu-Page gel running buffer (Invitrogen).  
Alternatively, gels were used which comprised a 4% stacking gel with an 8 or 10% 
separating gel.  10% separating gels (8.33ml H2O, 5ml 4x Lower Tris buffer (see 
Materials section), 6.67ml acrylamide, TEMED 20µl, 10% ammonium persulphate 
(APS) 100µl) with 4% stacking gel (3.25ml H2O, 1.25ml Upper Tris buffer (see 
Materials section), 0.55ml acrylamide, 10µl TEMED, and 20µl 10% APS) were 
electrophoresed in 1x Tris-Glycine buffer (see Materials section) with 0.1% SDS. 
 
Proteins were electrophoresed through the stacking gels at 15mA and then the 
current was increased to 25mA for the separating gel.  Benchmark pre-stained 
protein standard (Invitrogen) was included on each gel.  Gels were stained with 
Coomassie brilliant blue stain (50% methanol, 7 % acetic acid, and 0.25g Coomassie 
brilliant blue R) or Sypro Ruby protein stain (Sigma) according to the manufacturer’s 
protocol. 
 
Silver staining of SDS-PAGE gels 
Samples were boiled in SDS buffer (see above) and electrophoresed on a 10% PAGE 
gel, then fixed in 200mls Fix I (30% ethanol, 10% acetic acid) for 30 mins at room 
temperature with shaking.  Gels were transferred to 200mls Fix II (30% ethanol, 
0.5M sodium acetate, 0.2% (w/v) sodium thiosulfate-5 H2O, 0.125% glutaraldehyde) 
for 30 mins as before.  The gel was then washed three times in distilled water for 10 
mins each.  The gel was stained for 20 mins in 200mls stain (0.1% (w/v) silver 
nitrate, 0.01% formaldehyde) and then transferred to developing solution (2.5% 
sodium carbonate, 0.01% formaldehyde) until stain could be visualized.  When stain 
was visible the gel was transferred to stop solution (1% glycine).  Gel images were 
created by scanning the dried gels. 
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Western Blot Analysis 
Proteins were electrophoresed on SDS-PAGE gels and then transferred to a 
nitrocellulose membrane (Whatman).  Transfer of protein was confirmed by 
incubating memebranes in Ponceau S solution (Sigma) for 5 mins at room 
temperature.  Excess ponceau S solution was removed by washing in running water 
and membranes were scanned.  Non-specific binding sites were blocked by 
incubation of the membrane in 5% non-fat dry milk (marvel) in 0.2% PBS-Tween 20 
(PBS-T) solution for 30 mins at room temperature.  Proteins were detected by 
incubation of primary antibody dilution in 5% non-fat dry milk in PBS-T for either 1 
h at room temperature or overnight at 4oC.  Primary antibodies were used at the 
following dilutions: mouse anti-FLAG M2 antibody (Sigma) 1:3000, guinea pig anti-
A4 antibodies 1:100, and mouse anti-SR protein 1H4 antibody (Zymed) 1:500.  
Membranes were washed three times in PBS-T for 5-10 mins each and then 
incubated in the appropriate secondary antibody at room temperature for 1 h.  
Secondary antibodies used were anti-mouse conjugated HRP at 1:10,000 or anti-
guinea pig conjugated HRP at 1:5,000.  Signals were detected with enhanced 
chemiluminescence with the Super Signal West Pico detection reagent (Pierce). 
 
2.6 Recombinant protein production and purification 
Baculovirus expression of recombinant protein in Sf9 insect 
cells 
Sf9 cells are derived from pupal ovarian tissue from the Fall armyworm (Spodoptera 
frugiperda).  They are susceptible to infection by the Autographa california multiple 
nuclear polyhedrosis virus (AcMNPV), and the AcMNPV polyhedrin promoter is 
used to drive recombinant protein expression in Sf9 cells following infection with the 
recombinant baculovirus.  Wildtype and mutant A4, with and without FLIS6 epitope 
tags, were cloned into the pENTR vector kindly donated by Tedd Hupp (CRUK) 
using the Gateway cloning technique (Invitrogen).  Plasmids were checked by 
sequencing and subsequently recombined into the pDESTTM8 vector for use with the 
Bac-to Bac Baculovirus expression system (Invitrogen).  From the pDESTTM8 vector 
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A4-FLIS6 was recombined into the Baculovirus shuttle vector (bacmid) with the aid 
of a helper plasmid encoding a transposase, and the bacmid was amplified in E.coli.  
High molecular weight recombinant bacmid DNA was isolated from mini cultures 
and transfected into Sf9 insect cells.   
 
Sf9 cells obtained from S.Meek (University of Edinburgh) were grown at 26oC with 
continuous stirring in Sf-900 II serum free media (Gibco) containing 1% penicillin 
and streptomycin.  Plasmids were transfected into Sf9 cells with Cellfectin 
Transfection Reagent (Invitrogen) following the manufacturer’s protocol.  Briefly, 
for each transfection 4µg DNA were mixed with 0.5ml Sf-900 II media minus 
antibiotics, and separately 8µl Cellfectin was mixed with another 0.5ml Sf-900 II 
media minus antibiotics.  The DNA/media and Cellfectin/media were combined and 
incubated at room temperature for 15-45 mins.  For transfections in 2ml wells, 1 x 
106 cells were counted and washed in media minus antibiotics.  Cell pellets were 
resuspended in the DNA/Cellfectin/media mix, plated out and incubated at 26oC for 
5 h.  After 5 h 1ml Sf-900 II media containing antibiotics was added, and cells were 
incubated for 3 days at 26oC. 
 
Cells were harvested and supernatant containing virus particles was kept to infect 
future cultures.  To prepare a stock of high titre viral supernatant, the supernatant 
was used to infect 1x106 cells, which were grown for 5 days.  These cells were 
harvested and a third round of infection was performed with 2x107 cells.  The 
supernatant from the third round of infection was kept and used to infect cells for all 
further experiments.   
 
Harvested cells were washed once in PBS and the pellet was resuspended in Q200 
buffer (50mM Tris-HCl pH8.0, 200mM KCl, 20% glycerol, containing protease 
inhibitors: 0.7mg/ml pepstatin, 0.4mg/ml leupeptin, 1mM DTT, 1mM PMSF).  The 
cell suspension was sonicated for 3x 10-sec intervals with a microtip sonicator at 
15% power and placed on ice for 1 min in between.  Samples were then centrifuged 
at 20,817 x g for 15 mins at 4oC.  The supernatant was kept for future analysis, and 
the pellet was resuspended in 100µl Q200 buffer for comparison of soluble and 
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insoluble protein.  Purification with FLAG-M2 agarose and Nickel2+ NTA resin were 
performed as described previously (Ring et al, 2004). 
 
Generation and purification of a polyclonal antibody to A4  
Recombinant A4 protein generated for use as an antigen to inoculate guinea pigs and 
generate a polyclonal antibody was produced in E.coli using the pGEX-A4-FLIS6 
plasmid (created by A. Ruzov from the pGEX_6P-3 plasmid (Amersham Pharmacia) 
and the pPICZa-A4-FLIS6 plasmid).  The plasmid was transformed into E.coli 
BL21(DE3), which was grown to an O.D.600nm of 0.5-0.8 and then induced for 4 h at 
30oC by addition of 1mM IPTG.  Cells were pelleted at 20,817x g for 15 mins at 4oC 
and lysed for 30 mins at room temperature in 1ml Bugbuster protein extraction 
reagent (Novagen) and 1µl lysozyme per gram wet weight cells.  Lysed cells were 
centrifuged at 10,000 x g for 30 mins and supernatant was added to 250µl 
Glutathione Sepharose 4B beads (Amersham Biosciences) that had previously been 
washed three times for 5 mins each in PBS.  The lysed cells were incubated with the 
beads overnight at 4oC, then washed three times with PBS for 5 mins each.  GST 
tagged FLAG-A4-HIS and GST tagged FLAG-HIS proteins were eluted from beads 
in 1ml 10mM Glutathione in PBS by end-over end rotation for 1 h at 4oC.  This 
elution step was performed twice, followed by a final elution in 50mM glutathione in 
PBS.  Samples were analysed by western blot with an anti-FLAG antibody.  Eluates 
were run on a 10% polyacrylamide gel to determine purity and a Bradford Assay was 
performed to determine the protein content.  Recombinant protein was used to 
inoculate 3 guinea pigs (Eurogentec). 
 
Affinity purification of the A4 antibody 
For affinity purification of the guinea pig anti-A4 antibodies recombinant GST-A4-
FLIS6 protein was generated as described above for immobilization onto a column 
matrix.  To remove antibodies which recognise the epitope tags on the recombinant 
GST-A4-FLIS6 antigen an additional protein was generated.  The pGEX-A4-FLIS6 
plasmid was digested with SpeI enzyme to remove the A4 coding sequence, creating 
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the pGEX-FLIS6 plasmid, which encodes a GST-FLIS6 protein.  Both the original 
pGEX-A4-FLIS6 plasmid and the modified pGEX-FLIS6 plasmid were transformed 
into E.coli BL21(DE3) and recombinant proteins were produced as described above.  
Purification varied from the protocol above as proteins were eluted from beads with 
1ml 10mM Glutathione dissolved in Coupling Buffer (0.1M Sodium carbonate, 0.5M 
Sodium chloride, pH8.3: for the following immobilization of the protein to a matrix) 
by end-over end rotation for 1 h at 4oC.  This elution step was performed twice, 
followed by a final elution in 50mM glutathione in coupling buffer.   
 
For affinity purification of the guinea pig anti-A4 antibodies two different columns 
were generated.  One column matrix was bound to the GST-A4-FLIS6 protein which 
was used as antigen to generate the antibodies, and the other column matrix was 
bound to the GST-FLIS6 protein and used to remove antibodies which recognised 
the epitope tags.  To generate these columns purified proteins were immobilized on a 
Cyanogen Bromide (CNBr)-activated sepharose matrix (GE Healthcare), as 
described in the manufacturer’s protocol.  Briefly, 1g lyophilized CNBr-activated 
sepharose 4B powder was activated by suspension in 1mM HCl and washed with 
approximately 200mls 1mM HCl for 15 mins on a sintered glass filter.  The protein 
to be coupled to the matrix was already in suspension in the coupling buffer; this was 
added to the matrix and incubated overnight at 4oC with end-over-end rotation.  The 
following day the gel matrix was loaded onto a column and washed with 5 column 
volumes of coupling buffer.  Remaining active groups were blocked with 2 h 
incubation in 0.1M Tris-HCl (pH8.0), and uncoupled proteins were eluted with three 
cycles of alternating pH (0.1M acetic acid pH4.0 containing 0.5M NaCl, followed by 
0.1M Tris-HCl pH8.0 containing 0.5M NaCl).  The column matrix was then washed 
with Q200 buffer and stored at 4oC until required. 
 
For affinity purification of the guinea pig anti-A4 antibodies 5ml serum from an A4 
inoculated guinea pig was filtered through a 0.22uM membrane filter and diluted 1:1 
in Q200 buffer (50mM Tris-HCl pH8.0, 200mM KCl, 20% glycerol, containing 
protease inhibitors: 0.7mg/mg pepstatin, 0.4mg/ml leupeptin, 1mM DTT, 1mM 
PMSF).  This was incubated overnight at 4oC with end-over-end rotation with the 
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GST-FLIS6 matrix to remove antibodies raised to the epitope tags as they would 
bind to this matrix.  The following day the flow through was collected and applied to 
the GST-A4-FLIS6 matrix to enrich for antibodies which recognise A4 antigens.  
This was incubated overnight at 4oC with end-over-end rotation and the following 
day the matrix was loaded into a column and the flow through was re-applied to the 
column twice to ensure maximal binding.  The column was washed three times with 
10x column volumes of Q200 buffer.  Bound anti-A4 antibody was eluted with 0.1M 
glycine-HCl pH2.5; 1ml fractions were collected and the pH was immediately 
neutralised with 50µl 1M Tris-HCl pH9.0.  Antibody concentration was determined 
by absorbance at 280nm in a Nanodrop, and 50% glycerol was added prior to long 
term storage at –70oC. 
 
2.7 Drosophila methods 
Fly maintenance and fly strains 
Flies were raised on standard cornmeal-agar medium which was prepared by 
technicians in the Michael Swann kitchen at Kings building’s, University of 
Edinburgh.  Fly stocks were maintained and virgins were collected at 18oC, whilst 
crosses and amplified stocks were kept at 25oC.  Flies were aged in batches of 1-10 
flies per vial and they were tipped on to fresh vials every two days.  The genotypes 
of the flies used are listed in Table 2.1. 
Fly strain Description Genotype
w 1118 Control w
Adar 5G1 Adar deletion y, Adar 5G1 , w 1 /FM7 B 1  g 4  sc 8  sn X2  v Of  w a  y 31d
Cha-GAL4 Driver line w* ; P{Cha-GAL4.7.4}19B P{UAS-GFP.S65T}T2
UAS-dAdar Active Adar  w; ; UAS-Adar 3/4un 1-4a (III)
UAS-dAdar EA Inactive Adar w; ;UAS-Adar 3/4  EA 6a /TM3 Sb 
UAS-hADAR2 Human ADAR2 w; UAS-hADAR2 1-4c3 /SM5 Cy;
UAS-hADAR2 RRM Human ADAR2 RRM mutant w; ; UAS-hADAR 2 RRM /TM3 Sb  
Table 2.1: Fly strains and genotypes. 
The strain description and genotypes of flies used in this thesis.  Adar5G1 flies were initially 
described in (Palladino et al., 2000b).  Where B indicates bar eye which is linked to the FM7 
balancer, w indicates white eyes, y indicates yellow which gives a yellow-brown body colour, 
Sb insictes stubble which gives short bristles, and Cy indicates curly which gives curly wings. 
The Cha-GAL4 is available from the Bloomington stock centre reference number 6793. 
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Open Field locomotion assay 
Flies were collected when 1 day old by CO2 anaesthetic and locomotion was 
analysed at 5 days with no anaesthesia on the intervening days.  The assay was 
performed in the fly room which is maintained at 20oC.  Individual flies were placed 
into a 5mm Petri dish which had been marked into 7 equal areas, one central and 6 
peripheral.  The dish was tapped and the number of times a fly crossed the line was 
counted over a 2 min period.  Three measurements were recorded for each fly and an 
average was calculated, and 10 flies of each genotype were assayed.  The standard 
deviation was calculated using the average value for each fly. 
 
Histology techniques 
Decapitated fly heads were fixed in Carnoy’s fixative (6: 3: 1, ethanol: chloroform: 
acetic acid) for 4 h at room temperature with rotation.  Fixative was removed and 
heads were dehydrated through 70%, 80%, 90% and two changes of 100% ethanol 
for 20 mins each at room temperature.  The following steps were performed in a 
Sakura Tissue Tek VIP tissue processor (Sakura) which was pre-programmed.  To 
clear the alcohol, the fly heads were incubated three times in xylene for 5 mins each 
at room temperature and then once at 60oC.  To embed the heads they were incubated 
in paraffin wax pre-heated to 63oC for 5 mins.  This was repeated three times and the 
fly heads were orientated and mounted onto blocks for cutting.  8µM sections were 
cut on a Leica microtome with ACCU-edge low profile blades (Sakura).  Sections 
were floated out in a 42oC waterbath and attached to Superfrost plus slides and baked 
at 50oC overnight. 
 
To remove the embedding wax slides were incubated in xylene three times for 5 
mins each.  Xylene was removed by incubating slides in three changes of 100% 
ethanol for 5 mins each.  Slides were then re-hydrated through 90%, 70%, 50%, and 
30% ethanol for 2 mins each and then rinsed in water.  Slides were incubated in 
freshly filtered haematoxylin for four mins and then rinsed in running water until the 
water ran clear.  Slides were then dipped in twice into acid alcohol (70% ethanol 
with 2 drops of concentrated hydrochloric acid) and washed in running water.  The 
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slides were dipped twice into lithium carbonate and washed in running water, then 
incubated in 1% eosin for 5 mins.  Slides were washed briefly in running water and 
then dipped into 100% ethanol.  Slides were incubated in fresh 100% ethanol three 
times for 5 mins each and then taken through three 5 min incubations in xylene prior 
to mounting in DePeX mounting media (EMS).  Sections were imaged with an 
imaging system comprising a Qimaging Micropublisher 3.3mp cooled colour CCD 
camera (Qimaging, Burnaby, BC), Zeiss Axioplan II fluorescence microscope with 
Plan-neofluar or Plan Apochromat objectives (Carl Zeiss, Welwyn Garden City, 
UK). Image capture and analysis were performed with IPLab Spectrum software 





Primer pairs were designed with the Primer 3 web-based program 
(http://frodo.wi.mit.edu/primer3/).  Primers for real time PCR were designed using 
the Universal probe library assay design centre (Roche) which is freely available at 
(https://www.roche-applied-science.com/sis/rtpcr/upl/index.jsp?id=uplct_030000), 
however universal probes were not used in this thesis.  The universal probe library 
design centre runs in silico PCR reactions to analyse primer pairs.   Primer sequences 
are listed in Appendix II, Table AII.4. 
 
Alignments were performed with the Clustalw2 program from the European 
Bioinformatics Institute (Labarga et al., 2007).  The A4 NES was predicted using the 
freely available NES predictor program at (http://www.cbs.dtu.uk) and the isoelectric 
point of A4 was estimated with the free program available at 
(http://www.scripps.edu/~cdputnam/protcalc.html).  The freely available miRNA 
prediction programs TargetScanMouse (Friedman et al., 2009) and miRBD software 
(Wang, 2008; Wang and El Naqa, 2008). 




Unpaired t-test was performed with the web-based programs available at Graphpad 
QuikCalcs (http://www.graphpad.com/quickcalcs/index.cfm).  An unpaired t-test was 
used to analyse the locomotion data by comparing the means of two data sets in this 
case w1118 and Adar5G1 flies were compared, and the rescue lines Adar5G1:Cha-
GAL4>Adar and Adar5G1:Cha-GAL4>Adar EA flies. 
 
Affymetrix Microarray Analysis 
Microarrays were analysed with the free DNA-Chip Analyzer (dChip) software (Li 
& Wong, 2001).  Affymetrix CEL files were read into the software and analysed 
using a model based expression profile with perfect match probes only.  Arrays were 
normalised to the array with the median overall intensity.  Pattern searches were used 
to identify significantly altered genes (>1.2 fold change with a p value of p< 0.05) 
which show altered expression in Adar5G1 samples and are rescued by expression of 
active or inactive Adar transgenes in the cholinergic neurons. 
 
Alternative Splicing Array Analysis 
The alternative splicing (AS) array data was analysed with the Sparrow analysis 
package written by Marco Blanchette.  The analysis was performed in parallel by 
Marco Blanchette in the USA and at the HGU with the help of Graeme Grimes.  The 
Sparrow package was written and used in the R software environment.  Analysis 
involved scaling and normalisation of the arrays using the Lowess method to remove 
variation due to dye bias and this was performed with the marray package in R.  
Genes were then analysed individually using an ANOVA test to determine whether 
any of the junction probes for a given gene were significantly altered from the other 
probes for that gene, and this generated a list of genes with altered junctions.  To 
identify the significantly altered junctions a t-test was performed and the Benjamini-
Yekutieli correction was applied to correct for multiple testing (Benjamini and 
Yekutieli, 2001).  To determine the expression of the exon junctions, a net 
expression (NE) value was calculated from the common exonic probes which are 
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constitutively present, and this was subtracted from the individual junction probe 
expression data.  These calculations highlight differences in exon junction use 
irrespective of changes in the NE across the transcripts between samples.  
Subsequently scripts were written in the R environment to display the data 
graphically and on the UCSC genome browser (http://genome.ucsc.edu/). 






Chapter 3: APOBEC4 characterisation 
Chapter 3: APOBEC4 Characterisation 
 108
3.1 Introduction 
The APOBEC/AID family of deaminases display a wide variety of functions in vivo, 
with different substrate specificities and expression patterns.  What has fascinated 
scientists for a long time is why these potentially powerful mutators exist and how 
they are regulated.  The discovery of a new member of this family that is highly 
expressed in the testis is intriguing.  The germline genome is heavily protected from 
mutation, therefore why would an active deaminase be found there?  Interestingly it 
has been observed that the point mutation rate is two-fold higher in the male 
germline than the female germline (Lander et al., 2001), leading us to wonder if 
APOBEC4 (A4) could be responsible for generating novel point mutations.  
However increased proliferation in the male germline may be responsible for the 
increased mutation rate due to replication errors. 
 
A4 was identified by Rogozin and colleagues via bioinformatic searches for the zinc-
coordinating motif (H/C)xE….PCxxC that is conserved throughout cytidine 
deaminase enzymes (Rogozin et al., 2005).  The deaminase motif is conserved from 
deaminases that work on free nucleotides through the ADAR/ADAT family of 
enzymes that act on adenosine in RNA to the vertebrate-specific AID/APOBEC 
family that deaminate C-to-U in DNA and RNA.  The search revealed an 
uncharacterized vertebrate protein family with orthologs in many species from 
humans to Xenopus tropicalis, although the A4 protein was not found in any fish 
databases.  The novel A4 protein family showed greatest similarity to A1 (28%), 
however it is found to be more widespread in the vertebrate lineage indicating it 
emerged earlier from a common AID/A2 ancestor (Rogozin et al., 2005).  
 
Analysis of the gene structure of A4 indicates it is not likely to be a pseudogene as 
there is only one copy present and it contains one intron that is efficiently spliced out 
in the annotated ESTs from this locus.  The putative A4 EST was only found in 
mouse testis although the human database contained 8 testis ESTs, 1 brain EST and 1 
EST from uterus (Rogozin et al., 2005).  In situ hybridisation was performed on 
mouse testis and confirmed expression of Apobec4 in the round spermatids and no 
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signal was detected in mouse ovaries (Diana Best, data not shown).  However, to 
further define the Apobec4 expression pattern throughout spermatogenesis and to 
determine whether Apobec4 was expressed in mature sperm I performed RT-PCR 
analysis.  The preliminary data published on A4 was generated in silico, to analyse 
its predicted deaminase function in vitro we decided to generate a recombinant A4 
protein.   
 
To characterize the A4 protein in vitro I cloned and expressed recombinant A4 in 
several different expression systems including E.coli, the yeast Pichia pastoris and a 
Baculovirus expression system for infection of Sf9 insect cells.  However, the 
recombinant A4 protein was intrinsically insoluble and despite numerous attempts to 
purify the small fraction of soluble protein obtained I could not isolate sufficient 
amounts for in vitro analysis.  After many attempts I concluded that the soluble 
recombinant A4 produced was not a homogeneous preparation, as I could not purify 
it under the same conditions. 
 
To investigate the A4 protein localization in vivo we generated an antibody to 
recombinant GST-tagged A4 protein.  The GST tag made the protein more soluble 
and I was able to purify a sufficient quantity to inoculate three guinea pigs.  
Specifically, we were interested in determining whether the A4 protein is present in 
testis and mature sperm, as this would help us to elucidate its biological function.  In 
addition, to determine whether A4 could deaminate DNA an E.coli DNA mutator 
assay was performed.  This assay has been used to characterise other members of the 
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3.2 Results 
Bioinformatic Analysis of APOBEC4 
Clustal alignment of mouse proteins from the AID/APOBEC family clearly shows 
the extra four amino acids inserted in the active site of the deaminase domain (Figure 
3.1: motif C).  These extra bases fall within the zinc-coordinating motif, yet the 
residues that make contact with the zinc molecule (histidine and cysteine) and the 
proton donor for the nucleophilic attack on the target residue (glutamic acid) are 
conserved throughout the family.  This suggests the active site may be larger in A4, 
which we hypothesised could have evolved to accommodate a modified residue such 
as 5-methylcytosine.  A1 and AID have both been shown to be capable of 
deaminating 5-methylcytosine in vitro (Morgan et al., 2004).  This indicates that a 
larger active site may not be necessary for this catalysis, however it may have 
evolved separately and specifically in A4.  A4 may be able to catalyze the 
deamination of 5-methylcytosine at a faster rate than the other two enzymes.  
 
Interestingly, A4 does not share the conserved SWS motif immediately preceding the 
PCx(2-6)C motif, instead it contains an NNS sequence (Figure 3.1: motif B).  A2 
does not share this SWS motif either, but only differs in one residue with SSS at the 
corresponding position.  Strikingly, an A1 mutant (W90S) that contains the A2 
sequence SSS behaves similarly to A2 in an E.coli DNA mutator assay, showing no 
mutator activity (Harris et al., 2002).   A similar loss of function phenotype was 
observed with mutations in the core catalytic glutamic acid residue (E63A) and a 
cysteine residue (C93A) which coordinates the zinc atom in the active site of A1.  
This indicates these residues play an important role in the deamination reaction, 
possibly in substrate recognition as they are located so close to the active site.  This 
observation does not imply that A4 is catalytically inactive; these residues may 
confer different substrate specificity on A4, as is potentially the case for A2.  
Furthermore, the behaviour of A1 in this in vitro assay is not biologically relevant as 
it has been demonstrated that the in vivo substrate of A1 is RNA not DNA. 
 




Figure 3.1: Clustal analysis of Mus musculus APOBEC/AID proteins. 
Alignment of APOBEC 1, 2, 3, 4 and AID protein sequences generated by clustal analysis 
software from the European Bioinformatics Institute (Labarga et al., 2007).  Black bars 
indicate functional motifs; red triangle indicates a functional conserved arginine residue.  
Motif A (HxE) which acts as a proton donor during the deamination reaction, motif B (SWS) 
which may be important for substrate recognition and motif C (PCx(2-6)C) which coordinates 
the zinc atom in the active site of the deaminase.  A4 shows 4 extra amino acids inserted 
into motif C not seen in other family members.  The red triangle indicates an arginine residue 
involved in allowing substrate access to the active site.  Where * indicates complete 
conservation across all proteins and : indicates an amino acid of similar charge. 
A
B C
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Several other amino acids are conserved in the AID/APOBEC family members as 
distinct from other CDA family members.  Intriguingly, A4 seems to share some of 
these amino acids but diverges at others.  Specifically a number of conserved leucine 
residues downstream of the PCx(2-6)C motif are conserved in A4, whilst arginine 
and glycine residues share by other family members are not present in A4 (Conticello 
et al., 2005).  As yet no function has been attributed to these residues. 
 
Furthermore, mutational analysis of the AID protein based on predictions from the 
crystal structure of A2 highlighted the arginine residue found at position 24 in AID 
and 65 in A2 as being crucial for function (Prochnow et al., 2007) (Figure 3.1 red 
triangle).  The crystal structure showed that this residue is involved in stabilising an 
“open” hairpin conformation that allows access to the active site.  The substitution of 
a glutamic acid at this residue in the AID protein results in a “closed” loop 
conformation and deamination activity is lost.  In further support of this observation 
several patients with hyper-IgM-2 syndrome caused by a loss of AID function were 
found to have a R24W mutation, indicating this site is crucial for AID function 
(Revy et al., 2000).  The arginine is conserved across other APOBEC family 
members but a glutamine residue is found at the corresponding position in A4. 
 
Human A3C and A3G are also expressed in the testis; therefore differences between 
A4 and other family member may reflect different functions.  Finally, analysis of 
multiple APOBECs has revealed that many members of this family are under strong 
positive selection, and as such have evolved at a fast rate.  It is entirely likely that 
differences in A4 reflect further evolution of this gene, although analysis of 
synonymous and non-synonymous amino acid changes is required to determine this. 
 
Alignment of A4 protein sequences from human, macaque monkey, rat and mouse 
showed that these proteins were highly conserved at the amino terminus where the 
deaminase domain is located (Figure 3.2, where red boxes indicate functional motifs 
within the deaminase domain).  This indicates that the function encoded at this 
region is protected from mutation over time and is of some benefit to the fitness of 
the organism.  However there is considerable divergence at the carboxy terminus 
Chapter 3: APOBEC4 Characterisation 
 113
indicating the function of this region is less well protected from mutation or has a 






Figure 3.2: Alignment of A4 proteins across species. 
A4 amino acid sequence from homologues across mammalian species were aligned by 
clustal analysis software from the European Bioinformatics Institute (Labarga et al., 2007).  
Species shown are Rattus norvegicus, Mus musculus, Homo sapiens, and Macaca mulatta, 
where functional motifs are indicated by red boxes.  There is high conservation across the 
fist 180 amino acids of the A4 protein, but the conservation is considerably lower at the C-
terminal region.  Where * indicates complete conservation across all proteins and : indicates 
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Conserved domain searches revealed only the deaminase domain, however a short 
coiled-coil domain was found at the carboxy terminus between residues 334-354.  
This is not present in other members of the AID/APOBEC family.  BLAST searches 
with this domain did not reveal any significant homology.  Coiled-coil domains are 
often involved in protein-protein interactions indicating A4 may bind to co-factors or 
regulatory proteins.  Many APOBEC family members contain both nuclear 
localization signals (NLS) and nuclear export signals (NES) to allow shuttling 
between the nucleus and cytoplasm.  A putative NES was found centred around 
lysine residue 317 using a NES predictor site (http://www.cbs.dtu.dk), however no 
putative NLS was found.  This indicates the A4 protein may enter the nucleus by 
diffusion as occurs with single-deaminase domain A3 proteins, or it may require a 
co-factor to be imported into the nucleus.  AID and A1 are capable of shuttling 
between the nucleus and the cytoplasm as they contain both bipartite NLS signals in 
the N-terminal region and carboxy terminal NES (Bennett et al., 2006; Chester et al., 
2003; Ito et al., 2004).  Import into the nucleus is dependent on importin α binding, 
and as the NLS signal occurs within a RNA-binding domain, nuclear localisation 
does not occur when the APOBEC/AID proteins are bound to RNA.  A1 is exported 
from the nucleus by exportin 1 (Chester et al., 2003).  In contrast, human A3G lacks 
an NLS and is actively maintained in the cytoplasm, even when fused to a strong 
SV40 NLS sequence (Bennett et al., 2006). 
 
The isoelectric point of the protein was expected to be 9.5 using a charge predictor 
site (http://www.scripps.edu/~cdputnam/protcalc.html), and the molecular weight 
was predicted to be 42.7kDa. 
 
Expression Analysis of APOBEC4 
Previously in situ hybridisation analysis performed by Diana Best confirmed that A4 
is expressed in round spermatid cells in the mouse testis.  To further clarify the 
expression of A4 throughout spermatogenesis, RT-PCR was performed on RNA 
extracted from mouse testis at defined points during development {kindly donated by 
Howard Cooke} (Maratou et al., 2004).  The first wave of spermatogenesis in mice is 
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synchronous, allowing isolation of RNA from specific cell types by time point 
analysis.  Time points analysed were 7, 11, 15, 18, and 22 days post partum (dpp) 
and adult mouse testis, which were all taken from C57Bl6 mice.  The cell types 
present in these samples are: A and B spermatogonia, zygotene spermatocytes, early 
and middle pachytene spermatocytes, late pachytene spermatocytes, and round 
spermatids respectively.  Adult mouse testis includes all cell types as 
spermatogenesis occurs continuously after birth.  Supporting somatic sertoli cells are 
also present at all stages.  The RNA was polyA+ purified and 1ug was used for first 
strand synthesis.  RT-PCR analysis revealed that A4 expression was restricted to late 
stages of testis development, with a full length transcript not detected until 22 dpp 
and remaining present in adult testis (Figure 3.3).  This is consistent with induction 
of A4 expression in the round spermatids, although further analysis is required to 
determine if expression persists in mature sperm.  Analysis of the GAPDH transcript 
revealed the RNA and cDNA were intact, and amplification of samples lacking 
reverse transcriptase (RT-) indicates there was no DNA contamination. 
 
It has been shown recently that the expression of AID is regulated by miR-155 
through a target site in the 3’UTR of the Aid transcript (Dorsett et al., 2008; Teng et 
al., 2008); therefore I investigated the 3’UTR of the Apobec4 transcript with several 
miRNA target prediction software programs.  The TargetScanMouse software 
(Friedman et al., 2009) predicted 10 miRNAs could bind to mouse Apobec4 3’UTR, 
but miRBD software (Wang, 2008; Wang and El Naqa, 2008) predicted only 2 
miRNAs.  Comparing both lists revealed one miRNA in common; miR-741 showed 
an exact match at the seed region to nucleotides 1518-1524.  Interestingly this region 
of Apobec4 is conserved in humans, chimpanzees and rhesus monkeys.  Further 
investigation of the expression pattern of miR-741 revealed that it was recently 
identified as one of a novel group of miRNAs transcribed from the X chromosome 
during spermatogenesis (Watanabe et al., 2006).  miR-741 expression is testis-
specific and increases during spermatogenesis, being undetectable at 8 dpp then 
present at both 15dpp and in adult testis, similar to the expression profile of Apobec4.  
This indicates that if miR-741 is regulating A4 expression it may be acting to block 
translation of the Apobec4 transcript as both miR-741 and Apobec4 mRNA are 
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expressed at the same stage of spermatogeneis.  However further investigation is 
required to determine if both miRNA-741 and Apobec4 are expressed in the same 
cells and whether miRNA-741 binds to and regulates Apobec4 transcript levels in a 





Expression of recombinant tagged APOBEC4 in E.coli 
The coding region of A4 was cloned into the E. coli expression vector pET21b with 
an N-terminal FLAG tag and a C-terminal 6x histidine tag, referred to as a FLIS6 tag 
hereafter.  This combination of two tags has been used in the O’Connell lab to 
successfully purify recombinant ADARs from the yeast Pichia pastoris (Ring et al., 
2004).  Following transformation into E.coli several colonies were grown up in mini-
cultures and screened for expression of A4-FLIS6 following induction with 1mM 
IPTG.  Cultures were centrifuged and total extract was boiled in laemelli buffer 
before loading onto an SDS-PAGE gel.  Recombinant A4-FLIS6 was detected using 
an antibody to the FLAG tag (Figure 3.4).  A band of approximately 45kDa is seen 
clearly in both the coomassie stained gel and the immunoblot, which corresponds to 
recombinant A4-FLIS6 indicating robust induction and expression of the protein.  
The predicted molecular weight of A4 is 42.7kDa however the epitope tags cause a 
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small increase in the molecular weight to 44.5kDa.  Expression of recombinant 
protein was absent in samples before induction indicating robust control in this 
expression system.  Following induction with IPTG recombinant A4 can be seen on 
both coomassie gel and western blot however expression varied a little between 
independent cultures.   A band of similar molecular weight (~45kDa) is present in 
uninduced samples, indicating a single or multiple endogenous E.coli proteins of 
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One highly expressing starter culture was used to inoculate a larger 500ml culture.  
Following induction with IPTG for 2 hours the bacterial cells were harvested by 
centrifugation.  Cells were broken by passing through a French Press three times and 
the resulting extract was centrifuged to separate soluble from insoluble material.  
Aliquots were analysed by coomassie gel (Figure 3.5) which indicated the majority 





The induction and expression of recombinant A4 indicated sufficient amounts of 
protein were produced however the majority of the protein was insoluble.  It is 
widely noted that proteins over-expressed in E.coli can accumulate in aggregates 
inside insoluble inclusion bodies (For a review, see (Marston, 1986)).  Specific 
protocols have been developed to purify first the inclusion bodies, and secondly the 
protein from within it.  The protocol I followed was modified from Sambrook & 
Russell, 2001, and involved two digestion steps to release the inclusion bodies and 
sequential incubations with detergent and urea to release the protein from the 
inclusion bodies (See Methods section for detailed description).  An E.coli culture 
that had been transformed with the empty backbone vector pET21b was used as a 
negative control and induced with the same conditions as the A4-FLIS6 culture.  For 
analysis, aliquots of supernatant were taken after isolation of inclusion bodies, after 
treatment with Triton X-100, and after incubation with alkaline monopotassium 
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phosphate and urea (S1, S2, and S3 respectively, panel A, Figure 3.6).  Coomassie 
gel analysis revealed that the majority of the recombinant A4 remained in the 
insoluble pellet despite all these treatments.  A band of similar molecular weight to 
A4 is present in the S1 and S2 fractions, but this band also is present in the control 
purification indicating it is an E.coli protein.  The remaining insoluble pellet 
containing A4 was divided subjected to a longer incubation of 2 hours with buffer 
containing varying concentrations of urea (2M, 4M, 6M, or 8M, panel B, Figure 3.6) 
however A4 clearly remained in the insoluble pellet fraction.  Very few of the 
insoluble E.coli proteins were solubilzed by 2M urea, as shown by the lack of protein 
in lane 2 (Figure 3.6, panel A).  However, with progressively higher concentrations 
of urea many of the insoluble E.coli proteins initially found in the pellet fraction 
showed a shift to the supernatant, indicating the conditions used were able to 
solubilize some of the insoluble proteins (Figure 3.6, compare 2M-S fraction with 
8M-S fraction).   




At the time of these experiments a paper was published reporting the crystal structure 
of human A2 protein produced in E.coli, however instead of using the full length 
protein the authors used a fragment lacking the first 40 amino-acids (Prochnow et al., 
2007).  At the time there were no other crystal structures published for members of 
the AID/APOBEC family due to problems with purification.  Believing this 
modification might make recombinant A4 more soluble I replicated this truncation.  
Analysis of human A2 predicted secondary structure revealed that there was a break 
between two predicted loop conformations between amino-acids 40 and 41.  
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Therefore I searched A4 secondary structure predictions to determine where would 
be best to cleave the protein with minimal disruption.  A natural break between two 
short β-sheets occurred between amino acids 45 and 46, therefore I created a 
fragment consisting of A4-46-end-FLIS6 by PCR and cloned this into the pET21b 
expression vector.  Following induction with IPTG for 2 hours cells were lysed and 
purified. 
 
For A4-46-end-FLIS6 purification the 6-histidine epitope tag was utilised by 
applying the extract to a Ni2+ NTA superflow resin (Qiagen), which binds 6-histidine 
epitopes with a binding capacity between 5-20mg/ml.  Following this purification the 
protein was eluted into one fraction as this method has been successful in purifying 
recombinant ADAR proteins, and it has been demonstrated that immidazole does not 
affect binding to anti-FLAG affinity resin (Ring et al., 2004).  This was then applied 
to an anti-FLAG M2 affinity resin (Sigma) which has a binding affinity of 
>0.6mg/ml.  Aliquots were taken for analysis by coomassie gel and immunoblot 
(Figure 3.7).  Recombinant truncated A4 can clearly be seen as a band of ~40kDa in 
the insoluble pellet fraction (P) on the coomassie gel, and as an intense smear on the 
immunoblot due to the presence of large amounts of recombinant protein.  The 
immunoblot indicates a small amount of soluble protein is present and successfully 
purified using the 6-histidine tag as a band is detected in the Ni2+ NTA eluate/FLAG 
load (E/L) fraction.  However, the following purification over a FLAG affinity resin 
was not successful as the protein is present in the flow through (FT) indicating it did 
not bind to the FLAG resin.  Unfortunately the purified protein eluted from the Ni2+ 
NTA resin is not detectable by coomassie staining, indicating the amount is below 
the 50ng detection limit of the coomassie stain.   
 
 





In summary, the purification using the Ni2+ NTA resin was successful; however as 
the majority of the recombinant full length or truncated APOBEC4 remained 
insoluble this system was not sufficient for generating enough protein to 
biochemically characterize in vitro.  Amount of IPTG inducer, and the time and 
temperature of induction were all varied in an attempt to produce less protein, which 
may have been more soluble but these approaches were not successful so I decided to 
try a different expression system. 
 
Baculovirus-driven expression of recombinant tagged 
APOBEC4 in insect cells 
Expression of recombinant A4 in E.coli resulted in large amounts of insoluble 
protein therefore a different expression system was required.  Baculovirus-driven 
expression of recombinant proteins in Sf9 insect cells is an efficient method of 
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producing recombinant protein with many eukaryotic post-translational 
modifications and can be scaled up easily.  For future studies a catalytic site mutant 
of A4 was generated by Jim Brindle who performed site-directed mutagenesis to 
change the glutamic acid to alanine (EA), which is the proton donor for the 
deamination reaction.  Analogous mutations have been made in many members of 
the cytidine deaminase family and shown to abolish deaminase function, such as A1 
and ADARs (Harris et al., 2002).  Both wild type and catalytically inactive A4-
FLIS6 were cloned into a Bac-to-Bac Baculovirus expression vector using 
Gateway™ cloning technology (Invitrogen), which abrogates the need for PCR 
therefore reducing the risk of errors in the final vector.  The destination vector 
contained a baculovirus-specific polyhedrin promoter directing expression of wild 
type A4-FLIS6 or of putative catalytic-site mutant A4 EA-FLIS6.  The Bac-to-Bac 
Baculovirus Expression system (Invitrogen) utilises a high molecular weight 
baculovirus shuttle vector (bacmid) which can be replicated in E.coli.  With the aid 
of a helper plasmid containing a transposase gene, recombinant tagged A4 was 
transposed from a Gateway pFastBac vector into a recombinant bacmid.  Following 
screening of colonies for presence of the correct insert, high molecular weight 
bacmid DNA was isolated and transfected into Sf9 insect cells using Cellfectin 
(Invitrogen).  Baculovirus expression of recombinant A4 was performed in the lab of 
Ted Hupp at the Edinburgh Cancer Research Centre with the help of Sarah Meek.  
After incubation for 72 hours cells were harvested, cells were checked for expression 
of recombinant A4 and supernatant containing recombinant virus was kept for 
amplification and future rounds of infection.    
 
Initial screening of the soluble fraction of cellular extract for the presence of a 
protein of approximately 45 kDa with an anti-FLAG antibody revealed the 
Baculovirus Expression system was able to produce soluble recombinant A4-FLIS6 
protein (Figure 3.8 A).  Approximately 30-40% of the amount in the total extract (T) 
was present in the soluble supernatant fraction (S), however the majority of the 
protein remained in the insoluble pellet fraction (P), but this fraction also showed 
considerable non-specific staining with the anti-FLAG antibody making 
quantification difficult.  To optimise the soluble recombinant A4-FLIS6 production I 
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performed a time course experiment, analysing samples 24, 48 and 72-hours post-
infection (Figure 3.8 B).  No soluble A4-FLIS6 was detected 24 hours after infection 
as analysed by western blot with an anti-FLAG antibody.  A band of approximately 
45kDa was detected after 48 hours and increased in intensity by 72 hours; however at 
72 hours a lower molecular weight band was also detected indicating degraded 
protein was present.  As the degraded protein was detected with an anti-FLAG 
antibody it must have retained the FLAG epitope, and would probably be purified 
along with full-length protein if this epitope was used for purification.  Therefore 48 
hours post-infection was chosen as the best time to harvest cells for future 
experiments.  Further optimisation to determine the optimal infection conditions for 
soluble A4-FLIS6 production involved infecting 1x106 cells with increasing amounts 
of recombinant baculovirus (0, 5, 10 15 and 20μl) and analysing protein expression 
by immunoblot (Figure 3.8 C).  The amount of soluble recombinant A4-FLIS6 
produced was low with 5μl inoculum and increased when 10μl inoculum was used, 
however it then decreased with amounts greater than 10μl indicating that viral load 
was not a limiting factor in the protein production.  This also indicates that higher 
amounts of virus are detrimental to protein expression.  This could be a toxic effect 
of the viral load on the cells or inhibition of protein production, but from previous 
experiments it is likely due to an increase in insoluble protein, which would reduce 
soluble protein through aggregation.  The ratio of 10ul inoculum per 1x106 cells was 
used for future experiments.  Optimisation was performed with wild type A4-FLIS6, 
however the catalytic site mutant A4-FLIS6 was generated in parallel. 
 
The baculovirus expression system makes scaling up cultures relatively easy as the 
virus can be amplified easily and the number of cells infected increased.  Therefore, 
despite the majority of the recombinant protein remaining insoluble I focused on 
optimising the purification method for the soluble fraction.  





Initial attempts to purify the soluble fraction of recombinant A4-FLIS6 from Sf9 
cells focused on utilising the epitope tags.  1x107 Sf9 cells were inoculated and 
maintained in identical conditions.  They were purified over either anti-FLAG 
affinity matrix or Ni2+ NTA resin to assess which epitope tag performed best.  
Fractions were analysed by immunoblot and PAGE gels which were silver-stained 
(Figure 3.9). The results were disappointing as neither epitope tag was able to bind 
the total amount of soluble A4-FLIS6 in the samples, and in both cases showed 
protein was lost during the washes.  However, it was unclear from these results 
whether the presence of other proteins in these samples was affecting the ability of 
recombinant A4-FLIS6 to bind to the matrices. Direct comparison of both 
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purifications showed the anti-FLAG affinity column performed best, although the 





Ni2+ NTA resin can be used to purify proteins from a crude lysate as it has a high 
binding capacity (5-20mg/ml).  However FLAG M2 affinity matrix has a low 
binding capacity (0.6mg/ml) therefore it is sometimes necessary to first purify 
protein over another matrix.  As the starting samples were total protein extracts I 
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thought that purifying these further using other matrices to reduce the amount of 
protein loaded onto the epitope columns might improve the binding of the epitope 
tags to the affinity matrices.  This should also result in cleaner elution fractions after 
purification with epitope tags.  To achieve this I took the flow through fractions from 
these columns and tested them on several different matrices, summarised in Figure 
3.10.  The flow through from the Ni-NTA column in Figure 3.9 was further purified 
over Affi-Gel Blue Gel matrix (Bio Rad) as this is often used to purify proteins that 
bind nucleic acids.  However, recombinant A4-FLIS6 did not bind to Affi-Gel Blue 
Gel matrix as a band is detected in the flow through.   
 
The flow through fraction from the anti-FLAG affinity column in Figure 3.9 was 
loaded onto an anionic exchange resin DEAE sepharose fast flow (Pharmacia 
Biotech), as the predicted isoelectric point of recombinant A4-FLIS6 is 9.5.  All the 
recombinant A4-FLIS6 bound to the DEAE sepharose column and eluted with 
500mM potassium chloride in elution fractions E4 and E5.  Further analysis of this 
purification by silver-stained SDS-PAGE revealed contaminants were still present in 
these elution fractions; however the total amount of protein present was substantially 
less than in the load fraction (Compare Figure 3.10 panel C lane marked L with lanes 
marked E4 and E5).  As I had successfully reduced the total protein without loss of 
A4-FLIS6 I then pooled the DEAE sepharose elution fractions E4 and E5 and loaded 
them onto an anti-FLAG affinity column.  Unfortunately none of the recombinant 
A4-FLIS6 bound to the affinity column as demonstrated by the presence of a band in 
the flow through fraction.  This indicates that irrespective of the total protein content 
of the sample there is a limited amount (approximately 20% estimated from Figure 
3.9) of recombinant A4-FLIS6 that is able to bind to the anti-FLAG affinity column.  
The A4-FLIS6 in the initial flow through was unable to bind to the FLAG M2 resin 
and this was not due to over loading the column.  This could be due to several 
reasons; firstly the epitope tag may not be exposed; and secondly, the epitope tag 
may be concealed due to multimerisation of the protein, members of the 
APOBEC/AID family are thought to function as homodimers or homotetramers. 
In a final attempt to purify these fractions further the flow through from this anti-
FLAG affinity column was loaded onto a poly dI:dC column in the hope that 
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recombinant A4-FLIS6 might show non-specific binding to RNA.  But A4-FLIS6 
failed to bind strongly to poly dI:dC matrix and what was bound was lost during the 




To repeat the most promising result that was obtained with DEAE Sepharose fast 
flow resin, fresh inoculations were performed, this time the catalytic site mutant A4 
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EA-FLIS6 was included.  2x107 Sf9 cells were inoculated with 200ul recombinant 
Baculovirus as determined in the optimisation process performed on WT A4-FLIS6 
(Figure 3.8).  Cell extracts were analysed by Bradford assay and total protein content 
was calculated to be 9mg for WT A4-FLIS6 and 10.5mg A4 EA-FLIS6 in 1ml 
volume.  As the binding capacity of DEAE Sepharose is ~100mg/ml therefore the 
total extract was loaded onto a 1ml DEAE Sepharose resin.  The matrix was washed 
in Q200 buffer and protein was eluted with increasing concentrations of potassium 
chloride (250mM, 500mM and 750mM).  Aliquots were taken and analysed by 
immunoblot using an anti-FLAG antibody (Figure 3.11).  Immunoblot analysis of 
WT A4-FLIS6 showed that in contrast to earlier results recombinant A4 did not bind 
to the DEAE Sepharose matrix with high affinity.  Only a small fraction of the 
recombinant A4-FLIS6 was retained on the column and eluted as before with 
500mM potassium chloride, the majority of the protein remained in the flow through 
fraction.  Taking into account the volume loaded onto the gel and the total fraction 
volume it can be estimated that less than 10% of the protein was retained on the 
column. 
 
Analysis of the catalytic site mutant A4 EA-FLIS6 aliquots by immunoblot with an 
anti-FLAG antibody revealed that this protein was expressed to a much higher level 
than WT A4-FLIS6.  This could be due to several reasons, notably the difference in 
total protein content in the extracts loaded onto the columns.  However this was not 
corrected initially to avoid protein loss.  The optimisations described were performed 
on WT A4-FLIS6; therefore optimal conditions for the mutant protein were not 
determined.  The recombinant Baculovirus engineered to express A4 EA-FLIS6 may 
have a higher multiplicity of infection, or be more virulent than the wild type.  
Finally, it has consistently been observed with ADAR protein purifications that more 
protein is obtained with a catalytic mutant than a wild type protein preparation, 
although the difference is not usually as striking as that seen here (personal 
observation).  However, the high level of A4 EA-FLIS6 expression highlights the 
inadequate binding of the protein to the DEAE Sepharose column as protein is 
present in all fractions analysed.  This indicates that despite the large binding 
capacity of the DEAE Sepharose fast flow resin the interaction is not strong enough 
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to retain large amounts of recombinant A4-FLIS6 protein.  This level of protein loss 




As the most promising results were obtained with DEAE Sepharose, another stronger 
anionic matrix Macro-prep High Q Support (Bio Rad) was tested.  Unfortunately 
very low amounts (approximately 5%) of recombinant A4-FLIS6 bound to this 
matrix, and protein was lost during the washes before a salt gradient was applied to 
elute protein (data not shown). 
 
In addition to these purification procedures described I also followed a protocol 
published for the purification of recombinant human A3G from Baculovirus-infected 
Sf9 cells for small angle X-ray scattering experiments (Wedekind et al., 2006).  
Briefly, cells were harvested 48 hours after infection and cell pellets were frozen at -
70oC.  Cells were lysed by three freeze thaw cycles in liquid nitrogen and luke-warm 
water, followed by shearing through a 22 gauge needle.  Detergent was added and 
nucleic acid degraded by addition of DNase and RNase.  The sample was then 
incubated in 1M urea and centrifuged.  The supernatant was incubated with Ni2+ 
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NTA agarose (Qiagen), washed with increasing concentrations of urea, and eluted 
with imidazole.  Unfortunately this purification procedure failed to produce any 
soluble protein (data not shown).    
 
Purified AID was only found to be active on ssDNA following treatment with RNase 
indicating the protein is capable of binding RNA tightly but cannot deaminate it 
(Bransteitter et al., 2003).  In case A4-FLIS6 was binding nucleic acids which could 
alter its structure or interfere with binding to the resins, DNase and RNase was added 
to extracts and incubated at either 4oC or 16 oC prior to purification.  Unfortunately 
this did not increase binding to the matrices.  As APOBEC/AID proteins are difficult 
to purify there is not a vast range of literature on the subject, however a paper 
published by Harold Smith detailed extensive recommendations for purifying 
APOBEC/AID proteins (Smith, 2007).  Therefore factors thought to affect the 
purification of other APOBEC/AID proteins were tested.  These included epitope tag 
purifications following attempts to break potential dimers or multimers with high salt 
conditions (2M potassium chloride or 1M sodium chloride), and purification at room 
temperature in the presence of Triton X-100 detergent.  But these approaches were 
not successful as the majority (if not all) A4-FLIS6 protein was detected in the flow 
through fraction (data not shown). 
 
In conclusion, attempts to purify a soluble C-terminal fragment of recombinant A4-
FLIS6 from an E.coli expression system were not successful.  Despite eventually 
obtaining soluble recombinant tagged A4-FLIS6 from Sf9 insect cells, purification 
proved to be extremely difficult.  Taken together these results indicate that the 
soluble recombinant A4-FLIS6 expressed in Sf9 cells comprises a mixed population 
of protein in different conformations with different binding specificities.  The epitope 
tags added to aid purification do not appear to be uniformly exposed, such that a 
maximum of only 20% of the soluble recombinant A4-FLIS6 could be purified.  
With no understanding of why there are differences in the protein produced there is 
no guarantee that the protein fraction purified would be representative of the 
biologically functional protein.  Furthermore, the volume of cells required to produce 
enough soluble recombinant A4-FLIS6 with such inefficient purification would be 
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Generation and purification of polyclonal antibodies to 
recombinant APOBEC4 
To generate soluble A4 Alexey Ruzov subcloned recombinant A4-FLIS6 into the 
pGEX-6p-3 vector (GE Lifesciences) to produce a Glutathione S-transferase (GST) 
fusion protein in E.coli.  The amino terminal GST-tag has a molecular weight of 
approximately 26kDa, which creates a fusion protein of approximately 71kDa 
hereafter called GST-A4-FLIS6.  The presence of a large GST-tag made the 
recombinant protein soluble, and allowed purification using Glutathione sepharose 
(GE Lifesciences), however it was not used initially as the presence of such a large 
epitope tag may interfere with protein function.  However, previous studies have 
successfully used GST-tagged APOBEC proteins purified from E.coli (Chester et al., 
2004).  Recombinant GST-A4-FLIS6 was expressed in E.coli, purified using 
Glutathione sepharose and used to inoculate three guinea pigs for antisera production 
(Eurogentec).  Sera from the final bleed was tested for its ability to detect 
recombinant A4-FLIS6 (Figure 3.12), all sera were able to detect the recombinant 
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For affinity purification of the antisera raised to GST-A4-FLIS6 two purification 
columns were generated.  Recombinant GST-A4-FLIS6 was expressed in large 
volumes (using conditions determined by A.Ruzov) and extracts of E.coli were made 
using the Bugbuster kit and protocol (Novagen).  For purification Glutathione 
sepharose high performance (Amersham Biosciences) agarose beads were used, and 
recombinant protein was eluted with 20-50mM Glutathione.   To remove antibodies 
that recognised the three epitope tags present on the antigen used for immunisation 
the A4 coding sequence was excised from the construct using the SpeI restriction 
enzyme and the vector was re-ligated to produce a recombinant GST-FLAG-6xHIS 
coding sequence, hereafter referred to as GST-FLIS6.  This was also expressed and 
purified from E.coli. 
 
Recombinant GST-A4-FLIS6 and GST-FLIS6 proteins were dialysed into coupling 
buffer to remove contaminating Glutathione, concentrated and then covalently bound 
to Cyanogen-Bromide-activated Sepharose (GE Healthcare).  Of the three antisera 
two were purified over the GST-FLIS6 column first and the unbound fraction (flow 
through) was then loaded onto the GST-A4-FLIS6 column.  The remaining antisera 
was purified in the opposite order, however this was not as successful.  Initial 
experiments with affinity purified anti-A4 antibodies revealed all three could detect 
recombinant A4 protein expressed in either E.coli or Sf9 insect cells, however no 
bands were detected in mouse testis protein extracts.  A4-null mice generated by Ian 
Adams were used as a negative control in these experiments.  To determine the 
sensitivity of the antibodies the amount of recombinant GST-A4-FLIS6 protein 
present in the extract was quantified.  Aliquots of known volume were analysed by 
SDS-PAGE with known amounts of bovine serum albumin (BSA).  SDS-PAGE gels 
were stained with Sypro Ruby (Sigma) and quantified with ImageQuant software 
(GE Healthcare).  A standard curve was generated from the BSA protein and used to 
calculate the concentration of full length recombinant GST-A4-FLIS6 (Figure 3.13).  
Importantly a much stronger band of lower molecular weight is seen on the Sypro 
Ruby-stained gel indicating degradation has occurred, but the full length protein was 
used for calculating concentration.  From this gel it was estimated that 6ul extract 
contained 1ng full length recombinant GST-A4-FLIS6 protein. 






Numerous attempts were made to detect endogenous A4 in mouse testis extracts; 
however no bands could be detected.  Finally, testis extracts from several different 
strains of mice were analysed by coomassie gel and immunoblot using anti-A4 
SKC003 at a 1:100 dilution with known concentrations of recombinant GST-A4-
FLIS6 (Figure 3.14).  A large amount (100ug) of total testis extract was loaded to 
maximise the chance of detecting a small amount of protein.  No endogenous A4 
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protein could be detected in 100ug total testis extract, where the affinity-purified 
anti-APOBEC antibody SKC003 could detect 1ng recombinant GST-A4-FLIS6, 
indicating if A4 protein is present in mouse testis it is at a lower amount than 
1ng/100ug.  Similar results were obtained with the two other affinity-purified sera.  
The epitope tag protein GST-FLIS6 was included as a control.  The coomassie gel 
shows it was expressed at a significantly higher concentration than the A4 protein as 
there is a strong band present at approximately 30kDa (indicated by lower 
arrowhead).  However purification of the antibody was completely successful as 
there is no corresponding signal present on the immunoblot.  There is a higher 
molecular weight band present in the GST-FLIS6 sample that is recognised by the 
A4 antibody indicating contamination of this sample preparation has occurred with 
GST-A4-FLIS6 protein, this probably occurred during purification.   
 
Another explanation for the lack of detection of endogenous A4 is that the protein 
used to immunize the rabbits was not in the same conformation as the endogenous 
protein.  Given the problems detailed earlier with purifying recombinant A4 protein 
this may explain the lack of detection here.  However, it would be highly unusual to 
have no antigen recognised with polyclonal antibodies.   
 
Protein extracts were made from wild type mouse sperm and analysed by western 
blot but no bands were observed (data not shown).  However, one explanation for the 
failure to detect endogenous A4 protein is that it is not expressed until after 
fertilization.  Sperm mRNAs have been found in the embryo 3 hours post-
fertilisation indicating that some mRNAs are delivered at fertilisation and not 
immediately degraded (Ostermeier et al., 2004).  However, due to problems 
collecting sufficient material, post-fertilization embryos could not be screened.  A 
more likely explanation is that endogenous A4 protein is present at a level that is 
below the detection limits of the antibody.  Given the problems with formation of 
insoluble inclusions when overexpressing the recombinant A4-FLIS6 protein it is 
likely that endogenous protein levels are maintained at a low level.   
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In addition to the three polyclonal antibodies generated in guinea pig, four custom 
peptide antibodies were raised in mouse (Eurogentec).  All of the peptide antibodies 
detected recombinant A4 when analysed by western blot however the signal was 
considerably lower than the polyclonal antibodies.  None of these antibodies detected 





Subcellular localisation of GFP-tagged APOBEC4 
As there are no suitable cell lines derived from germline cells a heterologous 
expression system was used to determine the subcellular localisation of A4.  Alexey 
Ruzov had previously shown that A4 expression was toxic in wild type Mouse 
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Embryonic Fibroblasts (MEFs; data not shown).  The reason for this was not 
determined; however both the wild type A4 and the catalytic site mutant A4 elicited 
the same reaction.  Therefore a p53-null cell line was used where the apoptotic cell 
death pathway initiated by p53 is no longer functional (Lande-Diner et al., 2007).  
Wild type A4 and a catalytic site mutant A4 EA were cloned into a pEGFP 
expression vector under the control of a CMV promoter.  Transient transfections 
were performed with lipofectamine (Invitrogen); cells were fixed in 
paraformaldehyde and imaged.   
 
GFP-tagged A4 was predominantly cytoplasmic, however differences were observed 
with some cells showing diffuse cytoplasmic and nuclear staining (approximately 65-
75% cells) with others displaying punctate cytoplasmic inclusions (approximately 
25-35% cells; see Figure 3.16).  These differences were attributed to different levels 
of protein expression whereby low levels of expression show diffuse cytoplasmic 
staining but higher levels of expression leads to aggregation of the protein into 
insoluble cytoplasmic inclusions as seen with other expression systems. The catalytic 
site mutant A4 EA displayed the same proportion of cells with diffuse cytoplasmic 
staining or punctate cytoplasmic inclusions.  APOBEC/AID family members show a 
mix of nuclear and cytoplasmic localisation, which does not appear to correlate with 
antiretroviral activity, therefore we cannot infer targets of A4 from its expression 
pattern in a heterologous system.  The localisation of AID/APOBEC family members 
correlates with size, such that smaller proteins show both nuclear and cytoplasmic 
localisation as seen here, whereas larger AID/APOBEC proteins display cytoplasmic 
localisation.  This is attributed to the ability of smaller proteins to diffuse through the 
nuclear membrane, as may be occurring with A4.  It is likely that these foci are 
insoluble aggregates of A4 but it cannot be ruled out that they could represent RNA-
processing foci such as P bodies or stress granules which A3G has been shown to co-
localise with (Wichroski et al., 2006). 
 






p53-null MEFs transiently transfected with GFP-tagged A4 were used to analyse the 
specificity of the affinity-purified A4 antibodies.  Immunofluorescence with a Texas 
Red conjugated anti-guinea pig IgG secondary antibody showed that anti-A4 
antibody SKC003 signal appeared to co-localise with some of the punctate 
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cytoplasmic foci, however there was a high level background staining in cells that 
were not transfected, or transfected with a GFP construct alone (Figure 3.16). The 
non-specific background staining indicates these antibodies are not suitable for use in 
immunocytochemical analysis.   
 
However, to confirm this result and determine whether these antibodies could detect 
endogenous A4 immunohistochemistry was performed on paraffin-embedded testis 
sections from wild type and A4-null mice.  No specific staining was observed in the 
wild type testis and background staining was detected in both genotypes (data not 
shown).  All three polyclonal antibodies were used for immunohistochemical 
analysis of paraffin-embedded testis sections however no signal could be detected 
that was absent in the A4-null mice indicating there was no specific staining.  In 
addition to the three polyclonal antibodies generated in guinea pigs, four custom 
peptide antibodies were tested for their ability to detect both GFP-tagged A4 and 
endogenous A4 in mouse testis sections.  However none of the antibodies analysed 
showed complete co-localisation with the GFP-tagged protein, and they all failed to 
detect a specific signal in the immunohistochemical analysis (data not shown).  
Different fixation methods (paraformaldehyde, alcohol based and Bouin’s fixative) 
were tested with the guidance of Ian Adams, and two different detection methods 
were used (fluorescence-conjugated secondary antibodies and DAB detection) and 
antigen retrieval was also used (data not shown).  However despite many attempts no 
specific signal A4 could be detected.   
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Taken together these results indicate that the affinity-purified antibodies can detect 
recombinant A4 overexpressed in several different systems when analysed by 
immunoblot.  However, these antibodies are not suitable for immunocytochemistry.  
No endogenous A4 could be detected in mouse testis by immunoblot or 
immunhistochemistry; however I cannot conclude that it is not present as it may be 
expressed at a level that is below the detection limit of these antibodies.  Further 
attempts were made to enrich endogenous A4 present in testis extracts by 
immunoprecipitation however no specific protein could be detected when comparing 
wild type and A4-null testis extract (data not shown).   
 
E.coli DNA mutator assay of APOBEC4 
To determine whether A4 could deaminate DNA an E.coli DNA mutator assay was 
performed as previously published (Coker et al., 2006; Harris et al., 2002) (Figure 
3.17).  Briefly, E.coli was transformed with a plasmid encoding either wild type A4 
or catalytic site mutant A4 EA.  The positive controls AID and A3G were also 
assayed along with the empty pTrc99a vector to give a background mutation 
frequency.  Deamination events were determined by mutation of the rpoB gene 
which caused resistance to rifampicin, and a viable count was performed.  The 
positive control A3G deaminated DNA with a median rate of 75 mutations per 109 
cells (Figure 3.17).  However the other positive control AID only displayed 12 
mutations per 109 cells.  This is much lower than the published data for AID activity 
in this assay, however there is considerable variation in the published data.  One 
study reported AID median values of 103 mutants per 109 viable cells compared to a 
vector alone control which had 13 mutants per 109 viable cells (Petersen-Mahrt et al., 
2002), whilst another reported 180 mutants per 109 viable cells with a vector alone 
control frequency of 33 mutants per 109 viable cells (Harris et al., 2002).  This gives 
a range of 5.5-7.9-fold enhancement of mutation frequency in the presence of AID, 
which is slightly higher than the 4-fold enhancement seen here.  However the 
background mutation frequency is also higher in the published data.  Harris and 
colleagues also assayed A3G which showed a median mutation frequency of 180-400 
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mutants per 109 viable cells (Harris et al., 2002), which is two-fold higher than the 
mutation frequency presented here. 
 
However, A4 did not have a significant mutation rate above the background level of 
3 mutants per 109 cells, indicating that in this assay A4 is not able to deaminate E.coli 
DNA.  In addition there was no significant difference between wild type A4 and 
catalytic site mutant A4 which we would expect to see as catalytic activity would be 
required to generate mutations.  
 
In addition to this assay a modified version was performed to analyse the ability of 
A4 to deaminate methylated DNA (Morgan et al., 2004).  The modified assay 
involves transformation of a plasmid encoding the SssI DNA methyltransferase along 
with the plasmid encoding an AID/APOBEC protein, and selecting for both with 
ampicillin and kanamycin resistance.  A modified strain of E.coli (ER1821, NEB) is 
required that is termed methylation-restrictive defective due to inactivation of four 
genes involved in restricting foreign methylated DNA (Kelleher and Raleigh, 1991).  
Transformation of either wild type A4 or catalytic site mutant A4 EA did not 
produce any colonies in this assay (data not shown).  However the positive control 
for this assay is AID as it has been shown to deaminate methylated DNA (Morgan et 
al., 2004) and this also failed to give any colonies (data not shown), indicating that 
there was a problem with the assay or the AID clone used.  In the absence of an 
antibody or epitope tags it was not possible to confirm expression of AID from this 
vector.  Therefore no conclusion can be drawn about whether A4 is able to deaminate 
methylated DNA in E.coli.  
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Figure 3.17: E.coli DNA mutator assay of APOBEC family members 
E.coli KL16 cells were transformed with plasmids expressing wild type A4, catalytic site 
mutant A4 E/A, AID, A3G or the empty expression vector pTrc99a.  Following induction with 
IPTG cultures were plated onto rifampicin plates or ampicillin plates to establish a viable 
count.  RifR colonies were counted and plotted per 109 viable cells.  A3G was capable of 
mutating E.coli DNA., whilst AID showed only a slight increase in mutation rate compared to 
vector control.  A4 did not show a mutation rate above background.  Black diamonds indicate 






Detailed microarray profiling of both rodent and human spermatogenesis has 
revealed that conserved genes which are expressed early in spermatogenesis, either 
in somatic sertoli cells or mitotic spermatogonia are often expressed in other tissues 
and are therefore not specific for spermatogenesis (Chalmel et al., 2007).  In contrast, 
genes expressed at later stages of spermatogenesis, either during meiosis or post-
meiotic spermatid stage are uniquely expressed in these highly specialised cell types.  
This microarray analysis confirmed that Apobec4 is differentially expressed 
throughout spermatogenesis, with low expression detectable in spermatocytes and 
high expression in round spermatids, indicative of a specialised function in the post-
meiotic spermatid (Chalmel et al., 2007).  However over 1,400 genes had a similar 
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expression profile including genes associated with the GO processes of fertilization 
and spermiogenesis.  Following meiosis the sperm nucleus undergoes extensive 
remodelling when histones on the DNA are exchanged for protamines and this 
compact chromatin is transcriptionally dormant.  Therefore transcription of genes 
encoding proteins required for spermiogenesis and fertilization occurs prior to 
chromatin compaction and mRNAs are stored in a translationally silent state until 
required.  This means A4 protein expression may occur either at the round spermatid 
stage or later during spermiogenesis. 
 
However, further work is required to determine whether Apobec4 is regulated by 
miRNAs in general, and miR-741 or 742 in particular.  Given that miRNAs can 
function in different ways it is of particular interest to determine whether A4 is 
regulated at the level of translation.  This would provide an explanation as to why the 
Apobec4 transcript is expressed during spermatogenesis but no endogenous A4 
protein could be detected in mouse testis.  As the expression pattern of miR-741 is 
similar to that of Apobec4 mRNA it is an interesting hypothesis to suggest miR-741 
acts to inhibit translation of A4 protein.  Perhaps miRNA-741 regulates translation of 
Apobec4 to maintain low levels of endogenous A4 protein.  Expression of 
recombinant A4-FLIS6 led to aggregation of protein in insoluble inclusion bodies 
raising the possibility that the endogenous A4 levels may be kept low to prevent 
toxic aggregates from forming. 
 
Whether mRNA is present in mature sperm is a somewhat controversial phenomenon 
with suggestions that any mRNAs detected arise from contamination, reviewed in 
(Miller et al., 2005).  However, without further investigation it cannot be excluded 
that Apobec4 mRNA is present in mature sperm and delivered to the oocyte at 
fertilisation.  The sperm mRNA may be degraded upon entry to the embryo; however 
there is evidence that some sperm mRNAs are present 3 hours after fertilisation 
indicating these mRNAs may have a function in the developing embryo (Ostermeier 
et al., 2004).  
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Generating soluble recombinant A4-FLIS6 proved more difficult than expected, with 
initial E.coli and Pichia pastoris (M.Hogg, Masters Rotation Project) expression 
systems providing insufficient amounts for biochemical analysis.  Amino-terminal 
truncation of A4 did not improve solubility as it did for A2.  The Baculovirus 
Expression system generated more soluble recombinant A4-FLIS6, but the majority 
of the protein was still insoluble indicating A4 is an inherently insoluble protein.  
Other members of the AID/APOBEC family are also difficult to express and purify, 
and several groups have been trying to solve the crystal structure of A3 proteins for 
some time.  However, much of the biochemical work on these proteins has been 
performed in cell culture models.  This is not possible for A4 due to the lack of 
reliable germline cell culture models.  Using a heterologous system for analysis of 
A4 is not ideal as co-factors may be required for function or regulation which may 
not be expressed in other cell types.  Furthermore if the substrate of A4 is mRNA 
then these mRNAs may only be expressed during spermatogenesis. 
 
A4 protein contains a putative coiled-coil domain at the carboxy terminus that is not 
found in other family members.  This region may exacerbate problems with 
solubility and aggregation of overexpressed A4 protein as coiled-coil domains are 
often involved in protein-protein interactions.  Removal of the coiled-coil domain 
may make purification easier, although this may alter biological function. 
 
It has been hypothesised that the seclusion of recombinant APOBEC proteins in 
insoluble inclusion bodies serves a function to protect the E.coli cells from non-
specific deamination that occurs when AID/APOBEC family members are expressed 
at high levels (Smith, 2007).  If this is true then it could indicate that A4 may possess 
catalytic deaminase activity, however as it was also difficult to purify the 
catalytically inactive A4 protein this is unlikely to be the reason for the insolubility.  
In addition, the results from the E.coli DNA mutator assay do not support this 
hypothesis as A4 did not induce mutation above background levels.  However, when 
A4-FLIS6 was overexpressed in E.coli for purification it formed insoluble aggregates 
and this may also have occurred when A4 was expressed in E.coli for the DNA 
mutator assay.  If A4 was sequestered into insoluble aggregates it may not have 
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access to the E.coli DNA which would explain why no mutator activity was detected.  
However further work is required to determine whether a lower level of A4 
expression would induce DNA mutations in this assay. 
 
AID-induced mutation levels were significantly lower than published results in this 
assay indicating the controls for this assay may not have been optimal (Harris et al., 
2002).  It should be noted that published data from this assay varies greatly, however 
even the vector alone control used to assay background mutation frequency presented 
here is low by comparison to published results, indicating the assay conditions were 
not optimal.  As mentioned earlier the absence of enhanced mutation frequency in 
E.coli expressing A4 may be due to aggregation of the A4 protein into insoluble 
inclusions.  An alternative explanation for the low mutation frequency observed in 
the E.coli DNA mutator assay is that A4 does not deaminate DNA.  This hypothesis 
is supported by the lack of a significant difference between the wild type and 
catalytic site mutant A4 in the E.coli DNA mutator assay.  The A4 substrate could be 
RNA; this is supported by the fact that ADAR and ADAT proteins which deaminate 
RNA substrates contain multiple amino acids between the conserved cysteine 
residues (see alignment in Figure 1.2).  In support of A4 deaminase activity of some 
kind it has been observed that when transformed, cultured and purified under the 
same conditions more protein is observed with a plasmid encoding the putative 
catalytic mutant of A4 (see Figure 3.11, and also personal observation from different 
expression systems).  This has been observed in several different expression systems 
but until a function can be described for A4 this cannot be tested.  In addition this 
phenomenon has also been observed for ADAR proteins, see Appendix I. 
 
In his chapter on C-U editing that was published as this work was being undertaken, 
Harold Smith details the problems he encountered trying to purify and assay 
members of the AID/APOBEC family, specifically AID and APOBEC1 (Smith, 
2007).  This chapter was very useful as the extent of the solubility problems with 
other AID/APOBEC proteins was not apparent from published data.  One of his first 
observations is that expression in E.coli is not recommended as these proteins are 
often sequestered into insoluble inclusion bodies.  Furthermore he explains that once 
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purified, or even during purification, these proteins are liable to form insoluble 
aggregates which cannot be dissociated with 6M urea or 1% SDS treatment.  This 
problem is apparently exacerbated by freezing, which is how all the protein I 
produced was stored during purification and analysis.  The problems encountered in 
this project are not specific to A4, however much work on other family members has 
made use of cell culture systems to study the protein function and to avoid the 
processes of expression and purification.  However a recent publication by Stenglein 
et al, (2010) characterises a novel function of A3 proteins in deamination and 
degradation of foreign DNA (Stenglein et al., 2010).  This indicates cell culture 
systems which rely on transfection of plasmid DNA may not be ideal for studying 
members of the AID/APOBEC family as foreign DNA may be degraded leading to 
unstable expression of the plasmid-encoded protein. 
 
The antibodies raised to recombinant A4 were able to detect 1ng recombinant protein 
by immunoblot.  Affinity purification was successful as the antibody did not detect 
the epitope tags present in the antigen.  However no signal was detected in 100ug 
testis extract indicating that if the protein is expressed in testis it is expressed at a low 
level.  This cannot be ruled out as we would only expect to detect A4 protein in a 
subset of cells within the testis as indicated by the Apobec4 transcript expression 
pattern.  Further, given the problems with aggregation of overexpressed protein it is 
possible that the endogenous A4 levels are low.  GFP-tagged A4 expressed in p53-
null cells could be detected on an immunoblot by the affinity-purified A4 antibodies, 
indicating the antibody recognises the A4 protein when expressed in different 
systems with different epitope tags.  However when analysed by 
immunocytochemistry there was little co-localisation of the GFP-tag and the 
antibody staining and considerable background staining was observed.  
Immunohistochemical analysis of paraffin-embedded testis sections from wild type 
and A4-null mice failed to demonstrate a specific A4 signal and attempts to enrich 
for endogenous A4 by immunoprecipitation were also unsuccessful. 
 
The discovery that AID is able to inhibit LINE-1 retrotransposons through a 
deamination-independent manner is fascinating (MacDuff et al., 2009).  Similar 
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inhibition of retroviral elements has been reported for A3 proteins that are localised 
in the cytoplasm (Bogerd et al., 2006a; Bogerd et al., 2006b; Esnault et al., 2005; 
Kinomoto et al., 2007; Schumacher et al., 2005; Stenglein and Harris, 2006).  
Interestingly, key catalytic residues in the active site were not required for 
retrotransposon inhibition (Stenglein and Harris, 2006).  This enables one to envisage 
a model whereby A4 may have retained its ability to interact with retrotransposons in 
the germline, but may have lost catalytic deaminase activity due to the deleterious 
consequences of mutagenising the germline.  In addition, the demonstration that A3G 
has a cellular role as an RNA-binding protein which can be relocated to stress 
granules and binds to transcribed retrotransposon RNAs (Chiu et al., 2006; Gallois-
Montbrun et al., 2007; Kozak et al., 2006; Wichroski et al., 2006) offers another 
potential mechanism of A4 activity as an RNA-binding protein.  However further 
work is required to determine whether A4 is capable of binding to RNA.  
 
Unfortunately the technical problems with purification of A4 protein prevented 
biochemical characterisation of the protein.  This, combined with the difficulty in 
detecting the endogenous protein, led to the decision that I should work on another 
project. 
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4.1 Introduction 
There is only one Adar gene in Drosophila melanogaster.  The Adar5G1 deletion 
encompasses the coding region and promoter of the Adar gene.  Adar-null flies have 
decreased viability, approximately 20% of wild type levels, and they display 
decreased locomotor activity and develop age-dependent neurodegeneration 
(Palladino et al., 2000b).  Expression of wild type Adar in the cholinergic neurons 
using the GAL4-UAS binary system is able to suppress the Adar5G1 phenotype 
(Keegan et al., 2005).  Intriguingly, expression of a catalytically inactive Adar EA 
transgene also under the Cha-GAL4 promoter is able to suppress the age-dependent 
neurodegeneration but does not restore the locomotion defects or reduced viability 
(Leeanne McGurk, Thesis).  Several transcripts which are known substrates of Adar 
have been implicated in locomotor activity, taken together with our earlier data this 
implies that there are site-specific editing events which are crucial for locomotion, 
which are absent in the flies expressing the catalytically inactive Adar EA.  However, 
this also suggests that the age-dependent neurodegeneration observed in the Adar5G1 
flies is due to loss of a deaminase-independent function of the ADAR protein, as it is 
suppressed by expression of the catalytically inactive Adar EA transgene.  This 
potential second function of ADAR is investigated further. 
 
Ultrastructural investigation of the Adar5G1 neurodegenerative phenotype using 
transmission electron microscopy performed by a previous PhD student in the lab 
revealed multiple membrane-bound vacuoles.  These aberrant multilamellar whorls 
and vesicles are similar to those seen in lysosomal storage disorders including Tay-
Sachs disease in humans.  In Drosophila there are several mutants in components 
involved in carbohydrate storage that show similar phenotypes such as benchwarmer 
(Dermaut et al., 2005) and Swiss cheese (Kretzschmar et al., 1997).  The 
benchwarmer mutation has been mapped to a sugar transporter indicating this 
mutation models lysosomal storage disorders seen in humans.  However, this 
phenotype could also be due to aberrant autophagy.  Recently the Drosophila blue 
cheese mutant, which develops progressive neurodegeneration (Finley et al., 2003), 
was shown to have impaired lysosomal trafficking (Lim and Kraut, 2009).  A screen 
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for modifiers of the blue cheese phenotype identified components of the autophagy 
pathway (Simonsen et al., 2007).   
 
The catalytic function attributed to ADAR is RNA editing of A-to-I in dsRNA.  
However, recent work has shown that binding of ADAR protein to dsRNA can affect 
RNA processing, independent of deaminase activity.  This was demonstrated in 
experiments investigating the effect of ADARs on micro-RNA processing, which 
showed that ADAR binding was capable of inhibiting cleavage by both DROSHA in 
the nucleus and DICER in the cytoplasm.  This provides direct evidence that ADAR 
may have a role as an RNA-binding protein independent of its ability to deaminate 
adenosine residues (Heale et al., 2009).  Further, as no catalytic activity has been 
described for mammalian ADAR3, elucidating a deaminase-independent function for 
Drosophila ADAR may shed some light on the function of ADAR3.  This chapter 
aims to elucidate the deaminase-independent role of ADAR in the Drosophila brain. 
 
To determine whether Adar had a more general role in RNA processing transcript 
levels were analysed by microarray.  This revealed that a group of transcripts showed 
altered levels in the absence of Adar.  Expression of either an active or inactive Adar 
transgene in the cholinergic neurons was used to isolate transcripts that showed 
“rescue” in response to Adar expression by searching for patterns of ADAR-
regulated expression.  This approach identified a subset of genes expressed in fly 
head that had altered expression indicative of regulation by the presence of ADAR.  
Cytochrome genes involved in response to oxidative stress were both upregulated 
and down regulated indicating ADAR is involved in the stress-response pathway.  
Transcript changes observed with the microarray analysis were confirmed using real 
time PCR analysis. 
 
In vitro binding experiments were used to characterise the interaction of ADAR with 
novel transcripts identified as being regulated by ADAR according to the microarray 
data.  This revealed ADAR is capable of binding many transcripts in vitro with a 
similar affinity to known substrates and therefore has the potential capacity to affect 
many transcripts through RNA-binding.  To determine whether these effects could 
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also be seen in vivo an RNA-immunoprecipitation experiment was performed in 
Drosophila S2 cells overexpressing FLAG-tagged ADAR.  In vitro editing assays 
were used to analyse whether the identified transcripts were substrates for 
deamination by ADAR.   
 
ADARs have been shown to antagonise the RNAi pathway, leading to the hypothesis 
that antagonism of RNAi may explain the alteration in transcript levels seen in 
Adar5G1 flies.  To investigate this transcript levels were analysed in several different 
fly strains which have mutations in Dicer-2. 
 
As Adar encodes an RNA-binding protein implicated in regulation of response to 
oxidative stress, an alternative approach to investigating the neurodegenerative 
phenotype observed in Adar5G1 flies was employed through analysis of RNA 
oxidation levels.  RNA oxidation has been shown to selectively occur in subsets of 
neurons which go on to develop pathological inclusions in several different 
neurodegenerative disorders.  To determine whether levels of RNA oxidation 
differed in Adar5G1 flies an in vitro immunoprecipitation was performed on RNA 
isolated from wild type and Adar5G1 fly heads, with an antibody raised to 8-





Adar-null flies show locomotion defects and age-dependent 
neurodegeneration 
As previously described Drosophila melanogaster lacking the Adar gene develop 
locomotion defects and age-dependent neurodegeneration (Ma et al., 2001; Palladino 
et al., 2000b).  Further investigation of this phenotype demonstrated that it was due 
to lack of the Adar gene as the locomotion defects and age-dependent 
neurodegeneration could be suppressed by expression of an Adar transgene in the 
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cholinergic neurons, however expression of a catalytically inactive Adar EA 
transgene suppressed the neurodegeneration but could not alleviate the locomotion 
defects (Leeanne McGurk, Thesis).  This implies that ADAR has an editing-
independent function in the fly nervous system, and when this function is disrupted 
flies develop age-dependent neurodegeneration.  To further characterise the 
neurodegenerative phenotype in Adar5G1 flies and identify transcripts that are 
regulated by ADAR microarray analysis was performed.  However, to ensure the 
changes observed were primary effects due to the lack of Adar rather than secondary 
effects induced by the neurodegenerative process flies were analysed at 5 days old.   
 
Before further investigation of these phenotypes by microarray analysis, histological 
examination of 5 day old heads was performed on flies of four different genotypes: 
w1118, Adar5G1, Adar5G1:Cha-GAL4>UAS-dAdar, and Adar5G1:Cha-GAL4>UAS-
dAdar EA.  Haematoxylin and eosin staining of 8μm brain sections revealed that 
there was no evidence of neurodegeneration at five days, whilst holes in the brain are 
present in Adar5G1 flies aged to 25 days (Figure 4.1).  Large holes are observed in the 
mushroom body calyces which are involved in olfactory learning and memory 
processing (reviewed in (Heisenberg, 2003)).  Small holes were occasionally 
observed in the rescue lines expressing active Adar or inactive Adar EA transgenes at 
the 25 day time point (arrowhead Figure 4.1) indicating the neurodegeneration is not 
completely suppressed but is significantly delayed by expression of ADAR in 
cholinergic neurons.  Comparison of flies expressing wild type ADAR with flies 
expressing catalytically inactive ADAR EA in the cholinergic neurons revealed that 
flies expressing the catalytically inactive ADAR EA had fewer holes in the brain that 
wild type, which confirmed earlier observations made by a former PhD student 
Leeanne McGurk.  This was attributed to differences in expression observed for the 
two transgenes, see Figure 4.4 and associated discussion.  
 
No signs of neurodegeneration were observed at 5 days in the four lines analysed 
indicating any changes in transcript level observed should be due to absence of 
ADAR rather than secondary effects of neurodegeneration processes.  A minimum of 
three brains were analysed per genotype. 
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Flies were genotyped at one day old and aged to five days without anaesthesia prior 
to analysis of locomotion.  Locomotion defects were analysed by placing flies in a 
marked chamber for 2 mins and counting the number of times they crossed the lines.  
This assay was performed at 20oC.  Ten flies of each genotype were analysed and 
three measurements were taken per fly which were then averaged.  Figure 4.1 shows 
the w1118 flies, here used as wild type, crossed the lines an average of 12 times in 2 
mins, this was severely reduced in Adar5G1 which showed 10-fold lower level of 
movement.  This was significantly different from w1118 when analysed using an 
unpaired t-test (p<0.0001, t =17.5).   The Adar5G1 flies were obviously uncoordinated 
and often fell over onto their backs, spending large amounts of time trying to stand 
up.  Adar5G1 flies frequently died due to falling over and getting stuck in the food, 
although this could be prevented by frequently tipping flies onto fresh food.  The 
locomotion defects were reversed by expression of a wild type dAdar transgene in 
the cholinergic neurons; however they were not rescued by expression of a 
catalytically inactive dAdar EA mutant transgene in the same system.  Again, this 
difference was significant when analysed by unpaired t-test (p<0.0001, t =10.92).   
 
This indicates that there are site-specific editing events lost in the Adar5G1 flies which 
are essential for locomotor function.  These sites are edited when active dAdar is 
expressed and not when the catalytic mutant is present.  This is perhaps not 
surprising as many of the known substrates of Drosophila melanogaster Adar are 
voltage or ligand-gated ion channels.  This demonstrates that correct editing of these 
targets is essential for correct locomotion in adult flies.  These data also suggest that 
Adar has a second function independent of adenosine deamination, which when lost 
leads to neurodegeneration which is observed as holes in the brain.  As Adar contains 
two RNA-binding domains that function independently of the deaminase domain, 
mechanisms of RNA processing were investigated further.  Firstly I sought to 
determine whether ADAR regulated mRNAs levels in Drosophila brain.  Microarray 
analysis was performed to identify transcripts that were altered in Adar5G1 flies, and 
rescued by expression of an Adar transgene. 
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Adar5G1 flies display reduced viability, estimated to be approximately 20% of w1118 
levels.  This viability defect is rescued by expression of an active Adar transgene in 
the cholinergic neurons; however it is not rescued by expression of the catalytically 
inactive Adar EA transgene.  Therefore obtaining progeny from the Adar5G1 strain is 
difficult, and generating Adar5G1:Cha-GAL4>UAS-dAdar EA progeny from crosses 
is even more difficult.  For RNA extraction 50 fly heads were collected in TRIZOL 
(Invitrogen) and stored at -70oC prior to extraction according to the manufacturer’s 
protocol.  In some experiments Adar5G1:Cha-GAL4>UAS-dAdar EA RNA was not 
available due to problems obtaining flies of the correct genotype, therefore 
experiments were performed with Adar5G1:Cha-GAL4>UAS-dAdar RNA. 
 
Therefore there are four separate phenotypes associated with loss of ADAR 
expression, details are summarised in Table 4.1.  The phenotypes are reduced 
viability, locomotion defects and uncoordinated movement, age-dependent 
neurodegeneration in the mushroom body calyces, and loss of site-specific editing of 
multiple adenosine residues in known substrates.   
 
Genotype Viability (%) Locomotion (%) Neurodegeneration Editing
w 1118 100 100 -
Adar 5G1 20 10.7 +++
Adar 5G1 :Cha-GAL4>UAS-dAdar 95 90.9 +
Adar 5G1 :Cha-GAL4>UAS-dAdar EA 20 11.3 +
Phenotype
 
Table 4.1: Summary of phenotypes associated with deletion of Adar. 
Summary of the four phenotypes associated with Adar5G1 deletion.  Viability measurements 
are estimates based on flies collected for each genotype, locomotion was analysed as the 
number of times flies crossed the line in a marked chamber and data is given as a percent of 
w1118 levels, neurodegeneration is scored as present (+) or absent (-) based on histological 
examination, and editing is indicated as either present or absent based on sequence 




To further characterise the defects in Adar5G1 flies microarray analysis was 
performed on RNA isolated from heads of five day old flies using the Affymetrix 
Drosophila Genome 2.0 array platform.  This expression microarray contains 10-14 
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probes aligned to each 3’UTR to allow analysis of over 18,500 transcripts according 
to the Flybase database release 3.1.  w1118 RNA was compared with Adar5G1 RNA, 
and to detect transcripts that are regulated by ADAR RNA from flies expressing 
Adar in the cholinergic neurons was compared with RNA from flies expressing an 
inactive Adar EA transgene in the cholinergic neurons.  Direct comparisons between 
w1118 flies and the rescue fly strains is not possible as in the rescue strains ADAR 
expression is restricted to the cholinergic neurons.  In w1118 fly brain ADAR is 
expressed in the nucleus of all neurons (Leeanne McGurk, Thesis), whereas choline 
acetyltransferase expression is widespread but excluded from antennal primary 
sensory neurons (Yasuyama et al., 1995).  Importantly immunohistochemical 
analysis of choline acetyltransferase expression showed strong staining in the 
mushroom body calyces.  However, direct comparison of expression patterns is 
difficult as ADAR is a nuclear protein whereas choline acetyltransferase is 
cytoplasmic.  
 
Each sample was hybridised to the array individually and expression data was 
compared in silico to remove the need for dye swap replicates.  The five day time 
point was chosen in an attempt to detect changes in transcript level due to lack of 
ADAR before neurodegeneration induced secondary effects.  RNA was extracted 
with TRIZOL reagent according to the protocol and then further purified and 
concentrated over RNeasy MINelute kit (Qiagen) columns.  Three replicates of each 
sample were hybridised to Affymetrix expression arrays at the Sir Henry Wellcome 
Functional Genomics Facility at the University of Glasgow.  Initial analysis was 
performed as part of the service by Pawel Herzyk at The University of Glasgow to 
yield rank profile lists of changed transcripts when arrays were analysed in a pair-
wise fashion (Breitling et al., 2004).  This analysis revealed that 364 genes were 
upregulated and 297 genes were down regulated with a false discovery rate (FDR) of 
less than 5%.  As transcripts were both upregulated and down regulated this indicates 
that there is not a general affect occurring such as a lower level of transcription or 
increased turnover in Adar5G1 flies.  Of interest was the observation that some 
transcripts changed dramatically when comparing w1118 and Adar5G1.  In Adar5G1 flies 
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the top-changing transcripts showed 18-fold down regulation (CG11205, photolyase) 
and 46-fold up regulation (CG14204) respectively.   
 
However this analysis was not very useful for comparing one transcript across all fly 
strains.  Therefore I performed a more comprehensive analysis using the freely 
available DNA-Chip Analyzer (dChip) software (Li and Wong, 2001).  CEL files 
were converted into dChip files and MAS normalisation was performed using the 
array which displayed the median intensity value (10_dAdar_02; 129).  I then 
searched the array data for patterns; specifically I wanted to isolate genes that were 
regulated by Adar.  To do this I searched for genes that were mis-regulated in 
Adar5G1 flies and “rescued” with re-expression of either the active or the inactive 
Adar transgene.  If ADAR has a secondary function separate from RNA editing this 
would be present in both the active and inactive “rescue” lines; therefore I searched 
for the two patterns described in Table 4.2. 
 
w 1118 Adar 5G1 UAS-dAdar UAS-dAdar EA
Upregulated baseline up down down
Downregulated baseline down up up
Adar 5G1 :Cha-GAL4>
 
Table 4.2: Patterns used for analysis of microarray data.   
Where w1118 was used as a baseline to compare other strains to.  Colours correspond to the 
colours used in the heat maps in Figures 4.2 & 4.3 showing results of the searches, where 
upregulated is red and downregulated is green. 
 
Searching for upregulated transcripts revealed a list of 59 genes with and a FDR of 
0%, as estimated using dChip to search 100 permutations of these search criteria.  A 
heat map showing these 59 genes clustered by expression profile is shown in Figure 
4.2.  A comprehensive list of the gene expression values and fold changes is shown 
in Appendix II, Table AII.1.  Similarly a search for downregulated transcripts 
produced a list of 73 genes with a p value of less than 0.05 and a FDR of 0%, which 
are displayed as a heat map of expression data in Figure 4.3, and listed in detail in 
Table AII.2.  One caveat for these searches is that transcript levels do not need to be 
restored to w1118 levels in the “rescue” lines; they only need to be significantly 
different from Adar5G1 in the direction specified.  These refined lists of genes should 
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comprise a list of transcripts that are affected by the presence of Adar, indicative of 
regulation by ADAR.  Importantly transcripts were identified that were upregulated 
and downregulated when comparing w1118 with Adar5G1 flies, indicating there is not a 
general lower level of transcription in Adar-null flies.     
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Figure 4.2: Heat map of results from a search for upregulated transcripts in the microarray data. 
The 3 individual replicates for each genotype are listed on the right.  Genes are clustered according to similar expression profiles.  
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Figure 4.3: Heat map showing results from a search for donwregulated transcripts in the microarray data.  
The 3 individual replicates for each genotype are listed on the right.  Genes are clustered according to similar expression profiles.
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The Adar transcript was absent from the downregulated list.  However investigation 
of Adar transcript level by real time PCR revealed that expression of the active Adar 
transgene in the cholinergic neurons is very low, such that it would not be detected 
by the specified search parameters (Figure 4.4).  However, given that this level of 
expression is sufficient to suppress the neurodegeneration and locomotion defects 
these parameters were not changed.  Normally Adar expression is highly regulated 
and high levels of expression are detrimental to organisms, indeed expression of a 
highly active Adar S transgene under an Actin-GAL4 promoter is lethal (Keegan et 
al., 2005).  Therefore this low level of expression from the transgene is expected.   
 
What is unexpected is the high level of expression of the catalytically inactive dAdar 
EA transgene.  This could be due to several reasons.  Firstly, the transgenes are 
inserted randomly in the genome and could be under the influence of neighbouring 
gene regulatory signals.  Or secondly, hyper-editing seen with high levels of active 
Adar is detrimental to the organism and therefore selected against so expression of 
active Adar is usually low.  However the catalytic mutant is not capable of editing 
RNAs; therefore this low level of expression may not be necessary with the catalytic 
mutant.  The second hypothesis is supported by observations that the mutant ADAR 
protein is consistently expressed at a higher level that the wild type ADAR protein 
when overexpressed in yeast for biochemical analysis (personal observation, data not 
shown).  Further support comes from the observation that three independent lines of 
each genotype were generated and analysed in a locomotion assay (Liam Keegan and 
Jim Brindle, unpublished data).  Similar results were obtained for all three lines 
indicating regulatory signals from genes surrounding the insertion site are not 
contributing to the expression level. 
 
Interestingly, expression of the inactive transgene in the cholinergic neurons 
produces a better suppression of the neurodegenerative phenotype than the wild type 
ADAR.  This is likely to be partly due to the high level of expression of this 
transgene; however human ADAR1 is also regulated post-translationally via 
sumoylation (Desterro et al., 2005). 
 





Unfortunately immunoblot analysis of ADAR protein levels in these transgenic 
strains using either an anti-human Adar2 antibody which cross reacts with 
Drosophila ADAR or an anti-FLAG antibody was not successful, indicating the 
endogenous protein and the expression from the transgenes is low in vivo.  To 
definitively quantify the protein levels an antibody specific to Drosophila Adar is 
required, this would allow direct comparison of expression patterns and levels 
between the transgenic strains and wild type levels in w1118 flies.   
 
Analysis of the microarray data confirmed earlier work to define the Adar5G1 
mutation (Leeanne McGurk, Thesis).  TAIL-PCR was performed to define the 
breakpoints of the Adar5G1 mutation and revealed that the deletion removed 36.5kb 
of genomic sequence surrounding the Adar gene on the X chromosome.  The deleted 
region contains Adar and two additional genes CG14809 and CG38206, which are 
not known to be expressed in the brain.  However, sequence analysis revealed that P 
element mobilization used to generate the deletion had also generated a small 
inversion with a breakpoint within a neighbouring gene called Sarcoglycanδ 
(CG14808).  Neither of these genes are annotated as being expressed in the CNS, 
however analysing the microarray data it can now be confirmed that these transcripts 
are not altered in the RNA extracted from Adar5G1 fly heads. 
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Two lists of genes that were altered in the microarray were generated, those that were 
upregulated in Adar5G1 flies (59 in total) and those that were down regulated in 
Adar5G1 flies (72 in total).  These lists were analysed further using the functional 
enrichment of gene ontology tool FatiGO from BABELOMICS (Al-Shahrour et al., 
2006).  Transcripts identified from both pattern searches were compared to the rest of 
the Drosophila genome (14,703 genes) to determine whether any gene ontology 
(GO) terms were significantly over-represented.  The list of over-represented GO 
terms is shown in Table 4.3.  Terms are classed according to cellular component or 
location, molecular function, or conserved domains as defined by Interpro database.  
The number listed with the GO term indicates the level of the term within a 
hierarchical cluster, where lower numbers indicate general processes and as the 
number increases the specificity increases.  Therefore some processes appear 
multiple times, indicating both general terms associated with the process and more 
specific terms are significantly over-represented. 
 
The GO analysis revealed that cytochrome p450 genes were over-represented in the 
Adar downregulated list, both in GO terms such as “mono-oxygenase activity” and 
cellular compartments like “microsome” and in Interpro domains.  However, 
although not statistically significant cytochrome-associated genes were also present 
in the upregulated list indicating a general de-regulation.  Studies into transcriptional 
responses to both paraquat stress and hydrogen peroxide stress have shown a similar 
altered regulation of cytochrome genes (Girardot et al., 2004).  The downregulated 
list showed GO terms associated with cytoplasmic membranous structures, which 
could represent components involved in synaptic transmission.  The upregulated list 
showed fewer statistically significant terms, with cytoplasmic membrane-associated 
terms showing significance.  Surprisingly, the upregulated list also showed over-
representation of GO terms related to flagella.  This was not expected; however a 
Drosophila mutant in the sas-4 centrosomal protein has defects in flagella formation 
and demonstrates severe uncoordination due to lack of sensory neuron cilia involved 
in mechanosensation (Basto et al., 2006).  The sas-4 mutants hatch but die shortly 
afterwards, often getting stuck in the food due to the uncoordinated movement.  
Adar5G1 flies frequently fall over and often get stuck in the food; however it is 
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possible to keep them alive by frequently changing the food indicating this 
phenotype is not as severe as the sas-4 mutants. 
 
However, as cytochrome genes have been shown to be regulated in response to 
oxidative stress it cannot be ruled out that this de-regulation may be a response to 
initial stages of neurodegeneration occurring rather than a causative change.  
Cytochrome genes have also been shown to be upregulated in response to the 
accumulation of a substrate, although this data was generated in humans with 
reference to drug metabolism this could be extrapolated to indicate the presence of an 
endogenous toxic product in the brains of Adar-null flies.  Interestingly Glutathione 
S transferase genes were also found on both the lists although not significantly over-
represented, these have also been shown to be regulated in response to oxidative 
stress (Girardot et al., 2004).   
Class GO term Adjusted p-value
Down regulated genes
4: cell fraction (GO:0000267) 0.00174
5: membrane fraction (GO:0005624) 0.00195
6: vesicular fraction (GO:0042598) 0.00174
7: microsome (GO:0005792) 0.00189
7: cytoplasmic part (GO:0044444) 0.01906
3: tetrapyrrole binding (GO:0046906) 0.00210
4:  monooxygenase activity (GO:0004497) 0.00163
4: heme binding (GO:0020037) 0.00163
IPR001128: Cytochrome p450 0.00966
IPR002401: Cytochrome p450, E-class, group I 0.00966
IPR002403: Cytochrome p450, E-class, group IV 0.00966
IPR002402: Cytochrome p450, E-class, group II 0.02202
Up regulated genes
4: cell projection (GO:0042995) 0.04635
5: flagellum (GO:0019861) 0.01076
5: membrane fraction (GO:0005624) 0.04913
6: flagellin-based flagellum (GO:0009288 0.01169










Table 4.3: Analysis of enriched GO terms associated with transcripts 
identified as altered according to microarray analysis. 
Gene Ontology (GO) terms and identifiers associated with the list of 72 down regulated 
genes and 59 upregulated genes.  GO terms are grouped into cellular component, molecular 
function, and Interpro domains and within these classes GO terms are organised in 
hierarchical levels 1-9 where 1 indicates general terms and 9 indicates specific terms.  No 
significantly over-represented GO terms associated with molecular function or Interpro 
domains were found in the upregulated gene list.  Adjusted p-values are listed, all terms 
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listed have a p-value <0.05.  Data compiled using the FATiGO software on the 
BABELOMICS website (Al-Shahrour et al., 2006). 
 
The hypnos-2 mutant which is a deletion in Adar, was originally discovered in a 
screen for mutants that show increased susceptibility to oxygen deprivation (Ma et 
al., 2001).  The authors hypothesised that this was due to the lack of site-specific 
editing of ion channels in the absence of Adar, which prevents adaptation to 
environmental stresses such as low oxygen levels.  Therefore in the absence of Adar 
flies were more susceptible to oxygen deprivation and neuronal degeneration.  
Transcript analysis in hypnos-2 mutants showed that several cytochrome genes were 
upregulated (Chen et al., 2004), further these genes were downregulated in flies 
overexpressing ADAR indicating they are regulated by ADAR.  However, the 
cytochrome genes identified by Chen et al (2004) are different genes from those 
identified here (Chen et al., 2004).  This correlates with a general de-regulation of 
genes involved in response to oxidative stress.  The microarray data presented here 
indicates that Adar may regulate transcripts involved in the response to oxidative 
damage, in a manner independent of site specific editing as levels of these transcripts 
are restored by expression of a catalytically inactive Adar transgene.   
 
ADAR2 has also been implicated in neuronal cell death following forebrain ischemia 
(Peng et al., 2006).  Elegant experiments in mouse have demonstrated that Adar2 
expression is down regulated following ischemic insult in vulnerable neurons, which 
leads to neuronal degeneration due to calcium influx.  Interestingly, the transcription 
factor responsible for Adar2 regulation in this system, CREB, was shown to be 
upregulated in resistant neuron populations indicating Adar2 may be part of a 
protective response in these neurons.  There is a parallel in Drosophila as in the 
absence of Adar flies are more sensitive to oxygen deprivation, similar to the 
vulnerable CA1 pyramidal neurons in mouse, and cytochrome genes are de-
regulated.  Intriguingly the hypnos-2 Adar mutant was shown to have increased 
resistance to paraquat treatment, a compound that is used to induce oxidative stress 
through the generation of reactive oxygen species (Chen et al., 2004).   
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Importantly, this kind of analysis depends entirely on how well the genome and the 
genes of interest are annotated.  Of the list of 131 genes analysed 81 (61.8%) had a 
molecular function GO term attributed to them, and 94 (71.8%) contained a 
functional motif as recognised by the Interpro integrated database.  This can be 
compared to 60.8% and 73.5% for the rest of the genome annotated with molecular 
function GO terms and Interpro domains respectively.  These numbers indicate the 
annotation levels are comparable for the lists being analysed and the genome 
annotation, however it also indicates that 30-40% of the genes identified have no 
function attributed to them making comprehensive analysis difficult.   
 
Confirmation of microarray results by real time PCR 
Transcripts identified as being altered in the microarray data were analysed by real 
time PCR to confirm the changes (Figure 4.5).  Primers were initially designed to the 
body of the gene however to accurately measure the same region of the transcript as 
the microarray probes, primers were also designed to the 3’UTR region.  Initial 
analysis was performed with Actin and GAPDH reference genes, however as results 
were generally consistent further analysis was performed with GAPDH for 
normalisation.  Graphs show the average fold change as calculated from a minimum 
of two biological replicates and two technical replicates with error bars indicating the 
standard deviation.  Analysis of Adar transcript levels revealed a 10-fold decrease in 
Adar5G1 flies; however some signal was still detected.  This could be due to the 
technique of real time PCR which rarely gives an absolute zero value, although a low 
level of contamination with wild type RNA cannot be excluded.  Adar expression is 
known to be low in w1118 flies, meaning the fold change is unlikely to be large.   
 
Rab3 GEF was investigated as initial results from microarray analysis of w1118 and 
Adar5G1 showed it was 10.9-fold downregulated in Adar5G1, and it is known to be 
edited in the 3’UTR region by ADAR (Stapleton et al., 2006).  Rab3 GEF was an 
interesting candidate for investigation as may be regulated in response to oxidative 
stress (Zou et al., 2000).  However real time PCR analysis of RNA extracted from 
flies expressing dAdar and dAdar EA transgenes showed that Rab3 GEF transcript 
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levels were not restored (Figure 4.5), which confirms the results obtained by 
microarray analysis of the rescue strains.  As the expression of Rab3 GEF is not 
significantly different in the rescue lines from the expression in Adar5G1 flies, this 
indicates its activity is not linked to the phenotypes of locomotion defects or age-
dependent neurodegeneration.  One explanation for this is that Rab3 GEF may be 
expressed and regulated by ADAR outside the cholinergic neurons.  Rab3 GEF is 
part of a conserved pathway involved in synaptic vesicle recycling at the 
neuromuscular junction and mice lacking the Rab3 GEF homolog Rab3 GEP die 
postnatally with 10-fold fewer synaptic vesicles (Tanaka et al., 2001).  However, 
localisation of Drosophila Rab3 GEF is required to determine whether it is expressed 
outside the cholinergic neurons. 
 
Photolyase (Phr, also known as photorepair) transcript level was dramatically 
altered in Adar5G1 flies when analysed by both microarray (18-fold downregulated) 
and real time PCR (10-25 fold downregulated depending on primer pair used, see 
Figure 4.5).  Photolyase is an enzyme that catalyzes the repair of UV induced 
pyrimidine dimers using energy from white light.  Mutational analysis originally 
isolated a recessive allele that was defective in both photorepair and base-excision 
repair indicating a dual or common role between these pathways (Boyd and Harris, 
1987).  Interestingly, the 3’ region of the photolyase coding sequence is present in 
two copies in the D.melanogaster genome.  This duplication likely arose through 
either large-loop mismatch repair or replication slippage as the fused gene and the 
parental genes lie within 2 annotated genes of each other (Rogers et al., 2009).  One 
complete copy is present at locus CG11205, and a partial duplication has produced 
another gene with the same 3’UTR region (CG18853) which is itself a fusion product 
with another gene.  As such, primers or probes designed to the 3’ end of the 
transcript will detect RNA from both genomic loci.  Therefore primers within the 
body of the gene were used to analyse the levels of photolyase (CG11205) by real 
time PCR.  Analysis of CG18853 transcript levels was not possible as the 5’ region 
of this gene is shared with another gene, therefore specific primers could not be 
designed. 
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Drosophila Insulin-like peptide 3 (Ilp3) was also found to be down regulated in 
Adar5G1 flies and expression was recovered with expression of dAdar and dAdar EA 
transgenes, although not to the same level as transcripts in w1118(Figure 4.5).  Ilp3 
expression was 4.5-fold downregulated according to the microarray and 10-fold 
downregulated according to real time PCR analysis.  Ilp3 is one of seven insulin-like 
signalling molecules identified through searching the Drosophila genome for 
residues that are conserved in insulin.  Ilp3 is unique among these seven genes for 
showing the most restricted expression pattern, being expressed in only seven cells 
within each hemisphere of the developing larval brain, which are known as median 
neurosecretory cells (Brogiolo et al., 2001).  Ilp3 is one of three ILP’s expressed in 
adult brain, yet there is only one insulin receptor.  Flies lacking 5 of the Ilp genes 
(Ilp1-5) that are clustered on chromosome III are small with poor growth and 
viability (Zhang et al., 2009).  However deletion of the one insulin receptor gene 
(DInR) is lethal (Chen et al., 1996), indicating compensation by Ilp6 & 7 is occurring 
in the Ilp1-5-null flies.  Interestingly expression of Ilp3 and Ilp5 is regulated by 
nutrient availability such that these transcripts are not produced under starvation 
conditions (Ikeya et al., 2002).  Adar5G1 flies may have problems feeding due to lack 
of coordinated movement and long periods lying on their backs; however we might 
expect both Ilp3 and Ilp5 to be altered if starvation were the cause of altered gene 
expression. Characterisation of single Ilp mutants has revealed that there is 
functional redundancy and compensation of expression (Gronke et al., 2010).  Indeed 
we observe a slight upregulation on Ilp7 in our microarray analysis (1.38-fold, 16% 
FDR), although this difference is too low to be statistically significant. 
 
Several upregulated transcripts were also confirmed by real time PCR analysis.  
Metallothionein D (MtnD) was also found to be upregulated 4.17-fold according to 
the microarray and 5–fold by real time PCR in Adar5G1 flies (Figure 4.5).  MtnD is 
one member of a family of four proteins involved in metal ion homeostasis.  
Interestingly, two other metallothionein genes were upregulated according to the 
microarray data, MtnC was 7.09-fold upregulated and MtnB was 1.48-fold 
upregulated.  MtnA was not changed.  Analysis of the evolution of the four genes 
indicates that MtnA is the ancestral gene, whereas MtnB, -C, and -D are arose from 
Chapter 4: Microarray analysis of Adar-null flies 
 171
several duplication events and are closely related (Egli et al., 2006a).  Drosophila 
mutants lacking all four Mtn genes display increased sensitivity to heavy metals and 
decreased life span (Egli et al., 2006b).  However, analysis of the contribution of 
individual Mtn genes to metal ion homeostasis revealed that MtnA and -B have the 
major role in metal ion homeostasis, whereas MtnC and -D play minor roles (Egli et 
al., 2006a).  This preference was reflected in analysis of promoter responsiveness, as 
MtnA and -B were preferentially induced by copper and cadmium respectively. All 
four metallothionein genes are regulated by metal response elements in the promoter 
region which are activated by the metal-responsive transcription factor (MTF-1) 
(Zhang et al., 2001).  This indicates that MtnC and -D may have diverged in function 
from MtnA and -B, and may be induced in response to an as yet uncharacterised 
stress or cytotoxic agent.  As metal ions can generate reactive oxygen species, 
metallothioneins also exert an antioxidant effect by chelating metal ions.  Indeed 
overexpression of MTF-1 protects flies against heavy metal toxicity and oxidative 
stress (Bahadorani et al., 2008).  Hence, elevated levels of Metallothionein genes in 
Adar5G1 flies may explain the increased resistance to oxidative stress observed in 
Adar mutant flies (Chen et al., 2004). 
 
Expression of CG30091 was approximately 30-fold upregulated in Adar5G1 flies 
according to real time PCR, whereas the microarray data indicated it was 7.3–fold 
upregulated (Figure 4.5). The CG30091 gene has not been characterised yet, 
although the molecular function attributed to it in Flybase is serine-type peptidase 
activity and therefore it is described as being involved in proteolysis.   
 
Many primers were designed to analyse other transcripts that were altered according 
to the microarray data however despite giving product when tested in an RT-PCR 
reaction, they did not amplify transcripts in a linear fashion when analysed by real 
time PCR and therefore could not be used.   
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Known substrates of ADAR enzymes show extensive secondary structure whereby 
stretches of dsRNA are interrupted by bulges and mismatches, which are important 
for ADAR-binding.  Therefore a preliminary analysis of the predicted secondary 
structure of transcripts identified in the microarray analysis was performed to 
investigate whether these transcripts could be bound by ADAR.  Secondary structure 
prediction software, RNAfold (University of Vienna) (Gruber et al., 2008) was used 
to model the predicted structures of pre-mRNAs encoding Ilp3, Phr, and CG30091 
(Figure 4.6).  These pre-mRNAs show extensive stem-loop structures with bulges 
and mismatches that could be bound by ADAR.  However another transcript that was 
not altered according to the microarray data, GAPDH2 also showed significant 
secondary structure suggesting ADAR may bind to many transcripts, both those 
altered on the microarray and those that remained unchanged.  
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When comparing w1118 and Adar5G1 only a few known edited substrates of ADAR 
were present on the pair-wise microarray analysis list generated as part of the 
microarray service by Pawel Herzyk (data not shown).  However these transcripts 
were not altered dramatically and they ranked low down on the rank profile list 
where the false discovery rate is increased.  For example the nicotinic acetylcholine 
receptor α-34E gene (nAcR-alpha34E) was ranked number 343 showing a 1.66-fold 
increase in transcript levels in Adar5G1 compared to w1118, with a FDR of 4.2%.  
None were present in the lists generated by searching for specific patterns.  However 
a lack of ADAR protein and site-specific editing may affect the levels of known 
substrates of ADAR through alterations in RNA processing or stability therefore a 
subset of edited transcripts were analysed by real time PCR.  The genes analysed 
were: nicotinic acetylcholine receptor α--34E (CG32975), nicotinic acetylcholine 
receptorα-30D (CG4128), nicotinic acetylcholine receptor β-64B (CG11348), 
resistance to dieldrin (CG10537), and Shaker (CG12348).  All the transcripts 
analysed showed a similar profile across the four genotypes assessed (see Figure 
4.7), however the changes were not dramatic (2-5-fold) when compared to the 
changes confirmed in phr (25-fold, Figure 4.6).  nAcR-alpha34E was shown to be 
increased in Adar5G1 flies according to the microarray data, yet the real time PCR 
indicates it is decreased.  This disparity indicates the changes observed are probably 
not significant as they are subject to variability.  Indeed previous reports have shown 
difficulty in confirming minor changes from microarray data, for this reason most 
analysis focuses on changes of greater than two-fold as these are more readily 
confirmed (Rajeevan et al., 2001).  Results shown in Figure 4.7 are the analysis of 
one biological replicate; however a separate replicate was performed with primers 
designed to the 3’UTRs of these transcripts to more accurately measure the same 
region of the transcript as the microarray.  Both the gene body primers and the 
3’UTR primers display the same profile across the four genotypes analysed (data 
shown for Rdl transcript).   
 
The profile of expression of edited transcripts across the four genotypes analysed 
appears similar for the subset of edited transcripts analysed by real time PCR.  The 
pattern is distinct from that seen with the novel substrates analysed by real time PCR 
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in Figure 4.6.  This suggests that I have identified a novel class of transcripts that are 
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One class of transcripts that were altered in Adar5G1 flies according to the microarray 
data were histone RNAs.  Transcript levels changes were not large (maximum 2.4-
fold lower in Adar5G1) however histones 1, 2A, 2B, 3, and 4 were downregulated.  
Histone transcripts are not polyadenylated; instead they are regulated post-
transcriptionally through a stem-loop structure in the 3’UTR (for a review see 
(Marzluff et al., 2008)).  As ADARs bind to stem-loop structures this could implicate 
ADAR in histone mRNA processing.  However these transcripts were not restored by 
expression of active Adar or the catalytically inactive Adar EA transgenes in the 
cholinergic neurons, according to the microarray data.  Further, an RNAi screen in 
Drosophila S2 cells to determine the genes involved in post-transcriptional 
regulation of histone mRNA processing did not identify Adar (Wagner et al., 2007).  
Therefore the downregulation of histone transcripts in Adar5G1 flies may be indirect. 
 
When Xia and colleagues (2005) attempted to identify new substrates for Drosophila 
ADAR using an antibody to inosine, they generated a list of 62 potential new 
substrates (Xia et al., 2005b).  Further investigation of a subset of these transcripts 
showed that 7 out of 12 tested contained A-G changes indicative of editing.  
Comparison of the lists generated by searching the microarray data for patterns of 
expression with the list of 62 transcripts did not reveal any transcripts common to 
both lists.  This further suggests I have identified a novel group of transcripts whose 
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In vitro analysis of ADAR binding to microarray-identified 
transcripts 
Pattern analysis of the microarray data generated two lists of transcripts that were 
potentially regulated by ADAR.  However it was unclear whether ADAR can bind to 
these transcripts or whether the observed change in transcript levels was a secondary 
effect.  To determine whether ADAR could interact with these transcripts several 
different methods were used.  Binding of ADAR to candidate transcripts and controls 
was analysed in vitro using filter-binding assays.  Briefly, recombinant epitope-
tagged wild type or a catalytic site mutant of the ADAR protein was purified from 
Pichia pastoris using an existing protocol (Ring et al., 2004).  As editing occurs co-
transcriptionally before splicing takes place genomic DNA was cloned into T-easy 
(Promega) to allow transcription of pre-messenger RNAs for the candidate genes 
using either T7 or Sp6 polymerases (Ambion).  The transcripts chosen for analysis 
were Photolyase and Ilp3, and controls GAPDH and RP49 were included, the size of 
each pre-mRNA is listed in Table 4.4.  The positive controls used were a 187bp 
fragment of the Adar transcript surrounding the self-editing site in exon 7 termed 
Adar160 which has been shown to be edited to approximately 70% in vitro, and a 
perfect dsRNA fragment of 296bp prepared by in vitro transcription of ΔKP DNA 
and shown be extensively hyper-edited in a non-specific manner as described by 
Scadden & O’Connell (2005).  Transcripts were incubated with varying 
concentrations of ADAR protein (0-240nM) for 10 minutes before reactions were 
applied to nitrocellulose filters.  Filters were washed and allowed to air-dry, and 
bound RNA was determined by reading the radioactivity using a scintillation 
counter.  Binding curves generated by plotting protein concentration against bound 
RNA were used to determine the dissociation constant (Kd) of the binding reactions 















Sp6-Phr 1911  
Table 4.4: Size of in vitro pre-mRNA transcripts analysed by filter 
binding. 
RNAs were in vitro transcribed from the promoters listed using either T7 or Sp6 polymerase 
(Ambion).   
 
 
Filter binding analysis revealed that whilst recombinant ADAR bound with very high 
affinity to the perfect dsRNA as described previously (Gallo et al., 2003), binding to 
the other transcripts was with considerably lower affinity and maximal binding 
including the Adar160 self editing site fragment.  This result was unexpected as the 
Adar160 fragment is edited to ~70% in vitro (Keegan et al., 2005), and therefore I 
was anticipating high affinity binding.  This data suggests that binding affinity and 
editing efficiency are separate properties of ADAR.  However, it has been suggested 
that different RNAs cannot be directly compared using the filter-binding method as 
the interaction between protein and RNA may differ for each transcript (Haynes, 
1999).  Further, the transcripts are of different lengths (see Table 4.4) and long 
transcripts may surround or coat the protein and allow it to pass through the filter.  
Therefore an alternative method was sought to validate these results. 
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The alternative method employed was to analyse ADAR RNA-binding by 
electrophoretic mobility shift assay (EMSA), as this method has been used to analyse 
binding of human ADAR2 to the GluR-B transcript (Ohman et al., 2000).  Binding 
of wild type dADAR (WT) to the Adar160 self editing site was analysed.   
 
An ADAR RNA-binding mutant (RRM) with similar mutations to those described in 
ADAR2 in Figure 4.11 was generated by site-directed mutagenesis.  The proteins 
were expressed and purified in Pichia pastoris with the assistance of Jim Brindle 
using the protocol described by Ring and colleagues (Ring et al., 2004).  The RRM 
mutant contains three amino acid changes such that lysine residues which are critical 
for RNA-binding are replaced with alanine or glutamine residues (KKxxK-
>EAxxA).  ADAR1 and ADAR2 containing these mutations in their dsRBDs were 
described in (Valente and Nishikura, 2007).  Mutation of these residues was designed 
to abolish RNA-binding without disrupting protein structure based on mutations 
made in Drosophila Staufen dsRBD3 (Ramos et al., 2000).  However, the ADAR 
RRM protein was expressed at a lower level than wild type ADAR, see Appendix I.  
Purified protein was quantified using a Bradford assay and an equal amount was used 
for binding analysis. 
 
EMSA analysis of binding of WT dADAR produced a shift in molecular weight with 
increasing protein concentration such that the entire RNA probe was bound at 
400nM ADAR (Figure 4.9 A).  The complex could also be super-shifted by 
incubation with an anti-FLAG antibody indicating the complex was formed by the 
FLAG-tagged ADAR.  The complex could be competed by addition of increasing 
amounts of cold Adar160 RNA, amounts analysed were 1ng, 10ng, 100ng, 500ng, 
and 1ug, which corresponds to 100-500,000-fold excess.  Adar160 transcript was 
transcribed in vitro in the presence of 32P-GTP, and 10pM was used per reaction.  
Labelled and unlabelled RNAs were added to protein at the same time and reactions 
were incubated at 37oC for 15 minutes before loading onto a native polyacrylamide 
gel.  The EMSA was repeated twice and the bands quantified using ImageQuant 
software (GE Healthcare) then the data was plotted using Sigmaplot (Systat software 
Incorporated). 
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Competition analysis revealed the amount of cold competitor required to compete the 
reaction was between 10ng and 100ng.  However the complex could not be disrupted 
by addition of a 1000-fold excess of yeast tRNA (5ug) indicating the interaction was 
specific.  The equation listed in Figure 4.9 (C) was used to calculate the dissociation 
constant (Kd) of recombinant WT dADAR as 3.68 nM +/- 0.91.  This is lower than 
the estimate based on the filter-binding assay which showed the Kd of wild type 
ADAR binding to Adar160 RNA to be 14 nM +/-1.98.  However, the results are 
consistent and taken together these results indicate wild type Drosophila ADAR has 
a dissociation constant within the range of 2.77-15.98 nM depending on the 
experimental conditions used. 
 
In contrast the RNA binding mutant (dADAR RRM) did not show a significant shift 
in molecular weight until high amounts of protein were included (Figure 4.9 B).   
Interestingly the small shift that was observed could be disrupted by addition of 5ug 
yeast tRNA indicating the binding observed is non-specific.  It has previously been 
reported that the ADAR1 deaminase domain is capable of binding to RNA in the 
absence or mutation of the dsRBDs (Herbert and Rich, 2001), which may explain the 
residual binding observed here, although this would imply weak non-specific binding 
is mediated through the deaminase domain as it can be competed by yeast tRNA.  A 
catalytic site mutant dADAR EA protein showed similar binding to wild type and 
could not be competed off by yeast tRNA.  
 
The dissociation constant of mammalian ADAR1 has been estimated at 0.11nM (Lai 
et al., 1995).  This was calculated from filter-binding analysis with a perfect duplex 
dsRNA.  Analysis of ADAR1 binding to a GluR-B fragment containing the Q/R site 
gave a Kd of 0.3nM (Lai et al., 1997).  ADAR1 does not preferentially edit the 
GluR-B Q/R site, however there is an intronic “hot-spot” site that ADAR1 edits 
which is included in the fragment analysed.  The Kd of ADAR2 monomer binding to 
a GluR-B fragment as determined by EMSA was 1nM +/- 0.1 (Ohman et al., 2000).  
The binding of ADAR2 to fragment of the GluR-B transcript containing the Q/R site 
was determined to have a Kd of 0.2nM and binding to a fragment of the serotonin 
receptor gave a Kd of 0.5nM (Chen et al., 2000).  In the same study the binding of 
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ADAR2 to perfect duplex dsRNA was estimated to be 0.2nM.  ADAR3 which has no 
known substrates binds to the GluR-B fragment with a Kd of 0.4nM, the serotonin 
receptor fragment with a Kd of 0.6nM, and  to perfect duplex dsRNA with a Kd of 
0.5nM (Chen et al., 2000).  This highlights the high affinity ADAR proteins have for 
RNA, regardless of whether deamination occurs.  However, these reports indicate 
that there is variability between methods used to analyse binding and also between 
transcripts analysed.   
 
Comprehensive analysis of the kinetics of ADAR2 binding to the GluR-B R/G site 
by EMSA showed that there was a progressive shift of RNA to a low molecular 
weight complex comprised of enzyme (E) and substrate (S) (Jaikaran et al., 2002), 
which were clearly visible as two distinct bands. With addition of more protein this 
shifted to a high molecular complex, comprising two monomers of enzyme and one 
molecule of substrate (ESE), this corresponds to the active editing complex.  The 
dissociation constant for each complex was determined (ES = 4nM and ESE = 
21nM).  A similar stepwise shift was observed with ADAR2 and the GluR-B R/G 
site by Ohman et al, (2000), however the Kd for monomer binding was 1nM (Ohman 
et al., 2000).  In comparison with the data presented here the GluR-B R/G fragment 
used for these experiments was 78bp long, whereas the Adar160 fragment used in the 
experiments shown here was 269bp.  A shorter RNA fragment would likely show a 
stepwise complex formation as observed for ADAR2 as it would be easier to resolve 
by EMSA.   Importantly the filter binding analyses would not discriminate between 
monomer binding and dimer binding. 
 
When comparing Drosophila ADAR to these mammalian ADARs it appears to have 
a lower affinity for the Adar160 RNA, which is a known substrate.  However the 
dissociation constants for ADAR2 determined by EMSA, are calculated for 
monomer binding and therefore direct comparisons with the data presented here for 
Drosophila ADAR cannot be made.  The binding affinity is most similar to ADAR2, 
which is consistent with the high level of similarity (dADAR shares 67% identity 
with ADAR2 within the deaminase domain) shared between these proteins 
(Palladino et al., 2000a). 
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It has been shown that the dissociation constant for ADAR2 binding to an edited 
GluR-B R/G site fragment containing an inosine residue is lower than binding to the 
unedited transcript (Ohman et al., 2000).  Therefore the fraction of edited RNA 
present in the sample may influence the RNA-binding; however it is not possible to 
control this variable without altering nucleotides within the substrate. 
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The binding of WT dADAR to Adar160 was used to investigate the potential 
interaction to the transcripts identified as altered by microarray analysis.  This was 
performed by analysing the ability of different transcripts to compete with the 
binding of dADAR to Adar160 RNA.  As shown in Figure 4.9 the interaction 
between WT dADAR can be partially competed by 10-100ng cold Adar160 
transcript, and completely competed with 500ng.  However the interaction could not 
be competed with an excess of yeast tRNA, which has significant secondary 
structure.  Therefore increasing concentrations of cold in vitro transcribed pre-
mRNAs were incubated with 100nM dADAR protein and labelled Adar160 RNA to 
determine if they were good competitors. 
 
Figure 4.10 shows the EMSA gels and quantification of competition with Adar160, 
Photolyase (Phr), Insulin-like peptide 3 (Ilp3), RP49, GAPDH, and Cacophony 
(Cac).  The amounts of RNAs used were 0ng, 1ng, 10ng, 50ng, and 500ng, which 
correspond to 100-500,000-fold excess.  These were incubated with 10pM 
radiolabelled Adar160 RNA and 100nM WT dADAR protein for 15 minutes at 37oC.  
The reaction was stopped by loading onto a 5% native polyacrylamide gel.  Gels 
were electrophoresed for 7 hours at 4oC, dried and exposed to a phosphorimager 
screen for 48 hours.  Band intensity was quantified using ImageQuant software (GE 
Healthcare) and concentration of bound RNA was plotted against amount of 
competitor RNA.  Cold competitor RNAs were analysed by amount rather than 
molar concentration so as not to assume prior knowledge of binding kinetics.  
However when differences in size of RNAs analysed was taken into account and the 
binding data was plotted against the molar concentration of the size of the RNA 
became apparent.  This data suggests that ADAR binds multiple times to longer 
transcripts.  Further experiments such as RNA footprinting are required to determine 
where the binding site for ADAR lies on these transcripts, and whether the 
interaction is stable.  Although the positive control Adar160 RNA has been shown to 
be edited at one site in vitro the predicted secondary structure for this molecule 
contains two stem-loop regions indicating ADAR could bind multiple times to this 
RNA.   
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It is unclear from this data whether any pre-mRNA tested would be bound by ADAR 
in vitro, as it would be difficult to find an RNA that does not show some secondary 
structure.  Yet recombinant ADAR does not bind to yeast tRNA, so clearly some 
specificity exists. 
 
Analysis of ADAR2 binding to a fragment of the GluR-B transcript has been used to 
analyse competition with other known substrates including a fragment of the 
serotonin receptor mRNA (Dawson et al., 2004).  However, these experiments were 
done with fragments of the total transcript rather than the full pre-mRNA, and they 
specifically include the regions surrounding known editing sites as the quantification 
is based on editing frequency.  This is the first investigation into binding of ADARs 
to transcripts that are not known to be substrates. 
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RNA-binding is an essential property of ADAR 
In vitro data suggests that ADAR can bind to the transcripts that are altered in the 
Adar5G1 flies, along with transcripts that are not altered according to the microarray 
data.  However to determine whether binding of ADAR to substrates is important for 
in vivo activity an ADAR mutant was made with mutations in several key residues in 
both of the dsRBDs.  A construct was generated by site-directed mutagenesis of an 
existing construct containing human Adar2, this was injected injected into 
Drosophila oocytes and the resulting fly strain was crossed to a balancer line (Jim 
Brindle and Liam Keegan).  However, as this mutant was specifically created for this 
project it was only available at the end of my PhD.  The mutations used were initially 
described in (Valente and Nishikura, 2007), and they were specifically chosen to 
disrupt RNA-binding without perturbing the structure of the protein based on studies 
of other RNA-binding proteins including Staufen and PKR.  The location of the 
mutations is shown in Figure 4.11 (A).  The RNA-binding mutant termed hAdar2 
RRM (KKxxK>EAxxA in dsRBD1 and 2) was expressed in the cholinergic neurons 
using the binary GAL4 system as previously described.  Wild type human Adar2 was 
used as a control as it has been shown to suppress neurodegeneration and locomotion 
defects (Leeanne McGurk, Thesis).   
 
The flies expressing the hAdar2 RRM construct in the cholinergic neurons showed 
severe locomotion defects similar to the Adar5G1 strain (Figure 4.11 C).  These flies 
showed holes in the brain characteristic of neurodegeneration, however they were 
smaller and fewer in number than those observed in Adar5G1.  8μm sections were 
analysed by haematoxylin and eosin staining from a minimum of three flies, and 
although the holes are not as striking as those in Adar5G1 in the images in Figure 4.11 
B, they were clearly visible under the microscope.  The holes do not penetrate the 
thickness of the sections used, however thinner sections were lost during processing.  
This result indicates that RNA-binding is a crucial function for ADAR2.  The 
presence of an ADAR protein may delay the onset of the neurodegenerative 
phenotype observed, however analysis of flies expressing the hAdar2 RRM at 30 
days may show a more pronounced degeneration. 
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Ex vivo analysis of Adar binding to microarray-identified 
transcripts 
Biochemical analysis of transcripts identified as altered in Adar5G1 flies by 
microarray analysis demonstrated that ADAR can bind to these pre-mRNAs in vitro.  
However ADAR also bound to transcripts that were unchanged by microarray 
analysis.  To determine whether ADAR could preferentially bind to these transcripts 
in an ex vivo system an immunoprecipitation of ADAR was performed in Drosophila 
S2 cells followed by analysis of the bound transcripts.  Drosophila S2 cells were 
transfected with a construct containing ADAR-FLIS6 under the control of a 
metallothionein promoter which is copper-inducible.  Cells were transiently 
transfected with the construct or an empty vector control with Insect GeneJuice 
(Novagen) and treated for 24-hours with 0.6mM copper sulphate to induce 
expression of ADAR.  Cells were harvested and protein concentration determined by 
Bradford assay.  Equal amounts of protein were added to anti-FLAG agarose beads 
to immunoprecipitate ADAR, and following several washes, RNA was eluted by 
addition of TRIZOL reagent (Sigma).  RNA was reverse transcribed with random 
hexamer primers (Promega) to ensure amplification of all transcripts bound and 
analysed by real time PCR.  Transcripts were quantified with an aliquot of 10% of 
the input as determined by protein concentration.   
 
Drosophila S2 cells are difficult to transfect with a maximal transfection efficiency 
of 20%; however immunocytochemical analysis of fixed cells with an anti-FLAG 
antibody revealed approximately 10% of cells were expressing ADAR (Figure 4.12 
A).  Non-transfected cells which were also treated with copper sulphate were used as 
a negative control.  Non-specific cytoplasmic staining was observed in both control 
and transfected cells indicating the anti-FLAG antibody recognises endogenous 
epitopes in Drosophila S2 cells.  However, cells transfected with FLAG-tagged 
ADAR showed nuclear staining which was absent from non-transfected controls and 
nuclear localisation has been observed for endogenous Drosophila ADAR protein in 
the brain (Leeanne McGurk, Thesis). 
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Immunoblot analysis revealed enrichment of ADAR protein following 
immunoprecipitation with an anti-FLAG antibody (Figure 4.12 B); however protein 
levels were too low to be detected by coomassie stain (data not shown).  Ataxin2 
(Atx2) was used as a positive control as it is expressed in Drosophila S2 cells and it 
was identified as a substrate of ADAR by stapleton and colleagues (Stapleton et al., 
2006).  Investigation of transcripts immunoprecipitated revealed that the positive 
control Atx2 was enriched by approximately 20% in the presence of ADAR, 
calculated relative to the 10% input fraction.  The control immunoprecipitation 
which shows how much transcript can be bound by the beads showed a negligible 
amount of Atx2, approximately 1.2%.  These values were used to calculate the 
enrichment of the Atx2 transcript when ADAR was present using the following 
equation: transcript immunorecipitated in the presence of ADAR divided by 
transcript immunoprecipitated with no ADAR expression.  The enrichment of the 
Atx2 control was approximately 16%.  The other transcripts investigated showed 
lower levels of transcript immunoprecipitated by ADAR; however they also showed 
lower levels of background binding to beads.  Calculating the enrichment revealed 
that Photolyase, Actin and GAPDH all showed a similar level of enrichment of 
approximately 8-fold, which was half that of the positive control Atx2.   
 
These results indicate that ADAR does not preferentially bind to the photolyase 
transcript in vivo as the level of enrichment did not differ from the negative controls 
of Actin and GAPDH.  Enrichment of binding was observed for the positive control 
Atx2.  However, using non-transfected S2 cells as a control was not ideal.  Following 
site-directed mutagenesis to disrupt key residues in the RNA-binding domain of 
Drosophila ADAR an ADAR RRM mutant was generated for use as a negative 
control.  However immunoblot analysis revealed this protein was expressed at 
approximately half the level of the wild type protein (see Appendix I and Figure 
AI.2) and immunoprecipitated amounts also differed (data not shown).  Despite 
many attempts to optimise this experiment I was unable to repeat it with more 
appropriate controls.  Therefore the data suggests that the binding of ADAR to 
transcripts identified by microarray analysis that was demonstrated in vitro is not 
observed in a cell culture model. 
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Editing of novel Adar substrates 
A surprising result from the microarray analysis was that the levels of known 
substrates of ADAR were not dramatically altered.  However, recent high-throughput 
sequencing of candidate transcripts revealed that many more mammalian RNAs are 
edited than was previously thought (Li et al., 2009).  The photolyase and Ilp3 
transcripts investigated in this thesis are not known to be substrates of ADAR, 
however further analysis was required to determine whether they are edited in vivo.    
 
Photolyase and Ilp3 were amplified from w1118 head RNA and sequenced to 
determine whether they were edited in vivo.  No editing was observed in 70 sequence 
reads from Ilp3 transcript.  The Photolyase transcript is longer and was less abundant 
therefore sequencing was more difficult and data was only obtained for 12 full length 
transcripts, which showed no evidence of editing.  However, editing may occur at a 
specific developmental stage or in response to a specific stimulus.  Therefore, to 
determine whether these transcripts can be edited by Drosophila ADAR an in vitro 
editing assay was performed.  Conditions were optimised using the Adar self-editing 
site fragment Adar160, and recombinant ADAR protein.  Figure 4.13 (A) shows the 
results of sequencing a mixed population of Adar160 cDNA following incubation 
with recombinant dADAR protein.  A mixed peak indicates the site-specific editing 
event.  No editing was observed with mutant dADAR RRM or dADAR EA, 
indicating both binding and catalysis are required for editing. 
 
In vitro transcribed Ilp3, Phr, or RP49 were incubated with 50nM recombinant 
ADAR for 2.5 hours at 37oC.  RNA was extracted with TRIZOL (Sigma), reverse 
transcribed and cloned into the T-easy vector (Promega) for sequence analysis with 
primers specific for the T7 and Sp6 promoter regions.  Sequence analysis of 78 
transcripts of Drosophila Ilp3 revealed no clear “hotspot” site for editing.  Single 
point mutations observed were spread randomly throughout the clones analysed and 
no significant difference was observed for A-to-G mutations over G-to-A mutations.  
However one clone exhibited A-to-G mutations at multiple residues within a short 
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60bp fragment.  This is reminiscent of hyper-editing where up to 50% of adenosines 
are edited to inosines.   
 
Similarly, hyper-editing was observed in one clone of the photolyase transcript out of 
approximately 40 clones analysed and other point mutations were spread randomly 
throughout the sequence indicating no clear site-specific editing (see Figure 4.13 B).  
Photolyase was divided into three regions for sequence analysis as it is too large to 
sequence in one read.  Indeed, when the 60bp fragment containing the changes was 
analysed further, in Ilp3 only 5 other adenosines were present indicating 58% editing 
for one transcript, whereas in Phr there were 7 other adenosine residues giving 50% 
editing in one transcript.  This hyper-editing occurred within the coding region and at 
the 3’ end of each transcript.  This hyper-editing was not observed in 41 clones 
sequenced from a control transcript RP49.  The point mutations observed are likely 
to be PCR or sequencing artefacts. 
 
One example of hyper-editing has been reported in vivo in the Drosophila 4f-rnp 
transcript where 263 A-to-G mutations were observed in a 4kb mRNA (Petschek et 
al., 1996).  However, despite extensive sequence analysis this hyper-editing was only 
observed in one cloned 4f-rnp cDNA (Peters et al., 2003).  The dsRNA duplex 
containing 4f-rnp was formed with a neighbouring transcript sas-10, which showed 
developmentally regulated read-through of a transcription termination signal.  It is 
intriguing that I have observed the same phenomena occurring in vitro through 
intramolecular dsRNA formation; however it is unclear what role the biological 
significance of hyper-editing is.  
 
This type of hyper-editing like that described here (and seen in Figure 4.13) has been 
observed for mammalian ADARs when analysing perfect duplex RNAs (Scadden 
and O'Connell, 2005).  At low protein concentration the ADAR protein appears to 
bind to one transcript and edit it multiple times, producing an all or nothing effect 
where one transcript shows high levels of editing whilst others remain unedited 
(Mary O’Connell, unpublished observation).  This indicates that more editing may be 
observed with a higher concentration of protein, however it is unlikely to be site-
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specific editing as the control Adar160 RNA fragment was efficiently edited in a 
site-specific manner under the same conditions. 
 
Hyper-editing has also been observed for ADAR1 when analysing the GluR-B R/G 
editing site in vitro, but was rarely seen with the ADAR2 enzyme which showed 
much higher site selectivity (Kallman et al., 2003).  In this study no evidence of 
promiscuous editing was observed in vivo indicating this may be an artefact of the in 
vitro editing assay. Indeed, altering the substrate conformation by introducing point 
mutations was sufficient to reduce site-specific editing of the GluR-B R/G site by 
ADAR2 from 80% to 30% indicating for ADAR2 the catalytic activity is highly 
determined by the local structure of the substrate (Kallman et al., 2003).  This 
indicates that in vitro the dADAR protein may behave more similarly to mammalian 
ADAR1, showing less substrate specificity as it has to edit a wider range of 
Drosophila transcripts.   
 
Previously in vitro editing assays have been employed to analyse the structural 
requirements and specificity of site-specific editing on known substrates of ADARs.  
As such, specific and promiscuous editing can easily be defined.  The sequence 
changes observed in phr and Ilp3 results are indicative of promiscuous editing, which 
confirms that these transcripts form secondary structures that ADAR can bind to in 
vitro, although I cannot conclude from these experiments whether Ilp3 or Phr are 
substrates of ADAR in vivo.  In vitro editing assays are usually performed on known 
substrates to analyse the kinetics of the interaction rather than to identify novel 
substrates.  However as the hyper-editing is not observed with the control RP49 
RNA this suggests that dADAR has an affinity to phr and Ilp3. 
 
  




Analysis of transcript levels in Dicer-2 mutant flies 
The processes of RNA interference and RNA editing both require dsRNA formation.  
In C.elegans defective chemotaxis observed in adar-null (adr-1/adr-2) worms can be 
rescued by mutations in the RNAi pathway components rde-1 and rde-4 (C.elegans 
homologs of AGO-1 and TRBP-1) indicating the phenotype associated with loss of 
adar in worms is due to aberrant RNAi (Tonkin and Bass, 2003).  Therefore the 
observed changes in transcript levels in the absence of Adar could be explained by an 
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inhibition or antagonism of the RNAi pathway by ADAR which normally occurs in 
w1118 flies, but which is lost in Adar5G1 flies.  A loss of inhibition of RNAi would 
result in a decreased transcript level in Adar5G1 flies.  Therefore, to determine 
whether transcript changes observed in Adar5G1 flies are due to alterations in the 
RNAi pathway candidate transcripts were analysed by real time PCR in flies with 
defective RNAi due to mutation of the Dicer-2 gene.  If the hypothesis is true and 
RNAi is affecting the candidate transcripts then we would expect to see elevated 
transcript levels in Dicer-2 mutant flies where siRNA production is impaired. 
 
Drosophila melanogaster contains two dicer genes (dcr-1 and dcr-2), which both 
contain two ribonuclease domains and an RNA-binding domain but differ outside 
these regions (Lee et al., 2004).  Depletion of both genes severely impairs production 
of short RNAs and RNA interference in S2 cells (Bernstein et al., 2001).  Dicer-1 
contains a PAZ domain but does not contain a functional helicase domain normally 
found in DICER family members.  dcr-1 is preferentially involved in the miRNA 
production pathway and as such it is an essential gene.  dcr-2 however is not 
essential and functions in the production of siRNA.  DICER-2 contains a canonical 
DExH-type ATP-dependent RNA helicase domain, but does not contain a PAZ 
domain (a cartoon depiction of DCR-2 is shown in Figure 4.14 A).  Point mutations 
in dcr-2 generated by EMS mutagenesis show impaired siRNA generation, however 
low levels were present indicating dcr-1 may also be able to compensate for dcr-2 in 
the siRNA pathway (Lee et al., 2004).  Two of the mutations analysed were nonsense 
mutations which resulted in truncated proteins lacking the ribonuclease domain, 
whilst others were missense mutations in the helicase domain.  Interestingly all the 
mutants have similar low levels of siRNA, indicating the nonsense mutations in the 
helicase domain have the same phenotype as the ribonuclease-null mutants.  Further 
investigation revealed a separate role for Dicer-2 downstream of siRNA production 
as response to a synthetic siRNA is also impaired in these mutants.   
 
Rab3 GEF was downregulated in Adar5G1 flies according to the microarray and 
confirmed by real time PCR in Figure 4.5.  The 3’UTR region of Rab3 GEF overlaps 
with the neighbouring transcript Cyp4s3, which was also downregulated 2.45-fold in 
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Adar5G1 according to the microarray data.  This confirms that both of these 
transcripts are expressed in the head.  If transcripts were produced from these 
convergent genes in the same cell then perfect duplex dsRNA may form, providing a 
substrate for ADAR or for the RNAi pathway.  Interestingly Rab3 GEF has been 
shown to be edited by Adar in the 3’UTR region indicating dsRNA is formed in this 
region and ADAR binds to it.  Photolyase was also investigated as the 3’ region of 
the gene shows a short (<200bp) overlap with a neighbouring gene which is 
transcribed from the opposite strand, prosα6, and both of these transcripts were 
downregulated in Adar5G1 flies.  Further, as described earlier the photolyase 3’ region 
has been duplicated; therefore siRNAs produced from one of the photolyase 
transcripts may target the other transcript for RNAi.  To determine whether RNA 
interference was impaired in the Adar-null flies I performed real time PCR on 
candidate transcripts photolyase and Rab3 GEF in dcr-2 mutant flies.  Three 
different dcr-2 mutants were used (G31R, R416X and A500V) which contain 
nonsense or missense mutations in the helicase domain and have been shown to be 
severely impaired in siRNA production (Lee et al., 2004), (see Figure 4.14 panel A 
for cartoon depicting the location of the mutations within the dicer-2 gene).   
 
Two different primer sets were used to investigate these transcripts, one in the body 
of the gene and one at the 3’UTR where the Affymetrix probes are located.  The 
reason for this is to determine which photolyase transcript is being analysed as the 
3’UTR primer pair will detect transcripts from both genes (CG11205 and CG18853) 
while the primers in the gene body are specific to gene CG11205.  The Affymetrix 
probes used for microarray quantification are located in the 3’UTR and detect 
transcripts from both genes.  The data presented shows the result of one experiment 
where real time analysis was performed in duplicate; however the three different dcr-
2 mutants all behaved in a similar way. 
 
Transcript levels were normalised to GAPDH levels and expression is shown relative 
to w1118 levels.  Comparison of the levels of Rab3 GEF in all fly genotypes indicates 
a similar profile across the transcript with levels low in Adar-null flies and not 
showing recovery with re-expression of active or inactive Adar, which confirms the 
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microarray data.  This expression pattern is similar to the pattern observed for other 
known substrates of ADAR (compare with Figure 4.7).  However, in the three dcr-2 
mutant fly strains levels of Rab3 GEF are slightly lower than w1118 (ranging from 0 
to 2-fold difference, see Figure 4.14 B) but this not as severe as seen in the Adar-null 
flies (~2.5-fold).  If Adar were acting to antagonise siRNAs produced from the Rab3 
GEF locus we would expect the dcr-2 mutants to show a similar or stronger 
phenotype as siRNA production is severely impaired in these mutants.  
 
Analysis of Photolyase revealed that while transcript levels within the gene and at 
the 3’UTR are similar in Adar mutant flies, they show dramatic differences in dcr-2 
mutant flies (see Figure 4.14 B).  The primers within the photolyase gene which are 
specific for gene CG11205 show approximately 25-fold reduction in transcript level 
in Adar5G1 flies, and a similar reduction (14 to 33-fold) in all three dcr-2 mutant fly 
strains indicating a similar pathway is perturbed in both flies.  However analysis of 
the 3’UTR region (shared between CG11205 and CG18853) showed a similar 
decrease in Adar5G1 flies of 10-fold but this was not observed in the dcr-2 mutant 
flies.  The dcr-2 mutants showed levels similar to or higher than w1118 levels.  This 
indicates that dcr-2-null flies show expression of transcripts from the CG18853 locus 
that are seen in w1118 but are not observed in Adar-null flies. 
 
Taken together these results indicate that Adar and dcr-2 are not functioning in the 
same pathway as transcript levels are not consistent between mutants.  If ADAR 
were antagonising the RNAi pathway for these specific transcripts we would expect 
lower levels of transcript in the Adar-null flies where antagonism is relieved which is 
what we observe.  However we would also expect levels of these transcripts to rise in 
the absence of dcr-2 which is not observed, indicating these transcripts are not 
altered in Adar-null flies due to antagonism of the siRNA pathway.  As mutations in 
dcr-1 are lethal it is not possible to examine in this way whether the miRNA pathway 
is altered in Adar-null flies.   
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Does RNA oxidation influence transcript levels in Adar-null 
flies?  
There has been a lot of recent interest in the role of nucleic acid oxidation in 
neurodegenerative disease, specifically RNA as is more vulnerable to oxidation than 
DNA.  In Alzheimer’s disease (AD) and Parkinson’s disease (PD) elevated levels of 
RNA oxidation was shown to precede neuronal cell death and the presence of 
pathological inclusions indicating this is a primary pathological event (Nunomura et 
al., 2009).  Interestingly, the oxidised RNA was present only in the distinct subset of 
cells that would go on to develop pathological inclusions, for example dopaminergic 
neurons in the substantia nigra of patients with Parkinson’s disease had elevated 
oxidised RNA but these neurons were not affected in patients with Alzheimer’s 
disease.  Further, oxidation of RNA does not interfere with the ability of the mRNA 
to associate with polysomes but it does cause translation errors such that short 
polypeptides are produced (Tanaka et al., 2007).  Analysis of oxidised mRNA in 
primary neuronal cultures revealed that oxidised mRNAs had a corresponding lower 
level of protein (Shan et al., 2007).  Indeed analysis of oxidised mRNA species in a 
transgenic mouse model of ALS that have a mutation in superoxide dismutase 1 
(SOD1) revealed that a specific set of transcripts were oxidised (Chang et al., 2008).  
An antibody was used to separate oxidised mRNAs from non-oxidised mRNAs 
isolated from spinal chord tissue, which were then analysed by microarray 
hybridisation.  This identified a subset of transcripts, some of which have been 
associated with ALS disease progression, including SOD1, dynactin 1 and vesicle-
associated membrane protein 1.  
  
To determine whether RNA oxidation was responsible for the neurodegeneration and 
associated changes in transcript levels observed in Adar5G1 flies I used an antibody 
directed to 8-OHG to separate oxidised RNA from non-oxidised RNA.  This 
antibody was raised to the product that is generated following oxidation of guanosine 
(8-oxoguanosine, 8-OG), however the antibody cross reacts with 8-
oxodeoxyguanosine in DNA; therefore the immunoprecipitation was performed on 
purified DNase I treated RNA.  Following the immunoprecipitation cDNA was 
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generated with oligo (dT) primers to select for mRNAs, and three dilutions were 
used in the subsequent PCR reactions to determine the presence of specific 
transcripts in the oxidised and non-oxidised fractions without saturating the PCR 
reaction. 
 
Figure 4.15 shows the results obtained for Ilp3 and GAPDH analysed with this 
method.  These transcripts were analysed in RNA extracted from w1118, Adar5G1 and 
Adar5G1:Cha-GAL4>UAS-dAdar flies.  Quantification of the gel images was 
performed using ImageQuant software (GE Healthcare).  Band intensity was 
normalised to input for each sample to account for overall differences in expression.  
The ratio of oxidised RNA: non-oxidised RNA was then calculated for each 
transcript in each fly strain, and the results are presented in a graph (Figure 4.15).  
Surprisingly these calculations revealed that the fraction of oxidised RNA in Adar5G1 
flies was lower than that seen in w1118 flies and flies expressing the dAdar transgene 
for both transcripts analysed, indicating RNA oxidation does not play a role in the 
neurodegenerative phenotype observed in Adar5G1 flies.  However, as RNA oxidation 
has been shown to be specific for the neuronal populations that undergo 
degeneration, a more detailed analysis of RNA isolated from neurons in the 
mushroom bodies may be more informative, although technically challenging.   
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4.3 Discussion 
Recently Drosophila with mutations in the blue cheese gene, which develops 
progressive neurodegeneration (Finley et al., 2003), was shown to have impaired 
lysosomal trafficking (Lim and Kraut, 2009).  A genetic screen for modifiers of the 
blue cheese neurodegenerative phenotype identified components of the autophagic 
pathway including Atg1 and Atg8a indicating these genes are active in a common 
autophagy pathway (Simonsen et al., 2007).  However there are differences between 
these mutants and Adar-null flies, notably Drosophila that have mutations in 
autophagy genes show accumulation of ubiquitin positive aggregates in neurons, 
which increases with age.  This has not been addressed definitively in Adar-null 
flies; some electron dense inclusions were observed in electron micrographs of Adar-
null brain but these require further investigation (Leeanne McGurk, Thesis).  Indeed, 
overexpression of a key gene in the autophagic pathway Atg8a in wild type flies can 
extend the normal lifespan and reduce the occurrence of age-related neuronal 
inclusions (Simonsen et al., 2008), indicating the processes of autophagy and 
neurodegeneration are linked.   
 
Interestingly flies overexpressing Atg8a also show increased resistance to oxidative 
stress, which is also observed in Adar-null flies (Chen et al., 2004).  This shows that 
upregulation of the autophagic pathway can increase resistance to oxidative stress, 
which could be occurring in Adar-null flies.  However, known regulators of 
autophagy were not returned in pattern searches of the microarray data, and GO 
terms associated with autophagy were not found to be overrepresented.  As these 
search processes are dependent on informative genome annotation, and a large 
number of transcripts returned in pattern searches were unannotated, it cannot be 
excluded that transcripts involved in the autophagy pathway are regulated by ADAR.  
Indeed, this would fit with the observation that ADAR regulates transcripts involved 
in stress response.  Further work analysing the role of ADAR in response to different 
environmental stressors such as starvation may help to elucidate this.  In addition, 
comprehensive analysis of gene networks which are altered may provide a better 
understanding of the role of ADAR in the Drosophila brain. 
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The four phenotypes associated with Adar deletion in Drosophila which are 
investigated herein are reduced viability, decreased and uncoordinated locomotion, 
loss of editing, and age-dependent neurodegeneration.  Using the GAL4 binary 
expression system (Brand and Perrimon, 1993) to express an Adar transgene in the 
cholinergic neurons restores all four phenotypic defects to levels which are 
comparable to wild type strain w1118.  However expression of a catalytically inactive 
transgene does not restore editing, viability or locomotion defects, but suppresses the 
neurodegenerative defect. This allows dissection of the phenotypic components into 
editing-dependent phenotypes, which include reduced viability and the locomotion 
phenotype, and the editing-independent phenotype of age-dependent 
neurodegeneration.  Many of the edited substrates of Drosophila ADAR are involved 
in synaptic transmission, indicating site-specific editing may account for the 
locomotion defects observed in Adar-null flies. To further characterise the editing-
independent effects of ADAR in suppression of neurodegeneration microarray 
analysis was performed.   
 
According to the microarray data ADAR expression influences the expression of 
several cytochrome genes which are known to be regulated in response to stress.  
This implicates ADAR as a regulator of stress response, analogous to the role 
ADAR2 has in the brain.  In mouse CA1 pyramidal neurons which are vulnerable to 
degeneration following ischemic insult, ADAR2 has a role in mediating cell death 
through decreased editing of the GluR-B Q/R site which alters the permeability of 
the channel to calcium (Peng et al., 2006).  ADAR2 was shown to be regulated by 
CREB transcription factor, indicating it is an effector of cell death rather than a 
regulator.  Adar-null flies show increased sensitivity to hypoxic stress which mirrors 
the hypoxic environment in mouse CA1 pyramidal neurons following ischemic 
insult.  What remains unclear is why Adar-null flies show increased resistance to 
oxidative stress induce by paraquat treatment (Chen et al., 2004), indicating 
responses to hypoxic stress and oxidative stress are mediated through different 
pathways. 
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Although extensive details were not provided, Wang et al, (2004) indicated that 
microarray analysis of RNA extracted from E11.0 ADAR1-null mice revealed anti-
apoptotic transcripts Bcl2-like 10 and Bcl-x were 13-fold and 4-fold decreased, 
respectively (Wang et al., 2004).  In the microarray presented here there was no 
significantly over-represented GO terms associated with apoptotic cell death, and 
known regulators of the process were not found to be altered in the pattern analysis.  
This supports previous TUNEL staining data showing that apoptotic cell death is not 
the mechanism of neuronal degeneration seen in Adar5G1 flies (Leeanne McGurk, 
Thesis).   
 
Discovering an alternative function of ADAR may reveal an as yet undetermined 
role for ADAR during development.  Expression analysis revealed the presence of 
Adar transcripts during early embryogenesis which are lost during the mid blastula 
transition.  This expression pattern is frequently observed with maternally inherited 
transcripts, indicating ADAR could have a function at a very early stage of 
development (Chen et al., 2009).  However, initial investigation of Adar deletion 
mutants did not detect any phenotypic differences in the progeny from homozygous 
or heterozygous females indicating this function is not essential (Palladino et al., 
2000b).  Indeed multiple isoforms of Adar are expressed in the developing oocyte 
(Marcucci et al., 2009).  The viability of Adar-null flies is approximately 20%, it is 
unclear at what stage of development this defect arises, however it is not restored by 
expression of an inactive Adar EA transgene indicating the viability defect is 
associated with editing.  Further work to determine the role of ADAR during 
development is required. 
 
Subsequent analysis of ADAR antagonism of the RNAi pathway in the Drosophila 
eye revealed overexpression or deletion of Drosophila Adar did not perturb RNAi 
(Heale et al., 2009).  This study utilised expression of a cytoplasmic white hairpin 
RNA which directs silencing of the white gene producing a red eye phenotype.  
Expression of human ADAR1 p150 which is a cytoplasmic ADAR antagonised 
RNAi to produce a red eye phenotype; however human ADAR1 p110 or ADAR2 did 
not affect RNAi likely due to their nuclear localisation.  Partial antagonism of RNAi 
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was observed in flies expressing a catalytically inactive ADAR p150 indicating 
ADAR binding alone can affect siRNA production from dsRNA.  Interestingly the 
white hairpin RNA was found to be endogenously edited by Drosophila ADAR to a 
low level (<10%) indicating ADAR does interact with the white RNA hairpin in the 
nucleus prior to cytoplasmic export and processing by DICER (Heale et al., 2009).  
A more comprehensive analysis using flies with mutations in several loci required 
for small RNA production crossed to Adar-null flies confirmed that the locomotion 
defects associated with loss of Adar do not arise due to aberrant RNAi (Jepson and 
Reenan, 2009). 
 
Immunoprecipitation of FLAG-tagged ADAR from Drosophila S2 cells was 
performed as it provided a method for screening novel candidate transcripts 
identified in the microarray analysis for interaction with ADAR.  Constructs 
containing wild type Adar were created by a former lab member and conditions for 
induction were determined (Angela Gallo, unpublished data) for experiments to 
analyse editing levels in known substrates of ADAR.  However using this system for 
RNA-immunoprecipitation proved technically difficult.  There are several factors 
which affected this experiment, most notably the low transfection efficiency of the 
Drosophila S2 cells in conjunction with no way to isolate cells expressing ADAR 
made these experiments very difficult.  In the future a cell line which endogenously 
expresses epitope-tagged ADAR would be beneficial.  Stable cell lines generated 
from Drosophila S2 cells are able to express ectopically encoded proteins for a long 
period of time (Towers and Sattelle, 2002).  Alternatively, transiently-transfected 
cells which express a GFP-tagged ADAR protein to allow fluorescence activated cell 
sorting (FACS) analysis prior to immunoprecipitation could be used.   
 
A neuronal cell line may be more representative of endogenous ADAR expression; 
several have been described including the Kc cell line which is thought to be neural 
or glial in origin (Echalier and Ohanessian, 1969).   Strains derived from the Kc line 
such as Kc-167 and Kc-H can be further differentiated into cells of a more neuronal 
appearance which express acetylcholinesterase by the addition of ecdysone (Cherbas 
et al., 1977). One possibility discussed was performing cross-linked 
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immunoprecipitation (CLIP) (Ule et al., 2003), which has been optimised for low 
amounts of precipitated RNA (Wang et al., 2009).  However this method requires 
extensive optimisation.  Ideally this would be performed in vivo but endogenous 
Adar is expressed to a very low level and obtaining sufficient material may prove 
difficult.  However, as the catalytic mutant Adar EA transgene is expressed to a 
higher level than wild type this may be of use in the identification of ADAR 
substrates.  Preliminary work revealed the increased expression observed with the 
Adar EA transgene results in higher levels of ADAR EA protein (data not shown). 
 
The RNA-binding mutant used in these experiments was chosen to disrupt RNA-
binding without affecting the structure of the protein (Ramos et al., 2000; Valente 
and Nishikura, 2007).  However, when the ADAR RRM-FLIS6 protein was 
overexpressed in Pichia pastoris prior to purification for biochemical analysis the 
protein was expressed to approximately half the level of wild type ADAR (see 
Appendix I).  The same result was obtained when overexpressing FLAG-tagged 
ADAR RRM in Drosophila S2 cells.  This is unusual as ADAR mutants that are 
unable to edit substrates are usually expressed to a higher level than wild type ADAR 
(unpublished observations).  This indicates the ADAR RRM mutant protein may not 
be an ideal control for these experiments, as it may not be folded correctly. 
 
Attempts to characterise the in vitro binding of ADAR to several candidate 
transcripts that were shown to be altered according to the microarray failed to 
establish a difference in binding between altered transcripts and control transcripts, 
although some specificity was observed as ADAR does not bind to yeast tRNA.  It is 
likely that this reflects an innate RNA-binding function of ADAR, indeed it has been 
observed in vitro for ADAR2, although this was an artificial substrate generated from 
a known substrate (GluR-B) and a double-stranded RNA region from the potato 
spindle tuber viroid (Klaue et al., 2003).  Interestingly, promiscuous editing was 
observed here, likely due to the perfect dsRNA used which is known to be hyper-
edited by ADARs.  This study employed scanning force microscopy to allow 
visualisation of ADAR bound to RNA, as previously binding and editing were 
analysed by the presence of inosine within the RNA following interaction.  Therefore 
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the data presented in this chapter is the first investigation of ADARs interaction with 
pre-mRNAs that are not known to be substrates of ADAR.  This data indicates that 
ADAR has a wide range of binding substrates, yet only edits a select few.  This 
specificity may be imparted by the deaminase domain. 
 
Taken together these results indicate that Adar5G1 flies develop age-dependent 
neurodegeneration with lower levels of transcripts that are altered in response to 
oxidative stress, and lower levels of oxidised RNAs.  This could be interpreted as 
showing that Drosophila Adar has a role in response to oxidative stress similar to the 
role of ADAR2 in mouse CA1 pyramidal neurons.  However although capable of 
interacting with candidate transcripts in vitro it is unclear whether ADAR interacts 
with these transcripts in vivo, and therefore the possibility of an effect on 
transcription cannot be excluded. 
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5.1 Introduction 
As described in Chapter 4 microarray analysis performed on RNA extracted from 
Adar-null flies revealed a class of transcripts which were miss-regulated in the 
absence of ADAR.  However it remains unclear how ADAR is affecting the level of 
these transcripts and how this contributes to the neurodegenerative phenotype.   
 
ADAR functions as a RNA-editing enzyme, and flies which lack editing due to 
deletion of Adar show locomotion defects and develop age-dependent 
neurodegeneration (Palladino et al., 2000b). However, the age-dependent 
neurodegeneration phenotype can be suppressed by expression of a catalytically 
inactive Adar EA transgene in the cholinergic neurons, indicating ADAR has a 
deaminase-independent function.  ADAR contains a conserved deaminase domain 
which is mutated in the catalytically inactive Adar EA transgene, while the two 
dsRBDs remain intact in this mutant.  Therefore, to characterise the editing 
independent function of ADAR I focused on biological processes which require 
RNA-binding.   
 
Alternative splicing (AS) is the process by which several different transcripts can be 
produced form the same pre-mRNA due to inclusion or exclusion of exons (Black, 
2003).  AS is a mechanism of generating protein diversity without expanding the 
genome, and it can change the function of the protein produced or alter the regulation 
of expression through use of different promoter or UTR regions.  There are several 
ways in which RNA editing could impact on AS.  Firstly, editing by ADAR could 
alter regulatory sequences required for AS including the consensus 5’ and 3’ splice 
site sequences which both include adenosine residues.  Therefore A-to-I editing 
could abolish existing splice sites or create new splice sites which is demonstrated in 
the rat ADAR2 autoediting event (Rueter et al., 1999), and the PTPN6 transcript 
(Beghini et al., 2000).  Editing could also strengthen or weaken splicing enhancer or 
silencer sequences which can be located in either exonic or intronic regions.  
However as many splicing enhancer or silencer sequences are poorly defined 
changes induced through editing these sequences may be subtle, and alterations in 
these elements through A-to-I editing has not been well characterised to date.   
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ADAR binding could also influence AS through blocking access of splicing factors 
to splice sites.  Inhibiting the access of splicing factors in this way would only 
require RNA-binding and is therefore independent of editing events.  Interestingly 
the catalytically inactive ADAR which is able to rescue the neurodegenerative 
phenotype associated with deletion of Adar retains RNA-binding activity.  Editing 
independent inhibition of miRNA processing has recently been shown to occur as 
ADAR binding can inhibit cleavage of miRNA hairpin precursors by DROSHA or 
DICER ribonucleases (Heale et al., 2009; Kawahara et al., 2007a; Yang et al., 2006).  
The dsRNA structure required for editing often forms between exonic and intronic 
sequences indicating editing must occur before splicing, therefore binding of ADAR 
to pre-mRNA may alter splice site use or processing of introns. 
 
Finally, A-to-I editing could alter the secondary structure of an RNA molecule, either 
through stabilising a dsRNA stem-loop structure or weakening it.  The ECS required 
for editing by ADARs has only been determined for some Drosophila ADAR 
substrates and these structures can contain looped regions of several kilobases or be 
complex pseudoknots.  Investigation of the para transcript isolated from flies which 
lack the RNA helicase encoded by maleless revealed aberrant editing and splicing 
catastrophe with large sections of the transcript which show extensive secondary 
structure absent from the mature message (Reenan et al., 2000).  This indicates that 
the secondary structure required for ADAR editing may be detrimental to the 
splicing process in some transcripts. 
 
Several studies have been performed to analyse the association between RNA editing 
and alternative splicing, yet no consensus has been reached (Agrawal and Stormo, 
2005; Bratt and Ohman, 2003; Flomen et al., 2004; Jin et al., 2007; Jones et al., 
2009; Schoft et al., 2007).  Specifically the hypothesis I wanted to investigate was 
whether aberrant alternative splicing could account for the difference in transcript 
levels observed with the gene expression microarray analysis described in Chapter 4. 
 
There have been extensive attempts to characterise splicing isoforms at specific 
developmental time points, in different tissues, or in response to different external 
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stimuli.  A recent technological advance which has aided these studies is the use of 
microarrays designed to recognise specific splice forms.  Global analysis of AS 
events in tissues or whole organisms using microarrays has allowed specific 
questions about alternative splicing and its regulation.  There are several different 
types of AS-sensitive microarrays that are routinely used, which are reviewed in 
(Moore and Silver, 2008).  Briefly, exon arrays detect all known exons but cannot 
distinguish specific isoforms therefore require extensive validation to determine 
specific isoform differences.  Tiling arrays utilise probes spanning the entire genome 
or the genomic region around transcripts of interest and are capable of detecting 
novel exons and retained introns which other arrays may miss.  However tiling arrays 
generate large datasets making analysis difficult and interpretation of results can be 
confused by non-coding transcripts.  Splice-junction arrays contain many probe 
sequences per transcript, some specific to exon-exon junctions whilst others lie 
within constitutive exons which detect background expression levels to allow 
correction for overall differences in transcript level.  These arrays require prior 
knowledge of AS and therefore cannot identify novel splicing events. 
 
AS arrays have been used successfully to identify targets of the mammalian neuronal 
splicing protein NOVA (Ule et al., 2005) indicating this technique can be used to 
analyse complex splicing patterns found in the brain.  Splice junction arrays have 
also been used to analyse the effect of siRNA knockdown of the homologs of 
mammalian hnRNP A/B family in Drosophila S2 cells (Blanchette et al., 2009).  
hnRNP proteins are specific regulators of AS and depletion of individual members of 
the family revealed combinatorial regulation with multiple hnRNP proteins binding 
to the same transcript.  Investigation of responses to external stimuli was also 
investigated using splice-junction arrays.  AS changes associated with activation of 
the wingless signalling cascade were analysed alongside changes induced by insulin 
treatment (Hartmann et al., 2009).  These pathways have been extensively studied for 
effects on transcript levels, however little is known about how AS events are 
regulated in response to signalling cascades. Analysis of these pathways in parallel 
revealed distinct transcripts were subject to regulation at the levels of splicing 
(Hartmann et al., 2009). 
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A custom designed AS array was used to analyse global changes in splicing in RNA 
extracted from flies lacking the Adar gene.  This identified a specific set of genes 
which are aberrantly spliced in Adar-null flies.  These genes were distinct from the 
genes which showed altered transcript levels according to the Affymetrix array and 
few known ADAR substrates were included in this list.  Real time PCR with primers 
which spanned the affected junctions confirmed the AS array data.  3’ Rapid 
Amplification of cDNA Ends (RACE) was used to analyse the transcripts from these 
genes in w1118, Adar5G1 and Adar5G1:Cha-GAL4>UAS-dAdar flies and this revealed 
that transcripts isolated from Adar5G1 flies used alternative polyadenylation sites.  
These alternatively polyadenylated transcripts were not observed in RNA extracted 
from wild type flies or in flies expressing an Adar transgene in the cholinergic 
neurons.  Investigation of the AS array data indicated this phenomena may be more 
widespread although further work is required to characterise the use of alternative 




AS array design 
To determine the profile of AS changes in Adar-null flies global analysis of AS was 
performed using a custom-made Drosophila melanogaster splice junction array in 
the laboratory of Marco Blanchette, Stowers Institute for Medical Research, 
Missouri, USA.  The AS array and the analysis package named Sparrow were 
designed and run by Marco Blanchette, and analysis was performed using Sparrow 
run in the R software environment.   
 
The array was designed to analyse splice junctions in 13,344 genes, however not all 
of the genes included are known to be alternatively spliced.  The array comprises 
three overlapping probes which span each exon-exon junction, and probes within 
constitutively spliced exons to determine expression levels (Figure 5.1).  However 
when analysis was performed the differences in expression levels were normalised so 
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only differences in the exon-exon junctions used were calculated.  This allows a 
comprehensive analysis of alternative splicing differences, but also provides 
information on expression of transcripts.  Three tiled probes per junction were used 
to maximise the chance of obtaining data for each junction.  In contrast to expression 
or exonic arrays, junction array probes cannot be chosen for optimal probe design as 
they must span the junction to be analysed.  In the past junction arrays have utilised 
one probe per junction and this resulted in large amounts of missing data.  For 
statistical analysis all three probes must be detected, however if fewer than three 
probes are detected the remaining data is still plotted as this can be informative 





RNA preparation for AS Array 
RNA was isolated from 100 heads of 5 day old flies from the w1118 and Adar5G1 
strains to allow direct comparison with the Affymetrix expression microarray data.   
Due to the cost of the arrays the AS array analysis was only performed on w1118 and 
Adar5G1 RNA.  RNA extraction was performed with TRIZOL reagent and protocol 
(Invitrogen), DNase I treated (Ambion) and purified using a Qiagen Minelute 
column (Qiagen).  RNA samples were sent to Marco Blanchette at the Stowers 
Institute for Medical Research in the USA for cDNA amplification and hybridisation 
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to the microarrays.  Prior to microarray analysis RNA was analysed on an Agilent 
Bioanalyzer (Agilent Technologies) to determine the quality and quantity.  The 
results of the Agilent Bioanalyzer are shown in Figure 5.2.  This indicated that one of 
the Adar5G1 biological replicates was significantly degraded (Adar_5G1_B).  During 
purification the pellet in sample Adar_5G1_B appeared discoloured, indicating there 
was a problem and this sample may have been contaminated.  A fresh batch of 100 




AS array results 
For hybridisation the w1118 cDNA was pooled to create one control sample and each 
of the three biological replicates of Adar5G1 cDNA were compared to this control to 
minimise variation.  w1118 and Adar5G1 cDNA samples were labelled with different 
fluorescent dyes and both were hybridised to the arrays at the same time.  This is a 
different procedure to the Affymetrix arrays where only one sample is hybridised at a 
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time and the relative quantities are calculated in silico.  The arrays were scaled and 
normalised using the Lowess method in the marray package in R.  Genes were 
analysed individually with an ANOVA test to determine whether any of the junction 
probes for a given gene were significantly altered from the exonic probes for that 
gene.  This generates a list of genes which contain significantly altered junctions.  A 
t-test was then performed to find the significantly altered junctions within these 
genes and multiple testing corrections were applied.  Finally, to determine the 
expression of the exon junctions, a net expression (NE) value was calculated from 
the common exonic probes which are constitutively present, and this was subtracted 
from the junction probe expression data.  This highlights differences in exon junction 
use irrespective of changes in the NE value between samples.  This analysis was run 
using commands built in to the Sparrow package. 
 
Analysis indicated that signal was detected for 12,311 genes out of 13,344 analysed. 
Of these, 759 genes analysed showed significantly altered splicing using the cut off 
of a p value of 0.001.  A comprehensive list of these genes can be found in Appendix 
II.  A summary list of the 10 most significantly altered genes is shown in Table 5.1.  
The table shows that 4 of the 10 genes listed are not annotated as being alternatively 
spliced.  This could indicate novel isoforms of these genes have been detected or 
cryptic splice sites utilised.  Of the six genes which are known to be alternatively 
spliced only three showed altered junction usage at junctions involved in alternative 
splicing events.  The remaining seven genes showed changed levels at constitutively 
spliced junctions.  This was not expected as the majority of the genes included in the 
array are alternatively spliced.  Taken together the analysis of the most significantly 
affected genes indicate that ADAR is not a major component in splice-site choice 
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Symbol Gene Name Function Splicing status
dp Dumpy electron carrier; endonuclease not known to be AS
Strn-Mlck Stretchin-MLCK myosin light chain kinase different isoforms affected but not AS jxns
Syd Sunday driver kinesin binding  alternative first exon affected
ord orientation disrupted protein binding not known to be AS; many probes failed
CG13900 damaged DNA binding different isoforms affected but not AS jxns
Adh Alcohol dehydrogenase alcohol metabolism locus overlaps with Adhr
TepIII phagocytosis (S.aureus ) not known to be AS
CG31190 Dscam3? cell adhesion different isoforms but not AS jxns
CG3734 serine-type peptidase not known to be AS
alternate 2nd exon affected; but all 
possibilities over-representedSap47 synapse assoc 47kDa synaptic transmission
 
Table 5.1: Details of the 10 most significantly altered genes from the AS 
array analysis of RNA from Adar-null flies. 
Four of the 10 most significantly altered genes are not known to be alternatively spliced (AS).  
Of the remaining six which are known to be AS only three are affected at junctions which are 
alternatively spliced, the remaining 7 genes have altered splicing at constitutive junctions. 
 
 
The AS array data can be visualised in several ways.  Initially graphs were generated 
plotting the log ratio of Adar5G1 to w1118 for each junction across a gene.  Figure 5.3 
shows the graphs of the 12 genes which showed the most significant alteration in 
alternative splicing.  The junction probes are listed along the x-axis and the common 
(constitutive) exonic probes are listed at the left hand side of the graph for 
comparison.  Red coloured probes indicate highly significantly altered probes (p < 
0.001), and pink are mid-significance probes (p = 0.01-0.001).  The y-axis represents 
fold change in expression between Adar5G1 and w1118 samples. 
 
A striking observation from the graphical representation of the data is the variation 
across the common exonic probes.  The common exonic probes are placed in 
constitutive exons throughout the gene and therefore there may be differences in 
signal intensity between 5’ and 3’ region due to differences in amplification.  The 
cDNA was generated using oligo (dT) primers and the 3’ region of transcripts may 
have been amplified preferentially using this method.  However, oligo (dT) primers 
were used to specifically amplify polyadenylated mature RNA transcripts from total 
RNA, and any variation across transcripts should be similar in the RNA samples 
analysed.  The variation appears higher across transcripts with low signals which is 
consistent with previous AS array data (Marco Blanchette, unpublished observation). 
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Three probes were analysed across each junction to try and optimise the likelihood of 
obtaining a consistent signal as probe design is limited to the region spanning the 
exon-exon junction and therefore may not be optimal.  However for some junctions 
analysed one or more probes failed leaving gaps in the data.  The probes that gave 
signals for these junctions are included as they may be informative, but the results 
are not statistically significant. 
 
Another striking observation was that many transcripts showed completely separate 
junctions being altered, often with many unaltered junctions in between.  This was an 
unexpected result as inclusion or exclusion of exons should produce an alteration in 
two or more junctions surrounding the exon which is affected.  However this could 
indicate that cryptic splice sites are used which are not annotated on the fly genome 
and therefore were not included on the array.  Another explanation is that the 
processing of introns is altered or inefficient and this is observed by microarray 
analysis as a decrease in junction use.  Therefore further investigations focused on 
analysing altered transcripts to determine whether they contained cryptic splice sites 
or retained introns. 
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Another script developed by Marco Blanchette during the AS array analysis allowed 
the AS array data to be superimposed onto the UCSC genome browser 
(http://genome.ucsc.edu).  This was very useful for visualising the affected junctions 
within a gene and determining which isoforms were affected.  Previously only the 
coordinates of the affected junctions were available and primer design was difficult, 
therefore visualising the affected region on the genome browser was very useful.   
Examples of two affected genes visualised on the UCSC genome browser are shown 
in Figure 5.4.  Two different tracks could be manually added to the genome browser, 
one mapping the junction probes used with their corresponding numbers, and one 
mapping the fold change difference in signal between wild type and Adar-null flies, 
although significance is not shown on this display.  The scale used for the fold 
change data varies for each transcript.  The UCSC genome browser also displays 
cloned expressed sequence tags for each locus allowing a clear view of the affected 
isoforms. 
 
The examples shown are CG13900 which encodes SF3b120 a component of the U2 
snRNP (Mount and Salz, 2000) and CG31190 which is also known as Dscam3 
(Andrews et al., 2008).  CG13900 contains one splice junction which is highly 
overrepresented in Adar-null flies (4.32 fold), despite the neighbouring junctions 
being present at similar levels in both strains.  The affected junction is a constitutive 
junction which is located within the 3’UTR region and is present in both transcripts 
annotated from this locus.  Analysis of the expression data from the constitutive 
exonic probes within CG13900 revealed there was no change in expression of these 
isoforms in Adar-null flies.  This example demonstrates how some of the data 
obtained did not fit the expected pattern of a change in known isoform levels and 
may indicate another isoform is expressed from this locus which is not annotated on 
the Drosophila genome and is therefore not analysed by the AS array. Alternatively, 
the probes which analyse the overrepresented junction could cross-hybridise to 
another transcript although this would have to be differentially expressed between 
wild type and Adar-null flies to produce a signal like the one shown.  A BLAST 
search of the region targeted by the affected exon-junction probes did not reveal any 
significant homology to transcribed Drosophila sequences in the Ensembl database.   
Chapter 5: Analysis of alternative splicing in ADAR-null flies 
 222
It is intriguing to discover altered splicing in a gene which encodes a component of 
the splicing machinery in Adar-null flies.  Many proteins involved in the RNA 
processing pathway are regulated at the level of alternative splicing, and this may 
contribute to the altered splicing seen in other transcripts.  However as the expression 
of the CG13900 isoforms is not altered this seems unlikely.  Furthermore the U2 
snRNP is a core component of the splicing machinery and we might expect to see 
many more transcripts affected if it were incorrectly processed.  Interestingly 
CG13900 contains an Interpro domain which is also present in cleavage and 
polyadenylation specificity factor (CPSF). 
 
CG31190/Dscam3 is one of four Dscam genes in Drosophila involved in cell 
adhesion and axon guidance (Andrews et al., 2008).  Dscam3 does not show the 
same transcript diversity as Dscam (described in the Introduction section on 
Alternative Splicing), with only four transcripts annotated from the CG31190 locus.  
One splice junction was significantly underrepresented in Adar-null flies (-3.06 fold).  
This junction is only present in one isoform of Dscam3 indicating there may be 
downregulation of this isoform in Adar-null flies however other junctions which are 
shared between all isoforms are not altered.  Further work is required to determine 
whether one Dscam3 isoform is downregulated in Adar-null flies. 
 




Analysis of GO terms which were significantly overrepresented in aberrantly spliced 
transcripts when compared to the list of genes analysed on the AS array revealed that 
genes involved in neurotransmission, cytoskeletal organisation and glutamate 
receptor activity were overrepresented.  The list of overepresented GO terms is 
shown in Table 5.2. 
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The observation that genes annotated with the GO term of glutamate receptor activity 
are overrepresented in the AS array analysis is intriguing as glutamate receptor 
transcripts are known substrates of mammalian ADARs.  The mammalian GluR-B 
transcript is edited at two sites, the Q/R site and the R/G site, which leads to changes 
in the amino acid sequence (Higuchi et al., 1993).  Editing at the Q/R site alters the 
processing of the GluR-B subunits (Greger et al., 2002) and also impacts on the 
tetramerisation of the mature AMPA receptors (Greger et al., 2003).  Q/R site editing 
also alters the function of the receptor by altering the calcium permeability of the 
multisubunit receptor and changing the rate of desensitisation (Burnashev et al., 
1992).  The mammalian glutamate receptor subunits are also alternatively spliced at 
the mutually exclusive FLIP/FLOP exons which impacts on AMPA receptor 
desensitisation kinetics (Koike et al., 2000; Sommer et al., 1990).  Therefore it is 
intriguing that several transcripts encoding Drosophila ionotropic glutamate 
receptors were recovered in analysis of AS changes in Adar-null flies.   
 
In total eleven genes associated with the GO term “glutamate receptor activity” were 
identified as aberrantly spliced in Adar-null flies.  These include the genes GluRIIB, 
GluRIIC, and GluRIIE which encode glutamate receptor subunits that form kainate-
gated receptors.  Mammalian kainate-gated glutamate receptors are also ADAR 
substrates and both GluR-5 and GluR-6 transcripts are edited at one site which leads 
to an amino acid change at the position which corresponds to the Q/R site in GluR-B.  
GluR-6 is also edited at two other sites which lead to re-coding events.  Editing 
levels vary throughout development and also vary in different regions of the rat brain 
(Bernard et al., 1999).  Similar to editing of the GluR-B subunit transcript, editing of 
mammalian kainate-gated receptor subunits alters the permeability of the receptor to 
calcium.  However, in Drosophila these transcripts are not known to be ADAR 
substrates, and each have only one annotated transcript indicating they are not 
alternatively spliced.  The three aberrantly spliced genes each contain one affected 
junction which is annotated as a constitutive junction.  However this may indicate 
multiple isoforms are generated by AS which are not annotated on the Drosophila 
genome.  Intriguingly the Drosophila glutamate receptors are composed of four 
different subunits; they contain either a GluRIIA subunit or a GluRIIB subunit and 
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three common subunits (GluRIIC, GluRIID, and GluRIIE) (Qin et al., 2005).  
Therefore the three glutamate receptor subunits which show altered splicing in the 
absence of ADAR form one type of kainate receptor (B-form) along with the 
GluRIID subunit.  This suggests that ADAR has a role in the regulation of glutamate 
receptor subunit transcript processing, which is analogous to the role of mammalian 
ADARs which edit several glutamate receptor subunit transcript.  However receptor 
composition and processing is extensively regulated and indirect effects cannot be 
excluded (Liebl and Featherstone, 2005). 
 
Several other genes associated with the glutamate receptor activity GO term were 
also aberrantly spliced in Adar-null flies including Nmdar1 and Nmdar2 transcripts 
which encode NMDA-gated glutamate receptor subunits (Xia et al., 2005a).  These 
genes are alternatively spliced however they both contain only one affected junction 
which is a constitutively spliced junction.  Interestingly the genes associated 
glutamate receptor activity all encode cation channels, anion channel genes were not 
overrepresented in this analysis. 
 
Further work is required to determine whether ADAR binds directly to these 
glutamate receptor subunit transcripts and therefore regulates calcium permeable 
glutamate receptors in the Drosophila brain.  It is intriguing that these transcripts 
show a similar profile whereby many of the glutamate receptor subunit genes (3 out 
of 5 mentioned here) have only one annotated transcript and all have only one 
affected junction which is significantly different from all other junctions.  One 
hypothesis which could explain this pattern is that the intron at the affected junction 
is retained or that the junction is skipped altogether in Adar-null flies.  Alternatively 
ADAR could be acting in the wild type flies to promote intron retention and in its 
absence the intron is efficiently spliced.  Further work is required to confirm these 
changes detected by AS array.  However these transcripts only contained single 
affected junctions therefore initial experiments to confirm the AS array changes 
focussed on genes which contained multiple affected junctions and were most 
significantly altered. 
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Genes with a tropomyosin Interpro domain were also overrepresented which could 
be interpreted as a role for ADAR in regulating muscle contractions however 
tropomyosin is also involved in cytoskeletal organisation.  Genes associated with the 
GO term tropomyosin that were aberrantly spliced in Adar-null flies include myosin 
heavy chain (Mhc) and Mhc1, along with tropomyosin -1 (Tm1) and -2 (Tm2).  These 
genes represent a biologically linked group of genes which are known to be 
alternatively spliced in a developmentally regulated and tissue specific manner, and 
which are aberrantly spliced in Adar-null flies.  For example, Mhc contains 5 exon 
clusters which are spliced in a mutually exclusive manner similar to the Dscam locus 
and potentially generates 480 isoforms (reviewed in (Swank et al., 2000)).  In Adar-
null flies Mhc shows AS changes at many exon-exon junctions, which likely 
represents a subtle shift in the isoforms produced from this locus.  AS of Drosophila 
Mhc is developmentally and tissue-specifically regulated and altered isoform 
expression can lead to a flightless phenotype (Wells et al., 1996).  Therefore aberrant 
AS of genes containing tropomyosin Interpro domains may contribute to the lack of 
coordinated movement and flight observed in the Adar-null flies. 
 
Class GO term Adjusted p-value
4: membrane-bound vesicle (GO:0031988) 0.00537018
6: cytoplasm (GO:0005737) 0.000800717
7: intracellular non-membrane-bound organelle (GO:0043232) 0.000250861
7: cytoplasmic part (GO:0044444) 0.00419151
8: cytoskeleton (GO:0005856) 0.000532567
8: cytoplasmic vesicle (GO:0031410) 0.00196266
8: contractile fiber (GO:0043292) 0.0129711
9: actin cytoskeleton (GO:0015629) 0.0298812
9: cytoplasmic membrane-bound vesicle (GO:0016023) 0.0298812
9: contractile fiber part (GO:0044449) 0.0298812
5: transmission of nerve impulse (GO:0019226) 0.001393
5: cytoskeleton organization and biogenesis (GO:0007010) 0.038149
6: synaptic transmission (GO:0007268) 0.00164881
4: cytoskeletal protein binding (GO:0008092) 0.000574523
4: calmodulin binding (GO:0005516) 0.00396343
5: actin binding (GO:0003779) 0.000138492
5: glutamate receptor activity (GO:0008066) 0.0287268








Table 5.2: Significantly overrepresented GO terms associated with 
aberrantly spliced transcripts. 
Analysis of 759 genes which showed significantly altered alternative splicing revealed that 
genes involved in neurotransmission, cytoskeletal organisation and glutamate receptor 
activity were overrepresented.   
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Few edited transcripts are altered according to the AS array 
As with the Affymetrix expression array analysis, few known substrates of ADAR 
were differently spliced in the absence of ADAR.  This indicates that ADAR may be 
interacting with a wider range of transcripts than previously thought.  Known 
substrates are useful in this analysis as they can be used to define the region of the 
transcript which ADAR binds to.  Mapping editing sites onto UCSC genome browser 
AS array data reveals that in some transcripts the exon-junctions surrounding the 
edited adenosines are overrepresented in Adar-null flies, whereas in other transcripts 
the neighbouring junctions are underrepresented in flies lacking Adar (Figure 5.5).  It 
is not always possible to determine the ECS region which forms the dsRNA structure 
required for editing as the ECS can be located up to 2 kilobases away from the edited 
nucleotide therefore it is unclear whether adjacent sequences are also bound by 
ADAR.  However as with the Affymetrix array data there are only a few known 
substrates of ADAR which are aberrantly spliced in the absence of Adar.  This 
suggests that the processes of editing and splicing are not linked for all transcripts 
and general conclusions cannot be drawn, rather any effects observed are specific to 
the transcript involved.  Detailed bioinformatic analysis of the secondary structures 
of these transcripts is required to determine whether the affected junctions are within 
the dsRNA structure which is bound by ADAR. 
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AS array expression data correlates with Affymetrix 
expression array data 
Analysis of expression data obtained from the AS array allows comparisons with the 
Affymetrix expression array data described in Chapter 4.  Analysis of the expression 
data obtained form the AS array revealed that 281 genes were downregulated with a 
log(2) fold change of greater than 1.5, whilst 221 genes were upregulated with the 
same criteria.  This is similar to the results obtained the Affymetrix arrays, however 
fewer genes are analysed on the AS array.  Graphing the log fold change for 
transcripts which were called as present on both arrays showed a clear trend in the 
data (Figure 5.6), however the correlation was weak (R2 = 0.1987).  The data has a 
Pearson correlation of 0.45 (p-value < 2.2e-16, 95% confidence interval: 0.3750685 - 
0.5112486) and the number of genes used in this analysis was 534 genes.  The weak 
correlation was due to a large number of genes which showed upregulated levels 
according to the Affymetrix array but showed downregulated levels according to the 
expression data obtained from the AS array (highlighted with a red box in Figure 
5.6).    
 
However when the analysis was repeated limiting the genes analysed to those which 
showed greater than two-fold change in expression this revealed a strong correlation 
(R2 = 0.8819), indicating that the significantly altered transcripts were consistent 
when analysed with both microarrays.  Restricting the analysis to genes which 
showed over two-fold changes in transcript level gave 60 genes and a Pearson 
correlation score of 0.939 with a p-value < 2.2e-16 (95 percent confidence interval: 
0.8997563 - 0.9633247).  Therefore the transcripts with the most significantly altered 
expression profiles were detected by both microarrays indicating these are the 
transcripts which should be analysed further.  The arrays differ significantly in the 
detection methods which could account for the observed differences in expression 
data.  The Affymetrix array utilises 10-14 probes per gene, all located in or near to 
the 3’UTR of the transcript.  As analysis is usually performed on oligo (dT) primed 
cDNA, these arrays are designed to maximise signal reads.  The AS array however 
utilises numerous exonic probes throughout the gene to detect the basal expression 
Chapter 5: Analysis of alternative splicing in ADAR-null flies 
 230
level and the data is presented as the median level for all the exonic probes.  The 
cDNA analysed is also amplified with oligo (dT) primers which can preferentially 
amplify the 3’ end of transcripts.  However as the value used is a median transcript 
level any differences across a transcript due to unequal amplification of end regions 
would be lost.  Therefore the expression data from the AS array does not show the 
wide range of values observed with the Affymetrix array data.   
 
These differences can be used to explain why the AS array data does not show the 
same dramatic changes in expression as the Affymetrix array.  However it cannot 
explain the group of genes which show upregulation according to the Affymetrix 
array but are downregulated according to the AS array.  These transcripts may have 
different 3’UTR regions associated with them.  They may be long transcripts which 
have an increased likelihood of differential amplification across the transcript 
resulting in an elevated reading for 3’UTR probes but lower expression when the 
whole gene is analysed.  Finally, these may represent a group of genes with 
overlapping 3’UTR regions such that the Affymetrix probes detect multiple 









The AS array was performed to determine whether aberrant splicing was the cause of 
the altered transcript levels observed in Adar5G1 flies analysed by Affymetrix array.  
The expression data correlates well between the two arrays when analysing the most 
significant changes.  However, very few transcripts which were altered according to 
the Affymetrix array showed altered splicing profiles.  Of the 759 genes which 
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showed significantly altered junction use (p value of 0.001) only nine had altered 
expression according to the Affymetrix array.  Of these seven were downregulated 
and two were upregulated according to the Affymetrix array.  Therefore the different 
arrays analysed have identified two distinct subsets of genes, one group which is 
regulated at transcript level and the other which is regulated through changes in AS.  
This is consistent with other studies which have shown that distinct subsets of genes 
are regulated by AS changes and transcript level changes during the response to 
insulin treatment or stimulation of the wingless pathway in Drosophila S2 cells 
(Hartmann et al., 2009).  In this study Drosophila S2 cells were treated with insulin 
and RNA was extracted 5 hours later.  Using an AS array, changes in transcript level 
were detected in 149 genes and AS changes were found in 163 genes, following 
insulin treatment.  In comparison the AS array on Adar-null flies identified many 
more transcripts which showed altered splicing, however the AS arrays used were 
different and the RNA used for analysing insulin-induced changes was isolated from 
a homogeneous population of Drosophila S2 cells rather than total fly head RNA.  
Distinct regulation of transcript level changes and AS changes has also been 
demonstrated during T-cell activation (Ip et al., 2007).  Here it was shown that genes 
from functionally distinct groups were regulated by changes in transcript levels and 
changes in AS events.   
 
Confirmation of AS array changes by real time PCR 
As there were many AS changes observed in the Adar-null flies further investigation 
focussed on the genes which showed the most significant changes (see Table 5.1).  In 
a study on AS changes which occur during T-cell activation the authors indicated 
confirmation of AS array data is most reliable when restricted to the top third of the 
significantly altered genes (Ip et al., 2007).  To confirm the changes observed at 
specific splicing junctions, primers for real time PCR were designed to amplify a 
short region which spans the affected junction.  As a control primers were also 
designed to amplify a neighbouring constitutively expressed exon to analyse the local 
expression profile.  Junction use was determined relative to the expression of the 
neighbouring exon to mirror the analysis performed on the AS array data.  The AS 
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array analysis specifically highlights exon-exon junctions which are significantly 
altered compared to other junctions within the gene and the common exonic probes, 
whereas differences in expression between wild type and Adar-null flies are 
discounted.  However, the expression of the local constitutive exon was also 
calculated relative to GAPDH.   
 
Several genes from the list of the top 10 most significantly altered genes shown in 
Table 5.1 were investigated using real time PCR to confirm the changes observed on 
the AS array (see Figures 5.7 & 5.8).  One of these genes, Stretchin-Myosin light 
chain kinase (Strn-Mlck) has a complicated locus resulting from the fusion of two 
different genes encoding stretchin and myosin light chain kinase (Champagne et al., 
2000).  As well as transcripts which encode Stretchin and Mlck this locus also 
encodes a large fusion transcript which generates a large 926 kDa Titan-like protein.   
A recently discovered muscle protein termed Stretchin-klp has been mapped to the 
Strn-Mlck locus indicating the complex nature of the locus (Patel and Saide, 2005).  
There are two isoforms of Stretchin-klp, one of which is myosin dependent and 
expressed in the indirect flight muscles, the other is myosin-independent and is 
expressed in other tissues including the head.  However Stretchin-klp is expressed 
from the centre region of the Stretchin-mlck gene and therefore does not contain the 
affected junctions. 
 
Real time PCR analysis of an exon-exon junction (between exons 24 and 25) in Strn-
Mlck which was significantly overrepresented in Adar-null flies confirmed the AS 
array data (Figure 5.7, junction 24-25 is indicated by a red arrowhead).  Primers 
which span approximately 100bp across the junction indicate this region is 
overrepresented seven-fold in RNA extracted from Adar-null flies, and this is 
suppressed by expression of an Adar transgene in the cholinergic neurons.  Analysis 
of a neighbouring exon which is expressed in the same transcripts that contain the 
exon 24-25 junction revealed that the expression of transcripts containing this region 
is downregulated approximately 10-fold in Adar-null flies.  The difference in 
expression was partially rescued by expression of an Adar transgene in the 
cholinergic neurons.  The real time PCR confirmed that the Strn-Mlck junction 
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between exons 24 and 25 is overrepresented in Adar-null flies.  The Strn-Mlck locus 
is complicated therefore this result may indicate an alternative isoform is expressed 
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Graphing the AS array data from the Dscam locus revealed several junctions were 
altered in Adar-null flies, however some probes failed giving incomplete data sets for 
some of the junctions which means that statistical significance was not possible at 
these junctions.  The majority of the exon junctions in Dscam were not significantly 
altered in Adar-null flies, which was a surprising result given that the mutually 
exclusive splicing of Dscam exon 6 cluster is regulated through formation of a stem-
loop structure (Graveley, 2005).  The stem-loop structure is formed between a 
“docking site” within the intron following the constitutively spliced exon 5 and a 
“selector site” upstream of each exon 6 alternatives, however the splicing factor 
hrp36 binds throughout the exon 6 cluster indicating perhaps ADAR would not have 
access to this stem-loop structure (Olson et al., 2007).  Given the complex splicing 
patterns at the Dscam locus (described in the Introduction section on Alternative 
Splicing) this indicates ADAR does not play a role in the regulation of mutually 
exclusive splicing events within transcripts from the Dscam locus.  However the 
single altered junction was investigated further as the transcripts derived from the 
Dscam locus have been extensively characterised. 
 
One altered junction which showed significantly different expression in Adar-null 
flies was investigated further.  The junction spanned the intron between exons 14 and 
15, which are constitutively spliced exons.  Real time PCR analysis of the region 
spanning this junction revealed that the junction was overrepresented in Adar5G1 flies 
and this was rescued by expression of an Adar transgene in the cholinergic neurons 
(Figure 5.7).  Analysis of a neighbouring exon revealed that transcripts containing 
this exon were also overexpressed in Adar-null flies.  As this exon is constitutively 
expressed this indicates that there is higher expression of Dscam in Adar-null flies 
which is relieved by expression of Adar in the cholinergic neurons.  However this 
change in expression levels is not dramatic and was not detected in the Affymetrix 
gene expression array data indicating it is not significant.  PCR analysis of the region 
spanning the junction between exons 14 and 15 with primers located in exons 16 and 
18 did not reveal a difference in products between wild type and Adar-null flies 
therefore a different approach to analyse all the transcripts from this region was used. 
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RACE results for AS array targets 
The AS array data revealed 759 genes showed significantly altered AS in Adar-null 
flies, and several of these changes were confirmed by real time PCR analysis of the 
regions containing the altered junctions.  However, while the AS array indicates the 
affected genes it does not reveal how the transcripts from these genes are altered.  
Many genes which were altered according to the AS array showed differential use of 
single junctions, therefore to determine whether cryptic splice sites were utilised or 
processing of introns was altered 5’ and 3’ Rapid Amplification of cDNA Ends 
(RACE) was performed using the Firstchoice RLM RACE kit and protocol 
(Ambion).  This technique allows amplification of mRNAs using one specific primer 
and a general primer directed either to the 5’ cap structure or to the poly A+ tail.  
This method was chosen as it should reveal all the isoforms transcribed from one 
gene which contain the regions targeted by the gene-specific primer and extend to 
either the 5’ or 3’ end of the transcript.  5’ and 3’ RACE was performed using 1.5µg 
of total RNA isolated from w1118, Adar5G1 and Adar5G1:Cha-GAL4>UAS-dAdar flies 
using gene specific nested PCR primers. Two rounds of amplification of 30 cycles 
were used with 2ul of the first PCR product used as template for the second reaction.  
RACE products were analysed on 2% agarose gels and bands were purified and 
cloned into T-easy for sequence analysis.  
 
Unfortunately 5’ RACE was not successful and no specific bands were observed 
following gel electrophoresis; this was likely to be due to inefficient ligation of the 5’ 
linker prior to cDNA amplification.  3’ RACE was performed with gene-specific 
primers for several transcripts identified from the AS array in the attempt to discover 
whether cryptic splice sites were utilised in the absence of ADAR.  3’ RACE 
analysis using gene-specific primers for the Dscam locus (Figure 5.9) and the dumpy 
locus (Figure 5.10) revealed different products were present in RNA isolated from 
Adar-null flies when compared to wild type RNA. 
 
Surprisingly sequence analysis of the 3’RACE products from Adar-null flies did not 
reveal retained introns or use of cryptic splice sites.  Instead these products showed 
premature polyadenylation of transcripts from both the Dscam locus and the dumpy 
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locus (See Figures 5.9 & 5.10).  This result was not expected, however these 
products were observed at both loci and were not present in w1118 or Adar5G1:Cha-
GAL4>UAS-dAdar RNA.   
 
Analysis of 3’ RACE products from the Dscam locus using nested gene specific 
forward primers in exon 14 revealed a lower molecular weight band of 
approximately 100bp in the Adar5G1 sample that is not present in w1118 or 
Adar5G1:Cha-GAL4>UAS-dAdar RNA (Figure 5.9).  A higher molecular weight 
product of approximately 400bp is present in all three RNA samples.  A control of 
w1118 RNA which was incubated without reverse transcriptase enzyme was included 
to ensure no DNA contamination was present and no PCR product was detected in 
this sample.  Sequence analysis of the 3’ RACE products revealed that the ~400bp 
product corresponds to the Dscam transcript exons 14, 15, 16, and 17 with part of the 
intronic region between exons 17 and 18.  This is due to a large run of adenosine 
residues that occurs within the intron between exons 17 and 18, which would result 
in amplification of this region during the first strand synthesis reaction with an oligo 
dT primer.  This product occurs in all three RNA samples and therefore provides an 
internal control to ensure that Dscam transcripts are present and amplified in all RNA 
samples.  The 3’RACE product of approximately 100bp which was only amplified 
from Adar5G1 RNA corresponds to correctly spliced Dscam exons 14 and 15, but 
terminates within exon 15 with a run of adenosine residues indicative of 
polyadenylation. 
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Similarly analysis of 3’RACE products using gene specific forward primers within 
dumpy exon 33 revealed extra products were present in the Adar5G1 RNA sample that 
were not observed in w1118 or Adar5G1:Cha-GAL4>UAS-dAdar RNA (Figure 5.10).  
A single band of approximately 650bp was present in all three RNA samples; 
sequence analysis revealed this was not from the dumpy locus but was a 
contaminating product amplified from a different locus.  However, this was 
consistently amplified in all samples.  Two extra bands present in the Adar5G1 RNA, 
one of approximately 550bp and the other of approximately 850bp, correspond to 
correctly spliced product from dumpy exons 33 and 34.  However theses products 
both terminate within exon 34 of the dumpy locus with a run of adenosine residues 
which are not present in the annotated genomic sequence from this region indicative 
of alternative polyadenylation. 
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Canonical polyadenylation occurs at specific locations within transcripts directed by 
conserved cis element consensus sequences, the process of 3’ end processing is 
reviewed in (Mandel et al., 2008).  Briefly, a polyadenylation signal (PAS) sequence 
of AAUAAA site which is located 10-35bp upstream of the cleavage site is required 
for polyadenylation.  The cleavage site itself which is not highly conserved and often 
has a cytosine and an adenosine residue immediately preceding it.  Following this 
there is a downstream sequence element (DSE) comprising U/GU-rich sequence 
which is located up to 70bp downstream of the polyadenylation site and provides a 
binding site for the Cleavage Stimulation Factor (CstF).  Many protein factors are 
involved in cleavage and polyadenylation (Mandel et al., 2008), and these processes 
have been linked to transcription and alternative splicing, which is reviewed in 
(Proudfoot, 2004). 
 
However, examples of polyadenylation are increasingly found which do not contain 
these canonical sequences.  Polyadenylation can occur at regions that show variant 
sequences which resemble the canonical sequences but are not exact matches.  One 
study found that cleavage and polyadenylation in Drosophila ESTs occurs in 22.48% 
of sequences analysed in the absence of a recognisable polyadenylation signal 
(Retelska et al., 2006).  Further this study showed approximately half of the ESTs 
analysed contained the canonical AAUAAA consensus sequence indicating variation 
is widespread. 
 
Analysis of the sequences upstream of the alternative polyadenylation sites found in 
Adar-null flies revealed that the consensus polyadenylation signal AAUAAA was 
not present.  However, sequences which closely resemble the canonical site were 
present in Dscam an AGUUAA sequence is present 40bp upstream of the polyA site 
(Figure 5.9).  The dumpy transcript did not contain an obvious polyadenylation 
signal, however a less similar sequence of AAUUA was present near the first site and 
an AAAAGA was found near to the second site (Figure 5.10). 
 
Importantly the regions surrounding the alternative polyadenylation sites do not 
contain multiple adenosine residues indicating amplification of these sequences is 
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not likely to be due to spurious binding of the oligo dT primers during cDNA 
amplification.  Further, in the Dscam analysis, this type of spurious priming does 
occur in all the RNA samples analysed and is observed as a strong band of higher 
molecular weight than the alternative polyadenylated transcript.  This is clearly 
present to approximately equal amounts in all three RNA samples indicating the 
prematurely polyadenylated product amplified from Adar5G1 RNA only accounts for 
a small fraction of the product from this locus. 
 
Cleavage and polyadenylation of nascent transcripts normally occurs downstream of 
a translation stop codon, however only the 3’ regions of the Dscam and dumpy 
sequences were analysed here.  Further investigation of the full transcripts is required 
to determine whether these sequences arise from splice variants which terminate 
prior to the polyadenylation sites identified.  Both of these genes encode long 
transcripts which makes amplifying and cloning all the full length variants from one 
locus difficult.  
 
In these experiments total RNA was used rather than polyA+ purified RNA, either of 
which can be used according to the manufacturer’s protocol.  Total RNA was used as 
starting amounts of fly head RNA were limiting and when RNA amounts are low the 
loss during polyA+ purification can result in insufficient starting material.  Further, 
the aim of these experiments was to characterise changes observed with the AS array 
and this was performed on oligo dT amplified total RNA.  However further analysis 
using polyA+ purified RNA as starting material is necessary to exclude partially 
processed transcripts.   
 
These results were not expected.  Several other transcripts identified as altered 
according to the AS array were investigated using 3’ RACE and multiple products 
were obtained.  However sequence analysis revealed no difference in products from 
wild type and Adar-null flies.  Multiple cycles of amplification are required to detect 
these products and partially processed products may be amplified.  However, the 
Dscam region was amplified from all three RNA samples analysed indicating the 3’ 
RACE protocol used was able to amplify this region from Adar5G1 RNA.  One 
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explanation for these results could be altered secondary structure of the RNA isolated 
from Adar5G1 flies.  The total RNA was denatured at 70oC prior to first strand cDNA 
synthesis which makes this unlikely however further work is required to exclude this 
possibility.  Another explanation for these results is that these transcripts are 
aberrantly spliced such that a region which contains a run of adenosine residues is 
spliced with the region amplified using the gene-specific primer.  The Dscam locus 
contains a run of adenosines in the intron between exons 17 and 18, if aberrant 
splicing occurred this may appear as a polyadenosine tail in the mature transcript.  
However it would be difficult to distinguish these two products using RACE.   
Further investigation of all transcripts from the Dscam locus is required.  
 
Is alternative polyadenylation widespread in Adar5G1 flies? 
The discovery of two genes which appear to show alternative polyadenylation in 
Adar-null flies led to the question of whether ADAR influences polyadenylation site 
choice in other genes.  If the alternative polyadenylation site occurs upstream of the 
canonical site, as with the two examples shown, then this could lead to truncated 
transcripts which do not contain the 3’UTR region to which the Affymetrix array 
probes are designed.  Initial investigation of genes which were downregulated in 
Adar-null flies according to the Affymetrix array and also showed aberrant splicing 
according to the AS array revealed that there were 7 genes which fitted this criteria.  
Examination of the AS data for these genes indicated two of the seven showed 
decreased use of splice junctions at the 3’ end of the gene (see Figure 5.10).  Both 
CG11474 and Nocturnin genes showed AS array data profiles which could be 
consistent with alternative polyadenylation in Adar-null flies leading to truncated 
transcripts lacking the 3’UTR region used to analyse expression data on the 
Affymetrix array.  3’ RACE analysis to determine the sequence prior to the 
polyadenylation site is required to examine this hypothesis further. 
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B52/Srp55 expression is not altered in Adar5G1 flies 
Numerous splicing changes were detected in Adar-null flies however one of the 
genes affected encodes a splicing factor B52 (Figure 5.12 A).  B52 is the Drosophila 
melanogaster homolog of the mammalian splicing factor Srp55 and it is the 
predominant SR protein expressed in Drosophila brain (Hoffman and Lis, 2000).  
The overrepresented splice junction in B52 leads to inclusion of a large exon 
generating a long 3’UTR region and may therefore affect mRNA stability or 
translation.  However, the junctions downstream of the overrepresented junction do 
not show the same pattern; in fact the splice junctions in the 3’ region of the gene are 
all underrepresented in Adar-null flies.  This may indicate another isoform is present 
which stops upstream of the known isoforms or it may indicate that this gene 
undergoes alternative polyadenylation as demonstrated for the Dscam and dumpy 
genes.  The AS profile of B52 is similar to those of Nocturnin and CG11474 shown 
in Figure 5.11 indicating these genes may undergo alternative polyadenylation in 
flies which lack the Adar gene.  
 
B52 was one of the genes affected in Adar5G1 flies according to the AS array data and 
an antibody was available, therefore protein levels were analysed to determine 
whether a difference in B52 could explain the observed changes in splicing.  The 
anti-SR protein antibody 1H4 (Invitrogen) detects numerous SR proteins in 
mammalian cell extract however it has been shown to be specific for B52 in 
Drosophila S2 cells by siRNA depletion of B52 mRNA (Marcucci et al., 2009).  The 
1H4 epitope is phospho-dependent therefore protein extracts from fly heads were 
prepared in the presence of phosphatase inhibitors.  A band of approximately 70kDa 
corresponding to the B52 protein was detected in all strains analysed, although the 
protein migrated at a higher molecular weight than expected, likely due to the known 
phosphorylation events which regulate activity (Figure 5.12 B).  Slightly more 
protein was observed in the Adar5G1 sample; however examination of the ponceau 
stain to reveal the total protein loaded indicated that there was slightly more protein 
loaded in the Adar5G1 lane (Figure 5.12 B; lane 2).  A control of HEK293T extract 
was included to ensure the antibody detected multiple phosphorylated SR proteins in 
mammalian extract.  A HEK293T extract which has been de-phosphorylated with 
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calf intestinal phosphatase (CIP) prior to loading was also included to show the 







Chapter 5: Analysis of alternative splicing in ADAR-null flies 
 247
5.3 Discussion 
Analysis of RNA from flies lacking the Adar gene revealed 759 genes which showed 
significantly altered splice junction use.  This is a higher number than was expected, 
however many of these genes showed altered use of one junction rather than a 
coordinated change in isoforms.  When compared to other AS array data from 
Drosophila our data indicated a larger number of affected genes.  However, previous 
studies have used cell lines depleted for specific splicing factors (Blanchette et al., 
2009) or following stimulation of specific pathways (Hartmann et al., 2009).  
Analysis of total head RNA includes many different cell types and provides a global 
analysis of the splicing status, but the analysis cannot distinguish signals from 
different splice variants which contain the same splice junctions.  However, AS 
arrays have been used successfully to determine the substrates of the brain specific 
NOVA proteins indicating global analysis of samples which contain multiple 
different cell types can be used to identify specific substrates (Ule et al., 2005).   
 
Detailed investigation of transcripts from two genes which are altered in Adar-null 
flies did not reveal multiple alternatively spliced isoforms.  Instead transcripts were 
detected with abnormal polyadenylation, which was an unexpected result.  These 
results were obtained using the 3’RACE technique that includes a high number of 
amplification cycles which increases the chances of amplifying spurious products; 
however this is unlikely for several reasons.  Firstly, the alternative polyadenylation 
sites did not occur in regions that were rich in adenosine residues which may 
hybridise to oligo dT primers.  Secondly the wild type or canonical sequence was 
amplified from all three RNA samples indicating these alternative polyadenylation 
sites are only utilised in the absence of ADAR and only contribute a small fraction of 
the total transcripts from these loci.  Thirdly, the samples were denatured at 70oC 
prior to first strand cDNA synthesis to melt any secondary structure therefore it is 
unlikely that altered structure in the RNA from flies lacking the Adar gene could 
give rise to the observed results.  However these results need to be verified using 
polyA purified RNA as starting material to ensure partially processed transcripts are 
excluded. 
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Analysis of AS array data in the light of these findings has identified several genes 
that may produce transcripts which are alternatively polyadenylated in Adar-null 
flies indicating this may be a widespread phenomena.  However further work is 
required to determine the extent of this alternative polyadenylation and the role that 
ADAR plays in canonical polyadenylation in these transcripts. 
 
There are several mechanisms which could explain the alternative polyadenylation 
observed in Adar-null flies.  Firstly, ADAR could act to promote canonical 
polyadenylation in wild type flies through interactions with the 3’ region of nascent 
transcripts.  Several papers have described RNA editing in the 3’UTR region of 
transcripts isolated from Caenorhabditis elegans and humans indicating ADAR 
binds to the 3’UTR region of some transcripts (Morse et al., 2002; Morse and Bass, 
1999).  Indeed the majority (77%) of the new editing events described by Li et al, 
occur within non-coding regions (Li et al., 2009).  In addition, several Drosophila 
ADAR substrates identified by Stapleton et al, (2006) show editing in the 3’UTR 
region indicating these may be informative for future analysis (Stapleton et al., 
2006).  The majority of miRNA target sites are located within 3’UTR regions and 
use of alternative polyadenylation sites could alter the regulation of the transcript by 
removing miRNA target sites. 
 
Secondly, ADAR could bind to the regions identified and block these alternative 
polyadenylation sites in the wild type fly brain.  Therefore in the absence of ADAR 
these sequences would be exposed and available to interact with the 3’ end 
processing machinery.  Thirdly, ADAR could influence the secondary structure of 
these transcripts.  It has been demonstrated that absence of the RNA helicase 
encoded by maleless can result in aberrant editing and splicing catastrophe for the 
para transcript (Reenan et al., 2000).  This indicates that the secondary structure 
which is required for editing by ADAR is complex and can inhibit splicing in the 
absence of a RNA helicase to help resolve it.  A highly structured 3’ end of 
transcripts may inhibit normal processing by cleavage and polyadenylation factors.  
Fourthly, it cannot be excluded that these alternatively polyadenylated transcripts 
occur in wild type flies but are rapidly degraded.  ADAR could function in an RNA 
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surveillance role to aid in the degradation of aberrantly polyadenylated transcripts, 
and therefore these transcripts are stabilised and detected in the absence of ADAR. 
Lastly, it cannot be ruled out that the observed effects may be indirect.  ADAR may 
edit and regulate a key component in the polyadenylation machinery, and in the 
absence of this editing event polyadenylation site choice may be de-regulated.  In 
support of this hypothesis one gene which showed altered AS in Adar-null flies, 
CG13900, encodes a component of the U2 snRNP which participates in the splicing 
reaction (Mount and Salz, 2000).  However CG13900 also contains an Interpro 
domain which is also found in the cleavage and polyadenylation stimulation factor 
(CPSF) indicating alterations in this transcript may affect the processing of other 
transcripts.  Expression of CG13900 was not significantly altered in Adar-null flies 
which suggests if it is miss-regulated it is not at the transcript expression level.  
However, the altered splice junction use occurred in the 3’UTR region and could 
therefore affect translational regulation.  Further work to determine the level of 
CG13900 protein in Adar-null flies is required as it has been shown that the 
concentration of cleavage and polyadenylation factors can influence polyadenylation 
site choice. 
 
The Drosophila Sex-lethal RNA-binding protein regulates female specific expression 
of a polyadenylation variant of enhancer of rudimentary gene through binding to the 
G/U-rich region and competing with CstF-64 (Gawande et al., 2006).  This indicates 
that alternative polyadenylation sites are used in Drosophila and RNA-binding 
proteins can influence the choice of polyadenylation site through preventing access 
to cleavage and polyadenylation factors.  This mechanism may be used more widely 
than has previously been thought. 
 
Interaction between RNA editing and polyadenylation is not a new phenomenon as 
an example in polyomavirus has been described.  Editing of the first adenosine 
residue of the canonical AAUAAA polyadenylation signal in late viral transcripts is 
thought to decrease use of this polyadenylation signal (Gu et al., 2009).  This allows 
run-through of the transcription termination signals and generates multigenomic 
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primary transcripts which are then processed by alternative splicing to produce 
multiple copies of late viral transcripts.   
 
This chapter details the beginning of an investigation into the role of ADAR in 
alternative splicing.  A subset of transcripts have been identified which show altered 
splicing in the absence of ADAR, however further work is required to characterise 
the role of ADAR in these splicing events.  Crucial to the investigation of the role of 
ADAR in AS is determining whether ADAR binds to these transcripts in the regions 
which show altered splicing profiles.  Binding of ADAR to transcripts which show 
altered splicing was to be analysed using the RNA immunoprecipitation protocol 
described in Chapter 4 however technical difficulties with this method prevented 
further characterisation of the interactions between ADAR and the identified 
transcripts. 
 
A previous study into the role of Drosophila hnRNP family members in splicing 
utilised an AS array in conjunction with RNA SELEX to successfully identify 
consensus sequences for these RNA binding proteins (Blanchette et al., 2009).  
However SELEX with ADAR2 revealed that ADARs do not bind to a specific 
consensus sequence; it is the secondary structure which determines ADAR-binding 
(Hallegger et al., 2006).  AS array profiles from known substrates of ADAR indicate 
aberrant splicing occurs in regions which neighbour ADAR binding sites.  Therefore 
a particular focus on the local secondary structure surrounding junctions which show 
altered splicing according to the AS may be informative.  However, complicated 
secondary structures including stem loop structures with over 1.5kb of looped RNA 
and complex pseudoknots have been described for known substrates of Drosophila 
ADAR which makes modelling the secondary structure of some transcripts difficult 
(Reenan, 2005).  Detailed bioinformatic analysis of the regions which show altered 
splicing in Adar-null flies may be informative. 
 
Microarray analysis of transcript changes which occur during mammalian T cell 
activation revealed one group of transcripts were regulated through alternative 
splicing and another distinct group were regulated at the transcript level (Ip et al., 
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2007).  This is similar to what we observed in Drosophila lacking the Adar gene 
where there is very little overlap between genes which are altered according to the 
Affymetrix array and genes which show aberrant splicing according to the AS array.  
Interestingly the two groups of genes described by Ip et al (2007) were functionally 
distinct, indicating regulation of specific pathways or processes may occur through 
either regulation of transcript level or AS events (Ip et al., 2007).  A similar effect 
was observed in Drosophila S2 cells when analysing the response to insulin 
treatment or activation of the wingless pathway with functionally distinct groups of 
genes regulated either at the transcript level or through AS (Hartmann et al., 2009). 
 
GO term analysis performed on the datasets obtained from the Affymetrix expression 
array showed that cytochrome genes were miss-regulated at the gene expression level 
indicative of oxidative stress response.  Whereas GO term analysis on the AS array 
data revealed a different set of genes displayed altered splicing in Adar-null flies.  
These included several genes which contain a tropomyosin domain and are involved 
in movement and are known to be extensively alternatively spliced in Drosophila.  
Glutamate receptor subunit genes were also overrepresented in the AS array altered 
genes which may indicate a role for ADAR in processing these transcripts.  This 
would suggest evolutionary conservation of ADAR substrates as several mammalian 
glutamate receptor subunit transcripts are known substrates of ADAR.  Mammalian 
ADARs edit several ion channel receptor subunit transcripts which alters the 
processing of these subunits into functional receptors (reviewed in (Daniel and 
Ohman, 2009); a similar mechanism may occur in Drosophila. 
 
 
AS arrays provide a valuable tool for examining the global splicing profile however 
they are dependent on a well annotated genome and it is likely there are more 
transcript variants expressed than are detailed on the AS array as novel isoforms are 
regularly discovered.  Numerous AS changes were observed in RNA isolated from 
Adar-null flies indicating ADAR may have an additional function as an RNA-
binding protein.  The nature of the splicing changes, where single splice junctions 
were often dramatically affected in isolation could indicate that there are large 
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numbers of unannotated cryptic splice sites which occur in previously 
uncharacterised isoforms.  However RACE analysis of several genes which were 
altered in Adar-null flies did not reveal retained introns or cryptic splice site use.  
This suggests that the single affected junctions may be bound by ADAR in wild type 
flies and therefore processing of these junctions is altered in Adar-null flies.  Further 
work is required to determine whether ADAR binds to transcripts in the region of 
aberrant splicing. 
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The discovery of a putative novel member of the AID/APOBEC family of cytidine 
deaminases (Rogozin et al., 2005) that is expressed in the testis and which may have 
a role in the innate immune system led to many questions.  The aim of this thesis was 
to characterise the biochemical properties and expression pattern of this putative 
novel deaminase.  The primary question to answer was whether A4 is a catalytically 
active deaminase and what substrate specificity it has.  A4 is conserved across 
species from Xenopus tropicalis to human indicating it has a biological function 
(Rogozin et al., 2005).  Furthermore, key residues within the catalytic domain are 
also conserved so presumably a zinc atom is coordinated within the active site, which 
is a shared feature of the cytidine deaminase family.  This is suggestive that A4 has a 
catalytic deaminase function, however other residues which are conserved across 
other AID/APOBEC family members are not present which could indicate different 
substrate specificity.   
 
Despite generation of several different A4 expression vectors and the use of three 
different expression systems, recombinant A4 could not be purified in sufficient 
quantities for biochemical characterisation due to its inherent insolubility.  Other 
members of the AID/APOBEC family are also difficult to purify due to insolubility 
(Smith, 2007), however the presence of a coiled-coil domain in the carboxy terminus 
of A4 seems to have exacerbated the problem.  Coiled-coil domains are involved in 
protein-protein interactions and this may enhance the aggregation of A4 when 
overexpressed for purification.  Removal of the coiled-coil domain may improve the 
solubility of A4 for purification; however this may affect the behaviour of the protein 
as it could lose the ability to interact with a co-factor. 
 
An alternative approach for the biochemical characterisation of A4 is to purify 
endogenous A4 using classical size exclusion chromatography methods.  This may 
overcome the solubility problem however as there are problems detecting the 
endogenous protein it is difficult to predict whether testis or sperm should be used as 
starting material.  Therefore it may not be possible to perform in vitro biochemical 
analysis on A4.  Indeed, other members of the AID/APOBEC family have been 
analysed in cell culture systems or using the E.coli DNA mutator assay to circumvent 
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the need for purified protein preparations.  The lack of a suitable germline-derived 
cell line precludes analysis of A4 in a cell culture model which would re-create the 
endogenous A4 environment; however expression in a heterologous cell culture line 
may prove useful when the substrate of A4 has been identified. 
 
The insolubility of A4 could also have contributed to the lack of DNA deaminase 
activity in the E.coli DNA mutator assay as insoluble aggregated A4 may not have 
access to the DNA.  However, this may be an accurate result and indicate that A4 
does not have catalytic deaminase activity on DNA.  Independent verification of the 
substrate specificity of A4 is required yet without the ability to purify recombinant 
A4 this may prove difficult. 
 
Apobec4 transcripts are expressed at the round spermatid stage of spermatogenesis, 
which is a highly specialised cell type.  However during this stage of 
spermatogenesis mRNAs encoding proteins which are required for spermiogenesis 
and fertilisation are also transcribed and stored in translationally silent states for use 
after chromatin compaction when DNA cannot be accessed.  Therefore detection of 
Apobec4 mRNA is not indicative of A4 protein expression.  The discovery of a target 
site for miRNA-741 in the Apobec4 3’UTR indicates expression of A4 protein may 
be regulated post-transcriptionally.  miRNA-741 shows a similar expression pattern 
to Apobec4 suggesting they are expressed at the same stage of spermatogenesis.  
Further experiments are required to determine whether they are expressed in the 
same cell type and whether Apobec4 expression is regulated by miRNA-741.  This 
could be analysed by cloning the Apobec4 3’UTR region upstream of a luciferase 
reporter gene and analysing the luciferase signals in the presence or absence of 
miRNA-741 expression.  If the luciferase reporter experiments indicate miRNA-741 
is regulating Apobec4 then transgenic animals could be engineered lacking the target 
site for miRNA-741 to analyse the effects of Apobec4 overexpression. 
 
The polyclonal antibodies generated to recombinant A4 were able to recognise 
recombinant A4 produced with several different expression systems indicating the 
antibodies were specific for A4.  Furthermore following affinity purification the 
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antibodies were no longer able to recognise the epitope tags that were present on the 
recombinant protein used to inoculate the guinea pigs indicating the affinity 
purification was successful.  However endogenous A4 was not detected in testis or 
sperm extracts suggesting it is either expressed at a very low level or not expressed in 
these tissues.  To determine the expression pattern of A4 protein transgenic animals 
could be engineered that express a reporter gene under the control of the A4 
promoter.  Alternatively, transgenic mice expressing a GFP-tagged A4 would also be 
informative as this would enable visualisation of the endogenous A4 protein.  A 
GFP-tagged endogenous A4 would indicate whether the protein is expressed in 
mature sperm and whether A4 is present in the post-fertilisation embryo.  
Furthermore tagging the endogenous A4 would allow investigation of the subcellular 
localisation. 
 
Full characterisation of the phenotype of the A4-null mice is ongoing, however they 
are healthy, viable and fertile indicating there are no obvious defects in 
spermatogenesis (Ian Adams, personal observation).  Yet initial examination of A2- 
and A3-null mice showed no obvious phenotype (Mikl et al., 2005).  Whilst no 
function has been described for A2, a closer examination of the A2-null mice 
revealed a mild myopathic phenotype and diminished body mass indicating A2 has a 
biological function in maintaining muscle fibre ratios (Sato et al., 2009).  A3 has 
been shown to have a crucial role in the immune system where it acts to inhibit 
retroviral infection and retroelement activation yet the A3-null mice have no obvious 
phenotype (Mikl et al., 2005) unless challenged (Okeoma et al., 2007).  Therefore the 
phenotypic effect of loss of A4 may be subtle and require comprehensive analysis, 
and characterisation of the A4-null phenotype may indicate the biological function or 
substrate preference of A4. 
 
The debate over the substrate specificity of AID highlights the difficulties faced 
when trying to characterise members of the AID/APOBEC family.  AID has long 
been known to participate in the process of antibody diversification however 
clarification over whether AID deaminates DNA or RNA substrates has proved 
challenging.  Many different approaches have been used to circumvent the need for 
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purified protein to analyse in vitro, including analysis of whether translation is 
required for CSR to occur in cell culture models (Begum et al., 2004).  The substrate 
specificity of AID was eventually found to be ssDNA, although in vitro the enzyme 
was not active unless pre-treated with RNases to remove an inhibitory RNA 
(Bransteitter et al., 2003), leading to the hypothesis that RNA-binding may regulate 
the activity of AID on ssDNA via occupation of the catalytic active site.  However, 
knowledge of the process that AID is involved in and analysis of the mutation 
spectrum at the immunoglobulin locus have helped clarify AID’s role. In 
comparison, the lack of knowledge about the biological function of A4 has made 
identification of substrate specificity extremely challenging.   
 
In contrast, characterisation of Drosophila ADAR has been aided greatly by the 
generation of Adar-null flies (Palladino et al., 2000b).  Flies with the Adar5G1 
deletion show a range of phenotypes including locomotion defects and age-
dependent neurodegeneration (Palladino et al., 2000b).  Previously, substrates of 
Drosophila ADAR have been identified by the presence of guanosine in mRNAs that 
corresponds to adenosine residues in the DNA sequence, indicative of RNA editing.  
The discovery that the age-dependent neurodegeneration observed in Adar-null flies 
can be suppressed by expression of a catalytically inactive Adar EA transgene in the 
cholinergic neurons indicated that ADAR may have an additional deaminase-
independent function in the CNS. However, identifying ADAR substrates that are 
bound by ADAR but not deaminated has proved challenging.   
 
Previous analysis of Adar5G1 flies indicated that the neurodegenerative phenotype 
observed was due to aberrant autophagy as no apoptotic cells were detected by 
TUNEL staining and large vacuoles were present in neuronal cell bodies (Leeanne 
McGurk, Thesis).  However, microarray analysis of gene expression changes in 5 
day old fly heads did not reveal changes in transcripts that are associated with either 
apoptosis or autophagy.  Analysis of the GO terms associated with the altered genes 
indicated genes involved in the response to oxidative stress were altered indicating 
the onset of neuronal damage was occurring.  Five day old flies were used to allow 
detection of gene expression changes associated with loss of Adar without secondary 
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changes induced by the neurodegenerative process.  However, analysis of gene 
expression changes in older flies (10-15 days) is required to determine whether genes 
involved in programmed cell death are mis-regulated in Adar5G1 flies.  This question 
was not addressed in the study described herein due to time and cost restrictions. 
 
Using Affymetrix microarray technology to analyse gene expression levels I have 
identified a subset of transcripts which show altered expression in the absence of 
Adar, and are rescued in flies expressing either the active or the catalytically inactive 
Adar transgene.  These results were confirmed by real time PCR; however it was 
unclear whether these transcript level changes were direct or indirect.  I used two in 
vitro assays to characterise the interaction between ADAR and candidate transcripts 
further, however these assays indicated that ADAR binds to many transcripts in 
vitro.  Previously in vitro analysis of ADAR RNA-binding has been performed on 
known substrates or perfect duplex dsRNA.  This is the first demonstration that 
ADAR can bind to other pre-mRNAs with a similar affinity as known substrates.  
Furthermore promiscuous editing by ADAR was detected indicating these pre-
mRNAs have a secondary structure that ADAR recognises, however no editing was 
detected in RNA isolated from wild type fly head.  To analyse the interactions in vivo 
an RNA immunoprecipitation experiment was performed on transiently transfected 
Drosophila S2 cells.  This indicated that ADAR does not bind to the candidate 
transcripts with the same affinity as a known ADAR substrate Atx2, however the 
experiment was difficult to optimise due to the low transfection efficiency of the S2 
cell line.  These results highlight the need for in vivo analysis of the interaction 
between ADAR and substrates and indicate that other factors affect the range of 
substrates ADAR interacts with in vivo.  For example, competition for substrates 
with other RNA-binding proteins in vivo may restrict the set of transcripts which are 
bound by ADAR.  However these results also suggest the altered gene expression 
observed in the Adar-null flies may occur through an indirect mechanism.   
 
ADAR may affect the transcription of the altered genes through interactions with the 
RNA pol II CTD.  However, analysis of the GO terms associated with the genes 
which show altered expression in Adar-null flies indicate these changes may be 
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induced in response to oxidative stress.  The Adar-null flies do not show evidence of 
neurodegeneration at 5 days however ADAR may have a protective effect on 
neurons and when ADAR is absent the neurons may be more sensitive to oxidative 
stress.  This is comparable to the role of ADAR2 in CA1 pyramidal neurons of the 
mouse brain, where ADAR2 mediates the response to ischemic insult by regulating 
cell death (Peng et al., 2006).  However in the mammalian system the regulation is 
mediated through editing of the GluR-B Q/R site.  In the Drosophila system the role 
of ADAR in the stress response is unlikely to occur via site-specific editing of a 
single transcript as the neurodegenerative phenotype can be suppressed by 
expression of a catalytically inactive Adar EA transgene.  Therefore the role of 
ADARs may be similar but the mechanism is different. 
 
In further support of a role for ADAR in mediating the response to stress Gan et al 
have demonstrated that ADAR2 in mouse pancreatic islet cells is regulated in 
response to metabolic stress induced by a high fat diet (Gan et al., 2006).  Editing 
activity was also enhanced in mice fed on a high fat diet however it is not known 
what the role of ADAR2 in pancreatic islet cells is and why it is increased in times of 
metabolic stress.  Further work revealed that ADAR2 is required for efficient 
exocytosis of secretory vesicles containing proteins such as insulin and 
chromogranin B (Yang et al., 2010).  An intact deaminase domain was required for 
efficient exocytosis demonstrating that RNA editing is required; however no 
substrates were identified.  Decreased expression of Munc-18 and Synaptotagmin-7 
which are key components of the exocytosis pathway was observed in ADAR2 
deficient rat INS-1 cells; however it is unclear how ADAR2 affected their expression 
levels (Yang et al., 2010).  This suggest an additional role for ADAR2 in regulation 
of vesicle transport and exocytosis, and whilst the homologs of Munc-18 and 
Synaptotagmin-7 were not altered according to the microarray data presented here, 
analysis of GO terms indicated expression of vesicle associated genes was altered in 
Adar-null flies.   
 
Additionally the Ilp3 gene showed decreased expression in Adar-null flies which 
could indicate a role for ADAR in the regulation of glucose metabolism.  Further 
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work is required to distinguish the functional role of ADAR in regulating exocytosis 
and ADARs effect on regulation of the insulin pathway.  An essential role for 
ADAR1 in mediating the interferon response in the developing liver has also been 
described recently (Hartner et al., 2009), such that ADAR1-null mice die at E12.5 
due to interferon-induced apoptosis.  Taken together these studies implicate ADARs 
in the response to cellular stress, although it is unclear what role ADAR plays and 
whether this effect is editing dependent or independent. 
 
Numerous attempts have been made to characterise Drosophila ADAR substrates, 
however verification of novel substrates relies on identifying sequence changes 
indicative of RNA editing.  We have proposed that Drosophila ADAR has an 
alternative editing-independent function; however it is unclear what this function is.  
To try and elucidate this editing-independent function of ADAR I have investigated 
changes in transcript levels and AS that occur in Adar-null flies.  ADAR may have a 
much larger list of substrates than previously identified, however identification and 
verification of these substrates will require a new approach as these transcripts will 
not be edited.  Cross-linked immunoprecipitation (CLIP) of transcripts bound by 
endogenous ADAR would provide a comprehensive list of substrates but may be 
technically challenging (Ule et al., 2003).  CLIP requires an antibody which is 
specific for Drosophila ADAR and this is currently being generated in the lab.  An 
alternative would be to use the rescue lines which express an Adar transgene in the 
cholinergic neurons as these transgenes encode FLAG-tagged ADAR.  However this 
may limit the list of substrates as endogenous Adar is expressed throughout the brain.  
In addition, CLIP requires a large amount of dissected brains as starting material, and 
the protocol for dissociation of cells and cross-linking would need to be optimised.  
However, following optimisation of the procedure CLIP should provide a 
comprehensive list of edited and unedited substrates of Drosophila ADAR.  Once 
such a list is identified the editing-independent function of ADAR may become 
clearer.  A similar approach has been used successfully to identify substrates of 
ADAR2 in mouse brain (Ohlson et al., 2005), although cross-linking was not 
required here.  This approach identified many known ADAR2 substrates, however 
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the authors do not discuss their false discovery rate and therefore it is unclear 
whether they identified transcripts which are bound by ADAR2 but are not edited.   
 
It has been demonstrated that inosine-containing dsRNA can decrease gene 
expression and translation in trans (Scadden, 2007), however this is unlikely to 
account for the gene expression changes observed in Adar-null flies as transcript 
levels were both upregulated and downregulated.  Furthermore the gene expression 
changes detected in trans caused by inosine-containing dsRNA were widespread and 
non-specific, occurring in both endogenous and reporter genes analysed.  In contrast 
I have identified a significantly altered subset of mRNAs indicating the expression 
changes are specific.  The loss of site-specific editing resulted in a subtle decrease in 
transcript levels for several known substrates of ADAR.  This indicates that editing 
may stabilise these transcripts in vivo.  However many genes showed stronger 
changes in expression than the known ADAR substrates indicating the loss of ADAR 
has far reaching effects. 
 
Analysis of gene expression using an Affymetrix array identified a subset of 
transcripts which show altered transcript levels in Adar-null flies.  However, AS 
array analysis identified a different subset of genes which were aberrantly spliced in 
the absence of ADAR.  Known substrates of ADAR were not overrepresented in 
either group of transcripts indicating the loss of ADAR affects a wide range of 
transcripts.  The results presented here are consistent with previous studies into the 
regulation of AS which have identified two distinct groups of genes, one group that 
is regulated at the transcript level and another group which is regulated via changes 
in AS (Ip et al., 2007).  However it is unclear whether ADAR interacts directly with 
transcripts in either of these pathways.  Technical difficulties with the RNA 
immunoprecipitation experiment prevented investigation into whether ADAR binds 
to the transcripts identified from the AS array analysis.  Evidence in support of a 
direct interaction between ADAR and the transcripts which are aberrantly spliced in 
the absence of ADAR comes from the pattern of changes observed.  Many of the 
aberrantly spliced genes showed alteration of single exon-exon junctions indicating 
these were not coordinated changes in known isoforms.  Given the requirement of 
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dsRNA for ADAR binding it is interesting to hypothesise that dsRNA may be 
formed between the intron and the exon, similar to known editing site ECSs, and 
bound by ADAR in wild type flies.  In the absence of ADAR these dsRNA structures 
may not be resolved efficiently and these structures may inhibit splicing.  This has 
been shown to occur in the absence of the RNA helicase maleless where the para 
transcript undergoes a splicing catastrophe as the dsRNA structure required for 
editing is not resolved and this results in exclusion of the whole region from the 
mature transcript (Reenan et al., 2000). 
 
The observation that polyadenylation was altered in Adar-null flies was an 
unexpected result.  These results could be due to miss-priming or spurious 
amplification products and require further validation; however the products were 
only detected in Adar-null flies implicating a role for ADAR in the generation of 
these products.  Future experiments to characterise these changes include repeating 
the RACE experiment with polyA+ purified RNA to remove any partially processed 
transcripts.  It would be interesting to analyse transcripts from these loci by Northern 
blot however the aberrant transcripts only accounted for a small fraction of the 
transcripts and may be difficult to detect on a Northern blot.   
 
The alternative polyadenylation was not observed in rescued flies expressing an Adar 
transgene in the cholinergic neurons.  Future experiments with RNA extracted from 
Adar-null flies expressing the catalytically inactive Adar EA transgene are required 
to determine whether the effect is dependent on RNA editing.  Of note is that one of 
the aberrantly spliced transcripts (CG13900) encodes a protein component of the 
spliceosome (Mount and Salz, 2000) which contains an Interpro domain that is also 
found in the cleavage and polyadenylation stimulation factor (CPSF).  Therefore the 
aberrant polyadenylation observed may arise from aberrant splicing of a component 
of the 3’ end processing machinery.  Further work is required to determine whether 
the CG13900 protein level or activity is altered in Adar-null flies. 
 
The array analysis presented in this thesis provides a valuable resource for 
identifying novel ADAR substrates in Drosophila.  The AS array identifies the 
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specific region of the transcript which is affected by the loss of ADAR, however 
further bioinformatic analysis is required to determine whether the regions affected 
can form dsRNA required for ADAR to bind.  A systems biology approach may be 
useful to integrate the expression array data and the AS array data to determine 
whether there are any common factors or pathways involved.  This would allow 
integration of existing data on gene regulatory networks and protein interactions 
along with the array data described herein to provide a complete view of the 
biological impact of the loss of ADAR.  A gene network is currently being compiled 
in the lab with the aim of superimposing data from both the expression array and the 
AS array to assess whether common regulatory networks of genes are affected by the 
absence of ADAR.  This will provide a greater understanding of how ADAR 
interacts with other genes and may indicate which of the observed changes in 
transcript level and AS are direct and which may be indirect for future analysis.  The 
GO term analysis described herein indicates these two groups of genes are 
functionally distinct; however it will be interesting to see whether the systems 
biology approach reveals that they are connected.  The common feature shared 
between these groups may be a secondary structure RNA conformation which 
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ADAR RNA-binding mutant (ADAR-RRM) 
An ADAR RNA-binding mutant termed ADAR-RRM was generated as a negative 
control for analysis of ADAR RNA-binding.  Several mutations within the dsRBDs 
were introduced by site-directed mutagenesis, followed by sequence analysis to 
ensure only the specified changes were introduced.  These mutations changed basic 
lysine residues within a conserved motif (KKxxK, where x indicates any amino acid) 
involved in RNA interactions for either alanine or glutamic acid residues such that 
the motif is changed to EAxxA.  The mutations are described in Valente & Nishikura 
(2007), where they were used to demonstrate the ADAR proteins which are 
incapable of binding RNA are capable of forming homodimers (Valente and 
Nishikura, 2007).  The amount of protein produced is not described however an 
insect cell expression system is used and equivalent amounts of protein were loaded 
on the immunoblots.  These mutations were made in both dsRBD of Drosophila 
ADAR and cloned into different expression vectors, and human ADAR2 containing 
this mutation was generated for expression in flies.  The construct for expression in 
Drosophila had to be injected, balanced and crossed with a GAL4 driver line prior to 
analysis (Jim Brindle and Liam Keegan) and was therefore only available for use at 
the end of my PhD.   
 
However during various experiments I observed that the dADAR RRM mutant 
protein was expressed at a consistently lower level than wild type ADAR protein.  
The reason for the difference in expression level is unclear as inactive ADAR 
mutants are usually expressed at a higher level than wild type ADAR (unpublished 
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I observed that during expression and purification of ADAR RRM mutant protein 
from Pichia pastoris that the protein was expressed at a lower level than the wild 
type ADAR protein, which was expressed and purified alongside the mutant as a 
control (Figure AI.1).  Bradford assay confirmed the difference in protein content 
was approximately two-fold for the second elution fraction E2 (WT = 186ng/ul, 
RRM = 100ng/ul).  This is unusual as the catalytic site mutant ADAR EA protein is 
consistently expressed at a higher level than wild type protein (personal observation), 
leading to the hypothesis that proteins which are incapable of editing are less toxic to 
the organism overexpressing them.  However, the difference observed here could 
have been due to several different reasons.  The same amount of DNA was used to 
transform wild type and mutant constructs however there may have been a difference 
in transformation efficiency.  Variation may have been introduced during induction 
or growth due to starting culture differences.  Therefore this observation was noted 
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However, the same mutations (KKxxK->EAxxA) were subcloned under a 
metallothionein promoter for use in Drosophila S2 cell culture.  1x106 S2 cells were 
plated and transfected with 2ug DNA encoding either WT or RRM mutant ADAR.  
Following induction for 24 hours with 0.6mM copper sulphate cells were harvested.  
Protein content was determined by Bradford assay and 60ug total protein was loaded 
onto a PAGE gel.  Immunoblot analysis with an anti-FLAG antibody revealed that 
there was a higher amount of WT ADAR protein than ADAR RRM protein (Figure 
AI.2).  Both WT and RRM-mutant ADAR migrate at approximately 95kDa.  A non-
specific protein of approximately 60kDa is detected with the anti-FLAG antibody 
which indicates that equal amounts of protein were loaded in all lanes.  Both WT 
ADAR and ADAR RRM were only present after induction with copper sulphate.  
Immunocytochemistry revealed that both wild type ADAR and ADAR RRM had 
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Individually the observations shown here are not remarkable as they could be 
explained by variation in experimental procedure.  However, when analysed together 
with the observation that ADAR EA protein is consistently expressed to a higher 
levels than WT ADAR they indicate that the ADAR RRM protein may not be as 
stable as wild type protein.  This is further supported by the observation that an 
ADAR2-RRM protein expressed in HEK293T cells is also found at a lower level 
than other ADAR2 mutants when cells are transfected and treated in an identical 
manner (Roberto Marcucci, unpublished observation).  This indicates that this 
phenomenon is independent of the expression system used as it has been observed in 
three independent systems; yeast, Drosophila S2 cells, and HEK293T cells.  It also 
indicates it is independent of the species of origin the ADAR used as the same 
observations are made with Drosophila ADAR and human ADAR2.  Further, it is 
unlikely to be a problem with the process of site-directed mutagenesis as different 
primers were required for Drosophila ADAR and human ADAR2, and constructs 
were sequenced in their entirety prior to use (Jim Brindle).  However investigation of 
WT ADAR and ADAR RRM by circular dichroism is required to determine whether 
the mutant protein has altered stability. 
 
These mutants were generated and used in this thesis due to criticism of previous 
ADAR RNA-binding mutants generated in the lab (Gallo et al., 2003) on the basis 
that they disrupted the protein structure (Valente and Nishikura, 2007).  The 
observations presented here indicate that this RNA-binding mutation (KKxxK-
>EAxxA) creates a protein that is either unstable or unfavourable to the organism 
expressing it.  However, in the initial paper describing these mutants size exclusion 
chromatography was performed on a gel filtration column which indicates stable 
dimers were formed.  Therefore it cannot be excluded that these mutations generate a 
gain of function which is undesirable to the host organism.  In vitro analysis indicates 
that RNA-binding is impaired in this mutant (Figure 4.9), and no editing of a known 
substrate was observed (Figure 4.13).   
 
The implications of this observation are that the flies generated to analyse the human 
ADAR2-RRM mutant may not be expressing the protein to a high level.  This is 
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surprising as the neurodegeneration observed in these flies is not as advanced as that 
seen in age-matched Adar5G1 flies, although it is clearly present.  However, due to the 
low expression of ADAR protein in flies it would be very difficult to measure it.  
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This Appendix details the gene lists obtained from microarray analysis described in 
Chapters 4 & 5.   



































X67681 /transposon Transposon.8 123.7 879.1 7.11 879.1 49.12 -17.9 879.1 105.76 -8.31 
schnurri Transposon.24 1784.93 2659.53 1.49 2659.53 1463.64 -1.82 2659.53 1310.97 -2.03 
AY180916 /transposon Transposon.38 2418.3 4453.24 1.84 4453.24 3106.89 -1.43 4453.24 3023.28 -1.47 
GH06606 /chr2R:-9953073,9956759 GH06606 299.28 455.34 1.52 455.34 293.08 -1.55 455.34 293.56 -1.55 
CG3513 CG3513-RA 219.02 496.43 2.27 496.43 282.67 -1.76 496.43 224.79 -2.21 
TpnC25D CG6514-RA 4185.97 6279.91 1.5 6279.91 3305.83 -1.9 6279.91 4569.09 -1.37 
CG5958 CG5958-RA 1537.35 4743.55 3.09 4743.55 3235.73 -1.47 4743.55 3590.9 -1.32 
Cyp4d21 CG6730-RA 3943.92 7076.92 1.79 7076.92 4267.98 -1.66 7076.92 4194.09 -1.69 
CG31904 /Adult cuticle protein 1 CG7216-RA 227.07 624.99 2.75 624.99 211.02 -2.96 624.99 241.47 -2.59 
CG7203 CG7203-RA 2618.27 5337.51 2.04 5337.51 1749.09 -3.05 5337.51 1528.75 -3.49 
CG7214 CG7214-RA 57.17 243.99 4.27 243.99 58.21 -4.19 243.99 53.55 -4.56 
CG15267 CG15267-RA 294.34 411.39 1.4 411.39 260.25 -1.58 411.39 293.9 -1.4 
CG31780 /CG18477 CG31780-RB 97 218.08 2.25 218.08 92.33 -2.36 218.08 59.12 -3.69 
CG9317 CG9317-RB 1027.07 1420.22 1.38 1420.22 755.11 -1.88 1420.22 729.72 -1.95 
CG14401 CG14401-RA 552.29 824.99 1.49 824.99 576.95 -1.43 824.99 562.93 -1.47 
CG6675 CG6675-RA 301.41 479.39 1.59 479.39 260.61 -1.84 479.39 205.47 -2.33 
HDC00331 /chr2L:-2185138,2185389 HDC00331 2537.42 3779.65 1.49 3779.65 1973.28 -1.92 3779.65 2086.61 -1.81 
Immune induced molecule 1 CG18108-RA 6011.64 11153.7 1.86 11153.7 6862.32 -1.63 11153.7 5818.25 -1.92 
Glutathione S transferase E1 CG5164-RA 2723.92 4083.45 1.5 4083.45 2650.2 -1.54 4083.45 2493.17 -1.64 
Immune induced molecule 23 CG15066-RA 1643.33 7130.36 4.34 7130.36 2764.76 -2.58 7130.36 2559.28 -2.79 
CG30091 CG30091-RA 86.97 441.73 5.08 441.73 80.25 -5.5 441.73 22.62 -19.53 
CG30050 CG30050-RA 242.45 510.29 2.1 510.29 264.86 -1.93 510.29 344.82 -1.48 
Troponin C at 47D CG9073-RA 68.84 406.43 5.9 406.43 154.11 -2.64 406.43 102.59 -3.96 
FMRFamide-related CG2346-RA 415.48 618.87 1.49 618.87 356.68 -1.74 618.87 450.09 -1.37 
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Tetraspanin 42Ei CG12843-RA 977.4 1473.75 1.51 1473.75 1087.45 -1.36 1473.75 1084.06 -1.36 
CG15666 CG15666-RA 243.76 381.05 1.56 381.05 209.98 -1.81 381.05 193.24 -1.97 
maleless CG11680-RB 437.13 693.05 1.59 693.05 352.48 -1.97 693.05 337.21 -2.06 
Cytochrome P450-6a2 CG9438-RA 4149.61 5772.75 1.39 5772.75 3925.73 -1.47 5772.75 3636.01 -1.59 
CG12858 CG12858-RA 1274.05 1938.64 1.52 1938.64 939.28 -2.06 1938.64 1125.05 -1.72 
CG2065 CG2065-RA 311.16 983.51 3.16 983.51 341.47 -2.88 983.51 253.51 -3.88 
SCAP CG33131-RA 656.26 1268.66 1.93 1268.66 848.83 -1.49 1268.66 932.27 -1.36 
Sarcoplasmic calcium-binding protein 
1 CG15848-RA 1530.1 3495.9 2.28 3495.9 913.64 -3.83 3495.9 1032.18 -3.39 
CG8789 CG8789-RA 586.42 885.36 1.51 885.36 606.76 -1.46 885.36 659.72 -1.34 
CG6812 CG6812-RA 1198.8 1616 1.35 1616 1204.46 -1.34 1616 1194.14 -1.35 
Neuropeptide-like precursor 3 /Nplp3 CG13061-RA 10303.13 15591.2 1.51 15591.2 9575.77 -1.63 15591.2 7086.57 -2.2 
CG17029 CG17029-RA 757.56 1257.32 1.66 1257.32 855.8 -1.47 1257.32 750.55 -1.68 
CG17364 CG17364-RB 29.55 170.19 5.76 170.19 23.93 -7.11 170.19 23.9 -7.12 
CG6673 CG6673-RA 568.34 895.53 1.58 895.53 429.37 -2.09 895.53 350.3 -2.56 
CG8012 CG8012-RA 923.83 2132.21 2.31 2132.21 1070.13 -1.99 2132.21 970.18 -2.2 
Lcp65Ag2 CG10534-RA 212.04 347.48 1.64 347.48 182.03 -1.91 347.48 153.91 -2.26 
methuselah-like 8 CG32475-RA 43.75 175.49 4.01 175.49 44.24 -3.97 175.49 52.65 -3.33 
methuselah-like 8 CT37020 24.6 226.33 9.2 226.33 27.16 -8.33 226.33 42.65 -5.31 
CG10999 CG10999-RA 423.93 604.22 1.43 604.22 456.55 -1.32 604.22 426.75 -1.42 
CG1090 CG1090-RA 306.27 538.51 1.76 538.51 395.01 -1.36 538.51 402.93 -1.34 
Pheromone-binding protein-related 
protein 4 CG1176-RA 1741.72 2443.03 1.4 2443.03 1647.08 -1.48 2443.03 1700.25 -1.44 
CG12256 CG12256-RA 133.65 261.92 1.96 261.92 154.3 -1.7 261.92 108.94 -2.4 
CG14298 /GA12887 CG14298-RA 456.49 645.31 1.41 645.31 408.69 -1.58 645.31 351.21 -1.84 
CG5835 /CG11779 CG5835-RA 869.69 1268.03 1.46 1268.03 824.83 -1.54 1268.03 615.56 -2.06 
CG13833 CG13833-RA 3765.67 6617.96 1.76 6617.96 4733.5 -1.4 6617.96 3727.88 -1.78 
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CG13822 CG13822-RA 104.09 781.7 7.51 781.7 419.48 -1.86 781.7 495.48 -1.58 
CG33970 CG14559-RA 407.7 553.82 1.36 553.82 393.51 -1.41 553.82 344.83 -1.61 
CG33970 CG31085-RB 3155.79 4198.03 1.33 4198.03 3082.43 -1.36 4198.03 2816.36 -1.49 
CG12054 CG12054-RA 489.14 853.65 1.75 853.65 532.52 -1.6 853.65 608.46 -1.4 
Metallothionein D CG33192-RA 128.51 564.56 4.39 564.56 91.44 -6.17 564.56 155.94 -3.62 
lethal (1) G0237 CG1558-RA 502.68 755.5 1.5 755.5 386.29 -1.96 755.5 516.71 -1.46 
furrowed CG1500-RA 287.11 491.6 1.71 491.6 310.51 -1.58 491.6 288.86 -1.7 
found in neurons CG4396-RA 681.95 966.96 1.42 966.96 598.4 -1.62 966.96 710.19 -1.36 
Cyp6t1 CG1644-RA 704.68 1110.21 1.58 1110.21 833.96 -1.33 1110.21 520.18 -2.13 
CG40486 CG40486-RB 3040.75 4591.72 1.51 4591.72 2812.01 -1.63 4591.72 3021.03 -1.52 
Table AII.1: Genes which are upregulated in Adar5G1 flies when compared to w1118 and restored by expression of an 
active Adar or catalytically inactive Adar EA transgene in the cholinergic neurons. 





























X01472 /transposon  Transposon.2 3553.61 1577.1 -2.25 1577.1 5854.68 3.71 1577.1 5637.09 3.57 
Z27119 /transposon Transposon.35 1623.81 330.91 -4.91 330.91 546.78 1.65 330.91 656.16 1.98 
AF365402 /transposon  Transposon.47 600.85 260.69 -2.3 260.69 468.93 1.8 260.69 509.95 1.96 
HDC11981 /chrXh:-143303,143549 HDC11981 2641.87 308.74 -8.56 308.74 856.85 2.78 308.74 1047.72 3.39 
LP09838 /chr2h:-742011,743734 LP09838 549.89 174.37 -3.15 174.37 277.36 1.59 174.37 325.95 1.87 
hoepel2 CG15624-RA 1032.33 457.55 -2.26 457.55 759.18 1.66 457.55 676.49 1.48 
CG31955 CG31955-RA 552.78 329.67 -1.68 329.67 597.22 1.81 329.67 564.03 1.71 
CG17646 CG17646-RB 3065.04 2144.51 -1.43 2144.51 3252.47 1.52 2144.51 3312.56 1.54 
antennal protein 5 CG5430-RA 1991.57 1104.75 -1.8 1104.75 1542.15 1.4 1104.75 1865.47 1.69 
CG5156 CG5156-RA 361.58 148.21 -2.44 148.21 554.08 3.74 148.21 360.22 2.43 
Myo28B1 CG6976-RC 294.39 190.46 -1.55 190.46 415.26 2.18 190.46 390.4 2.05 
lectin-28C CG7106-RA 2909.72 1646.08 -1.77 1646.08 4504.01 2.74 1646.08 3098.63 1.88 
CG4364 CG4364-RA 2852.78 1922.9 -1.48 1922.9 2851.63 1.48 1922.9 3007.21 1.56 
CG6583 CG6583-RA 1574.02 911.18 -1.73 911.18 1304.39 1.43 911.18 1254.37 1.38 
vasa intronic gene CG4170-RD 2333.61 1556.1 -1.5 1556.1 2139.05 1.37 1556.1 2218.86 1.43 
dumpy CG33196-RB 510.33 304.62 -1.68 304.62 508.63 1.67 304.62 518.03 1.7 
G protein 30A CT12391 917.3 469.09 -1.96 469.09 737.05 1.57 469.09 681.29 1.45 
CG33679 Dm.2L.3922.0 177.62 56.69 -3.13 56.69 234.7 4.14 56.69 167.77 2.96 
CG11474 CG11474-RB 778.45 435.53 -1.79 435.53 742.99 1.71 435.53 675.64 1.55 
Cyp6d2 CG4373-RA 432.59 255.84 -1.69 255.84 426.26 1.67 255.84 386.13 1.51 
CG3105 CG3105-RA 600.05 444.8 -1.35 444.8 595.23 1.34 444.8 633.31 1.42 
RpL12 /Ribosomal protein L12 CG3195-RC 604.64 416.38 -1.45 416.38 675.88 1.62 416.38 658.83 1.58 
Cytochrome P450-9c1 CG3616-RA 516.75 269.2 -1.92 269.2 668.06 2.48 269.2 447.92 1.66 
Glutathione S transferase E5 CG17527-RA 809.01 295.88 -2.73 295.88 748.93 2.53 295.88 602.6 2.04 
Glutathione S transferase E7 CG17531-RA 689.46 430.53 -1.6 430.53 1151.74 2.68 430.53 939.75 2.18 
CG30118 CG30118-RA 1897.82 1328.48 -1.43 1328.48 1964.43 1.48 1328.48 2163.72 1.63 
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CG30083 CG30083-RA 514.98 304.86 -1.69 304.86 1382.64 4.54 304.86 1189.67 3.9 
Pyruvate dehydrogenase kinase CG8808-RA 3791.99 2426.02 -1.56 2426.02 3650.23 1.5 2426.02 4699.27 1.94 
Cyp4p2 CG1944-RA 505.62 249.79 -2.02 249.79 643.68 2.58 249.79 674.02 2.7 
Cyp4p3 CG10843-RA 296.42 179.86 -1.65 179.86 304.27 1.69 179.86 343.23 1.91 
photorepair CG11205-RA 710.6 48.39 -14.68 48.39 437.31 9.04 48.39 458.64 9.48 
CG18853 / photorepair CG11205-RA 1342.92 86.2 -15.58 86.2 669.44 7.77 86.2 669.31 7.77 
CG30382 /Proteasome 6 subunit CG30382-RA 3892.59 2193.29 -1.77 2193.29 3053.41 1.39 2193.29 2876 1.31 
Tetraspanin 42Eg CG12142-RA 507.92 330.95 -1.53 330.95 575.51 1.74 330.95 573.73 1.73 
Spn43Ad CG1859-RA 322.67 208.19 -1.55 208.19 517.86 2.49 208.19 423.47 2.03 
CG30404 CG30404-RA 1693.1 972.71 -1.74 972.71 1373.66 1.41 972.71 1412.15 1.45 
CG3270 CG3270-RA 1067.4 310.25 -3.44 310.25 882.66 2.84 310.25 646.67 2.08 
CG11400 CG11400-RA 2324.44 1645.46 -1.41 1645.46 3264.25 1.98 1645.46 2963.92 1.8 
Cyp6a20 CG10245-RA 1832.47 610.98 -3 610.98 1932.1 3.16 610.98 2424.86 3.97 
Argonaute 1 CG6671-RC 1031.55 653.15 -1.58 653.15 862.25 1.32 653.15 889.68 1.36 
CG2064 CG2064-RA 904.4 384.63 -2.35 384.63 874.43 2.27 384.63 828.11 2.15 
CG30492 CG30492-RE 1563.93 839.8 -1.86 839.8 1678 2 839.8 1362.54 1.62 
CG8801 CG8801-RA 4039.11 2945.09 -1.37 2945.09 4959.19 1.68 2945.09 5454.7 1.85 
RH09485 /chr2R:+13775110,13775672 RH09485 2412.16 1376.53 -1.75 1376.53 2812.35 2.04 1376.53 2120.22 1.54 
CG13877 CG13877-RA 1700.88 642.6 -2.65 642.6 970.7 1.51 642.6 1188.69 1.85 
CG13704 CG13704-RA 596.75 269.94 -2.21 269.94 1959.14 7.26 269.94 1535.74 5.69 
CG18135 CG18135-RB 7334.06 4317.52 -1.7 4317.52 9491.81 2.2 4317.52 10787.1 2.5 
lethal (3) neo26 /l(3)neo26 CG6874-RA 347.81 213.73 -1.63 213.73 386.98 1.81 213.73 394.65 1.85 
ypsilon schachtel CG5654-RA 6555 4385.02 -1.49 4385.02 5907.92 1.35 4385.02 6629.55 1.51 
insulin-like peptide 3 CG14167-RA 518.61 207.65 -2.5 207.65 494.99 2.38 207.65 370.89 1.79 
CG3552 CG3552-RA 384.89 242.28 -1.59 242.28 356.98 1.47 242.28 360.94 1.49 
CG5741 CG5741-RA 599.7 246.98 -2.43 246.98 458.34 1.86 246.98 397.62 1.61 
liquid facets CG8532-RB 2648.37 1926.28 -1.37 1926.28 2538.05 1.32 1926.28 2708.1 1.41 
CG33045-RA CG33045-RA 2838.03 1882.46 -1.51 1882.46 3570.25 1.9 1882.46 3888.01 2.07 
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/Kaz1/synonyms:(CG1220) 
CG1315 CG1315-RA 295.88 128.67 -2.3 128.67 362.23 2.82 128.67 277.5 2.16 
CG31349/pyd /synonyms:(CG9763 
CG11782 CG9729 CG12409 CG11962) CG31349-RE 899.67 575.89 -1.56 575.89 951.37 1.65 575.89 926.04 1.61 
CG9363 CG9363-RB 1108.13 754.81 -1.47 754.81 1383.64 1.83 754.81 1336.7 1.77 
CG8147 CG8147-RA 1216.76 424.78 -2.86 424.78 2084.3 4.91 424.78 3482.18 8.2 
fau CG6544-RA 756.31 546.56 -1.38 546.56 767.64 1.4 546.56 839.35 1.54 
nocturnin CG31299-RB 2002.69 1387.28 -1.44 1387.28 2189.05 1.58 1387.28 2057.22 1.48 
CG6764 CG6764-RA 4169.88 3064.69 -1.36 3064.69 5076.14 1.66 3064.69 5705.87 1.86 
CG17227 CG17227-RA 532.02 275.84 -1.93 275.84 515.38 1.87 275.84 449.51 1.63 
CG31469 CG31469-RA 467.39 293.31 -1.59 293.31 499.24 1.7 293.31 454.51 1.55 
CG12333 CG12333-RA 761.14 561.47 -1.36 561.47 780.61 1.39 561.47 776.09 1.38 
Cyp12a4 CG6042-RA 2438.43 964.08 -2.53 964.08 2285.64 2.37 964.08 1944.52 2.02 
CG6040 CG6040-RA 693.38 500.37 -1.39 500.37 738.71 1.48 500.37 677.39 1.35 
alternative testis transcripts ORF B/ORF 
A CG4241-RA 668.43 487.28 -1.37 487.28 716.64 1.47 487.28 819.98 1.68 
CG6656 CG6656-RA 3092.07 1969.48 -1.57 1969.48 3102.57 1.58 1969.48 3229.56 1.64 
CG13641 CG13641-RA 515.48 122.39 -4.21 122.39 266.96 2.18 122.39 229.09 1.87 
CG12656 CG12656-RA 2976.86 2115.03 -1.41 2115.03 3058.46 1.45 2115.03 2815.54 1.33 
CG3603 CG3603-RA 874.07 372.41 -2.35 372.41 629.61 1.69 372.41 617.15 1.66 
CG14419 CG14419-RA 731.05 472.35 -1.55 472.35 870.56 1.84 472.35 689.4 1.46 
CG15784 CG15784-RA 1659.61 1002.95 -1.65 1002.95 1409.67 1.41 1002.95 1544.86 1.54 
Table AII.1: Genes which are downregulated in Adar5G1 flies when compared to w1118 and restored by expression of 
an active Adar or catalytically inactive Adar EA transgene in the cholinergic neurons. 
The data is shown as a heat map in Figure 4.3. The mean expression value is given for each gene and the fold change when comparing samples in a 
pairwise fashion. 
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Table AII.3: 759 genes which were significantly altered according to AS 
array analysis of w1118 and Adar5G1 head RNA. 
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MtnD_3'UTR_R GTTGTCATGCCAAAGGGTCT  
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Name Sequence 5'-3'





































Dscam_14Fb AGGTCTATGCCACAGGATTCA  
 
Quickchange primers
dsRBD1_EAA_F (with BbvI site)
GGC CAG GGC CGT AGT GAA GCA GTT GCA GCC ATC GAA GCA GCA GCA
dsRBD1_EAA_R
TGC TGC TGC TTC GAT GGC TGC AAC TGC TTC ACT ACG GCC CTG GCC
dsRBD2_EAA_F (with AciI site)
GGA ACA GGT CCT TCC GAA GCG ACG GCC GCA AAT GCG GCA GCT AAG
dsRBD2_EAA_R
CTT AGC TGC CGC ATT TGC GGC CGT CGC TTC GGA AGG ACC TGT TCC  
